https://www.synbiobeta.com/ https://www.synbiobeta.com/trash/bu/old-home https://www.synbiobeta.com/policies/terms-of-service https://www.synbiobeta.com/policies/privacy-policy https://www.synbiobeta.com/policies/cookie-settings https://www.synbiobeta.com/signup https://www.synbiobeta.com/sign-in https://www.synbiobeta.com/access-denied https://www.synbiobeta.com/sign-up https://www.synbiobeta.com/forgot-password https://www.synbiobeta.com/update-password-email https://www.synbiobeta.com/update-password https://www.synbiobeta.com/account https://www.synbiobeta.com/watch https://www.synbiobeta.com/listen https://www.synbiobeta.com/jobs https://www.synbiobeta.com/trash/categories/aixbio https://www.synbiobeta.com/trash/categories/planetary-health https://www.synbiobeta.com/multimedia https://www.synbiobeta.com/insights https://www.synbiobeta.com/trash/industry-news https://www.synbiobeta.com/read https://www.synbiobeta.com/trash/page https://www.synbiobeta.com/synthetic-bio-news https://www.synbiobeta.com/about/advertising https://www.synbiobeta.com/categories https://www.synbiobeta.com/about/about https://www.synbiobeta.com/contact-us https://www.synbiobeta.com/events https://www.synbiobeta.com/reports/2025-investment-report https://www.synbiobeta.com/reports/2024-investment-report https://www.synbiobeta.com/reports/2023-investment-report https://www.synbiobeta.com/press-hub https://www.synbiobeta.com/maintenance https://www.synbiobeta.com/test-members-only https://www.synbiobeta.com/categories/ai-digital-biology https://www.synbiobeta.com/categories/biodesign https://www.synbiobeta.com/categories/bioeconomy-policy https://www.synbiobeta.com/categories/biomanufacturing-scale-up https://www.synbiobeta.com/categories/biopharma-solutions-tools-tech https://www.synbiobeta.com/categories/biosecurity-bioethics https://www.synbiobeta.com/categories/capital-markets https://www.synbiobeta.com/categories/chemicals-materials https://www.synbiobeta.com/categories/consumer-products https://www.synbiobeta.com/categories/desci https://www.synbiobeta.com/categories/engineered-human-therapies https://www.synbiobeta.com/categories/environment https://www.synbiobeta.com/categories/food-agriculture https://www.synbiobeta.com/categories/longevity https://www.synbiobeta.com/categories/neurotech https://www.synbiobeta.com/categories/psychedelics https://www.synbiobeta.com/categories/reading-writing-and-editing-dna https://www.synbiobeta.com/categories/space-exploration https://www.synbiobeta.com/categories/sponsored-content https://www.synbiobeta.com/watch/101-c-m-live-welcome-11-17-21 https://www.synbiobeta.com/watch/101-welcome-zoom https://www.synbiobeta.com/watch/102-exponential-change-what-should-we-expect-for-biopharma-2025 https://www.synbiobeta.com/watch/102-exponential-change-what-should-we-expect-for-biopharma-2025-live-q-a https://www.synbiobeta.com/watch/103-synbio-and-biopharma https://www.synbiobeta.com/watch/103-synbio-and-biopharma-what-can-biopharma-learn-from-synthetic-biologys-exponential-progress-live-q-a https://www.synbiobeta.com/watch/104-biological-engineering-the-next-generation-of-materials-and-chemicals-final https://www.synbiobeta.com/watch/104-inscripta-live-q-a-11-17-21 https://www.synbiobeta.com/watch/104-will-living-medicines-transform-the-treatment-of-disease https://www.synbiobeta.com/watch/105-bcg-live-q-a-11-17-21 https://www.synbiobeta.com/watch/105-bcg-move-out-petrochemicals-enzymes-are-coming-in-final https://www.synbiobeta.com/watch/105-synthetic-biology-investor-panel https://www.synbiobeta.com/watch/106-ginkgo-building-the-future-with-biology-final https://www.synbiobeta.com/watch/106-ginkgo-live-q-a-11-17-21 https://www.synbiobeta.com/watch/106-the-cannabis-question-exploring-potential-therapeutic-compounds https://www.synbiobeta.com/watch/106-the-cannabis-question-exploring-potential-therapeutic-compounds-live-q-a https://www.synbiobeta.com/watch/107-checkerspot-live-q-a-11-17-21 https://www.synbiobeta.com/watch/107-from-molecule-to-market-biomanufacturings-growing-real-world-impact-final https://www.synbiobeta.com/watch/1086-lightning-talks-3 https://www.synbiobeta.com/watch/1086-lightning-talks-3-4 https://www.synbiobeta.com/watch/109-solugen-live-q-a-11-17-21 https://www.synbiobeta.com/watch/109-the-bioforge-cell-free-chemienzymatic-manufacturing-at-scale-final https://www.synbiobeta.com/watch/109-the-promise-of-antibody-treatments-across-disease-states https://www.synbiobeta.com/watch/110-gene-editing-the-cutting-edge-of-biotherapeutics-development https://www.synbiobeta.com/watch/110-lanzatech-live-q-a-11-17-21 https://www.synbiobeta.com/watch/110-lanzatech-the-new-black-gold-how-microbes-are-recycling-carbon-pollution-final https://www.synbiobeta.com/watch/111-is-synthetic-biology-accelerating-drug-discovery https://www.synbiobeta.com/watch/112-c-m-live-wrap-up-11-17-21 https://www.synbiobeta.com/watch/112-delivering-on-the-promise-synthetic-biology-in-biopharma-bioproduction https://www.synbiobeta.com/watch/114-opportunities-for-using-phage-viruses-to-treat-disease https://www.synbiobeta.com/watch/115-3d-bioprinting-beyond-disease-models-to-practical-applications https://www.synbiobeta.com/watch/118-a-more-efficient-sustainable-design-build-test-solution https://www.synbiobeta.com/watch/118-static-picture https://www.synbiobeta.com/watch/119-lessons-from-covid19 https://www.synbiobeta.com/watch/120-the-future-of-antibody-therapeutics-lessons-from-covid19 https://www.synbiobeta.com/watch/121-loud-clear https://www.synbiobeta.com/watch/2022-built-with-biology-keynote-eric-schmidt https://www.synbiobeta.com/watch/2023-annual-synthetic-biology-investment-report https://www.synbiobeta.com/watch/accelerating-bio-r-d-with-new-funding-models https://www.synbiobeta.com/watch/ai-and-synbio-the-new-paradigm-in-drug-discovery https://www.synbiobeta.com/watch/algae-the-arising-synthetic-biology-platform-organism-v1 https://www.synbiobeta.com/watch/algae-the-arising-synthetic-biology-platform-organism-v1-2 https://www.synbiobeta.com/watch/algae-the-arising-synthetic-biology-platform-organism-v1-3 https://www.synbiobeta.com/watch/algae-the-arising-synthetic-biology-platform-organism-v1-4 https://www.synbiobeta.com/watch/beckman-coulter-life-sciences-spotlight-echo-liquid-handlers-for-synthetic-biology-mov https://www.synbiobeta.com/watch/beckman-coulter-life-sciences-spotlight-echo-liquid-handlers-for-synthetic-biology-mov-2 https://www.synbiobeta.com/watch/beyond-sustainability-achieving-a-truly-circular-carbon-economy-v1-mp4 https://www.synbiobeta.com/watch/beyond-sustainability-achieving-a-truly-circular-carbon-economy-v1-mp4-5 https://www.synbiobeta.com/watch/biocomputers-transforming-our-work-with-smarter-biology https://www.synbiobeta.com/watch/biomanufacturing-breakdown-lessons-learned-from-scale-up-failures-and-successes https://www.synbiobeta.com/watch/biotech-innovations-in-feed-and-agriculture-for-a-brighter-future https://www.synbiobeta.com/watch/bridging-biology-and-ai-for-genome-design https://www.synbiobeta.com/watch/bringing-cultivated-meat-to-scale-through-speed-and-efficiency https://www.synbiobeta.com/watch/build-a-better-tomorrow-with-sustainable-synthetic-biology-workflow-solutions https://www.synbiobeta.com/watch/building-a-coronavirus-pandemic-response-v1 https://www.synbiobeta.com/watch/building-a-coronavirus-pandemic-response-v1-2 https://www.synbiobeta.com/watch/building-a-coronavirus-pandemic-response-v1-3 https://www.synbiobeta.com/watch/building-market-leadership-in-times-of-change-v1 https://www.synbiobeta.com/watch/building-market-leadership-in-times-of-change-v1-2 https://www.synbiobeta.com/watch/building-market-leadership-in-times-of-change-v1-3 https://www.synbiobeta.com/watch/built-with-biology-summit-is-precision-fermentation-the-transformational-technology-for-cosmetics-and-fashion https://www.synbiobeta.com/watch/built-with-biology-summit-the-future-is-now-integrating-biodesign-into-the-beauty-industry-today https://www.synbiobeta.com/watch/catching-up-with-geltor-a-fireside-chat-with-alex-lorestani-and-erin-kim https://www.synbiobeta.com/watch/cell-free-avenues-for-accelerating-forward-engineering-in-biology https://www.synbiobeta.com/watch/cell-free-avenues-for-accelerating-forward-engineering-in-biology-2 https://www.synbiobeta.com/watch/cell-free-avenues-for-accelerating-forward-engineering-in-biology-3 https://www.synbiobeta.com/watch/conscious-capitalism-doing-good-in-the-world-with-biology-v1 https://www.synbiobeta.com/watch/conscious-capitalism-doing-good-in-the-world-with-biology-v1-2 https://www.synbiobeta.com/watch/conscious-convergence-melding-mycology-biotech-and-the-philosophy-of-interconnectedness https://www.synbiobeta.com/watch/covid-19-town-hall-on-environmental-sampling-for-coronavirus https://www.synbiobeta.com/watch/covid-19-town-hall-on-ginkgos-25m-pledge-and-the-communitys-responses https://www.synbiobeta.com/watch/covid-19-town-hall-with-moderna-ceo https://www.synbiobeta.com/watch/covid-19-town-hall-with-nanome-exploring-the-coronavirus-spike-protein-in-3d-virtual-reality https://www.synbiobeta.com/watch/crafting-cures-how-synthetic-biology-personalizes-precision-medicine https://www.synbiobeta.com/watch/day-1-morning-wrap-up-with-john-cumbers https://www.synbiobeta.com/watch/day-1-morning-wrap-up-with-john-cumbers-2 https://www.synbiobeta.com/watch/day-1-wrap-up-with-john-cumbers https://www.synbiobeta.com/watch/day-1-wrap-up-with-john-cumbers-2 https://www.synbiobeta.com/watch/day-2-morning-wrap-up-with-john-cumbers https://www.synbiobeta.com/watch/day-2-morning-wrap-up-with-john-cumbers-2 https://www.synbiobeta.com/watch/day-2-welcome-by-john-cumbers https://www.synbiobeta.com/watch/day-2-welcome-by-john-cumbers-2 https://www.synbiobeta.com/watch/day-2-wrap-up-with-john-cumbers https://www.synbiobeta.com/watch/day-2-wrap-up-with-john-cumbers-2 https://www.synbiobeta.com/watch/day-3-morning-wrap-up-with-john-cumbers https://www.synbiobeta.com/watch/day-3-morning-wrap-up-with-john-cumbers-2 https://www.synbiobeta.com/watch/day-3-welcome-by-john-cumbers https://www.synbiobeta.com/watch/day-3-welcome-by-john-cumbers-2 https://www.synbiobeta.com/watch/day-3-wrap-up-with-john-cumbers https://www.synbiobeta.com/watch/day-3-wrap-up-with-john-cumbers-2 https://www.synbiobeta.com/watch/delicious-technology-engineering-foods-that-people-love https://www.synbiobeta.com/watch/delicious-technology-engineering-foods-that-people-love-2 https://www.synbiobeta.com/watch/delicious-technology-engineering-foods-that-people-love-3 https://www.synbiobeta.com/watch/delicious-technology-engineering-foods-that-people-love-4 https://www.synbiobeta.com/watch/delicious-technology-engineering-foods-that-people-love-5 https://www.synbiobeta.com/watch/digital-biology-v1 https://www.synbiobeta.com/watch/digital-biology-v1-2 https://www.synbiobeta.com/watch/digital-biology-v1-3 https://www.synbiobeta.com/watch/digital-biology-v1-4 https://www.synbiobeta.com/watch/direct-air-capture-enzymatically-accelerated-rock-weathering https://www.synbiobeta.com/watch/dopamine-disinformation-and-the-ethics-of-technological-progress-a-leaps-talk-with-tristan-harris https://www.synbiobeta.com/watch/dopamine-disinformation-and-the-ethics-of-technological-progress-a-leaps-talk-with-tristan-harris-2 https://www.synbiobeta.com/watch/dopamine-disinformation-and-the-ethics-of-technological-progress-a-leaps-talk-with-tristan-harris-3 https://www.synbiobeta.com/watch/engineering-a-sustainable-economy https://www.synbiobeta.com/watch/engineering-equitable-outcomes-with-synthetic-biology https://www.synbiobeta.com/watch/engineering-equitable-outcomes-with-synthetic-biology-2 https://www.synbiobeta.com/watch/engineering-equitable-outcomes-with-synthetic-biology-3 https://www.synbiobeta.com/watch/equality-among-our-peers-v1 https://www.synbiobeta.com/watch/equality-among-our-peers-v1-2 https://www.synbiobeta.com/watch/equality-among-our-peers-v1-3 https://www.synbiobeta.com/watch/ethics-elixirs-and-enterprises-the-triad-of-longevitys-future https://www.synbiobeta.com/watch/expand-your-design-space-ask-bigger-questions-with-complex-dna-synthesis-service https://www.synbiobeta.com/watch/fermenting-the-future-while-making-biomanufacturing-nimble-with-shannon-hall https://www.synbiobeta.com/watch/finding-the-best-cells-v1 https://www.synbiobeta.com/watch/finding-the-best-cells-v1-2 https://www.synbiobeta.com/watch/finding-the-best-cells-v1-3 https://www.synbiobeta.com/watch/fireside-chat-catching-up-with-geltor-fireside-chat-with-alex-lorestani-erin-kim https://www.synbiobeta.com/watch/flavor-form-and-function-taking-plant-based-foods-to-the-next-level-mp4 https://www.synbiobeta.com/watch/flavor-form-and-function-taking-plant-based-foods-to-the-next-level-mp4-5 https://www.synbiobeta.com/watch/flavor-form-and-function-taking-plant-based-foods-to-the-next-level-mp4-6 https://www.synbiobeta.com/watch/food-from-thin-air-v1 https://www.synbiobeta.com/watch/food-from-thin-air-v1-2 https://www.synbiobeta.com/watch/food-from-thin-air-v1-3 https://www.synbiobeta.com/watch/food-from-thin-air-v1-4 https://www.synbiobeta.com/watch/from-ai-hallucinations-to-standardized-biomachines-the-solution-for-generative-biology https://www.synbiobeta.com/watch/from-complexity-to-commercialization-the-dna-synthesis-saga-continues https://www.synbiobeta.com/watch/from-lab-to-table-navigating-the-future-of-cellular-agriculture https://www.synbiobeta.com/watch/from-microbes-to-materials-zymochems-vision-for-a-plastic-free-future https://www.synbiobeta.com/watch/gene-meets-cell-the-synbio-evolution-in-targeted-therapeutics https://www.synbiobeta.com/watch/genscript-panel-discussion-on-mutant-libraries-for-precision-engineering-v1 https://www.synbiobeta.com/watch/genscript-panel-discussion-on-mutant-libraries-for-precision-engineering-v1-2 https://www.synbiobeta.com/watch/genscript-panel-discussion-on-mutant-libraries-for-precision-engineering-v1-3 https://www.synbiobeta.com/watch/heads-up-scale-up-the-hidden-costs-of-outsourcing-bioprocess-development https://www.synbiobeta.com/watch/how-to-build-a-synbio-lab-v1 https://www.synbiobeta.com/watch/how-to-build-a-synbio-lab-v1-2 https://www.synbiobeta.com/watch/how-to-build-a-synbio-lab-v1-3 https://www.synbiobeta.com/watch/how-to-build-a-synbio-lab-v1-4 https://www.synbiobeta.com/watch/how-to-build-a-synbio-lab-v1-5 https://www.synbiobeta.com/watch/how-to-build-a-world-class-technology-architecture-v1 https://www.synbiobeta.com/watch/how-to-build-a-world-class-technology-architecture-v1-2 https://www.synbiobeta.com/watch/how-to-build-a-world-class-technology-architecture-v1-3 https://www.synbiobeta.com/watch/how-to-make-sustainable-new-foods-that-people-and-pets-love https://www.synbiobeta.com/watch/how-to-make-sustainable-new-foods-that-people-and-pets-love-2 https://www.synbiobeta.com/watch/how-to-make-sustainable-new-foods-that-people-and-pets-love-3 https://www.synbiobeta.com/watch/how-to-make-sustainable-new-foods-that-people-and-pets-love-4 https://www.synbiobeta.com/watch/how-to-make-sustainable-new-foods-that-people-and-pets-love-5 https://www.synbiobeta.com/watch/interstellar-humans-engineering-biology-for-space-settlement https://www.synbiobeta.com/watch/jennifer-doudna-on-crispr-covid-19-and-bringing-discoveries-to-the-clinic-mov https://www.synbiobeta.com/watch/jennifer-doudna-on-crispr-covid-19-and-bringing-discoveries-to-the-clinic-mov-2 https://www.synbiobeta.com/watch/jennifer-doudna-on-crispr-covid-19-and-bringing-discoveries-to-the-clinic-mov-3 https://www.synbiobeta.com/watch/kids-coronavirus-town-hall https://www.synbiobeta.com/watch/lightning-talks-2 https://www.synbiobeta.com/watch/lightning-talks-2-3 https://www.synbiobeta.com/watch/lightning-talks-2-4 https://www.synbiobeta.com/watch/lightning-talks-2-5 https://www.synbiobeta.com/watch/lightning-talks-2-6 https://www.synbiobeta.com/watch/medicine-on-demand-reimagining-drug-development-through-oligo-innovation https://www.synbiobeta.com/watch/navigating-the-investment-ecosystem-de-risking-synbio-ventures-for-trend-savvy-investors https://www.synbiobeta.com/watch/neuromodulation-and-the-frontiers-of-bioelectronic-therapy-v1 https://www.synbiobeta.com/watch/nfx-draft-live-with-james-currier-v1 https://www.synbiobeta.com/watch/nfx-draft-live-with-james-currier-v1-2 https://www.synbiobeta.com/watch/nfx-draft-live-with-james-currier-v1-3 https://www.synbiobeta.com/watch/nfx-draft-live-with-james-currier-v1-4 https://www.synbiobeta.com/watch/optimize-your-workflow-bottlenecks-and-solutions-in-the-design-build-and-test-phases https://www.synbiobeta.com/watch/optimize-your-workflow-bottlenecks-and-solutions-in-the-design-build-and-test-phases-2 https://www.synbiobeta.com/watch/optimize-your-workflow-bottlenecks-and-solutions-in-the-design-build-and-test-phases-3 https://www.synbiobeta.com/watch/optimize-your-workflow-bottlenecks-and-solutions-in-the-design-build-and-test-phases-4 https://www.synbiobeta.com/watch/optimize-your-workflow-bottlenecks-and-solutions-in-the-design-build-and-test-phases-5 https://www.synbiobeta.com/watch/oriciro-launches-worlds-first-cell-free-amplification-technology-for-large-circular-dna https://www.synbiobeta.com/watch/oriciro-launches-worlds-first-cell-free-amplification-technology-for-large-circular-dna-2 https://www.synbiobeta.com/watch/oriciro-launches-worlds-first-cell-free-amplification-technology-for-large-circular-dna-3 https://www.synbiobeta.com/watch/pandemic-response-scaling-and-collaborating-in-the-face-of-the-coronavirus https://www.synbiobeta.com/watch/pandemic-response-scaling-and-collaborating-in-the-face-of-the-coronavirus-2 https://www.synbiobeta.com/watch/pandemic-response-scaling-and-collaborating-in-the-face-of-the-coronavirus-3 https://www.synbiobeta.com/watch/panel-recording-pharma-meet-synbio-v1 https://www.synbiobeta.com/watch/panel-recording-pharma-meet-synbio-v1-2 https://www.synbiobeta.com/watch/panel-recording-sustainability-food-security-and-the-climate-v1 https://www.synbiobeta.com/watch/panel-recording-sustainability-food-security-and-the-climate-v1-2 https://www.synbiobeta.com/watch/panel-recording-sustainability-food-security-and-the-climate-v1-3 https://www.synbiobeta.com/watch/partnering-intelligent-algorithms-and-enzymatic-dna-assembly-to-accelerate-the-future-of-synthetic-biology https://www.synbiobeta.com/watch/preventing-future-pandemics-with-a-global-network-of-vaccine-printers https://www.synbiobeta.com/watch/preventing-future-pandemics-with-a-global-network-of-vaccine-printers-2 https://www.synbiobeta.com/watch/programming-human-cells-the-next-frontier-of-synbio-for-human-health https://www.synbiobeta.com/watch/protein-engineering-and-the-future-of-dna-reading-writing-and-editing-v1 https://www.synbiobeta.com/watch/protein-engineering-and-the-future-of-dna-reading-writing-and-editing-v1-2 https://www.synbiobeta.com/watch/protein-engineering-and-the-future-of-dna-reading-writing-and-editing-v1-3 https://www.synbiobeta.com/watch/protein-engineering-and-the-future-of-dna-reading-writing-and-editing-v1-4 https://www.synbiobeta.com/watch/protein-engineering-and-the-future-of-dna-reading-writing-and-editing-v1-5 https://www.synbiobeta.com/watch/redefining-the-bottom-line-value-creation-for-shareholders-and-the-planet https://www.synbiobeta.com/watch/revolution-down-under-how-to-realize-a-30-billion-opportunity https://www.synbiobeta.com/watch/scaling-highly-engineered-strains-to-produce-complex-pharmaceuticals https://www.synbiobeta.com/watch/science-at-the-speed-of-a-pandemic-a-conversation-with-pardis-sabeti https://www.synbiobeta.com/watch/science-at-the-speed-of-a-pandemic-a-conversation-with-pardis-sabeti-2 https://www.synbiobeta.com/watch/science-at-the-speed-of-a-pandemic-a-conversation-with-pardis-sabeti-3 https://www.synbiobeta.com/watch/speeding-the-synbio-revolution-spotlight-talk-with-agilent https://www.synbiobeta.com/watch/speeding-the-synbio-revolution-spotlight-talk-with-agilent-2 https://www.synbiobeta.com/watch/speeding-the-synbio-revolution-spotlight-talk-with-agilent-3 https://www.synbiobeta.com/watch/speeding-the-synbio-revolution-spotlight-talk-with-agilent-4 https://www.synbiobeta.com/watch/spotlight-talk-with-absci https://www.synbiobeta.com/watch/spotlight-talk-with-absci-2 https://www.synbiobeta.com/watch/spotlight-talk-with-absci-3 https://www.synbiobeta.com/watch/spotlight-talk-with-codexis https://www.synbiobeta.com/watch/spotlight-talk-with-codexis-2 https://www.synbiobeta.com/watch/spotlight-talk-with-codexis-3 https://www.synbiobeta.com/watch/spotlight-talk-with-codexis-4 https://www.synbiobeta.com/watch/spotlight-talk-with-codexis-5 https://www.synbiobeta.com/watch/start-up-bio-draft-presentations https://www.synbiobeta.com/watch/start-up-bio-draft-presentations-2 https://www.synbiobeta.com/watch/synbicite-webinar-global-trends-and-business-opportunities-in-synbio https://www.synbiobeta.com/watch/synbiobeta-covid-19-town-hall-how-can-synthetic-biologists-contribute-to-the-response https://www.synbiobeta.com/watch/synbiobeta-covid-19-town-hall-with-jcvis-richard-scheuermann-on-coronavirus-immune-epitopes https://www.synbiobeta.com/watch/synbiobeta-deep-dive-amyris-and-labcyte-increasing-strain-construction-efficiency-and-reducing-reaction-volumes https://www.synbiobeta.com/watch/synbiobeta-deep-dive-webinar-with-tierra-biosciences-and-labcyte https://www.synbiobeta.com/watch/synbiobeta-membership https://www.synbiobeta.com/watch/synbiobeta-membership-2 https://www.synbiobeta.com/watch/synbiobeta-state-of-the-industry-town-hall-with-drew-endy https://www.synbiobeta.com/watch/synbiobeta-state-of-the-industry-town-hall-with-george-church https://www.synbiobeta.com/watch/synbiobeta-state-of-the-industry-town-hall-with-james-collins https://www.synbiobeta.com/watch/synbiobeta-town-hall-on-sequencings-vital-new-role-in-fighting-pandemics-a-covid-19-update-from-illumina-leadership https://www.synbiobeta.com/watch/synbiobetalive-lab-data-to-machine-learning-in-30-seconds-with-riffyn https://www.synbiobeta.com/watch/synbiobetalive-let-a-thousand-foundries-bloom-with-opentrons https://www.synbiobeta.com/watch/synbiobetalive-with-p-g https://www.synbiobeta.com/watch/synthetic-biology-annual-investment-report-2018 https://www.synbiobeta.com/watch/synthetic-biology-to-save-the-planet-an-environmental-perspective https://www.synbiobeta.com/watch/synthetic-biology-to-save-the-planet-an-environmental-perspective-2 https://www.synbiobeta.com/watch/synthetic-biology-to-save-the-planet-an-environmental-perspective-3 https://www.synbiobeta.com/watch/synthetic-biology-to-save-the-planet-an-environmental-perspective-4 https://www.synbiobeta.com/watch/synthetic-biology-to-save-the-planet-an-environmental-perspective-5 https://www.synbiobeta.com/watch/technology-culture-and-forging-audacious-aims-for-our-future-v1 https://www.synbiobeta.com/watch/technology-culture-and-forging-audacious-aims-for-our-future-v1-2 https://www.synbiobeta.com/watch/the-antibodies-update-promise-progress-and-lessons-learned https://www.synbiobeta.com/watch/the-antibodies-update-promise-progress-and-lessons-learned-2 https://www.synbiobeta.com/watch/the-antibodies-update-promise-progress-and-lessons-learned-3 https://www.synbiobeta.com/watch/the-antibodies-update-promise-progress-and-lessons-learned-4 https://www.synbiobeta.com/watch/the-antibodies-update-promise-progress-and-lessons-learned-5 https://www.synbiobeta.com/watch/the-bioeconomy-of-polymers-v1 https://www.synbiobeta.com/watch/the-bioeconomy-of-polymers-v1-2 https://www.synbiobeta.com/watch/the-bioeconomy-of-polymers-v1-3 https://www.synbiobeta.com/watch/the-dna-discovery-tour https://www.synbiobeta.com/watch/the-exit-strategy-acquisition-for-consumer-biotech-companies https://www.synbiobeta.com/watch/the-future-for-biosolutions-in-the-energy-transition https://www.synbiobeta.com/watch/the-future-is-dna-spotlight-talk-with-twist-bioscience https://www.synbiobeta.com/watch/the-future-is-dna-spotlight-talk-with-twist-bioscience-2 https://www.synbiobeta.com/watch/the-future-is-dna-spotlight-talk-with-twist-bioscience-3 https://www.synbiobeta.com/watch/the-future-is-dna-spotlight-talk-with-twist-bioscience-4 https://www.synbiobeta.com/watch/the-future-of-dna-synthesis-spotlight-talk-with-molecular-assemblies https://www.synbiobeta.com/watch/the-future-of-dna-synthesis-spotlight-talk-with-molecular-assemblies-2 https://www.synbiobeta.com/watch/the-future-of-open-access-on-demand-r-d-spotlight-talk-with-strateos https://www.synbiobeta.com/watch/the-future-of-open-access-on-demand-r-d-spotlight-talk-with-strateos-2 https://www.synbiobeta.com/watch/the-future-of-precision-fermentation-and-health-spotlight-talk-with-conagen https://www.synbiobeta.com/watch/the-future-of-precision-fermentation-and-health-spotlight-talk-with-conagen-2 https://www.synbiobeta.com/watch/the-future-of-precision-fermentation-and-health-spotlight-talk-with-conagen-3 https://www.synbiobeta.com/watch/the-microbiome-from-decoding-nature-to-biotech-breakthroughs https://www.synbiobeta.com/watch/the-microbiome-from-decoding-nature-to-biotech-breakthroughs-2 https://www.synbiobeta.com/watch/the-microbiome-from-decoding-nature-to-biotech-breakthroughs-3 https://www.synbiobeta.com/watch/the-microbiome-from-decoding-nature-to-biotech-breakthroughs-4 https://www.synbiobeta.com/watch/the-microbiome-from-decoding-nature-to-biotech-breakthroughs-5 https://www.synbiobeta.com/watch/the-molecular-engines-of-metabolism https://www.synbiobeta.com/watch/the-problem-is-522m-and-13-years https://www.synbiobeta.com/watch/the-road-to-ipo-ceos-who-have-gone-v1 https://www.synbiobeta.com/watch/the-road-to-ipo-ceos-who-have-gone-v1-2 https://www.synbiobeta.com/watch/the-road-to-ipo-ceos-who-have-gone-v1-3 https://www.synbiobeta.com/watch/the-role-of-synthetic-biology-in-promoting-health-and-sustainability https://www.synbiobeta.com/watch/the-scale-cost-paradox-navigating-biomanufacturings-biggest-challenge https://www.synbiobeta.com/watch/the-scale-up-valley-of-death-v1 https://www.synbiobeta.com/watch/the-scale-up-valley-of-death-v1-2 https://www.synbiobeta.com/watch/the-sea-the-city-outer-space-what-is-the-next-frontier-for-truly-sustainable-agriculture https://www.synbiobeta.com/watch/the-sea-the-city-outer-space-what-is-the-next-frontier-for-truly-sustainable-agriculture-2 https://www.synbiobeta.com/watch/the-sea-the-city-outer-space-what-is-the-next-frontier-for-truly-sustainable-agriculture-3 https://www.synbiobeta.com/watch/the-sea-the-city-outer-space-what-is-the-next-frontier-for-truly-sustainable-agriculture-4 https://www.synbiobeta.com/watch/the-sea-the-city-outer-space-what-is-the-next-frontier-for-truly-sustainable-agriculture-5 https://www.synbiobeta.com/watch/the-synbiobeta-2020-awards https://www.synbiobeta.com/watch/the-synbiobeta-2020-awards-2 https://www.synbiobeta.com/watch/the-synbiobeta-2020-awards-3 https://www.synbiobeta.com/watch/the-synbiobeta-2020-awards-4 https://www.synbiobeta.com/watch/the-synbiobeta-2020-awards-5 https://www.synbiobeta.com/watch/the-synbiobeta-2020-investor-panel https://www.synbiobeta.com/watch/the-synbiobeta-2020-investor-panel-2 https://www.synbiobeta.com/watch/the-synbiobeta-2020-investor-panel-3 https://www.synbiobeta.com/watch/the-uniquely-american-bioeconomy-synthetic-biology-for-life-liberty-and-the-pursuit-of-happiness-mov https://www.synbiobeta.com/watch/the-uniquely-american-bioeconomy-synthetic-biology-for-life-liberty-and-the-pursuit-of-happiness-mov-2 https://www.synbiobeta.com/watch/this-is-not-a-drill-how-covid-19-has-acted-as-a-referendum-on-antibody-therapeutic-discovery https://www.synbiobeta.com/watch/this-is-not-a-drill-how-covid-19-has-acted-as-a-referendum-on-antibody-therapeutic-discovery-2 https://www.synbiobeta.com/watch/this-is-not-a-drill-how-covid-19-has-acted-as-a-referendum-on-antibody-therapeutic-discovery-3 https://www.synbiobeta.com/watch/this-is-not-a-drill-how-covid-19-has-acted-as-a-referendum-on-antibody-therapeutic-discovery-4 https://www.synbiobeta.com/watch/this-is-not-a-drill-how-covid-19-has-acted-as-a-referendum-on-antibody-therapeutic-discovery-5 https://www.synbiobeta.com/watch/toward-synthetic-biology-2-0-moving-beyond-genome-engineering-to-whole-cell-engineering https://www.synbiobeta.com/watch/toward-synthetic-biology-2-0-moving-beyond-genome-engineering-to-whole-cell-engineering-2 https://www.synbiobeta.com/watch/toward-synthetic-biology-2-0-moving-beyond-genome-engineering-to-whole-cell-engineering-3 https://www.synbiobeta.com/watch/toward-synthetic-biology-2-0-moving-beyond-genome-engineering-to-whole-cell-engineering-4 https://www.synbiobeta.com/watch/toward-synthetic-biology-2-0-moving-beyond-genome-engineering-to-whole-cell-engineering-5 https://www.synbiobeta.com/watch/toward-synthetic-biology-v2 https://www.synbiobeta.com/watch/toward-synthetic-biology-v2-3 https://www.synbiobeta.com/watch/toward-synthetic-biology-v2-4 https://www.synbiobeta.com/watch/toward-synthetic-biology-v2-5 https://www.synbiobeta.com/watch/toward-synthetic-biology-v2-6 https://www.synbiobeta.com/watch/unlocking-possibility-leveraging-ai-to-accelerate-novel-protein-solutions-that-scale https://www.synbiobeta.com/watch/unlocking-the-potential-of-ai-for-biology-with-experimental-data https://www.synbiobeta.com/watch/unraveling-the-language-of-life-advances-in-protein-language-models https://www.synbiobeta.com/watch/value https://www.synbiobeta.com/watch/value-2 https://www.synbiobeta.com/watch/value-3 https://www.synbiobeta.com/watch/value-4 https://www.synbiobeta.com/watch/value-5 https://www.synbiobeta.com/watch/value-6 https://www.synbiobeta.com/watch/value-7 https://www.synbiobeta.com/watch/value-8 https://www.synbiobeta.com/watch/watch-panel-bio-is-not-another-app-investing-in-whats-important-at-synbiobeta-2018 https://www.synbiobeta.com/watch/welcome-by-john-cumbers https://www.synbiobeta.com/watch/welcome-by-john-cumbers-2 https://www.synbiobeta.com/watch/whats-next-in-unlocking-the-code-of-microalgae-for-materials-v1-mp4 https://www.synbiobeta.com/watch/whats-next-in-unlocking-the-code-of-microalgae-for-materials-v1-mp4-5 https://www.synbiobeta.com/watch/whats-next-in-unlocking-the-code-of-microalgae-for-materials-v1-mp4-6 https://www.synbiobeta.com/watch/whats-your-bio-strategy-biopharma-and-healthcare-industry-2018 https://www.synbiobeta.com/watch/wolfram-quake-live-in-san-jose-the-ai-bio-tour https://www.synbiobeta.com/watch/you-cant-engineer-biology-that-you-cant-measure-finding-high-producing-cell-lines-for-biomanufacturing-mov https://www.synbiobeta.com/watch/you-cant-engineer-biology-that-you-cant-measure-finding-high-producing-cell-lines-for-biomanufacturing-mov-2 https://www.synbiobeta.com/watch/you-cant-engineer-biology-that-you-cant-measure-finding-high-producing-cell-lines-for-biomanufacturing-mov-3 https://www.synbiobeta.com/jobs/scala-bio-account-executive https://www.synbiobeta.com/jobs/account-executive-(us-%E2%80%93-east-coast) https://www.synbiobeta.com/jobs/research-associate-zbiotics https://www.synbiobeta.com/jobs/research-associate-on-engineering-biology-for-food-applications https://www.synbiobeta.com/jobs/assistant-professor-in-plant-synthetic-biology-for-strategic-resources-research https://www.synbiobeta.com/jobs/science-fellow https://www.synbiobeta.com/jobs/assistant-associate-full-professor-engineering-artificial-intelligence-college-of-engineering https://www.synbiobeta.com/jobs/bio-strategies-leadership-two-year-postdoctoral-research-fellowship-for-policy-scholars https://www.synbiobeta.com/jobs/paid-internships https://www.synbiobeta.com/jobs/constructive-bio-executive-assistant-to-the-ceo-executive-team https://www.synbiobeta.com/jobs/laboratory-automation-engineer https://www.synbiobeta.com/jobs/machine-learning-researcher-in-protein-design https://www.synbiobeta.com/jobs/chemist-job-code-1000070 https://www.synbiobeta.com/jobs/field-technician-east-coast-or-pacific-northwest https://www.synbiobeta.com/jobs/postdoctoral-researcher-research-associate-in-synthetic-genomics https://www.synbiobeta.com/jobs/research-fellow-in-synthetic-genomics https://www.synbiobeta.com/jobs/chief-technology-officer-zymochem https://www.synbiobeta.com/jobs/group-manager-memory-technologies https://www.synbiobeta.com/jobs/phd-thesis-in-ic-design-with-focus-on-cmos-backplanes-2 https://www.synbiobeta.com/jobs/scientific-sales-representative-antibodies-market https://www.synbiobeta.com/jobs/bio-process-engineer https://www.synbiobeta.com/jobs/key-account-manager https://www.synbiobeta.com/jobs/key-account-manager-2 https://www.synbiobeta.com/jobs/senior-territory-sales-manager-bioprocessing https://www.synbiobeta.com/jobs/chief-technology-officer-94hn3 https://www.synbiobeta.com/jobs/creative-biology-writer https://www.synbiobeta.com/jobs/capital-projects-director https://www.synbiobeta.com/jobs/quality-and-regulatory-manager https://www.synbiobeta.com/jobs/phd-thesis-in-ic-design-with-focus-on-cmos-backplanes https://www.synbiobeta.com/jobs/research-assistant-in-ic-design-focus-analog https://www.synbiobeta.com/jobs/machine-learning-engineer https://www.synbiobeta.com/jobs/senior-software-engineer-4xs90 https://www.synbiobeta.com/jobs/director-strategy-business-development https://www.synbiobeta.com/jobs/planetary-atmosphere-climate-modeler https://www.synbiobeta.com/jobs/business-development-manager https://www.synbiobeta.com/jobs/downstream-process-engineer-at-industrial-microbes https://www.synbiobeta.com/jobs/program-manager https://www.synbiobeta.com/jobs/associate-director-product-management-dna-synthesis https://www.synbiobeta.com/jobs/associate-director-rna-purification-characterization https://www.synbiobeta.com/jobs/digital-marketing-manager-at-elegen https://www.synbiobeta.com/jobs/inside-sales-representative https://www.synbiobeta.com/jobs/it-support-specialist https://www.synbiobeta.com/jobs/key-account-manager-northeast https://www.synbiobeta.com/jobs/key-account-manager-westcoast https://www.synbiobeta.com/jobs/lead-chemist-at-elegen https://www.synbiobeta.com/jobs/lead-technical-program-manager-commercial-software https://www.synbiobeta.com/jobs/plant-pathologist-biocontrol https://www.synbiobeta.com/jobs/production-supervisor-enfinia-dna https://www.synbiobeta.com/jobs/production-supervisor-plasmids-and-long-dna https://www.synbiobeta.com/jobs/project-lead-big-pcr https://www.synbiobeta.com/jobs/research-associate-ii-associate-scientist-biochemistry https://www.synbiobeta.com/jobs/senior-applications-scientist https://www.synbiobeta.com/jobs/senior-automation-engineer-r-d https://www.synbiobeta.com/jobs/senior-bioinformatics-developer https://www.synbiobeta.com/jobs/senior-bioinformatics-engineer-2 https://www.synbiobeta.com/jobs/senior-npi-engineer https://www.synbiobeta.com/jobs/staff-process-engineer-2 https://www.synbiobeta.com/jobs/head-of-engineered-translation https://www.synbiobeta.com/jobs/director-of-research-and-development https://www.synbiobeta.com/jobs/head-of-informatics https://www.synbiobeta.com/jobs/science-manager-carbon-capture-venture-tech-lead https://www.synbiobeta.com/jobs/vp-of-business-development https://www.synbiobeta.com/jobs/analyticalscientist https://www.synbiobeta.com/jobs/strain-engineer-postdoc-or-intern-at-industrial-microbes https://www.synbiobeta.com/jobs/chief-of-staff-to-coo https://www.synbiobeta.com/jobs/group-leader-metabolism https://www.synbiobeta.com/jobs/head-of-operations https://www.synbiobeta.com/jobs/associate-account-executive https://www.synbiobeta.com/jobs/synthetic-biology-researcher-developer-term-bionet-fellow https://www.synbiobeta.com/jobs/analytical-chemistry-engineer https://www.synbiobeta.com/jobs/computational-biology-scientist https://www.synbiobeta.com/jobs/molecular-biology-engineer https://www.synbiobeta.com/jobs/protein-engineering-scientist https://www.synbiobeta.com/jobs/strain-engineering-scientist https://www.synbiobeta.com/jobs/associate-professor-synthetic-biology-vashee-lab https://www.synbiobeta.com/jobs/manager-sample-management https://www.synbiobeta.com/jobs/principal-scientist-distinguished-scientist-cell-biology-cotton-fiber-development https://www.synbiobeta.com/jobs/research-associate-ii-downstream-processing-2 https://www.synbiobeta.com/jobs/senior-bioprocess-engineer https://www.synbiobeta.com/jobs/sr-scientist-i-ii-analytical-development https://www.synbiobeta.com/jobs/sr-scientist-i-ii-protein-testing-assay-development https://www.synbiobeta.com/jobs/engineering-biology-team-lead-engineered-translation https://www.synbiobeta.com/jobs/post-doctoral-research-associate-pdra-in-responsible-research-and-innovation-future-biomanufacturing-university-of-manchester-uk https://www.synbiobeta.com/jobs/technical-advisor-protein-engineering https://www.synbiobeta.com/jobs/director-of-microbial-strain-engineering https://www.synbiobeta.com/jobs/director-of-strain-development https://www.synbiobeta.com/jobs/downstream-processing-engineer https://www.synbiobeta.com/jobs/materials-quality-lead https://www.synbiobeta.com/jobs/polymer-chemist https://www.synbiobeta.com/jobs/principal-scientist-strain-development https://www.synbiobeta.com/jobs/project-manager https://www.synbiobeta.com/jobs/research-associate-strain-engineering https://www.synbiobeta.com/jobs/scientist-fermentation https://www.synbiobeta.com/jobs/senior-engineer https://www.synbiobeta.com/jobs/senior-principal-scientist-synthetic-biology https://www.synbiobeta.com/jobs/sr-research-associate-enzyme-development https://www.synbiobeta.com/jobs/strain-development-scientist https://www.synbiobeta.com/jobs/strain-engineering-scientist-2 https://www.synbiobeta.com/jobs/technical-project-manager https://www.synbiobeta.com/jobs/analytical-scientist-lab-manager https://www.synbiobeta.com/jobs/microbiology-scientist-lab-manager https://www.synbiobeta.com/jobs/chemistry-r-d-lead https://www.synbiobeta.com/jobs/computational-evolutionary-biologist https://www.synbiobeta.com/jobs/director-applied-data-science https://www.synbiobeta.com/jobs/engineering-lead-bioreactor-development https://www.synbiobeta.com/jobs/fermentation-scientist-kenya https://www.synbiobeta.com/jobs/gordian-apprenticeship https://www.synbiobeta.com/jobs/head-of-platform https://www.synbiobeta.com/jobs/open-science-editor-publishing https://www.synbiobeta.com/jobs/project-management-and-production-officer https://www.synbiobeta.com/jobs/project-scientist-discovery https://www.synbiobeta.com/jobs/r-d-director https://www.synbiobeta.com/jobs/scientist-biochemist https://www.synbiobeta.com/jobs/scientist-entrepreneur-startup-creation https://www.synbiobeta.com/jobs/senior-scientist-plant-transformation https://www.synbiobeta.com/jobs/senior-scientist-machine-learning https://www.synbiobeta.com/jobs/strain-engineering-lead https://www.synbiobeta.com/jobs/research-associate-ii-downstream-processing https://www.synbiobeta.com/jobs/chief-technology-officer-cto https://www.synbiobeta.com/jobs/senior-data-engineer-full-stack https://www.synbiobeta.com/jobs/senior-scientist-scientist https://www.synbiobeta.com/jobs/senior-software-engineer-full-stack-2 https://www.synbiobeta.com/jobs/engineer-ii-process-development https://www.synbiobeta.com/jobs/associate-director-government-relations https://www.synbiobeta.com/jobs/program-director-rna-therapeutics https://www.synbiobeta.com/jobs/research-associate-ii-process-development-2 https://www.synbiobeta.com/jobs/staff-process-engineer https://www.synbiobeta.com/jobs/executive-assistant-to-founder-ceo https://www.synbiobeta.com/jobs/financial-analyst https://www.synbiobeta.com/jobs/manufacturing-associate-gene-production https://www.synbiobeta.com/jobs/principal-associate-scientist-rna https://www.synbiobeta.com/jobs/senior-director-rna-therapeutics https://www.synbiobeta.com/jobs/research-associate-ii-process-development https://www.synbiobeta.com/jobs/operations-director https://www.synbiobeta.com/jobs/senior-software-engineer https://www.synbiobeta.com/jobs/research-associate-i-analytical-chemistry https://www.synbiobeta.com/jobs/research-associate-molecular-biology-strain-improvement https://www.synbiobeta.com/jobs/bioprocess-scientist https://www.synbiobeta.com/jobs/surface-chemist https://www.synbiobeta.com/jobs/account-manager-senior-account-manager-west-coast-us https://www.synbiobeta.com/jobs/ai-scientist-deep-learning-2 https://www.synbiobeta.com/jobs/business-development-associate-2 https://www.synbiobeta.com/jobs/engineering-manager-epidemiology-and-modeling https://www.synbiobeta.com/jobs/head-of-product-and-technology https://www.synbiobeta.com/jobs/sales-associate-2 https://www.synbiobeta.com/jobs/senior-ai-research-scientist https://www.synbiobeta.com/jobs/senior-field-applications-scientist https://www.synbiobeta.com/jobs/senior-scientific-software-engineer https://www.synbiobeta.com/jobs/snr-scientific-implementation-manager https://www.synbiobeta.com/jobs/software-engineer-full-stack-3 https://www.synbiobeta.com/jobs/staff-machine-learning-engineer https://www.synbiobeta.com/jobs/outbound-sales-development https://www.synbiobeta.com/jobs/account-executive-east-coast https://www.synbiobeta.com/jobs/account-executive-europe-with-focus-on-uk-bnl https://www.synbiobeta.com/jobs/analytical-scientist https://www.synbiobeta.com/jobs/associate-technical-director-microbial-engineering https://www.synbiobeta.com/jobs/automation-engineer https://www.synbiobeta.com/jobs/automation-research-associate https://www.synbiobeta.com/jobs/bioinformaticist https://www.synbiobeta.com/jobs/bioinformatics-software-engineer-senior-engineer https://www.synbiobeta.com/jobs/bioinformatics-software-engineer-senior-engineer-2 https://www.synbiobeta.com/jobs/biotech-account-executive https://www.synbiobeta.com/jobs/business-development-associate https://www.synbiobeta.com/jobs/business-development-director-2 https://www.synbiobeta.com/jobs/cemvita-factory https://www.synbiobeta.com/jobs/chief-operating-officer https://www.synbiobeta.com/jobs/civil-engineer https://www.synbiobeta.com/jobs/client-solutions-engineer https://www.synbiobeta.com/jobs/communications-director https://www.synbiobeta.com/jobs/communications-director-2 https://www.synbiobeta.com/jobs/concrete-block-machine-specialist https://www.synbiobeta.com/jobs/director-of-biotechnology https://www.synbiobeta.com/jobs/director-of-business-development https://www.synbiobeta.com/jobs/director-of-facilities-and-laboratory-operations https://www.synbiobeta.com/jobs/director-of-finance https://www.synbiobeta.com/jobs/director-of-operations https://www.synbiobeta.com/jobs/director-reagents-kits-development https://www.synbiobeta.com/jobs/director-senior-director-mammalian-cell-biology https://www.synbiobeta.com/jobs/director-senior-director-mammalian-cell-biology-2 https://www.synbiobeta.com/jobs/director-sr-director-food-science-product-development https://www.synbiobeta.com/jobs/downstream-process-engineer-head-of-downstream-processing https://www.synbiobeta.com/jobs/electronic-engineer https://www.synbiobeta.com/jobs/engineering-technician https://www.synbiobeta.com/jobs/executive-assistant-office-manager https://www.synbiobeta.com/jobs/executive-assistant-to-the-founders https://www.synbiobeta.com/jobs/executive-assistant-to-the-founders-2 https://www.synbiobeta.com/jobs/fds https://www.synbiobeta.com/jobs/fermentation-scientist https://www.synbiobeta.com/jobs/field-applications-scientist-north-america-east https://www.synbiobeta.com/jobs/field-applications-scientist-north-america-west https://www.synbiobeta.com/jobs/field-service-engineer-senior-field-service-engineer https://www.synbiobeta.com/jobs/full-stack-software-engineer https://www.synbiobeta.com/jobs/head-of-customer-success https://www.synbiobeta.com/jobs/head-of-functional-genomics https://www.synbiobeta.com/jobs/head-of-people-operations https://www.synbiobeta.com/jobs/head-of-strategy https://www.synbiobeta.com/jobs/inorganic-chemist https://www.synbiobeta.com/jobs/instrument-manufacturing-engineer https://www.synbiobeta.com/jobs/lab-support-associate https://www.synbiobeta.com/jobs/lab-support-manager https://www.synbiobeta.com/jobs/lab-support-specialist-media https://www.synbiobeta.com/jobs/lab-technician-lab-manager https://www.synbiobeta.com/jobs/lead-data-automation-engineer https://www.synbiobeta.com/jobs/lead-engineer-late-stage-r-d-bioprocess https://www.synbiobeta.com/jobs/machine-learning-research-engineer https://www.synbiobeta.com/jobs/manager-technical-writing https://www.synbiobeta.com/jobs/marketing-director https://www.synbiobeta.com/jobs/mechanical-engineer-2 https://www.synbiobeta.com/jobs/molecular-biologist https://www.synbiobeta.com/jobs/multi-craft-maintenance-associate https://www.synbiobeta.com/jobs/plant-chemistry-manufacturing-director https://www.synbiobeta.com/jobs/plant-synthetic-biology-lead-scientist https://www.synbiobeta.com/jobs/platform-program-manager https://www.synbiobeta.com/jobs/postdoctoral-associate-yeast-synthetic-biology https://www.synbiobeta.com/jobs/principal-applications-engineer https://www.synbiobeta.com/jobs/process-engineer https://www.synbiobeta.com/jobs/process-engineer-2 https://www.synbiobeta.com/jobs/product-manager-molecular-biology https://www.synbiobeta.com/jobs/production-associate-evening-shift https://www.synbiobeta.com/jobs/production-associate-morning-shift https://www.synbiobeta.com/jobs/production-associate-weekends https://www.synbiobeta.com/jobs/research-associate https://www.synbiobeta.com/jobs/research-associate-chemist https://www.synbiobeta.com/jobs/research-associate-mammalian-synthetic-biology https://www.synbiobeta.com/jobs/research-associate-synthetic-biology https://www.synbiobeta.com/jobs/research-laboratory-technician https://www.synbiobeta.com/jobs/research-scientist https://www.synbiobeta.com/jobs/research-scientist-microbial-physiology https://www.synbiobeta.com/jobs/research-systems-engineer https://www.synbiobeta.com/jobs/scientific-project-manager https://www.synbiobeta.com/jobs/scientist https://www.synbiobeta.com/jobs/scientist-biology https://www.synbiobeta.com/jobs/scientist-fungal-biology https://www.synbiobeta.com/jobs/scientist-microbial-engineering https://www.synbiobeta.com/jobs/scientist-senior-scientist https://www.synbiobeta.com/jobs/scientist-senior-scientist-2 https://www.synbiobeta.com/jobs/scientist-senior-scientist-3 https://www.synbiobeta.com/jobs/scientist-senior-scientist-4 https://www.synbiobeta.com/jobs/scientist-senior-scientist-microfluidics https://www.synbiobeta.com/jobs/scientist-senior-scientist-synthetic-biology https://www.synbiobeta.com/jobs/scientist-sr-scientist-antibody-engineer https://www.synbiobeta.com/jobs/senior-applications-engineer https://www.synbiobeta.com/jobs/senior-bioinformatics-scientist-ii-staff-bioinformatics-scientist https://www.synbiobeta.com/jobs/senior-buyer-planner https://www.synbiobeta.com/jobs/senior-cellular-assay-scientist https://www.synbiobeta.com/jobs/senior-computational-protein-engineer https://www.synbiobeta.com/jobs/senior-customer-program-manager https://www.synbiobeta.com/jobs/senior-customer-service-representative https://www.synbiobeta.com/jobs/senior-electrical-engineer-staff-electrical-engineer https://www.synbiobeta.com/jobs/senior-knowledge-analyst-deep-tech https://www.synbiobeta.com/jobs/senior-lab-automation-systems-engineer https://www.synbiobeta.com/jobs/senior-manager-content-strategy https://www.synbiobeta.com/jobs/senior-molecular-biologist-cellular-engineer https://www.synbiobeta.com/jobs/senior-product-designer https://www.synbiobeta.com/jobs/senior-research-associate-biology-high-throughput-experimentation-f-m https://www.synbiobeta.com/jobs/senior-sales-manager https://www.synbiobeta.com/jobs/senior-scientist https://www.synbiobeta.com/jobs/senior-scientist-analytical https://www.synbiobeta.com/jobs/senior-scientist-biology-high-throughput-experimentation-f-m https://www.synbiobeta.com/jobs/senior-scientist-engineer https://www.synbiobeta.com/jobs/senior-scientist-gene-cell-therapy-biologics-discovery-engineering https://www.synbiobeta.com/jobs/senior-scientist-synthetic-biology https://www.synbiobeta.com/jobs/senior-software-engineer-bioinformatics https://www.synbiobeta.com/jobs/senior-software-engineer-full-stack https://www.synbiobeta.com/jobs/senior-software-engineer-staff-software-engineer https://www.synbiobeta.com/jobs/senior-software-engineer-staff-software-engineer-2 https://www.synbiobeta.com/jobs/senior-software-engineer-staff-software-engineer-3 https://www.synbiobeta.com/jobs/senior-technical-recruiter https://www.synbiobeta.com/jobs/software-engineer https://www.synbiobeta.com/jobs/software-engineer-bioinformatics https://www.synbiobeta.com/jobs/software-engineer-full-stack https://www.synbiobeta.com/jobs/software-engineer-full-stack-2 https://www.synbiobeta.com/jobs/staff-client-solutions-engineer https://www.synbiobeta.com/jobs/staff-data-engineer https://www.synbiobeta.com/jobs/staff-data-scientist-dna-products https://www.synbiobeta.com/jobs/staff-fellow https://www.synbiobeta.com/jobs/staff-scientist-senior-scientist-inscripta-pleasanton-ca https://www.synbiobeta.com/jobs/staff-systems-engineer-senior-staff-systems-engineer https://www.synbiobeta.com/jobs/systems-design-technician https://www.synbiobeta.com/jobs/systems-engineer-prototyping https://www.synbiobeta.com/jobs/the-built-with-biology-event-planner https://www.synbiobeta.com/jobs/user-experience-researcher https://www.synbiobeta.com/jobs/chief-strategy-bioeconomic-development-officer https://www.synbiobeta.com/jobs/multiple-positions-with-the-national-security-commission-on-emerging-biotechnology-nsceb https://www.synbiobeta.com/jobs/process-engineering-director https://www.synbiobeta.com/jobs/scientist-bioprocessing https://www.synbiobeta.com/jobs/senior-scientist-fermentation https://www.synbiobeta.com/jobs/various-positions https://www.synbiobeta.com/jobs/various-positions-2 https://www.synbiobeta.com/jobs/senior-government-team-coordinator https://www.synbiobeta.com/jobs/account-manager-antibody-discovery-services-ny-nj https://www.synbiobeta.com/jobs/associate-director-lab-enablement https://www.synbiobeta.com/jobs/bioprocess-lab-technician https://www.synbiobeta.com/jobs/director-business-development-cell-engineering https://www.synbiobeta.com/jobs/director-laboratory-operations https://www.synbiobeta.com/jobs/director-molecular-biology-and-antibody-engineering https://www.synbiobeta.com/jobs/director-sec-reporting-and-technical-accounting https://www.synbiobeta.com/jobs/director-senior-director-business-development-pharma-enterprise-sales https://www.synbiobeta.com/jobs/director-senior-director-business-development-pharma-enterprise-sales-2 https://www.synbiobeta.com/jobs/director-senior-director-business-development-rna https://www.synbiobeta.com/jobs/director-senior-director-marketing https://www.synbiobeta.com/jobs/director-senior-director-quality-compliance-gxp https://www.synbiobeta.com/jobs/scientist-ii-heterogeneous-metals-catalysis https://www.synbiobeta.com/jobs/scientist-senior-scientist-cell-type-development-neuro https://www.synbiobeta.com/jobs/scientist-senior-scientist-technical-operations https://www.synbiobeta.com/jobs/senior-bioinformatics-engineer https://www.synbiobeta.com/jobs/senior-director-gene-therapy https://www.synbiobeta.com/jobs/senior-research-associate-protein-enzyme-engineering https://www.synbiobeta.com/jobs/senior-scientist-i-protein-engineering https://www.synbiobeta.com/jobs/senior-scientist-rna-therapeutics https://www.synbiobeta.com/jobs/senior-scientist-strain-engineering https://www.synbiobeta.com/jobs/software-engineer-3 https://www.synbiobeta.com/jobs/sr-compensation-analyst https://www.synbiobeta.com/jobs/summer-2023-business-operations-internship https://www.synbiobeta.com/jobs/svp-pharma-business-development-cell-therapy-partnerships https://www.synbiobeta.com/jobs/research-associate-ii-iii-analytical-chemistry https://www.synbiobeta.com/jobs/scientist-ii-scientist-iii-microbial-innovation-group https://www.synbiobeta.com/jobs/senior-staff-research-associate-molecular-biology https://www.synbiobeta.com/jobs/synthetic-biology-strategist-and-program-manager https://www.synbiobeta.com/jobs/ai-scientist-deep-learning https://www.synbiobeta.com/jobs/computational-biologist-senior-computational-biologist https://www.synbiobeta.com/jobs/research-associate-2 https://www.synbiobeta.com/jobs/research-intern-artificial-intelligence https://www.synbiobeta.com/jobs/senior-scientist-antibody-engineering https://www.synbiobeta.com/jobs/vp-intellectual-property https://www.synbiobeta.com/jobs/chief-scientific-officer https://www.synbiobeta.com/jobs/scientist-fermentation-2 https://www.synbiobeta.com/jobs/director-of-commercial-operations https://www.synbiobeta.com/jobs/senior-manager-regulatory-affairs https://www.synbiobeta.com/jobs/anthropocene-institute-oceans-and-f3-aquaculture-program-coordinator https://www.synbiobeta.com/jobs/ux-software-engineer-full-stack https://www.synbiobeta.com/jobs/director-of-content https://www.synbiobeta.com/jobs/executive-assistant https://www.synbiobeta.com/jobs/r-d-inten https://www.synbiobeta.com/jobs/bioinformatics-engineer https://www.synbiobeta.com/jobs/business-developer https://www.synbiobeta.com/jobs/engineering-technician-instrument-manufacturing https://www.synbiobeta.com/jobs/head-of-production-engineering-dna-synthesis https://www.synbiobeta.com/jobs/software-engineer-2 https://www.synbiobeta.com/jobs/strategic-account-manager-field-sales https://www.synbiobeta.com/jobs/strategic-account-manager-field-sales-2 https://www.synbiobeta.com/jobs/field-applications-scientist-east-coast https://www.synbiobeta.com/jobs/field-applications-scientist-san-francisco https://www.synbiobeta.com/jobs/disease-biology-associate-director https://www.synbiobeta.com/jobs/experimental-engineer-for-nanopore-devices https://www.synbiobeta.com/jobs/microfluidic-electro-researcher-for-life-science-technologies https://www.synbiobeta.com/jobs/microfluidics-designer-life-science-technologies https://www.synbiobeta.com/jobs/protein-scientist https://www.synbiobeta.com/jobs/researcher-advanced-micro-physiological-systems-organ-on-chip https://www.synbiobeta.com/jobs/sales-associate https://www.synbiobeta.com/jobs/special-projects https://www.synbiobeta.com/jobs/senior-bioinformatics-data-scientist-ii-staff-bioinformatics-data-scientist https://www.synbiobeta.com/jobs/senior-scientist-staff-scientist-mammalian-cell-biology https://www.synbiobeta.com/jobs/software-quality-assurance-engineer https://www.synbiobeta.com/jobs/staff-systems-engineer-senior-staff-systems-engineer-inscripta-pleasanton-ca-or-boulder-co https://www.synbiobeta.com/jobs/business-development-director https://www.synbiobeta.com/jobs/chief-technology-officer https://www.synbiobeta.com/jobs/environmental-microbiologist https://www.synbiobeta.com/jobs/field-applications-scientist-fas https://www.synbiobeta.com/jobs/mechanical-engineer https://www.synbiobeta.com/jobs/research-associate-senior-research-associate https://www.synbiobeta.com/jobs/scientist-ii-automated-strain-engineering https://www.synbiobeta.com/jobs/senior-staff-systems-engineer https://www.synbiobeta.com/jobs/staff-mechanical-engineer https://www.synbiobeta.com/jobs/synbio-fungal-scientist https://www.synbiobeta.com/jobs/synthetic-biologist https://www.synbiobeta.com/jobs/vp-process-chemistry-manufacturing https://www.synbiobeta.com/listen/ai-in-action-synthesizing-the-future-of-drug-discovery-with-sean-mcclain https://www.synbiobeta.com/listen/bioeconomy-lessons-with-titus https://www.synbiobeta.com/listen/building-india-s-synthetic-biology-industry-with-santanu-dasgupta-of-ril https://www.synbiobeta.com/listen/catalog-tracy-kambara https://www.synbiobeta.com/listen/cemvita-factory-tara-karimi-and-moji-karimi https://www.synbiobeta.com/listen/culture-biosciences-masaki-yamada-and-kris-tyner https://www.synbiobeta.com/listen/deep-tech-and-synthetic-biology-the-big-picture https://www.synbiobeta.com/listen/dna-script-sylvain-gariel https://www.synbiobeta.com/listen/does-eating-animals-cause-pandemics-with-ryan-bethencourt-of-wild-earth https://www.synbiobeta.com/listen/does-eating-animals-cause-pandemics-with-ryan-bethencourt-of-wild-earth-5 https://www.synbiobeta.com/listen/empowering-cell-gene-manufaturing-using-computational-solutions-with-claire-aldridge-the-synbiobeta-podcast https://www.synbiobeta.com/listen/faster-better-and-cheaper-the-elusive-dna-triad-now-a-reality-with-mike-kamdar-phil-paik https://www.synbiobeta.com/listen/fermenting-the-future-while-making-biomanufacturing-nimble-with-shannon-hall https://www.synbiobeta.com/listen/from-ideas-to-reality-synthetic-biology-comes-of-age-with-jason-kelly-the-synbiobeta-podcast https://www.synbiobeta.com/listen/from-microbes-to-materials-zymochems-vision-for-a-plastic-free-future https://www.synbiobeta.com/listen/genscript-kay-chuang https://www.synbiobeta.com/listen/herophilus-saul-kato-and-sharath-hegde https://www.synbiobeta.com/listen/how-an-artist-becomes-an-investor-and-advisor-to-the-world-s-greatest-technology-companies-with-d-a-wallach https://www.synbiobeta.com/listen/how-can-we-welcome-everyone-to-the-bioeconomy https://www.synbiobeta.com/listen/how-dna-synthesis-is-powering-the-fourth-manufacturing-revolution-with-emily-leproust https://www.synbiobeta.com/listen/how-do-we-design-biology-get-ready-to-be-surprised https://www.synbiobeta.com/listen/how-is-amyris-saving-sharks https://www.synbiobeta.com/listen/how-is-bolt-threads-making-leather-out-of-mushrooms https://www.synbiobeta.com/listen/how-is-cemvita-factory-fighting-climate-change https://www.synbiobeta.com/listen/how-is-checkerspot-skiing-with-algae https://www.synbiobeta.com/listen/how-is-colorifix-making-sustainable-dyes-with-biology https://www.synbiobeta.com/listen/how-is-ecovative-molding-mushrooms-into-sustainable-packaging https://www.synbiobeta.com/listen/how-is-glowee-lighting-our-world-with-microbes https://www.synbiobeta.com/listen/how-is-wild-earth-making-pet-food-sustainable https://www.synbiobeta.com/listen/how-is-wildtype-growing-sushi-grade-salmon https://www.synbiobeta.com/listen/how-nature-co-design-is-changing-the-narrative https://www.synbiobeta.com/listen/how-nature-co-design-is-changing-the-narrative-with-massimo-portincaso https://www.synbiobeta.com/listen/how-protein-engineering-is-the-killer-app-for-biology-with-john-nichols https://www.synbiobeta.com/listen/how-spiber-is-spinning-proteins-into-spider-silk https://www.synbiobeta.com/listen/how-this-household-name-is-beating-climate-change-and-making-great-products-with-tom-dierking-of-p-g https://www.synbiobeta.com/listen/how-to-spot-a-synthetic-biology-unicorn-with-ali-tamaseb-of-dcvc https://www.synbiobeta.com/listen/how-to-tell-your-synthetic-biology-story-with-ben-kellogg-of-bwk https://www.synbiobeta.com/listen/how-will-dna-make-our-future https://www.synbiobeta.com/listen/indie-bio-aja-labs-microterra https://www.synbiobeta.com/listen/investing-at-the-frontiers-of-life-science-innovation-with-jenny-rooke-of-genoa-ventures https://www.synbiobeta.com/listen/jellatech-stephanie-michelsen https://www.synbiobeta.com/listen/leaps-by-bayer-ada-health https://www.synbiobeta.com/listen/making-data-and-computation-accessible-to-scientists-with-kyle-giffin https://www.synbiobeta.com/listen/mammoth-biosciences-janice-chen https://www.synbiobeta.com/listen/meet-the-future-deep-tech-and-synbio https://www.synbiobeta.com/listen/mycelium-magic-crafting-a-greener-future-with-eben-bayer https://www.synbiobeta.com/listen/nautilus-parag-mallick https://www.synbiobeta.com/listen/neubase-therapeutics https://www.synbiobeta.com/listen/nuclera-motif-foodworks-artificial https://www.synbiobeta.com/listen/phytolon-halim-jubran-and-tal-zeltzer https://www.synbiobeta.com/listen/program-a-cell-cure-a-disease-meet-the-future-of-medicine https://www.synbiobeta.com/listen/protein-design-101-for-synthetic-biology-with-alexandre-zhanghellini-of-arzeda https://www.synbiobeta.com/listen/scaling-new-heights-in-biomanufacturing-with-edward-shenderovich https://www.synbiobeta.com/listen/solugen-gaurab-chakrabarti-and-sean-hunt https://www.synbiobeta.com/listen/synthetic-biology-investing-in-an-age-of-open-platforms-with-ursheet-parikh-of-mayfield https://www.synbiobeta.com/listen/the-brothers-wright-flight-of-human-health-where-will-synbio-take-us-next-with-mark-kotter https://www.synbiobeta.com/listen/the-inside-track-ai-and-biomanufacturing-scale-up https://www.synbiobeta.com/listen/the-inside-track-biopharma-solutions https://www.synbiobeta.com/listen/the-inside-track-capital-markets-consumer-products https://www.synbiobeta.com/listen/the-inside-track-desci https://www.synbiobeta.com/listen/the-inside-track-biodesign https://www.synbiobeta.com/listen/the-mycelium-revolution-how-a-mushroom-can-make-food-plastic-and-more-with-eben-bayer-of-ecovative https://www.synbiobeta.com/listen/the-role-of-creativity-and-design-in-biotechnology-with-christina-agapakis-of-ginkgo-bioworks https://www.synbiobeta.com/listen/venture-visions-investing-in-the-future-of-synthetic-biology-with-ursheet-parikh-the-synbiobeta-podcast https://www.synbiobeta.com/listen/welcome-to-the-synbiobeta-podcast https://www.synbiobeta.com/listen/what-makes-a-microbe-a-superhero https://www.synbiobeta.com/listen/what-makes-crispr-like-a-movie-star https://www.synbiobeta.com/listen/what-role-can-fragrances-play-in-sustainability https://www.synbiobeta.com/listen/what-will-our-technology-future-look-like https://www.synbiobeta.com/listen/what-will-our-technology-future-look-like-star-trek-vs-star-wars https://www.synbiobeta.com/listen/where-brands-and-biology-meet-karl-schmieder https://www.synbiobeta.com/listen/where-brands-and-biology-meet-with-karl-schmieder https://www.synbiobeta.com/listen/why-should-everyone-care-about-biosecurity https://www.synbiobeta.com/listen/wild-earth-ryan-bethencourt https://www.synbiobeta.com/read/how-schmidt-sciences-is-building-the-sensors-biomanufacturing-never-had https://www.synbiobeta.com/read/strainx-has-raised-13m-from-the-vc-firm-behind-impossible-foods-in-one-of-the-largest-food-tech-private-funding-rounds-in-india%E2%80%99s-history https://www.synbiobeta.com/read/benchling-launches-three-products-during-synbiobeta-2026-%E2%80%94-and-its-head-of-ai-hints-at-what-comes-next https://www.synbiobeta.com/read/praio-launches-environment-screening-panel-at-synbiobeta-2026 https://www.synbiobeta.com/read/anthropic-is-hiring-biologists-building-wet-labs-and-betting-big-on-drug-discovery https://www.synbiobeta.com/read/openprotein.ai-selected-to-build-next-generation-protein-foundation-models-under-darpa-program https://www.synbiobeta.com/read/pumpkinseed-raises-20-million-series-a-to-build-the-read-layer-for-protein-biology https://www.synbiobeta.com/read/arzeda-and-kent-specialty-milling-announce-product-development-partnership https://www.synbiobeta.com/read/genyro-s-sidewinder-assembles-320-dna-molecules-in-parallel-from-a-single-oligo-pool https://www.synbiobeta.com/read/bioora-secures-rights-to-third-generation-car-t-cell-therapy-outside-china-and-india-using-automated-manufacturing-to-address-the-cost-barrier https://www.synbiobeta.com/read/lanzatech-and-dtu-39-s-bright-institute-launch-multi-year-partnership-to-build-a-c1-biofoundry-in-europe https://www.synbiobeta.com/read/centivax-fully-enrolls-180-subject-universal-flu-vaccine-trial-two-months-after-first-dose https://www.synbiobeta.com/read/leroy-hood-built-the-tools-biology-needed-most-now-hes-taking-on-the-dark-proteome https://www.synbiobeta.com/read/how-zymochem-is-redefining-industrial-manufacturing https://www.synbiobeta.com/read/press-release-combinatorial-synthetic-biology-and-a-revolution-in-ai-agent-biomodelling-at-synbiobeta-%E2%80%9826 https://www.synbiobeta.com/read/emily-leproust-on-a-decade-of-twist https://www.synbiobeta.com/read/inside-latent-labs-autonomous-drug-design-engine https://www.synbiobeta.com/read/constructive-bio-ola-wlodek-on-commercialising-the-expanded-genetic-code https://www.synbiobeta.com/read/biomatter-matthew-thompson-on-the-era-of-enzymes-on-demand https://www.synbiobeta.com/read/a-synthetic-biology-pioneer-has-left-us-remembering-j.-craig-venter-(1946-2026) https://www.synbiobeta.com/read/jason-gammack-the-constraints-were-always-manufacturing-artifacts https://www.synbiobeta.com/read/aspens-parkinsons-therapy-shows-compelling-clinical-potential https://www.synbiobeta.com/read/10x-genomics-unveils-atera https://www.synbiobeta.com/read/micha-breakstone-turns-to-predicting-cell-fate https://www.synbiobeta.com/read/pumpkinseed-shines-new-light-on-the-proteome https://www.synbiobeta.com/read/japan-biosolutions-the-growth-stage-coordination-opportunity https://www.synbiobeta.com/read/no-ice-no-delays-plasmidsaurus-brings-fast-rna-seq-to-europe https://www.synbiobeta.com/read/liliana-nordbakk-on-building-ai-native-biology-companies https://www.synbiobeta.com/read/herasight-develops-genetic-tests-for-embryos-that-can-reduce-disease-and-boost-iq https://www.synbiobeta.com/read/opening-the-biological-black-box-with-krish-ramadurai https://www.synbiobeta.com/read/the-world-s-largest-chemical-distributor-just-placed-its-bet-on-insempra-and-precision-fermentation https://www.synbiobeta.com/read/how-a-crispr-startup-took-on-a-50b-giant-%E2%80%94-and-won https://www.synbiobeta.com/read/evolution-built-the-perfect-bioreactor-neion-bio-is-finally-using-it https://www.synbiobeta.com/read/jamie-bacher-on-the-one-obstacle-synthetic-biology-must-finally-solve https://www.synbiobeta.com/read/lowering-the-barriers-to-biotech-how-douglas-crawford-built-an-engine-for-scientific-entrepreneurs https://www.synbiobeta.com/read/rybodyn-raises-10-million-to-build-the-world-s-best-map-of-cancer-targets-in-the-dark-proteome https://www.synbiobeta.com/read/inside-10x-genomics%E2%80%99-mission-to-measure-biology-at-scale https://www.synbiobeta.com/read/arzeda-and-mane-join-forces-to-bring-a-better-stevia-at-scale https://www.synbiobeta.com/read/the-four-molecules-to-scale-for-industrial-biotech https://www.synbiobeta.com/read/successful-pilot-scale-run-with-cayman-chemical-validates-exozymes-technology-and-scalability https://www.synbiobeta.com/read/breakout-ventures-launches-114m-fund-iii-to-double-down-on-deep-tech https://www.synbiobeta.com/read/centivax-doses-first-participants-in-phase-1-trial-of-universal-flu-vaccine https://www.synbiobeta.com/read/burn-baby-burn-epa-moves-to-dismantle-the-legal-backbone-of-u.s.-climate-policy https://www.synbiobeta.com/read/j.-craig-venter-launches-diploid-genomics-inc.-to-revolutionize-human-genomics https://www.synbiobeta.com/read/ginkgo-bioworks-autonomous-laboratory-driven-by-openai-s-gpt-5-achieves-40-improvement-over-state-of-the-art-scientific-benchmark https://www.synbiobeta.com/read/why-the-department-of-war-is-backing-visolis-to-scale-bio-based-solvents https://www.synbiobeta.com/read/the-bioelectric-tech-stack https://www.synbiobeta.com/read/colossal-biosciences-unveils-global-biovault-initiative-with-uae-to-preserve-endangered-species https://www.synbiobeta.com/read/twogee-biotech-raises-%E2%82%AC2.16m-seed-round-to-convert-residual-biomass-into-circular-low-co%E2%82%82-chemical-building-blocks https://www.synbiobeta.com/read/visolis-secures-2.86-million-expansion-from-u.s.-department-of-war-for-bioindustrial-manufacturing https://www.synbiobeta.com/read/phylo-launches-biomni-lab-and-secures-13.5m-seed-round https://www.synbiobeta.com/read/cellares-secures-257-million-series-d-to-revolutionize-cell-therapy-manufacturing https://www.synbiobeta.com/read/think-bioscience-secures-55m-in-oversubscribed-series-a-funding https://www.synbiobeta.com/read/zymochem-and-agile-biofoundry-join-forces-to-propel-bioeconomy-forward https://www.synbiobeta.com/read/the-1-in-a-million-breakthrough-behind-genyro%E2%80%99s-vision-for-a-post-darwinian-age https://www.synbiobeta.com/read/the-year-china-surpassed-the-usa-in-biotech-innovation-deal-value-and-clinical-output https://www.synbiobeta.com/read/the-prevention-economy-has-arrived-is-your-clinic-ready https://www.synbiobeta.com/read/new-phd-training-programme-aims-to-bridge-the-biomanufacturing-scale-up-gap https://www.synbiobeta.com/read/frontier-bio-redefining-the-future-of-regenerative-medicine https://www.synbiobeta.com/read/medra-secures-52-million-series-a-to-revolutionize-drug-discovery-with-physical-ai-scientists https://www.synbiobeta.com/read/ginkgo-bioworks-partners-with-deep-origin-for-revolutionary-drug-safety-project https://www.synbiobeta.com/read/manifold-bio-expands-leadership-team-to-drive-its-ai-in-vivo-targeted-biologics-platform https://www.synbiobeta.com/read/profluent-bio-has-teamed-up-with-ensoma-to-advance-in-vivo-hematopoietic-stem-cell-therapies-using-ai-designed-base-editors. https://www.synbiobeta.com/read/allonnia-secures-over-20-million-to-boost-critical-materials-biotechnology https://www.synbiobeta.com/read/exozymes-achieves-100%C3%97-scale-up-of-nct-production-using-exozymes-demonstrating-near-perfect-feedstock-conversion https://www.synbiobeta.com/read/ending-the-waiting-game-how-ansa-biotechnologies-guarantees-are-turning-dna-synthesis-into-a-predictable-industry https://www.synbiobeta.com/read/ginkgo-joins-genesis-project-to-build-a-47-million-autonomous-robot-lab https://www.synbiobeta.com/read/made-scientific-and-cellergy-therapeutics-form-partnership-to-advance-mitochondrial-therapy https://www.synbiobeta.com/read/aspen-neuroscience-secures-115-million-to-advance-parkinson-s-disease-therapy https://www.synbiobeta.com/read/flagship-and-gsk-initiate-feasibility-agreements-with-profound-and-quotient https://www.synbiobeta.com/read/king-abdullah-international-medical-research-center-and-flagship-pioneering-forge-partnership-for-clinical-trials-in-saudi-arabia https://www.synbiobeta.com/read/astrazeneca-announces-2-billion-manufacturing-investment-in-maryland https://www.synbiobeta.com/read/terray-unveils-emmi-an-advanced-ai-driven-drug-discovery-platform https://www.synbiobeta.com/read/ai-proteins-secures-41-5m-series-a-funding-to-propel-novel-miniprotein-therapeutics https://www.synbiobeta.com/read/biocentis-secures-19m-to-revolutionize-insect-control-through-programmable-biology https://www.synbiobeta.com/read/profluent-secures-106m-funding-to-enhance-ai-driven-biology-solutions https://www.synbiobeta.com/read/barry-callebaut-partners-with-notco-ai-to-unlock-next-level-chocolate-innovation https://www.synbiobeta.com/read/atcc-hosts-nsceb-for-important-biotechnology-discussions https://www.synbiobeta.com/read/hermes-biosciences-secures-seed-funding-for-advanced-ev-isolation-technology https://www.synbiobeta.com/read/antheia-and-tapi-partner-to-advance-global-commercialization-strategy-for-critical-pharmaceutical-ingredients https://www.synbiobeta.com/read/paradromics-secures-fda-approval-for-innovative-brain-computer-interface-study https://www.synbiobeta.com/read/constructive-bio-and-jason-chin-novel-polymers https://www.synbiobeta.com/read/built-for-the-synthetic-biology-workflow https://www.synbiobeta.com/read/erg-bio-6-5-million-seed-for-aviation-fuels https://www.synbiobeta.com/read/enzymit-and-cosun-have-successfully-pioneered-the-production-of-high-purity-hyaluronic-acid-through-a-novel-cell-free-biomanufacturing-process https://www.synbiobeta.com/read/pow-bio-buhler-atvtechnologies3000-liter-scale https://www.synbiobeta.com/read/feeding-the-future-isabelle-decitre-and-id-capitals-mission-in-asia-pacific-agrifoodtech https://www.synbiobeta.com/read/biomedit-secures-2-million-from-bezos-earth-fund-to-enhance-ai-for-methane-reduction-in-cattle https://www.synbiobeta.com/read/colossal-biosciences-acquires-viagen-the-leader-in-animal-cloning https://www.synbiobeta.com/read/ginkgo-bioworks-expands-partnership-with-bayer-to-enhance-agricultural-innovations https://www.synbiobeta.com/read/ginkgo-bioworks-partners-to-innovate-monoclonal-antibody-production-for-filovirus-countermeasures https://www.synbiobeta.com/read/invert-launches-ai-powered-bioprocess-analysis-tool https://www.synbiobeta.com/read/every-secures-55-million-in-new-funding-for-expansion https://www.synbiobeta.com/read/samsung-biologics-completes-spin-off-of-samsung-bioepis https://www.synbiobeta.com/read/manifold-bio-partners-with-roche-to-develop-innovative-brain-shuttles-for-neurological-disorders https://www.synbiobeta.com/read/iorganbio-launches-cellforge-tm-with-2m-funding-to-revolutionize-cell-manufacturing https://www.synbiobeta.com/read/resilience-secures-up-to-825-million-financing-to-enhance-cdmo-operations https://www.synbiobeta.com/read/ansa-biotechnologies-launches-50-kb-clonal-dna-product-revolutionizing-dna-synthesis https://www.synbiobeta.com/read/acies-bio-expands-biomanufacturing-capabilities-with-new-facility https://www.synbiobeta.com/read/elegen-launches-gen-ii-cell-free-dna-platform-for-enhanced-dna-production https://www.synbiobeta.com/read/expedition-medicines-launches-ai-platform-for-drug-discovery https://www.synbiobeta.com/read/biomedit-partners-with-bioversity-international-and-yale-to-develop-rumen-digital-twin https://www.synbiobeta.com/read/openfold-consortium-unveils-openfold3-a-game-changer-for-protein-structure-prediction https://www.synbiobeta.com/read/profluent-and-corteva-partner-to-apply-ai-designed-proteins-in-agriculture https://www.synbiobeta.com/read/symrise-and-cellibre-partner-to-deliver-precision-fermented-products-today https://www.synbiobeta.com/read/caldic-and-amphistar-collaborate-to-revolutionize-personal-care-with-upcycled-biosurfactants https://www.synbiobeta.com/read/gourmey-acquires-vital-meat-to-form-parima-a-global-leader-in-next-generation-animal-production https://www.synbiobeta.com/read/integrated-dna-technologies-and-profluent-forge-new-ai-driven-protein-design-partnership https://www.synbiobeta.com/read/waypoint-bio-appoints-meta-neuroai-pioneer-patrick-kaifosh-as-chief-technology-officer https://www.synbiobeta.com/read/plasmidsaurus-unveils-80-rna-seq-in-as-fast-as-3-days https://www.synbiobeta.com/read/ansa-biotechnologies-secures-54-4-million-in-series-b-financing-to-redefine-how-scientists-access-synthetic-dna-with-industry-s-first-guaranteed-on-time-service https://www.synbiobeta.com/read/arzeda-secures-7-8-million-nsf-award-to-advance-bioelectrochemistry https://www.synbiobeta.com/read/avant-technologies-announces-strategic-shift-towards-biotechnology-collaborations https://www.synbiobeta.com/read/aspen-neuroscience-advances-parkinson-s-disease-therapy-with-cohort-3-initiation https://www.synbiobeta.com/read/scindo-secures-ps4-million-investment-to-advance-ai-driven-enzyme-engineering https://www.synbiobeta.com/read/fredsense-secures-7-million-to-accelerate-pfas-testing-solutions https://www.synbiobeta.com/read/benchsci-partners-with-thermo-fisher-to-enhance-r-d-productivity-with-ai-tools https://www.synbiobeta.com/read/enveric-biosciences-publishes-two-articles-on-innovative-bioproduction-for-neuropsychiatric-drug-discovery-15efe https://www.synbiobeta.com/read/colossal-advances-dodo-de-extinction-with-significant-world-s-first-breakthrough-in-pigeon-pgcs-and-secures-an-additional-120m-in-funding-for-species-expansion-1764e https://www.synbiobeta.com/read/seoul-bio-hub-and-celltrion-launch-global-open-innovation-program-f2b76 https://www.synbiobeta.com/read/dr-harler-joins-flagship-pioneering-to-spearhead-novel-drug-development-77ade https://www.synbiobeta.com/read/ridge-biotechnologies-emerges-from-stealth-with-25-million-in-seed-financing https://www.synbiobeta.com/read/how-biofoundries-are-accelerating-life-enhancing-innovations-in-biomanufacturing https://www.synbiobeta.com/read/mrm-health-secures-eu55-million-in-series-b-financing-to-propel-microbiome-based-therapeutics https://www.synbiobeta.com/read/ginkgo-datapoints-and-apheris-launch-antibody-developability-consortium https://www.synbiobeta.com/read/remedium-bio-partners-with-lilly-to-advance-gene-therapies-for-obesity-and-type-2-diabetes https://www.synbiobeta.com/read/eat-just-expands-just-meat-to-texas-with-h-e-b-partnership https://www.synbiobeta.com/read/vedabio-partners-with-mammoth-biosciences-to-enhance-crispr-based-diagnostics https://www.synbiobeta.com/read/lilly-introduces-tunelab-platform-for-ai-driven-drug-discovery https://www.synbiobeta.com/read/cho-plus-inc-secures-patent-for-innovative-yeast-cell-technology https://www.synbiobeta.com/read/made-scientific-partners-with-hemogenyx-pharmaceuticals-to-advance-car-t-therapy https://www.synbiobeta.com/read/matica-bio-and-cirsium-forge-strategic-partnership-to-enhance-gene-therapy-manufacturing https://www.synbiobeta.com/read/cemvita-boosts-commercial-growth-with-new-technology-and-leadership-in-brazil https://www.synbiobeta.com/read/insitro-partners-with-lilly-to-innovate-small-molecule-drug-discovery-using-machine-learning https://www.synbiobeta.com/read/atlas-venture-announces-400-million-third-opportunity-fund https://www.synbiobeta.com/read/arzeda-to-lead-major-nsf-funded-initiative-advancing-cell-free-manufacturing-through-ai-designed-enzymes https://www.synbiobeta.com/read/persephone-biosciences-launches-innovative-synbiotic-for-infants-to-restore-essential-gut-microbes https://www.synbiobeta.com/read/elegen-launches-enfinia-tm-ivt-ready-dna-for-faster-mrna-synthesis https://www.synbiobeta.com/read/enveda-secures-150m-in-series-d-funding-enrolls-first-patient-in-lead-program-welcomes-mikael-dolsten-to-board https://www.synbiobeta.com/read/egenesis-secures-ind-clearance-for-egen-2784-in-kidney-transplant-and-reports-significant-patient-progress https://www.synbiobeta.com/read/renaissance-bioscience-secures-an-australian-patent-for-novel-rna-production-and-delivery-technology https://www.synbiobeta.com/read/beckman-coulter-life-sciences-and-hse-ag-join-forces-to-transform-nucleic-acid-quantification-and-purification-with-innovative-liquid-handling-solutions https://www.synbiobeta.com/read/cascade-bio-secures-6m-to-scale-biocatalysts https://www.synbiobeta.com/read/immortal-dragons-invests-in-frontier-bio-pioneering-3d-biofabrication-for-tissue-engineering https://www.synbiobeta.com/read/amyris-appoints-dr-sunil-chandran-as-chief-technology-officer https://www.synbiobeta.com/read/raina-biosciences-unveils-gemorna-a-revolutionary-ai-platform-for-mrna-design https://www.synbiobeta.com/read/ori-biotechs-iro-r-platform-earns-fda-advanced-manufacturing-technology-designation https://www.synbiobeta.com/read/sunflower-therapeutics-secures-nih-sbir-funding-for-innovative-vaccine-manufacturing-platform https://www.synbiobeta.com/read/twist-bioscience-partners-with-synthetic-design-lab-for-advancements-in-cancer-therapeutics https://www.synbiobeta.com/read/proteintech-launches-able-ai-to-streamline-antibody-selection https://www.synbiobeta.com/read/xampla-secures-14m-investment-to-revolutionize-plastic-alternatives https://www.synbiobeta.com/read/intron-bio-files-two-patents-for-a-novel-impa-tm-gene-editing-technology https://www.synbiobeta.com/read/arkeabio-names-dr-zach-serber-as-chief-technology-officer-to-propel-methane-reducing-livestock-vaccine-development https://www.synbiobeta.com/read/ai-proteins-appoints-james-bowman-as-first-chief-technology-officer https://www.synbiobeta.com/read/covation-biomaterials-welcomes-steven-ackerman-as-new-ceo https://www.synbiobeta.com/read/pivot-bio-partners-with-the-soil-and-water-outcomes-fund-to-enhance-sustainable-farming-practices https://www.synbiobeta.com/read/corbion-and-brain-biotech-partner-to-develop-biobased-antimicrobial-compounds-for-enhancing-food-preservation https://www.synbiobeta.com/read/future-origins-drop-in-replacement-nalo-tm-wins-icis-innovation-award https://www.synbiobeta.com/read/world-leading-developmental-biologist-andrew-pask-ph-d-joins-colossal-full-time-as-chief-biology-officer https://www.synbiobeta.com/read/nvidia-cdd-vault-bring-together-data-teams-ai https://www.synbiobeta.com/read/octarine-bio-teams-up-with-textile-leaders-to-launch-sustainable-bio-based-dyes https://www.synbiobeta.com/read/camena-bioscience-and-constructive-bio-launch-collaboration-to-advance-plant-genomics https://www.synbiobeta.com/read/neogen-forms-strategic-partnership-with-biomatter-to-create-enzyme-based-products https://www.synbiobeta.com/read/snipr-biome-raises-eur-35-million-series-b-financing-to-advance-crispr-medicines-targeting-antimicrobial-resistance https://www.synbiobeta.com/read/10x-genomics-to-acquire-scale-biosciences https://www.synbiobeta.com/read/switch-bioworks-strengthens-leadership-and-expands-facilities-for-microbial-fertilizer-development https://www.synbiobeta.com/read/probio-unveils-gmp-aav-manufacturing-services-to-propel-gene-therapy-forward https://www.synbiobeta.com/read/21st-bio-unveils-precision-fermentation-initiative-for-bovine-alpha-lactalbumin https://www.synbiobeta.com/read/synbios-bid-to-replace-petroleum-based-consumer-ingredients-if-it-can-scale https://www.synbiobeta.com/read/cellugy-secures-9-25m-to-combat-microplastics-in-personal-care-products-with-biobased-solutions https://www.synbiobeta.com/read/align-and-atcc-partner-to-launch-worlds-largest-ai-ready-microbial-phenotyping-dataset https://www.synbiobeta.com/read/liberation-labs-rebrands-as-liberation-bioindustries-to-reflect-global-biomanufacturing-scale https://www.synbiobeta.com/read/64x-bio-unveils-aav-apex-suite-to-address-gene-therapy-manufacturing-bottlenecks https://www.synbiobeta.com/read/fauna-bio-unveils-fauna-brain-tm-ai-platform-to-accelerate-drug-discovery-inspired-by-natures-most-resilient-species https://www.synbiobeta.com/read/integrated-dna-technologies-idt-launches-custom-solutions-program-to-advance-synthetic-biology-innovation https://www.synbiobeta.com/read/bitbiome-announces-manufacturing-partnership-with-leading-cmo-to-deliver-full-scale-biomanufacturing-capabilities https://www.synbiobeta.com/read/antheia-raises-56m-series-c-to-alleviate-global-drug-shortages-with-synthetic-biology https://www.synbiobeta.com/read/forget-factory-farms-french-startup-gourmey-makes-cultivated-foie-gras-for-3-43-lb https://www.synbiobeta.com/read/exclusive-how-kareem-barghouti-and-pragma-bio-are-mining-the-gut-microbiome-for-next-gen-immune-therapies https://www.synbiobeta.com/read/laurus-bio-unveils-r3-plant-as-part-of-2-million-liter-fermentation-vision https://www.synbiobeta.com/read/ansa-biotechnologies-breaks-traditional-synthetic-dna-length-barriers-and-redefines-future-of-life-science-research https://www.synbiobeta.com/read/dmc-launches-fermented-myo-inositol-a-cleaner-and-more-sustainable-alternative-benefiting-metabolic-reproductive-and-infant-health-markets https://www.synbiobeta.com/read/halting-deforestation-with-synthetic-biology-produced-fats https://www.synbiobeta.com/read/rootpath-launches-megabase-spark-program-to-support-underfunded-research-with-3-million-base-pairs-of-free-synthetic-dna https://www.synbiobeta.com/read/trilobio-raises-8m-to-deliver-whole-lab-automation-for-biologists https://www.synbiobeta.com/read/liberation-labs-announces-manufacturing-partnership-with-vivici https://www.synbiobeta.com/read/molecular-devices-launches-automated-qpix-flex-microbial-colony-picking-system https://www.synbiobeta.com/read/exozymes-launches-spin-out-nctx-to-unlock-a-promising-compound-for-gut-and-liver-health https://www.synbiobeta.com/read/ribbon-bio-launches-mirosynth-tm-dna-molecules-to-unlock-a-new-era-of-complex-synthetic-dna https://www.synbiobeta.com/read/pharma-leaders-end-reliance-on-endangered-marine-species https://www.synbiobeta.com/read/from-origami-to-synthetic-biology-how-jessica-baker-flechtner-is-reinventing-therapeutics-at-dorinano https://www.synbiobeta.com/read/kokomodo-leads-the-era-of-sustainable-cacao-at-synbiobeta-2025 https://www.synbiobeta.com/read/better-dairys-dr-david-nunn-on-reinventing-dairy-nutrition-and-sustainability-with-precision-fermentation https://www.synbiobeta.com/read/beyond-the-hype-patrick-rose-calls-for-a-new-era-of-biomanufacturing-at-synbiobeta-2025 https://www.synbiobeta.com/read/breaking-biologys-speed-limit-how-novel-bios-nbx-cyclone-tm-could-transform-molecular-cloning https://www.synbiobeta.com/read/prometheus-materials-is-reinventing-cement-concrete-with-algae-v2 https://www.synbiobeta.com/read/accelerating-discovery-vivek-adarsh-and-mithrl-usher-in-the-era-of-the-ai-co-scientist https://www.synbiobeta.com/read/kristina-simmons-on-commercializing-synthetic-biology-solve-the-biggest-problems-first https://www.synbiobeta.com/read/engineering-life-to-save-lives-egenesis-svp-of-innovation-dr-wenning-qin-on-ending-the-organ-shortage-with-synthetic-biology https://www.synbiobeta.com/read/why-synthetic-biology-could-define-our-century https://www.synbiobeta.com/read/inside-zymvols-bold-new-bet https://www.synbiobeta.com/read/biology-has-evolved-regulation-hasnt-heres-the-fallout https://www.synbiobeta.com/read/gene-therapys-goldilocks-problem-and-how-mits-engineers-are-solving-it https://www.synbiobeta.com/read/a-different-biology https://www.synbiobeta.com/read/this-tiny-engineered-protein-polymer-could-save-your-heart-after-a-heart-attack https://www.synbiobeta.com/read/pcr-is-so-last-pandemic-meet-the-laser-that-reads-your-dna https://www.synbiobeta.com/read/bespoke-crispr-enzymes-generated-by-ai-for-a-safer-genetic-future https://www.synbiobeta.com/read/waste-not-want-not-synthetic-biology-helps-achieve-circular-chemistry https://www.synbiobeta.com/read/from-bench-to-brand-a-first-timers-view-of-synbiobeta https://www.synbiobeta.com/read/genes-dreams-and-bio-machines-meet-the-synbiobeta-2025-award-winners https://www.synbiobeta.com/read/living-carbon-reclaims-appalachia-with-microsofts-backing https://www.synbiobeta.com/read/these-mice-tripped-once-and-got-smarter-for-weeks https://www.synbiobeta.com/read/uranium-extraction-goes-bio-the-rise-of-protein-miners https://www.synbiobeta.com/read/bird-flu-vaccine-gets-boost-from-nanoparticle-tech https://www.synbiobeta.com/read/can-a-building-material-be-alive-and-still-make-sense https://www.synbiobeta.com/read/chicken-rewired-scientists-grow-muscle-meat-using-tiny-straws-and-big-ideas https://www.synbiobeta.com/read/cell-therapy-breakthrough-gives-lung-failure-patients-a-fighting-chance https://www.synbiobeta.com/read/change-of-heart-literally-engineered-cells-flip-the-script-on-organ-failure https://www.synbiobeta.com/read/lsd-gets-a-brainy-makeover-with-new-potential-as-schizophrenia-treatment https://www.synbiobeta.com/read/nature-inspired-concrete-turns-heat-into-electricity https://www.synbiobeta.com/read/reading-the-microbial-spectrum-remote-sensing-breakthrough-in-synthetic-biology https://www.synbiobeta.com/read/why-some-protein-splicing-tools-fail-and-how-scientists-just-solved-it https://www.synbiobeta.com/read/fruit-flies-can-sense-electricity-and-yes-the-experiment-was-actually-that-cool https://www.synbiobeta.com/read/digital-twins-of-mouse-brains-could-rewrite-neuroscience https://www.synbiobeta.com/read/inside-the-most-complete-ape-genomes-ever-assembled https://www.synbiobeta.com/read/biotech-is-americas-to-win-if-we-choose-to-lead https://www.synbiobeta.com/read/the-weird-beautiful-origins-of-bioart-youve-probably-never-heard-about https://www.synbiobeta.com/read/cell-free-systems-evolving-to-fill-new-application-niches https://www.synbiobeta.com/read/microbes-that-finally-make-almond-milk-less-miserable https://www.synbiobeta.com/read/organoid-researchers-are-using-placenta-hack-for-improved-growth https://www.synbiobeta.com/read/fixing-the-photosynthetic-flaw-thats-costing-us-billions https://www.synbiobeta.com/read/deep-learning-in-metagenomics-makes-biology-faster-to-engineer https://www.synbiobeta.com/read/the-future-of-space-travel-is-microbial-and-astronaut-kate-rubins-knows-it https://www.synbiobeta.com/read/a-dna-aptmer-double-whammy-against-leukemia https://www.synbiobeta.com/read/33-000-biomarkers-111-pills-and-a-plan-to-defeat-time https://www.synbiobeta.com/read/synthetic-biologys-tinkerer-in-chief https://www.synbiobeta.com/read/what-peter-diamandis-wants-to-teach-us-about-never-getting-old https://www.synbiobeta.com/read/americas-bioeconomy-is-booming-and-it-could-double-by-2030 https://www.synbiobeta.com/read/ai-powered-medicine-just-got-a-600-million-vote-of-confidence https://www.synbiobeta.com/read/redesigning-blood-for-the-battlefield-and-beyond https://www.synbiobeta.com/read/the-bio-pixel-revolution-artificial-cells-are-about-to-light-up-diagnostics https://www.synbiobeta.com/read/synthetic-genomics-viral-engineering-platform-aids-in-swine-fever-fight-2 https://www.synbiobeta.com/read/long-dna-synthesis-gets-a-speed-boost-from-new-idt-and-elegen-partnership https://www.synbiobeta.com/read/folding-the-future-how-ai-is-reshaping-protein-engineering https://www.synbiobeta.com/read/theres-a-new-generation-of-probiotics-coming-to-a-store-near-you https://www.synbiobeta.com/read/protein-without-the-moo-brewing-the-future-of-food https://www.synbiobeta.com/read/flexible-electronics-are-growing-on-trees https://www.synbiobeta.com/read/the-biotech-revolution-in-your-skincare-cabinet https://www.synbiobeta.com/read/ai-supercharges-dna-data-storage-reads-data-3-200-times-faster https://www.synbiobeta.com/read/lighten-up-how-scientists-are-twisting-cells-at-will https://www.synbiobeta.com/read/galactic-gastronomy-the-science-of-producing-food-beyond-earth https://www.synbiobeta.com/read/synthetic-biologys-next-leap-rna-based-cells-that-build-themselves-without-proteins https://www.synbiobeta.com/read/engineered-muscles-that-move-like-the-real-thing-mit-just-made-it-happen https://www.synbiobeta.com/read/the-race-to-automate-natures-hidden-pharmacies https://www.synbiobeta.com/read/the-future-of-spinal-cord-injury-treatment-how-cellino-and-matricelf-are-leading-the-way https://www.synbiobeta.com/read/nasa-funded-study-targets-alaskas-frozen-dunes-to-uncover-clues-to-life-on-mars-and-titan https://www.synbiobeta.com/read/verinomics-unveils-ai-powered-platforms-to-revolutionize-crop-breeding https://www.synbiobeta.com/read/ala-cart-serving-up-a-made-to-order-cancer-cure https://www.synbiobeta.com/read/courts-congress-and-confusion-biotechnology-regulation-post-chevron https://www.synbiobeta.com/read/following-your-nose-could-be-the-key-to-cartilidge-repair https://www.synbiobeta.com/read/how-ai-wearables-are-giving-the-blood-pressure-cuff-the-squeeze https://www.synbiobeta.com/read/pow-bio-unveils-ai-powered-biomanufacturing-facility-in-alameda-to-accelerate-continuous-fermentation https://www.synbiobeta.com/read/forget-jurassic-park-biotech-could-prevent-extinctions-in-a-whole-new-way https://www.synbiobeta.com/read/arsenale-bioyards-wants-to-slash-biomanufacturing-costs-by-90-investors-just-bet-10m-on-it https://www.synbiobeta.com/read/how-tiny-cantilevers-are-transforming-water-testing https://www.synbiobeta.com/read/move-over-crispr-smaller-smarter-gene-editing-system-found https://www.synbiobeta.com/read/engineers-copy-sponge-skeleton-to-create-ultra-strong-energy-absorbing-material https://www.synbiobeta.com/read/the-next-asilomar-moment-why-genetic-innovation-needs-a-regulatory-revolution https://www.synbiobeta.com/read/bioprocessing-innovation-yields-high-value-products-alongside-biofuels https://www.synbiobeta.com/read/ignota-labs-secures-6-9m-to-bring-dead-drugs-back-to-life-with-ai https://www.synbiobeta.com/read/decentralized-platforms-upending-how-synthetic-biology-is-done https://www.synbiobeta.com/read/the-antibody-that-tricks-tumors-into-exposing-themselves https://www.synbiobeta.com/read/new-ai-model-predicts-rna-structures-with-unprecedented-accuracy https://www.synbiobeta.com/read/a-century-old-tb-vaccine-is-failing-a-new-mrna-shot-might-finally-change-that https://www.synbiobeta.com/read/the-nutty-science-behind-a-revolutionary-new-biomaterial https://www.synbiobeta.com/read/evo2-one-bio-ai-model-to-rule-them-all https://www.synbiobeta.com/read/coloring-outside-the-lines-microbes-meet-modern-fashion https://www.synbiobeta.com/read/melanoma-immunotherapy-decoded-device-reads-your-microbiome-to-predict-treatment-response https://www.synbiobeta.com/read/e-skin-that-heals-in-seconds-the-future-of-health-monitoring https://www.synbiobeta.com/read/rapid-protein-production-achieved-through-biologically-engineered-reaction-crucibles https://www.synbiobeta.com/read/genetically-modified-fish-could-erase-mercury-pollution https://www.synbiobeta.com/read/towards-an-ai-driven-crispr-future https://www.synbiobeta.com/read/protein-revolution-the-tiny-model-making-a-massive-impact https://www.synbiobeta.com/read/eyes-wide-open-how-stem-cell-shots-could-reboot-ocular-health https://www.synbiobeta.com/read/the-microbe-that-speaks-a-new-genetic-language https://www.synbiobeta.com/read/unlocking-genetic-blueprints-for-customizable-biomaterials https://www.synbiobeta.com/read/the-messy-complex-and-surprisingly-ubiquitous-origins-of-life https://www.synbiobeta.com/read/the-future-of-bioplastic-production-requires-targeted-collaboration-and-coordination https://www.synbiobeta.com/read/engineering-tomorrow-darpas-push-into-the-frontier-of-synthetic-biology https://www.synbiobeta.com/read/ai-is-decoding-the-3d-genome-and-its-doing-it-faster-than-humans-ever-could https://www.synbiobeta.com/read/light-tunable-chemicals-could-spark-new-era-in-protein-science https://www.synbiobeta.com/read/ai-powered-protein-editing-unlocked-through-text-guided-design https://www.synbiobeta.com/read/cancer-diagnostic-tool-hits-the-right-note-with-acoustic-tech https://www.synbiobeta.com/read/engineering-roots-for-climate-resilient-crops https://www.synbiobeta.com/read/the-brain-machine-interface-just-got-a-major-upgrade https://www.synbiobeta.com/read/computational-design-of-gpcrs-that-takes-their-environment-into-consideration https://www.synbiobeta.com/read/the-final-synthetic-yeast-genome-is-now-a-reality-and-what-that-means-for-biotech https://www.synbiobeta.com/read/gut-microbiome-is-the-key-to-unlocking-nafld-diagnostics https://www.synbiobeta.com/read/epigenetic-clocks-may-only-be-scratching-the-surface-of-aging https://www.synbiobeta.com/read/lab-grown-intestines-its-all-in-the-protein-printing https://www.synbiobeta.com/read/revolutionizing-industries-with-bacteria-from-extreme-environments https://www.synbiobeta.com/read/when-bacteria-go-gel-the-sticky-science-of-microbial-cables https://www.synbiobeta.com/read/ai-takes-a-bite-out-of-snake-venom https://www.synbiobeta.com/read/pump-up-the-volume-rosalind-3-0-is-set-to-revolutionize-biosensing https://www.synbiobeta.com/read/uk-at-risk-of-losing-engineering-biology-lead-lords-report-warns https://www.synbiobeta.com/read/arc-institute-and-nvidia-partner-to-redefine-biomedical-research-with-ai https://www.synbiobeta.com/read/can-ai-make-sense-of-mass-spec-data-this-startup-raised-360m-to-find-out https://www.synbiobeta.com/read/a-swiss-army-knife-for-gene-editing https://www.synbiobeta.com/read/biomanufacturing-breakthrough-biosphere-unveils-uv-sterilized-bioreactor https://www.synbiobeta.com/read/absci-and-amd-team-up-to-revolutionize-drug-discovery-with-ai https://www.synbiobeta.com/read/xenotransplantations-second-patient-a-step-forward-through-loss https://www.synbiobeta.com/read/zymochem-joins-the-b-corp-movement-setting-a-new-standard-for-sustainable-biotech https://www.synbiobeta.com/read/ai-tool-for-cancer-immunotherapy-uses-blood-tests-to-enhance-effectiveness https://www.synbiobeta.com/read/the-toxic-male-technique-revolutionizing-mosquito-control https://www.synbiobeta.com/read/basecamp-research-scales-up-with-boston-lab-new-cso-appointment-and-nvidia-powered-ai https://www.synbiobeta.com/read/precision-cancer-treatments-get-boost-from-new-gene-fusion-database https://www.synbiobeta.com/read/inside-the-smart-cell-revolution-new-circuits-new-possibilities https://www.synbiobeta.com/read/the-great-cancer-escape-how-scientists-are-shutting-down-a-key-trick https://www.synbiobeta.com/read/nanoparticles-with-a-mission-how-peptides-are-unlocking-brain-specific-treatments https://www.synbiobeta.com/read/bioengineered-yeast-are-the-future-of-drug-delivery https://www.synbiobeta.com/read/needle-free-vaccines-stanford-researchers-develop-topical-vaccine-cream-using-skin-bacteria https://www.synbiobeta.com/read/gene-control-startup-concinnity-secures-ps3m-seed-funding-to-advance-gene-therapy-safety https://www.synbiobeta.com/read/superman-bacteria-and-the-promise-of-a-greener-industrial-microbiology https://www.synbiobeta.com/read/ai-meets-agriculture-reinventing-crop-dna-for-a-food-secure-future https://www.synbiobeta.com/read/heart-failure-may-soon-be-reversible-with-new-gene-therapy https://www.synbiobeta.com/read/brain-tumor-organoids-mirror-glioblastoma-responses-to-car-t https://www.synbiobeta.com/read/blueprints-and-beyond-cracking-the-code-of-gene-regulation https://www.synbiobeta.com/read/new-study-reveals-key-enzymes-driving-pancreatic-tumor-growth https://www.synbiobeta.com/read/deep-learning-models-predict-high-quality-organoids-faster-than-human-experts https://www.synbiobeta.com/read/rubi-secures-1-million-nsf-grant-to-scale-carbon-to-cellulose-technology https://www.synbiobeta.com/read/bioprinting-breakthrough-creates-functional-tissue-at-warp-speed https://www.synbiobeta.com/read/how-ai-and-llms-could-revolutionize-functional-genomics-research https://www.synbiobeta.com/read/antheia-lands-12m-with-second-biomap-deal-to-reshape-u-s-pharma https://www.synbiobeta.com/read/from-trees-to-tupperware-lignin-industries-next-gen-bioplastic-solution https://www.synbiobeta.com/read/fear-anxiety-and-ayahuasca-what-a-decade-of-research-reveals https://www.synbiobeta.com/read/pancreas-organoid-breakthrough-sheds-light-on-stem-cell-mysteries https://www.synbiobeta.com/read/aging-muscles-and-the-mystery-of-declining-regeneration https://www.synbiobeta.com/read/hooked-on-a-feeling-dnas-catchy-new-role-in-stickiness https://www.synbiobeta.com/read/fabricating-nanostructures-with-rna-origami https://www.synbiobeta.com/read/leaf-sized-revolution-how-tiny-sensors-are-poised-to-transform-agriculture https://www.synbiobeta.com/read/precision-cancer-therapy-breakthrough-shines-light-on-cyanobacteria https://www.synbiobeta.com/read/crispr-clinical-trial-targets-sickle-cell-at-its-genetic-roots https://www.synbiobeta.com/read/revealing-rnas-hidden-dance-a-new-frontier-in-molecular-imaging https://www.synbiobeta.com/read/ai-powered-protein-engineering-heightened-by-cradle-bios-73m-series-b https://www.synbiobeta.com/read/artificial-protein-design-gets-boost-from-revolutionary-method https://www.synbiobeta.com/read/bio-base-europe-pilot-plant-launches-75-000-l-fermenter-to-meet-bioeconomy-demands https://www.synbiobeta.com/read/how-cultivated-meat-carved-out-its-plate-in-history https://www.synbiobeta.com/read/imicrobes-secures-10m-seed-round-to-power-sustainable-biomanufacturing https://www.synbiobeta.com/read/ferments-20m-bet-turning-waste-into-wealth-with-enzyme-innovation https://www.synbiobeta.com/read/turtletree-and-mad-foods-join-forces-to-launch-innovative-lf-coffee-line https://www.synbiobeta.com/read/evo-the-ai-thats-decoding-lifes-genetic-blueprint https://www.synbiobeta.com/read/anthrogen-raises-4m-to-tackle-carbon-emissions-with-co2-consuming-microbes-and-ai https://www.synbiobeta.com/read/tiny-nanopores-spark-big-strides-for-synthetic-biology https://www.synbiobeta.com/read/invention-of-synthetic-life-that-talks-back https://www.synbiobeta.com/read/microbe-atlas-project-aims-to-transform-mining-for-renewable-energy https://www.synbiobeta.com/read/shiru-secures-16m-to-lead-ai-powered-ingredient-discovery https://www.synbiobeta.com/read/breakthrough-in-protein-design-aims-to-use-bioluminescence-for-real-time-medical-imaging https://www.synbiobeta.com/read/new-study-shows-bio-based-plastics-may-harm-earthworms-and-soil-health https://www.synbiobeta.com/read/new-ai-tool-tracks-your-location-using-microbiome-data-from-bacteria https://www.synbiobeta.com/read/instar-1-0-future-fields-biofactory-revolutionizes-protein-production https://www.synbiobeta.com/read/lung-cancer-takes-big-beating-from-tiny-nano-particles https://www.synbiobeta.com/read/bioengineered-yeast-turning-herbal-medicine-into-mainstream-medicine https://www.synbiobeta.com/read/thread-lightly-biofabrication-and-the-end-of-fast-fashion https://www.synbiobeta.com/read/first-autonomous-robotic-scientist-launched-as-tetsuwan-scientific-secures-2-7m https://www.synbiobeta.com/read/maravai-lifesciences-to-acquire-officinae-bios-dna-and-rna-business-for-nucleic-acid-innovation https://www.synbiobeta.com/read/biomanufacturing-milestone-inscriptas-genoscaler-tm-brings-eco-friendly-skincare-ingredients-to-market https://www.synbiobeta.com/read/cancer-fighting-potential-hidden-in-a-parasitic-caterpillar-fungus https://www.synbiobeta.com/read/new-research-reveals-potential-risks-of-using-crispr-for-chronic-granulomatous-disease https://www.synbiobeta.com/read/absci-and-twist-bioscience-team-up-to-redefine-antibody-discovery-with-ai https://www.synbiobeta.com/read/modular-biology-the-ikea-of-synthetic-genes https://www.synbiobeta.com/read/how-ai-is-revolutionizing-mrna-stability-ginkgos-new-research https://www.synbiobeta.com/read/17-new-biomade-projects-aim-to-boost-u-s-bioeconomy-and-create-sustainable-jobs-with-26-9-million https://www.synbiobeta.com/read/the-synthetic-revolution-you-didnt-see-coming-a-glimpse-at-2024s-most-game-changing-biotech-inventions https://www.synbiobeta.com/read/from-sequence-to-function-with-protein-language-models https://www.synbiobeta.com/read/ginkgo-bioworks-and-octarine-bio-partnership-achieves-initial-success-in-to-advancing-sustainable-dye-production https://www.synbiobeta.com/read/inside-aixbio-demo-day-2024-the-top-startups-merging-ai-and-biotechnology https://www.synbiobeta.com/read/cultured-meat-porks-out-on-sorghum-proteins https://www.synbiobeta.com/read/meet-chonkus-the-algae-that-eats-carbon-and-sinks-like-a-rock https://www.synbiobeta.com/read/cultured-meats-new-ally-photosynthetic-microbes https://www.synbiobeta.com/read/novel-engineered-protein-promises-a-cleaner-rare-earth-extraction https://www.synbiobeta.com/read/national-university-of-singapore-advances-a-synthetic-biology-driven-future https://www.synbiobeta.com/read/antheias-first-commercial-thebaine-delivery-sets-new-standard-in-pharmaceutical-biomanufacturing https://www.synbiobeta.com/read/life-on-both-sides-how-cross-chiral-rna-could-redefine-evolution https://www.synbiobeta.com/read/the-one-mutation-that-could-change-cancer-therapy-forever https://www.synbiobeta.com/read/cracking-the-code-of-kokumi-the-key-to-full-bodied-cheese-flavor https://www.synbiobeta.com/read/egenesis-raises-191m-to-lead-the-future-of-cross-species-kidney-transplants https://www.synbiobeta.com/read/us-epa-approves-expanded-biosurfactant-production-list-for-locus-fs https://www.synbiobeta.com/read/lanzatech-secures-3m-doe-grant-to-transform-co2-into-sustainable-chemicals https://www.synbiobeta.com/read/kdt-ventures-closes-100m-fund-iv-to-fuel-early-stage-science-startups https://www.synbiobeta.com/read/nuclera-secures-75-million-to-accelerate-protein-expression-and-purification-in-drug-discovery https://www.synbiobeta.com/read/tiny-brains-big-discoveries-the-strange-science-behind-lewy-body-dementia https://www.synbiobeta.com/read/harnessing-ethanol-for-sustainable-biomanufacturing https://www.synbiobeta.com/read/induced-resistance-could-vaccinating-plants-help-us-outgrow-pesticides https://www.synbiobeta.com/read/novonesis-teams-up-with-benchling-to-supercharge-biosolutions-r-d https://www.synbiobeta.com/read/usp50-the-protein-key-to-dna-replication-and-stability https://www.synbiobeta.com/read/bit-bios-opti-ox-tm-tech-gains-unprecedented-global-patent-coverage https://www.synbiobeta.com/read/abolis-biotechnologies-lands-eu35m-to-boost-r-d-and-address-biotech-market-challenges https://www.synbiobeta.com/read/2024-nobel-winners-transform-protein-science-with-design-and-ai-predictions https://www.synbiobeta.com/read/arpa-h-unveils-program-to-revolutionize-drug-safety-and-efficacy-testing https://www.synbiobeta.com/read/tissue-engineerings-future-could-combine-morphogens-and-cell-adhesion-to-shape-organoids https://www.synbiobeta.com/read/towards-longer-purer-oligonucleotides-thanks-to-enzymatic-dna-synthesis https://www.synbiobeta.com/read/amyris-lands-12-3m-to-tackle-u-s-drug-shortages-through-synthetic-biology https://www.synbiobeta.com/read/enzymatic-approach-to-synthetic-ephedra-type-alkaloid-production https://www.synbiobeta.com/read/revolutionizing-gene-regulation-2024-nobel-prize-in-medicine-honors-the-discovery-of-microrna https://www.synbiobeta.com/read/prime-medicine-secures-55-million-deal-with-bristol-myers-squibb-to-develop-next-gen-t-cell-therapies https://www.synbiobeta.com/read/sekisui-chemical-and-lanzatech-to-build-multiple-commercial-scale-waste-to-ethanol-facilities-in-japan https://www.synbiobeta.com/read/dcvc-bio-closes-400-million-fund-iii-to-accelerate-breakthroughs-in-life-sciences-and-deep-tech https://www.synbiobeta.com/read/npol-debuts-bio-concrete-gathering-lamp https://www.synbiobeta.com/read/groundbreaking-study-reveals-genetic-link-between-bipolar-disorder-and-epilepsy https://www.synbiobeta.com/read/ai-and-automation-drive-bioreactor-innovations-from-pharma-to-precision-fermentation https://www.synbiobeta.com/read/silage-fermentation-a-new-focus-for-reducing-agricultural-emissions https://www.synbiobeta.com/read/the-science-behind-synthetic-spider-silk-bandages-a-web-of-healing-or-hype https://www.synbiobeta.com/read/how-the-microbiome-shields-the-gut-from-drug-damage https://www.synbiobeta.com/read/synthetic-genomics-startup-lands-58m-welcomes-nobel-laureate-to-board https://www.synbiobeta.com/read/zbiotics-launches-first-ever-sugar-to-fiber-probiotic-drink-mix-for-gut-health https://www.synbiobeta.com/read/forging-the-future-of-our-bioeconomy-by-bridging-the-valley-of-death https://www.synbiobeta.com/read/test-test https://www.synbiobeta.com/read/new-protein-relocation-method-could-transform-cancer-and-als-therapies https://www.synbiobeta.com/read/schmidt-sciences-polymath-program-awards-2-5m-grants-to-six-pioneering-researchers https://www.synbiobeta.com/read/new-chow-who-dis-upping-the-wood-shucks-appetite-for-chucking https://www.synbiobeta.com/read/the-future-of-epidemic-prevention-lies-in-wastewater-analysis https://www.synbiobeta.com/read/cellevate-raises-eu3-2m-to-power-biomanufacturing-revolution https://www.synbiobeta.com/read/ginkgo-and-google-cloud-team-up-to-supercharge-drug-development-with-new-protein-llm https://www.synbiobeta.com/read/computer-models-are-optimizing-microbial-communities-in-synthetic-biology https://www.synbiobeta.com/read/revolutionizing-vaccines-and-cancer-treatments-with-self-amplifying-rna https://www.synbiobeta.com/read/nanosyrinx-secures-13m-funding-to-advance-intracellular-drug-delivery-technology https://www.synbiobeta.com/read/is-virus-delivered-gene-editing-the-future-of-agriculture https://www.synbiobeta.com/read/sweet-science-carbohydrate-based-polymers-that-could-transform-water-purification https://www.synbiobeta.com/read/6m-in-cancer-research-grants-to-push-boundaries-of-ai-and-immunotherapy https://www.synbiobeta.com/read/synbio-challenges-2024-a-glimpse-into-the-future-of-synthetic-biology-in-shenzhen https://www.synbiobeta.com/read/organoids-created-using-new-molecular-engineering-technique https://www.synbiobeta.com/read/next-gen-biosensors-light-the-way-on-disease-detection https://www.synbiobeta.com/read/engineering-the-immune-system-to-heal-spinal-cord-injuries https://www.synbiobeta.com/read/slick-science-the-potato-based-breakthrough-in-sustainable-lubrication https://www.synbiobeta.com/read/innovative-brain-cancer-therapy-is-a-two-in-one-car-t-approach https://www.synbiobeta.com/read/synthetic-biology-in-the-open https://www.synbiobeta.com/read/21st-bio-secures-self-gras-status-for-its-precision-fermented-beta-lactoglobulin https://www.synbiobeta.com/read/tandem-repeat-secures-1-5m-dod-grant-to-scale-protein-based-fibers https://www.synbiobeta.com/read/driving-ai-and-synbio-breakthroughs-nsf-funds-15m-ibiofoundry https://www.synbiobeta.com/read/bioengineers-create-bacteria-yeast-hybrids-for-energy-and-pharma-advances https://www.synbiobeta.com/read/synthesizing-the-rules-how-dna-got-its-groove-back https://www.synbiobeta.com/read/zbiotics-to-revolutionize-probiotics-with-12m-series-a https://www.synbiobeta.com/read/how-synthetic-immunology-could-revolutionize-disease-treatment https://www.synbiobeta.com/read/japans-food-tech-titans-enter-the-u-s-market-with-j-starx-accelerator https://www.synbiobeta.com/read/zymochems-bio-based-innovation-secures-1-57m-dod-award https://www.synbiobeta.com/read/inari-unveils-major-expansion-with-new-west-lafayette-facility https://www.synbiobeta.com/read/engineered-spores-create-living-plastics-and-the-future-of-biodegradable-materials https://www.synbiobeta.com/read/gevo-and-shell-drive-sustainability-in-high-performance-racing https://www.synbiobeta.com/read/how-a-new-circularity-index-measures-bioeconomic-impact-on-climate-change https://www.synbiobeta.com/read/advanced-ai-reveals-how-proteins-act-in-their-natural-contexts https://www.synbiobeta.com/read/polymers-by-algorithm-how-ai-is-crafting-tomorrows-materials https://www.synbiobeta.com/read/got-saliva-you-might-just-have-a-heart-test-in-your-pocket https://www.synbiobeta.com/read/redesigning-synthetic-biology-with-automation https://www.synbiobeta.com/read/bolt-threads-completes-merger-with-golden-arrow-debuts-as-publicly-traded-company https://www.synbiobeta.com/read/engineering-black-soldier-flies-for-the-waste-management-revolution https://www.synbiobeta.com/read/stanford-research-unveils-molecular-transformations-in-your-40s-and-60s https://www.synbiobeta.com/read/gates-foundation-backs-prolific-machines-to-democratize-life-saving-antibodies https://www.synbiobeta.com/read/building-a-synthetic-biology-future-in-the-land-down-under https://www.synbiobeta.com/read/darpas-aixbto-initiative-pushing-bioinnovation-boundaries https://www.synbiobeta.com/read/methanotrophs-natures-methane-filters-and-climate-guardians https://www.synbiobeta.com/read/cambium-and-checkerspot-forge-partnership-to-develop-advanced-bio-based-foam-products https://www.synbiobeta.com/read/absci-corporation-partners-with-memorial-sloan-kettering-to-advance-ai-driven-cancer-therapeutics https://www.synbiobeta.com/read/new-bioactive-material-could-revolutionize-knee-surgery-and-joint-health https://www.synbiobeta.com/read/life-and-vitality-in-mice-extended-with-new-treatment https://www.synbiobeta.com/read/the-influence-of-synthetic-biology-on-national-bioeconomy-strategies https://www.synbiobeta.com/read/molecular-devices-unveils-qpix-insights-to-transform-microbial-colony-analysis https://www.synbiobeta.com/read/primient-and-synonym-forge-strategic-partnership-to-propel-u-s-bioproduct-innovation https://www.synbiobeta.com/read/twist-bioscience-and-bitbiome-announce-transaminase-enzyme-screening-kit https://www.synbiobeta.com/read/how-phages-infect-bacteria-latest-research-uncovers-crucial-details https://www.synbiobeta.com/read/ai-driven-cell-therapy-pioneer-outpace-bio-raises-144-million-in-series-b-funding https://www.synbiobeta.com/read/biomatter-raises-eu6-5m-to-revolutionize-enzyme-design-with-generative-ai https://www.synbiobeta.com/read/cauldron-appoints-david-weiner-as-new-cto-to-lead-biomanufacturing-breakthroughs https://www.synbiobeta.com/read/ajinomoto-health-nutrition-partners-with-shiru-to-develop-sweet-proteins https://www.synbiobeta.com/read/asimov-unveils-4th-generation-ai-driven-cho-edge-system-for-enhanced-therapeutic-manufacturing https://www.synbiobeta.com/read/bit-bio-welcomes-new-cfo-to-drive-financial-strategy-and-growth https://www.synbiobeta.com/read/genetically-engineered-skin-microbiome-outsmarts-mosquitoes https://www.synbiobeta.com/read/darpas-switch-program-seeks-to-advance-biomanufacturing-for-defense-needs https://www.synbiobeta.com/read/microrna-study-could-usher-new-era-for-crop-improvement https://www.synbiobeta.com/read/gene-edited-superfoods-addressing-global-nutrition https://www.synbiobeta.com/read/breakthrough-photoenzymatic-process-enhances-agrochemicals-and-pharmaceuticals https://www.synbiobeta.com/read/cemvita-achieves-major-milestone-500-barrels-of-sustainable-oil-per-day https://www.synbiobeta.com/read/antheia-secures-17-million-to-boost-u-s-production-of-critical-pharmaceutical-ingredients https://www.synbiobeta.com/read/grobio-secures-60-3-million-in-series-b-financing-to-advance-protein-therapeutics https://www.synbiobeta.com/read/gsk-partners-with-touchlight-for-mrna-vaccine-development-using-dbdna-technology https://www.synbiobeta.com/read/artificial-intelligence-reveals-protein-dna-interactions https://www.synbiobeta.com/read/bacterial-memory-a-new-frontier-in-probiotic-engineering https://www.synbiobeta.com/read/kurita-america-and-solugen-join-forces-to-develop-carbon-negative-water-treatment-products https://www.synbiobeta.com/read/hitched-to-lipid-rafts-targeting-cells-with-surgical-precision https://www.synbiobeta.com/read/anoxygen-grant-boosts-anaerobic-bacteria-research-and-biotechnology https://www.synbiobeta.com/read/bitbiome-welcomes-industry-veteran-john-nicols-as-strategic-advisor-to-propel-enzyme-product-development https://www.synbiobeta.com/read/briefly-bio-launches-to-tackle-reproducibility-crisis-in-science https://www.synbiobeta.com/read/building-a-durable-bioeconomy-demands-new-mindsets-and-approaches https://www.synbiobeta.com/read/zymochem-fuses-enzymes-and-chemistry-to-revolutionize-the-hygiene-industry https://www.synbiobeta.com/read/syngenta-and-ginkgo-bioworks-forge-new-collaboration-to-fast-track-biological-solutions https://www.synbiobeta.com/read/aspect-biosystems-secures-72-75-million-government-investment-to-advance-bioprinted-tissue-therapeutics https://www.synbiobeta.com/read/zymochem-launches-bayse-tm-the-worlds-first-bio-based-and-biodegradable-super-absorbent-polymer https://www.synbiobeta.com/read/harnessing-bacteriophage-as-a-new-weapon-against-acute-gvhd https://www.synbiobeta.com/read/eligo-bioscience-achieves-breakthrough-in-in-vivo-bacterial-genome-editing https://www.synbiobeta.com/read/spiber-unveils-new-sustainable-fabric-blends-with-italian-textile-giants https://www.synbiobeta.com/read/osv-awards-fellowship-to-dr-mariam-elgabry-for-innovative-microbiome-health-device https://www.synbiobeta.com/read/synthetic-biologists-outline-framework-for-assessing-data-hazards https://www.synbiobeta.com/read/remember-the-big-data-problem-yeah-me-neither https://www.synbiobeta.com/read/ai-tool-enhances-improves-cancer-therapy-response https://www.synbiobeta.com/read/revolutionizing-leukemia-treatment-with-engineered-plasma-b-cells https://www.synbiobeta.com/read/enhancing-genetic-sensor-technology-a-leap-towards-precision-and-versatility https://www.synbiobeta.com/read/new-genes-identified-to-reduce-biofilm-in-antibiotic-resistant-bacteria https://www.synbiobeta.com/read/lithuania-leading-the-way-in-dna-data-storage-innovation https://www.synbiobeta.com/read/a-holistic-approach-to-teaching-synthetic-biology https://www.synbiobeta.com/read/evolutionaryscale-raises-142m-and-unveils-ai-model-esm3-to-transform-biology https://www.synbiobeta.com/read/snipr-biome-secures-gates-foundation-funding-to-combat-environmental-enteric-dysfunction-in-pregnant-women https://www.synbiobeta.com/read/eli-lilly-collaborates-with-openai-to-discover-novel-antimicrobials-for-drug-resistant-pathogens https://www.synbiobeta.com/read/twostep-therapeutics-launches-with-6-5m-seed-funding-to-develop-solid-tumor-targeting-therapies https://www.synbiobeta.com/read/earth-venture-capital-invests-in-orbillion-bio-to-scale-up-cultivated-meat-production https://www.synbiobeta.com/read/non-model-organisms-expand-the-repertoire-of-synthetic-biology https://www.synbiobeta.com/read/exsilio-therapeutics-emerges-from-stealth-with-82-million-series-a-financing-to-develop-redosable-genomic-medicines https://www.synbiobeta.com/read/bit-bio-introduces-ioastrocytes-pioneering-toolkit-for-disease-research-and-therapeutic-development https://www.synbiobeta.com/read/30m-purse-bezos-center-for-sustainable-protein-launches-at-imperial https://www.synbiobeta.com/read/scientists-develop-digital-twin-for-gut-microbiome-to-enhance-nutrition https://www.synbiobeta.com/read/novel-enzyme-evolution-algorithm-yields-high-performance-mutations https://www.synbiobeta.com/read/the-dawn-of-edge-ai-in-sustainable-agriculture https://www.synbiobeta.com/read/revolutionary-wearable-patch-offers-continuous-health-monitoring https://www.synbiobeta.com/read/a-new-ageing-metric-how-protein-clumps-could-predict-your-health-future https://www.synbiobeta.com/read/basecamp-research-and-ferruz-laboratory-announce-zymctrl-a-revolutionary-ai-tool-for-enzyme-design https://www.synbiobeta.com/read/meiogenix-names-ricardo-garcia-de-alba-as-new-ceo-to-drive-global-agricultural-innovation https://www.synbiobeta.com/read/enveda-biosciences-secures-55-million-in-new-funding-to-accelerate-ai-powered-drug-discovery https://www.synbiobeta.com/read/calling-all-investors-positioning-synthetic-biology-in-the-service-of-climate-change https://www.synbiobeta.com/read/green-bioactives-announces-promising-results-for-new-memory-enhancing-supplement https://www.synbiobeta.com/read/solugen-secures-213-6-million-loan-guarantee-for-minnesota-bioforge-facility https://www.synbiobeta.com/read/prime-improvements-a-new-era-in-gene-therapy https://www.synbiobeta.com/read/syntis-bio-launches-with-15-5m-to-tackle-obesity-and-rare-metabolic-diseases https://www.synbiobeta.com/read/green-chemistry-breakthrough-co2-transformed-into-valuable-acids https://www.synbiobeta.com/read/cancer-therapy-game-changer-could-lie-in-bacteria-based-chemo https://www.synbiobeta.com/read/nuclera-secures-ps1-14m-in-innovate-uk-grants-to-enhance-protein-expression-technology https://www.synbiobeta.com/read/building-microbiomes-from-scratch https://www.synbiobeta.com/read/prolific-machines-secures-55m-series-b-funding-to-transform-biomanufacturing-with-light https://www.synbiobeta.com/read/huidagene-and-synthego-forge-partnership-to-advance-crispr-based-therapies https://www.synbiobeta.com/read/enveda-biosciences-collaborates-with-microsoft-to-unveil-prism-revolutionizing-drug-discovery-with-ai https://www.synbiobeta.com/read/allonnia-teams-up-with-terra-systems-to-tackle-groundwater-contamination-across-north-america https://www.synbiobeta.com/read/series-a-more-like-series-amazing-insempras-20m-win https://www.synbiobeta.com/read/the-ethics-of-accessibility-who-controls-the-power-in-synthetic-biology https://www.synbiobeta.com/read/idt-unveils-state-of-the-art-synthetic-biology-hub-propelling-innovation-in-coralville-iowa https://www.synbiobeta.com/read/detailed-single-cell-analysis-of-xenotransplanted-pig-hearts-and-kidneys-into-humans https://www.synbiobeta.com/read/newmoo-redefines-cheese-production-with-plant-based-innovation https://www.synbiobeta.com/read/the-state-of-ai-at-synbiobeta-2024 https://www.synbiobeta.com/read/meatable-appoints-seasoned-industry-veteran-as-ceo-to-spearhead-u-s-market-expansion https://www.synbiobeta.com/read/gene-editing-breakthrough-multiplex-genome-editing-for-complex-diseases https://www.synbiobeta.com/read/first-human-mini-brain-with-functional-blood-brain-barrier-unveiled https://www.synbiobeta.com/read/ai-powered-antibody-drug-discovery-gets-boost-as-labgenius-raises-ps35m-in-series-b-funding https://www.synbiobeta.com/read/natural-nanocarriers-deliver-gene-therapy-for-spinal-disc-recovery https://www.synbiobeta.com/read/spinning-sound-how-spider-silk-could-revolutionize-microphone-technology https://www.synbiobeta.com/read/interdisciplinary-innovation-pioneering-study-propels-biomaterial-development-forward https://www.synbiobeta.com/read/engineered-enzyme-produces-vanilla-from-plant-waste https://www.synbiobeta.com/read/the-startup-decarbonizing-industries-and-transforming-waste-gas-into-everyday-essentials https://www.synbiobeta.com/read/nabla-bio-secures-26-million-funding-boost-to-drive-protein-design-innovations https://www.synbiobeta.com/read/insempra-secures-20-million-investment-to-pave-the-way-for-next-gen-bio-based-ingredients https://www.synbiobeta.com/read/tiny-brains-big-breakthrough-mini-brain-innovation-could-revolutionize-alzheimers-treatment https://www.synbiobeta.com/read/novel-genetic-drivers-of-aging-and-blood-cancer-risk-discovered https://www.synbiobeta.com/read/elegen-reels-in-35m-to-turbocharge-dna-synthesis https://www.synbiobeta.com/read/olden-labs-launches-the-worlds-first-automated-animal-research-lab https://www.synbiobeta.com/read/ginkgo-brings-biotechs-groundbreaking-moment-closer-with-partnerships-and-ai https://www.synbiobeta.com/read/the-next-frontier-in-gene-synthesis-conquering-complex-dna https://www.synbiobeta.com/read/harnessing-biofilms-for-biomanufacturing-and-as-living-materials https://www.synbiobeta.com/read/intelligent-architecture-in-enzyme-design-for-a-sustainable-future https://www.synbiobeta.com/read/synthetic-biologys-path-to-sustainable-food-systems https://www.synbiobeta.com/read/biodesign-in-architecture-living-buildings-powered-by-synbio https://www.synbiobeta.com/read/this-single-cell-startup-wants-to-digitize-the-immune-system-with-engineered-yeast https://www.synbiobeta.com/read/dynamic-dna-artificial-cells-throw-shapes-with-dna-cytoskeletons https://www.synbiobeta.com/read/meatable-pioneers-cultivated-meat-tasting-in-the-european-union https://www.synbiobeta.com/read/a-guide-on-how-to-make-an-impactful-synbio-cosmetics-startup https://www.synbiobeta.com/read/michael-koeris-tapped-to-lead-biology-investments-for-this-4b-government-agency https://www.synbiobeta.com/read/gut-instincts-and-brainy-bets-driving-the-future-of-neuro-investments https://www.synbiobeta.com/read/meet-the-microbial-factories-pioneering-sustainable-plastics https://www.synbiobeta.com/read/enabling-psychedelics-research-with-precision-fermentation https://www.synbiobeta.com/read/a-vision-for-the-future-of-biomanufacturing-highlights-from-shanghais-precision-fermentation-forum https://www.synbiobeta.com/read/synbiobeta-brings-together-global-leaders-in-synthetic-biology-for-premier-annual-conference https://www.synbiobeta.com/read/cutting-loose-cytosolic-crispr-targets-rna-viruses-with-unprecedented-precision https://www.synbiobeta.com/read/ninthbio-welcomes-dr-kurt-klimpel-phd-mba-as-chief-scientific-officer https://www.synbiobeta.com/read/how-a-multi-omics-platform-is-transforming-microbiome-research-and-healthcare https://www.synbiobeta.com/read/shrinking-the-environmental-footprint-of-digital-data-storage-with-dna https://www.synbiobeta.com/read/securing-the-future-leveraging-dna-for-unhackable-authentication https://www.synbiobeta.com/read/ginkgo-bioworks-and-novo-nordisk-expand-alliance-to-collaborate-across-r-d-value-chain https://www.synbiobeta.com/read/sweet-revolution-conagen-and-sweegens-game-changing-partnership-in-sugar-reduction https://www.synbiobeta.com/read/can-biology-become-the-main-source-of-our-chemical-feedstocks https://www.synbiobeta.com/read/obsidian-therapeutics-secures-160-5m-series-c-financing-for-innovative-cell-therapy https://www.synbiobeta.com/read/halting-cellular-aging-with-senotherapeutics https://www.synbiobeta.com/read/connecting-the-quantum-dots-for-inorganic-molecule-synthesis-in-living-cells https://www.synbiobeta.com/read/synbiobeta-2024-the-global-synthetic-biology-conference-connecting-biology-technology-and-innovation https://www.synbiobeta.com/read/tiny-bubbles-big-impact-breakthrough-in-biomedical-engineering https://www.synbiobeta.com/read/synthetic-biology-in-everyday-life-from-lab-to-the-beauty-counter https://www.synbiobeta.com/read/the-new-plastic-era-denmarks-revolutionary-co2-conversion https://www.synbiobeta.com/read/the-four-day-meat-miracle-by-meatable https://www.synbiobeta.com/read/designing-programmable-cancer-therapies-with-synthetic-gene-circuits https://www.synbiobeta.com/read/personal-hygienes-renaissance-brought-to-you-by-synthetic-biology https://www.synbiobeta.com/read/profluent-secures-35m-funding-led-by-spark-capital-to-advance-ai-first-protein-design https://www.synbiobeta.com/read/yeast-proves-itself-a-budding-star-in-human-artificial-chromosome-construction https://www.synbiobeta.com/read/from-glucose-gauge-to-chemo-checker-with-a-dash-of-protein-engineering https://www.synbiobeta.com/read/the-buzz-in-food-tech-melibios-ai-enhanced-honey-alternatives https://www.synbiobeta.com/read/dna-synthesis-is-the-future-chemical-enzymatic-or-both https://www.synbiobeta.com/read/cordon-bleu-meet-crispr-engineered-fungi-enters-the-world-of-gourmet-cuisine https://www.synbiobeta.com/read/synthetic-biology-artificial-intelligence-next-generation-therapeutics https://www.synbiobeta.com/read/basecamp-research-unveils-basefold-revolutionary-deep-learning-model-for-protein-structure-prediction https://www.synbiobeta.com/read/the-uniqueness-of-our-microbial-identity https://www.synbiobeta.com/read/expanding-biosecurity-frontiers-ginkgo-bioworks-cdc-and-xprescheck-amplify-genomic-surveillance-at-us-airports https://www.synbiobeta.com/read/pearl-bio-inks-lucrative-deal-with-merck-to-pioneer-innovative-biologic-therapies https://www.synbiobeta.com/read/genetic-surf-and-turf-marine-algae-and-the-future-of-food-security https://www.synbiobeta.com/read/from-fat-to-follicles-advancing-reconstructive-surgery-with-3d-printed-skin https://www.synbiobeta.com/read/van-heron-labs-secures-1-1m-in-seed-funding-led-by-foodlabs https://www.synbiobeta.com/read/ginkgo-bioworks-unveils-ginkgo-technology-network-to-drive-collaborative-innovation-in-biotechnology https://www.synbiobeta.com/read/a-new-antimicrobial-arsenal-18-new-species-of-gut-microbes-discovered https://www.synbiobeta.com/read/pocket-sized-test-strips-achieve-pcr-precision https://www.synbiobeta.com/read/how-preparing-plants-for-space-can-push-synthetic-biology-boundaries-on-earth https://www.synbiobeta.com/read/is-pharma-finally-catching-onto-synbio https://www.synbiobeta.com/read/molecular-handedness-revealed-homochiralitys-role-in-lifes-beginnings https://www.synbiobeta.com/read/an-ai-approach-that-balances-genomic-discovery-with-privacy https://www.synbiobeta.com/read/peptide-powered-protein-lawnmower-gets-into-the-weeds-of-molecular-motors https://www.synbiobeta.com/read/engineering-against-the-odds-a-new-antibodys-battle-with-leukemia https://www.synbiobeta.com/read/ansa-biotechnologies-names-jason-t-gammack-as-ceo-amid-advances-in-dna-synthesis-technology https://www.synbiobeta.com/read/nist-collaborates-with-ebrc-to-enhance-safety-in-nucleic-acid-synthesis-amid-ai-advancements https://www.synbiobeta.com/read/syngenta-crop-protection-and-lavie-bio-forge-collaboration-to-develop-biological-insecticidal-solutions https://www.synbiobeta.com/read/pivot-bios-n-ovator-tm-program-pays-over-6-million-to-farmers-for-sustainable-nitrogen-practices https://www.synbiobeta.com/read/openfold-biotech-ai-research-consortium-unveils-groundbreaking-tools-for-protein-research https://www.synbiobeta.com/read/winging-it-in-gene-therapy-with-avian-retrotransposons https://www.synbiobeta.com/read/digital-twins-to-advance-biomanufacturing https://www.synbiobeta.com/read/turtletree-achieves-landmark-vegan-certification-for-sustainable-lactoferrin https://www.synbiobeta.com/read/ginkgo-bioworks-hosts-congressional-members-to-discuss-u-s-bioeconomy-and-national-security https://www.synbiobeta.com/read/profoundbio-raises-112-million-in-series-b-financing-to-advance-breakthrough-cancer-therapies https://www.synbiobeta.com/read/oxitec-establishes-new-r-d-hub-in-scotland-to-combat-invasive-cattle-ticks https://www.synbiobeta.com/read/intellia-therapeutics-and-recode-therapeutics-forge-alliance-to-pave-the-way-for-innovative-gene-editing-treatments-for-cystic-fibrosis https://www.synbiobeta.com/read/egenesis-and-pormedtec-achieve-milestone-genetically-engineered-porcine-donors-produced-in-japan https://www.synbiobeta.com/read/iambic-therapeutics-unveils-advances-in-ai-platform-to-streamline-drug-discovery https://www.synbiobeta.com/read/driving-decarbonization-again-partners-with-helm-for-global-sustainable-chemical-distribution https://www.synbiobeta.com/read/nnovative-microbe-set-to-revolutionize-synthetic-biology-as-it-outperforms-e-coli-in-protein-synthesis https://www.synbiobeta.com/read/ai-predicts-genetic-editing-efficiency-with-quantum-precision https://www.synbiobeta.com/read/can-biology-address-the-microplastics-problem https://www.synbiobeta.com/read/beefed-up-rice-takes-lab-grown-meat-to-the-next-level https://www.synbiobeta.com/read/synlogic-announces-plan-to-cease-operations-and-reduce-its-workforce-by-more-than-90 https://www.synbiobeta.com/read/the-uks-science-and-technology-secretary-announces-ps100-million-engineering-biology-investment https://www.synbiobeta.com/read/the-purple-tomato-a-bioengineered-crop-created-by-norfolk-plant-sciences-is-now-available-to-home-gardeners https://www.synbiobeta.com/read/renaissance-biosciences-innovative-yeast-technology-enhances-flavor-of-plant-based-foods https://www.synbiobeta.com/read/plant-based-technology-makes-leap-forward-in-rapid-vaccine-development https://www.synbiobeta.com/read/unlocking-mitochondrial-mysteries-link-between-mtdna-and-inflammation-revealed https://www.synbiobeta.com/read/synthetic-yeast-communities-get-new-molecular-toolkit-to-boost-production https://www.synbiobeta.com/read/scion-life-sciences-raises-310-million-to-fund-groundbreaking-medical-innovation https://www.synbiobeta.com/read/innovative-enzyme-research-unveils-new-paths-to-carbon-neutral-biofuels https://www.synbiobeta.com/read/carbon-neutral-biofuels-get-closer-to-reality-with-novel-method-to-break-down-lignin https://www.synbiobeta.com/read/cutting-edge-cure-crispr-sparks-hope-for-rare-immune-disorder https://www.synbiobeta.com/read/opentrons-r-introduces-innovative-protocol-library-and-ai-tools-to-boost-lab-automation-and-advance-scientific-r-d https://www.synbiobeta.com/read/avant-bio-takes-center-stage-as-premier-equity-firm-in-life-sciences-tech-bio-and-healthtech https://www.synbiobeta.com/read/1-9-million-nih-grant-for-penn-state-to-explore-the-human-microbiome-health-connection-with-machine-learning https://www.synbiobeta.com/read/light-bios-firefly-tm-petunia-casts-light-on-the-future-of-horticulture https://www.synbiobeta.com/read/spider-silk-is-woven-into-the-future-of-sustainability https://www.synbiobeta.com/read/phytolon-and-ginkgo-bioworks-hit-milestone-in-natural-food-color-production https://www.synbiobeta.com/read/21st-bio-introduces-sustainable-approach-to-industrial-scale-dairy-protein-production https://www.synbiobeta.com/read/elegen-partners-with-gsk https://www.synbiobeta.com/read/locus-biosciences-secures-23-9-million-to-advance-breakthrough-uti-treatment https://www.synbiobeta.com/read/phage-dna-sabotage-causes-self-destruction-of-deadly-pathogens https://www.synbiobeta.com/read/gene-jockeys-racing-towards-a-cure-for-heart-havoc https://www.synbiobeta.com/read/checkerspot-innovates-infant-nutrition-with-microalgae-based-human-milk-fat-analogue https://www.synbiobeta.com/read/aanika-biosciences-is-accelerating-the-adoption-of-synbio-through-insurance https://www.synbiobeta.com/read/lanzajet-unveils-worlds-first-ethanol-to-sustainable-aviation-fuel-saf-facility https://www.synbiobeta.com/read/meet-the-muscle-powered-robot-with-pep-in-its-step https://www.synbiobeta.com/read/elegen-and-gsk-forge-strategic-partnership-to-advance-cell-free-dna-production-technology https://www.synbiobeta.com/read/synthetic-biology-and-materials-science-working-together-to-redefine-entire-industries https://www.synbiobeta.com/read/how-is-the-current-synbio-startup-climate-affecting-innovation-in-the-global-south https://www.synbiobeta.com/read/breaking-the-mold-embracing-uncertainty-for-enhanced-bio-innovation https://www.synbiobeta.com/read/pioneering-crispr-off-switches-for-genetic-engineering https://www.synbiobeta.com/read/from-ice-to-life-the-revolutionary-cryo-em-view-of-an-rna-machine https://www.synbiobeta.com/read/pablo-pcasso-gives-crispr-technology-a-fresh-coat-of-paint https://www.synbiobeta.com/read/rice-university-launches-innovative-synthetic-biology-institute https://www.synbiobeta.com/read/shining-a-light-on-yeast-a-breakthrough-in-biological-engineering https://www.synbiobeta.com/read/advancing-the-frontier-of-long-dna-synthesis https://www.synbiobeta.com/read/johnson-johnson-to-acquire-synthetic-biology-company-ambrx-for-2-billion https://www.synbiobeta.com/read/psychedelic-evolution-psilocybes-journey-from-ancient-fungi-to-mental-health-revolution https://www.synbiobeta.com/read/scientists-engineer-skin-bacteria-for-breakthrough-acne-therapy https://www.synbiobeta.com/read/how-brain-fat-interactions-can-lead-to-healthier-aging https://www.synbiobeta.com/read/can-synthetic-biology-aid-in-the-race-against-rare-infectious-diseases https://www.synbiobeta.com/read/ginkgo-bioworks-launches-powerhouse-biopharma-advisory-board-to-further-develop-platform-technologies https://www.synbiobeta.com/read/menrich-ing-microbiome-research-with-groundbreaking-sequencing-technique https://www.synbiobeta.com/read/e-colis-new-diet-feasting-on-co2-for-a-healthier-planet https://www.synbiobeta.com/read/smart-plants-are-coming-to-a-field-near-you-this-year https://www.synbiobeta.com/read/synthetic-yeast-chromosome-created-marking-major-milestone https://www.synbiobeta.com/read/double-helix-remix-transcription-enzymes-embrace-unconventional-dna https://www.synbiobeta.com/read/ai-powered-breakthrough-in-enzyme-therapy-for-genetic-disorders https://www.synbiobeta.com/read/precision-gene-editors-to-be-developed-by-arbor-and-ginkgo-in-new-collaboration https://www.synbiobeta.com/read/a-synbio-carol-of-merriment-and-science https://www.synbiobeta.com/read/living-concrete-paves-the-way-for-more-sustainable-structures https://www.synbiobeta.com/read/muscle-specific-mrna-nanoparticle-delivery-developed https://www.synbiobeta.com/read/cambium-raises-19m-series-a-funding-round-to-build-next-generation-defense-products-with-biology https://www.synbiobeta.com/read/seeing-is-believing-turning-retinal-cells-into-neurons-for-vision-restoration https://www.synbiobeta.com/read/synthetic-biologys-miracle-milk https://www.synbiobeta.com/read/pioneering-gene-editing-firm-eligo-bioscience-raises-30m-for-genetic-medicines https://www.synbiobeta.com/read/whats-the-connection-between-synbio-and-neurotech-really https://www.synbiobeta.com/read/meet-anthrobots-your-bodys-new-biological-repair-crew https://www.synbiobeta.com/read/the-organoid-odyssey-a-leap-forward-in-understanding-pediatric-brain-tumors https://www.synbiobeta.com/read/the-molecular-maestro-synthetic-poly-adp-ribose-and-its-promises https://www.synbiobeta.com/read/unlocking-longevity-how-a-single-protein-shapes-mice-ageing https://www.synbiobeta.com/read/harnessing-floral-superpowers-for-cleaner-greener-medicines https://www.synbiobeta.com/read/danish-startup-again-launches-revolutionary-co2-utilization-plant-with-10m-funding https://www.synbiobeta.com/read/harnessing-environmental-biodiversity-for-synthetic-biology https://www.synbiobeta.com/read/robo-revolution-ucsb-harnesses-9-85m-grant-to-automate-synthetic-biology-research https://www.synbiobeta.com/read/saliva-substitute-offers-extended-dry-mouth-relief https://www.synbiobeta.com/read/cradle-raises-24m-for-ai-powered-protein-engineering-and-signs-partnerships-with-industry-leaders https://www.synbiobeta.com/read/the-compass-thats-aiding-pepper-bios-innovative-drug-dicovery-route https://www.synbiobeta.com/read/crispr-based-therapy-receives-regulatory-green-light-in-the-uk https://www.synbiobeta.com/read/achieving-mind-control-with-memory-boosting-molecular-switches https://www.synbiobeta.com/read/how-ai-is-transforming-synthetic-biology-reaching-far-beyond-biopharma https://www.synbiobeta.com/read/shaping-the-future-with-biodesign-join-the-bdcs-giving-tuesday-journey https://www.synbiobeta.com/read/mushrooming-potential-fungi-as-the-new-eco-champions https://www.synbiobeta.com/read/quantum-biology-meets-ai-to-give-crispr-a-microbial-makeover https://www.synbiobeta.com/read/green-glamour-interstellar-lab-and-loreal-craft-the-future-of-sustainable-beauty https://www.synbiobeta.com/read/its-alive-yeast-strain-thrives-with-over-50-synthetic-genome https://www.synbiobeta.com/read/new-dimension-in-bacterial-gene-regulation-could-be-boon-for-synthetic-biology https://www.synbiobeta.com/read/clickable-pseudoviruses-shine-a-light-on-virus-dynamics https://www.synbiobeta.com/read/is-dna-data-storage-ready-for-data-centers https://www.synbiobeta.com/read/light-powered-organoids-illuminate-nervous-system-development https://www.synbiobeta.com/read/biohybrid-brilliance-crafting-quick-charging-eco-friendly-batteries https://www.synbiobeta.com/read/pioneering-yeast-based-rna-delivery-technology-secures-chinese-patent https://www.synbiobeta.com/read/biofuel-and-bioproduct-generation-boosted-with-engineered-enzymes https://www.synbiobeta.com/read/are-american-pharmas-falling-behind-on-ai https://www.synbiobeta.com/read/the-brain-computer-interface-giving-an-als-patient-a-voice-and-control https://www.synbiobeta.com/read/gene-therapy-approach-reverting-the-script-on-hereditary-disease-treatment https://www.synbiobeta.com/read/ai-alchemy-unleashing-a-biotechnological-renaissance-in-textile-dyeing https://www.synbiobeta.com/read/precision-cell-programming-in-the-quest-to-cure-rare-diseases https://www.synbiobeta.com/read/dna-goes-full-throttle-the-smallest-engine-youve-never-seen https://www.synbiobeta.com/read/using-probiotics-to-guide-car-t-cells-along-the-tumultuous-terrain-of-solid-tumors https://www.synbiobeta.com/read/innovation-in-bloom-cambriums-eu8-million-seed-to-sow-sustainable-molecules https://www.synbiobeta.com/read/phage-research-scores-big-in-fight-against-drug-resistance-with-funding-bump https://www.synbiobeta.com/read/phages-and-synthetic-biology-team-up-to-tackle-antimicrobial-resistance https://www.synbiobeta.com/read/genes-jargon-and-a-dash-of-ai-the-starvar-method-of-making-sense-of-rare-disease-diagnosis https://www.synbiobeta.com/read/researchers-develop-a-hybrid-approach-for-efficient-and-sustainable-bioprocess-engineering https://www.synbiobeta.com/read/from-superfood-to-super-healer-spirulina-coatings-boost-wound-care https://www.synbiobeta.com/read/cellares-and-bms-are-pioneering-the-next-wave-in-cell-therapy-with-expanded-agreement https://www.synbiobeta.com/read/in-a-win-for-biosecurity-aclid-secures-3-3m-in-seed-funding https://www.synbiobeta.com/read/unraveling-psychedelics-role-in-ocd https://www.synbiobeta.com/read/breaking-tradition-could-synthetic-biology-shape-the-future-of-winemaking https://www.synbiobeta.com/read/vitadaos-digital-democracy-greenlighting-their-first-biotech-venture https://www.synbiobeta.com/read/3d-printed-biosensors-inspired-by-spiderwebs-could-provide-advanced-virus-detection https://www.synbiobeta.com/read/reshaping-biomanufacturing-with-intelligent-fermentation-technology https://www.synbiobeta.com/read/nobel-nods-the-penn-pioneers-powering-the-pandemic-response https://www.synbiobeta.com/read/carbon-capturing-cultures-marine-microbes-in-the-fight-against-greenhouse-gases https://www.synbiobeta.com/read/ginkgo-bioworks-and-novo-nordisk-are-shifting-the-synbio-biopharma-narrative https://www.synbiobeta.com/read/robertet-and-interstellar-lab-sowing-the-future-of-natural-ingredients https://www.synbiobeta.com/read/the-compact-crispr-enzyme-promising-breakthroughs-in-genetic-medicine https://www.synbiobeta.com/read/regulatory-and-manufacturing-insights-for-synbio-therapeutics https://www.synbiobeta.com/read/fixing-nitrogen-can-engineered-microbes-replace-synthetic-fertilizers https://www.synbiobeta.com/read/ecovative-unlocks-europes-plastic-free-future-with-open-patent https://www.synbiobeta.com/read/touch-feel-believe-the-u-s-bioeconomy-comes-alive https://www.synbiobeta.com/read/optogenetics-is-illuminating-the-path-to-speaking-with-plants https://www.synbiobeta.com/read/turning-the-tide-marine-microbes-combat-plastic-pollution https://www.synbiobeta.com/read/the-future-of-sustainable-biomanufacturing-is-microscopic-factories https://www.synbiobeta.com/read/meat-the-facts-how-your-burgers-carbon-footprint-just-got-grilled https://www.synbiobeta.com/read/machine-learning-enhances-antibody-discovery-a-glimpse-into-labgenius-and-sanofis-collaborative-endeavour https://www.synbiobeta.com/read/normal-phenomena-of-life-unveils-innovative-concept-store-for-biophilic-living https://www.synbiobeta.com/read/arzeda-partnership-looks-to-revolutionize-the-future-of-designer-proteins https://www.synbiobeta.com/read/a-car-t-cell-side-project-takes-center-stage-offering-hope-beyond-cancer https://www.synbiobeta.com/read/scala-biodesign-secures-seed-funding-to-improve-protein-engineering-and-development https://www.synbiobeta.com/read/e-coli-sparks-change-a-bioelectric-breakthrough-in-energy-production https://www.synbiobeta.com/read/dna-biosensor-finds-novel-material-for-early-diagnosis-of-hpv-related-cancers https://www.synbiobeta.com/read/turbocharging-rna-vaccines-for-a-needle-free-future https://www.synbiobeta.com/read/eco-friendly-enzymes-paving-the-path-to-sustainable-biochemicals https://www.synbiobeta.com/read/a-rallying-call-for-synthetic-biology-challenges-opportunities-and-future-of-the-bioeconomy https://www.synbiobeta.com/read/unlocking-evolutions-secrets-with-cell-free-fe-s-protein-synthesis https://www.synbiobeta.com/read/can-cotton-grown-inside-bioreactors-become-a-sustainable-reality-in-the-future https://www.synbiobeta.com/read/artificial-kidneys-prove-promising-in-pig-patients https://www.synbiobeta.com/read/ginkgo-google-cloud-when-biology-meets-ai-in-a-groundbreaking-alliance https://www.synbiobeta.com/read/using-biomimicry-to-harvest-water-from-thin-air https://www.synbiobeta.com/read/from-rats-to-riches-are-mole-rats-the-key-to-a-longer-life https://www.synbiobeta.com/read/pnp-editing-the-new-kid-on-the-gene-editing-block https://www.synbiobeta.com/read/cellares-secures-255m-to-revolutionize-cell-therapy-production-with-idmo-smart-factories https://www.synbiobeta.com/read/antheias-monumental-commercial-achievement https://www.synbiobeta.com/read/where-infant-formula-falls-short-synthetic-biology-comes-up-strong https://www.synbiobeta.com/read/y-not-full-sequence-of-y-chromosome-finally-assembled https://www.synbiobeta.com/read/retinol-revolution-conagens-sustainable-spin-on-skincare https://www.synbiobeta.com/read/a-dna-based-anticoagulant-is-set-to-disrupt-the-norm https://www.synbiobeta.com/read/unlocking-natures-secrets-the-promise-of-synthetic-catalysts-in-biomass-conversion https://www.synbiobeta.com/read/nanovesicles-the-tiny-sacks-engineered-to-target-cancer-cells https://www.synbiobeta.com/read/pioneering-gene-therapy-results-promising-for-rare-liver-disease https://www.synbiobeta.com/read/aviation-and-maritime-biofuels-get-sustainability-boost-from-novel-enzyme https://www.synbiobeta.com/read/inside-the-bellys-bazaar-probiotics-that-light-up-inflammation https://www.synbiobeta.com/read/bioengineers-unveil-method-to-profoundly-improve-gene-activation https://www.synbiobeta.com/read/green-is-the-new-gold-cascade-biocatalysts-secures-2-6m-to-scale-enzyme-technology https://www.synbiobeta.com/read/revolutionizing-drug-testing-with-3d-bioprinted-vascularized-lung-cancer-models https://www.synbiobeta.com/read/gene-therapys-breakthrough-for-alcohol-addiction https://www.synbiobeta.com/read/amyris-files-for-bankruptcy-as-part-of-its-strategic-transformation-plan https://www.synbiobeta.com/read/biosensor-potential-maximized-through-innovative-aptamer-nanopore-interaction https://www.synbiobeta.com/read/tiny-cellular-tattoos-emerge-as-nanoscale-health-sentinels https://www.synbiobeta.com/read/bridging-ai-biology-absci-and-caltechs-hiv-solution-gains-gates-foundation-support https://www.synbiobeta.com/read/ai-predicts-the-enigmatic-origins-of-tumors https://www.synbiobeta.com/read/fast-and-cost-effective-blood-vessel-engineering-offers-hope-for-cardiovascular-patients https://www.synbiobeta.com/read/meatables-rise-in-the-cultivated-meat-landscape-gets-35m-boost-for-pork-products https://www.synbiobeta.com/read/bit-bio-and-bluerock-set-to-revolutionize-cell-therapy-with-new-collaboration-on-tregs https://www.synbiobeta.com/read/microbial-cell-factories-a-delicious-and-glamorous-revolution https://www.synbiobeta.com/read/nanopore-sequencing-detects-protein-sequence-variation-in-pioneering-breakthrough https://www.synbiobeta.com/read/there-is-no-problem-biology-cant-solve-except-for-economics https://www.synbiobeta.com/read/the-bioconcrete-revolution-a-glimpse-into-a-greener-future https://www.synbiobeta.com/read/light-driven-method-boosts-eco-friendly-biomanufacturing-with-novel-enzyme-reactions https://www.synbiobeta.com/read/valleydao-fuels-the-future-by-backing-sustainable-oil-production-with-synthetic-biology https://www.synbiobeta.com/read/protein-nano-switches-building-better-diagnostics-for-the-future https://www.synbiobeta.com/read/visualizing-how-microbes-turn-co2-into-bioplastic https://www.synbiobeta.com/read/taming-the-t-cells-a-revolutionary-step-in-car-t-cell-therapy https://www.synbiobeta.com/read/rubi-and-walmart-collab-looks-to-weave-a-greener-future-with-carbon-capture-technology https://www.synbiobeta.com/read/unraveling-space-health-with-bioprinted-hearts https://www.synbiobeta.com/read/biological-materials-enter-the-solid-state-era https://www.synbiobeta.com/read/the-bioaction-projects-innovative-fight-against-antimicrobial-resistance https://www.synbiobeta.com/read/where-can-biopharma-best-leverage-synbio-today https://www.synbiobeta.com/read/photosynthesis-reimagined-in-cell-engineering-yields-remarkable-hybrid-catalysts https://www.synbiobeta.com/read/the-butterfly-biomaterial-effect-using-chitin-to-shape-the-future-of-engineering-and-biomedicine https://www.synbiobeta.com/read/single-cell-sequencing-gets-a-serious-boost-from-engineered-polymerase https://www.synbiobeta.com/read/synthetic-peptide-could-turn-the-tide-in-the-fight-against-antibiotic-resistant-bacteria https://www.synbiobeta.com/read/harnessing-synthetic-biology-for-climate-resilient-agriculture https://www.synbiobeta.com/read/farm-to-flask-using-yeast-to-turn-agri-waste-into-biofuels-and-beyond https://www.synbiobeta.com/read/shining-a-light-on-aging-optogenetic-approach-to-cellular-stress-creates-virtual-reality-for-cells https://www.synbiobeta.com/read/getting-plant-disease-diagnostics-right-for-future-biosecurity https://www.synbiobeta.com/read/virus-particles-get-a-bioengineered-makeover https://www.synbiobeta.com/read/are-citrus-rind-and-crustacean-shells-the-future-of-food-packaging https://www.synbiobeta.com/read/ai-in-drug-discovery-insilico-medicine-calls-for-stricter-standards https://www.synbiobeta.com/read/darpa-taps-ginkgo-bioworks-for-18m-project-in-therapeutic-protein-manufacturing https://www.synbiobeta.com/read/10m-series-a-funding-fuels-camena-biosciences-dna-synthesis-revolution https://www.synbiobeta.com/read/scaling-sustainability-locus-amplifies-its-green-footprint-and-commitment-to-decarbonization https://www.synbiobeta.com/read/bio-knit-how-fungi-and-textiles-are-weaving-the-future-of-construction https://www.synbiobeta.com/read/crispr-at-the-root-of-forestrys-sustainable-revolution https://www.synbiobeta.com/read/firefighting-fungi-myceliums-unexpected-flame-resistance https://www.synbiobeta.com/read/a-biological-camera-to-capture-the-full-potential-of-dna-data-storage https://www.synbiobeta.com/read/transforming-the-bioprocessing-landscape-the-sprind-circular-biomanufacturing-challenge https://www.synbiobeta.com/read/sailing-towards-a-greener-horizon-biofuels-and-hydrogen-lead-the-voyage https://www.synbiobeta.com/read/protein-engineering-of-artificial-allosteric-sites-into-molecular-motors https://www.synbiobeta.com/read/waste-not-allonnia-raises-30-million-to-accelerate-bio-ingenious-solutions https://www.synbiobeta.com/read/the-unexpected-evolution-of-minimalist-synthetic-microbes https://www.synbiobeta.com/read/how-geneticists-are-base-ically-revolutionizing-sickle-cell-treatment https://www.synbiobeta.com/read/sky-high-sustainability-synbiobloxs-route-to-cleaner-aviation-fuel https://www.synbiobeta.com/read/the-science-of-smooth-voodoo-and-ginkgos-gentle-spirits-revolution https://www.synbiobeta.com/read/amyris-ceo-john-melo-steps-down-company-to-undergo-workforce-reduction https://www.synbiobeta.com/read/u-s-bolsters-biotech-workforce-an-inside-look-at-the-new-white-house-action-plan https://www.synbiobeta.com/read/ai-uncovers-novel-proteins-for-base-editing https://www.synbiobeta.com/read/modern-biofuels-a-climate-solution-or-a-greater-threat https://www.synbiobeta.com/read/a-boon-for-biomaterials-nsf-invests-heavily-in-advanced-materials-research-centers https://www.synbiobeta.com/read/transforming-food-processing-wastewater-novel-approach-receives-9m-in-seed-funding https://www.synbiobeta.com/read/innovative-use-of-mrna-and-car-t-therapy-offers-hope-for-myasthenia-gravis-patients https://www.synbiobeta.com/read/designing-cell-free-biologically-active-architecture https://www.synbiobeta.com/read/understanding-the-inner-workings-of-spider-silk-a-leap-toward-synthetic-production https://www.synbiobeta.com/read/pioneering-synthetic-biology-workflows-biosyntia-adopts-sphere-fluidics-pico-mine-platform https://www.synbiobeta.com/read/dna-folding-technique-opens-array-of-possibilities-in-molecular-biology-nanotech https://www.synbiobeta.com/read/crispr-rice-created-that-is-resistant-to-multiple-diseases https://www.synbiobeta.com/read/nanopores-and-nanobodies-could-be-key-to-rapid-and-accurate-disease-diagnostics https://www.synbiobeta.com/read/the-journey-toward-an-artificial-kidney-is-a-whale-of-a-tale https://www.synbiobeta.com/read/novel-biopolymers-creating-a-fully-programmable-protein-translation-system https://www.synbiobeta.com/read/how-do-we-unite-synbio-and-pharma-insights-from-synbiobeta-2023 https://www.synbiobeta.com/read/handheld-bioprinter-could-usher-bespoke-tissue-generation-for-regenerative-medicine https://www.synbiobeta.com/read/rna-research-center-looks-to-advance-metabolic-disease-treatment https://www.synbiobeta.com/read/economic-partnership-between-us-uk-shored-up-with-new-tech-focused-framework https://www.synbiobeta.com/read/illumina-ceo-francis-desouza-resigns-amid-controversial-grail-acquisition https://www.synbiobeta.com/read/debut-to-create-next-gen-high-performing-active-ingredients-with-34m-in-series-b-funding https://www.synbiobeta.com/read/the-greatest-challenges-facing-synthetic-biology-are-no-longer-technical https://www.synbiobeta.com/read/telesis-bio-captures-28m-in-financing-46-2m-available-with-warrant-exercise https://www.synbiobeta.com/read/unnatural-amino-acid-produced-by-engineered-e-coli-that-can-aid-immunotherapies https://www.synbiobeta.com/read/beyond-carbon-capture-converting-co2-into-valuable-resources-in-the-biochemical-industry https://www.synbiobeta.com/read/how-scientists-are-trying-to-engineer-artificial-cells-to-move https://www.synbiobeta.com/read/reichman-university-ignites-innovation-the-scojen-institute-for-synthetic-biology https://www.synbiobeta.com/read/snipr-biomes-data-on-first-clinical-drug-candidate-to-prevent-infections-in-hematological-cancer-patients-published-in-nature-biotechnology https://www.synbiobeta.com/read/cultivarium-announces-collaboration-with-atcc-to-expand-repertoire-of-microbes-available-for-the-bioeconomy https://www.synbiobeta.com/read/ayana-bio-launches-first-plant-cell-derived-health-and-wellness-ingredients https://www.synbiobeta.com/read/enveda-biosciences-announces-oversubscribed-series-b1-bringing-total-round-to-us-119-million https://www.synbiobeta.com/read/twist-bioscience-launches-tcr-and-car-libraries-to-enable-the-development-of-cell-therapies https://www.synbiobeta.com/read/hellobiome-partners-with-k18-inc-to-bring-microbiome-innovation-to-hair-care https://www.synbiobeta.com/read/logomix-inc-starts-joint-research-of-sustainable-amino-acid-production-method-with-ajinomoto-co-inc https://www.synbiobeta.com/read/absci-partners-with-bioinformatics-company-m2gen-to-accelerate-drug-creation-for-oncology https://www.synbiobeta.com/read/telesis-bio-releases-bioxp-r-select-kits-to-enable-dna-amplification-and-scale-up https://www.synbiobeta.com/read/cemvita-promotes-co-founder-tara-karimi-to-cso-appoints-new-cto-liz-dennett https://www.synbiobeta.com/read/opinion-synbio-and-ai-combine-for-a-more-cohesive-approach-to-drug-discovery https://www.synbiobeta.com/read/looking-ahead-the-human-health-investment-landscape https://www.synbiobeta.com/read/aanika-biosciences-is-partnering-with-greenlight-re-innovations https://www.synbiobeta.com/read/cambrium-launches-novacoll-tm-first-micro-molecular-skin-identical-collagen-ingredient-for-personal-care-industry https://www.synbiobeta.com/read/arzeda-the-protein-design-company-tm-announces-collaboration-with-takeda-to-accelerate-protein-biologics-optimization https://www.synbiobeta.com/read/teselagen-offers-its-starter-edition-to-help-biotech-startups-scale-efficiently https://www.synbiobeta.com/read/ginkgo-bioworks-supports-the-biobuilder-educational-foundations-boston-learning-lab https://www.synbiobeta.com/read/synlogic-announces-data-presentations-at-the-society-for-inherited-metabolic-disorders-simd-44th-annual-meeting https://www.synbiobeta.com/read/elegen-launches-enfinia-tm-dna-rapid-long-dna-synthesis-to-power-the-bioeconomy https://www.synbiobeta.com/read/arzedas-new-portfolio-of-prosweet-enzymes-tm-unlocks-the-potential-of-stevia-by-efficiently-producing-reb-d-and-m-from-stevia-leaf-extract https://www.synbiobeta.com/read/checkerspots-pollinator-tm-kit-for-renewable-design-wins-sxsw-innovation-award-in-the-design-category https://www.synbiobeta.com/read/nalu-bio-announces-a-12m-series-a-to-set-a-higher-standard-for-cannabinoid-production https://www.synbiobeta.com/read/primordial-genetics-launches-high-performance-rna-polymerases https://www.synbiobeta.com/read/biomx-announces-7-5-million-private-placement https://www.synbiobeta.com/read/robigo-secures-7m-seed-round-to-protect-crops-from-untreatable-diseases https://www.synbiobeta.com/read/food-tech-leaders-come-together-to-form-the-precision-fermentation-alliance-to-champion-a-more-resilient-and-sustainable-future https://www.synbiobeta.com/read/telesis-bio-releases-bioxp-r-select-mrna-synthesis-kit-to-expand-the-utility-speed-and-impact-of-its-automated-synthetic-biology-workstation https://www.synbiobeta.com/read/indee-labs-partners-with-genscript-to-develop-direct-dna-knock-in-kit-for-large-transgene-inserts https://www.synbiobeta.com/read/lanzatech-and-tadweer-to-explore-collaboration-on-conversion-of-waste-to-alternative-fuels https://www.synbiobeta.com/read/codagenix-announces-close-of-25-million-extension-of-series-b https://www.synbiobeta.com/read/aera-therapeutics-launches-with-193-million-in-financing-to-enable-and-advance-the-next-generation-of-transformative-genetic-medicines https://www.synbiobeta.com/read/checkerspot-closes-55-million-series-c-to-bring-the-bioeconomy-to-your-doorstep https://www.synbiobeta.com/read/spira-inc-announces-start-of-fundraise-to-expand-sustainable-alternative-to-artificial-colors https://www.synbiobeta.com/read/logomix-closes-3-9m-usd-in-oversubscribed-seed-funding-to-accelerate-its-platform-and-pipeline-development https://www.synbiobeta.com/read/slingshot-biosciences-announces-11-million-in-series-a3-financing https://www.synbiobeta.com/read/opinion-leapfrog-improvements-in-drug-discovery-and-biomanufacturing-engaging-the-8-000-pound-elephant-hidden-in-the-bioreactor https://www.synbiobeta.com/read/looking-forward-insights-from-j-p-morgan https://www.synbiobeta.com/read/bioweg-and-ginkgo-bioworks-announce-partnership-to-develop-cost-effective-and-efficacious-bio-based-materials-to-reduce-the-use-of-microplastic-pollutants https://www.synbiobeta.com/read/premiere-synthetic-biology-event-on-track-for-record-attendance-2023 https://www.synbiobeta.com/read/amyris-launches-4u-by-tia-tm-haircare-line-exclusively-at-walmart https://www.synbiobeta.com/read/twist-bioscience-begins-shipping-commercial-product-from-synthetic-dna-manufacturing-factory-of-the-future https://www.synbiobeta.com/read/profluent-launches-to-design-new-proteins-with-generative-ai https://www.synbiobeta.com/read/the-biobuilder-educational-foundation-initiates-plan-to-train-bioeconomy-workforce https://www.synbiobeta.com/read/living-carbon-raises-new-funding-to-plant-4m-fast-growing-carbon-guzzling-supertrees-in-us https://www.synbiobeta.com/read/calyxt-and-cibus-announce-definitive-merger-agreement-to-create-industry-leading-precision-gene-editing-and-trait-licensing-company https://www.synbiobeta.com/read/breakthrough-crispr-technology-study-published-in-nature https://www.synbiobeta.com/read/crispr-qc-closes-seed-round-at-1-6m-and-appoints-george-bonaros-to-board-of-directors-to-fuel-commercial-growth-of-their-crispr-analytics-platform https://www.synbiobeta.com/read/yield10-bioscience-and-mitsubishi-corporation-sign-mou-to-evaluate-the-establishment-of-a-partnership-to-supply-offtake-and-market-camelina-as-a-feedstock-oil-for-biofuel https://www.synbiobeta.com/read/boehringer-ingelheim-and-3t-biosciences-join-forces-to-develop-next-generation-cancer-immunotherapies https://www.synbiobeta.com/read/twist-bioscience-and-astellas-enter-into-multitarget-antibody-discovery-research-collaboration https://www.synbiobeta.com/read/recode-therapeutics-announces-strategic-collaboration-with-askbio-to-explore-single-vector-gene-editing-platform https://www.synbiobeta.com/read/conagen-starts-first-commercial-production-of-sustainable-tyrian-purple-for-textile-dye https://www.synbiobeta.com/read/ginkgo-bioworks-expands-its-r-d-facilities-opens-bioworks7-to-conduct-mammalian-screening-at-scale-widening-capabilities-for-biopharma-partners https://www.synbiobeta.com/read/aanika-to-enter-bio-backed-insurance-agreement-with-satur-farms https://www.synbiobeta.com/read/arsenalbio-announces-first-patient-dosed-in-phase-1-clinical-trial-of-ab-1015-in-development-as-a-treatment-for-ovarian-cancer https://www.synbiobeta.com/read/ribbon-biolabs-reaches-key-milestone-with-automation-of-infinisynthtm-platform-for-commercial-scale-unlimited-length-dna-synthesis https://www.synbiobeta.com/read/lanzatechs-waste-gas-to-saf-facility-receives-ps25m-grant-from-uk-department-for-transport-advanced-fuels-fund https://www.synbiobeta.com/read/teselagen-biotechnology-launches-starter-edition-for-small-groups-to-accelerate-product-development https://www.synbiobeta.com/read/snipr-biome-further-strengthens-crispr-cas-ip-portfolio-with-patent-grant https://www.synbiobeta.com/read/ganymede-bio-the-cloud-provider-purpose-built-for-the-life-sciences-and-manufacturing-industries-raises-12-75-million-in-series-a-funding https://www.synbiobeta.com/read/enginzyme-raises-eu21-million-in-series-b-to-accelerate-the-commercialisation-of-its-cell-free-biomanufacturing-technology https://www.synbiobeta.com/read/synlogic-announces-achievement-of-proof-of-concept-for-synb8802-in-enteric-hyperoxaluria-based-on-urinary-oxalate-lowering-in-phase-1b-study https://www.synbiobeta.com/read/catalog-achieves-historic-dna-computing-milestone https://www.synbiobeta.com/read/portuguese-biotech-company-silicolife-secures-series-a-investment-of-up-to-eu9-8-million-to-accelerate-the-biological-production-of-ingredients https://www.synbiobeta.com/read/gamida-cell-announces-closing-of-25-million-financing-with-highbridge https://www.synbiobeta.com/read/genscript-partners-with-allozymes-to-accelerate-protein-discovery-and-target-identification https://www.synbiobeta.com/read/ginkgo-bioworks-launches-ginkgo-enzyme-services-enabling-applications-across-pharmaceuticals-and-diagnostics-food-and-agriculture-and-beyond https://www.synbiobeta.com/read/pixelgen-technologies-launches-to-advance-single-cell-spatial-proteomics https://www.synbiobeta.com/read/lanzatech-and-sumitomo-riko-partner-to-create-substitute-for-natural-rubber-production https://www.synbiobeta.com/read/touchlight-receives-grant-to-advance-rapid-scalable-and-thermostable-doggybone-dna-vaccine-platform https://www.synbiobeta.com/read/bighat-biosciences-announces-research-collaboration-with-merck https://www.synbiobeta.com/read/sherlock-biosciences-receives-grant-to-advance-development-of-power-free-diagnostics https://www.synbiobeta.com/read/strand-therapeutics-announces-series-a1-bringing-total-round-to-us-97-million https://www.synbiobeta.com/read/elemental-machines-raises-41-million-to-fuel-growth https://www.synbiobeta.com/read/prince-william-unveils-lanzatech-as-a-finalist-for-the-second-annual-earthshot-prize-awards https://www.synbiobeta.com/read/twist-bioscience-promotes-patrick-finn-ph-d-to-president-and-chief-operating-officer https://www.synbiobeta.com/read/provectus-algae-strengthens-r-d-team-reinforcing-commitment-to-delivering-sustainable-synbio-solutions https://www.synbiobeta.com/read/ginkgo-bioworks-and-the-ministry-of-investment-of-saudi-arabia-announce-plans-to-develop-biosecurity-and-biotechnology-capabilities-for-global-public-health https://www.synbiobeta.com/read/calyxt-successfully-produces-plant-based-squalene-an-important-ingredient-in-personal-care-products-and-critical-vaccine-adjuvants https://www.synbiobeta.com/read/amyris-and-world-wildlife-fund-announce-partnership-to-protect-biodiversity https://www.synbiobeta.com/read/amyris-successfully-launches-two-new-consumer-brands https://www.synbiobeta.com/read/lanzatech-and-woodside-energy-announce-strategic-collaboration https://www.synbiobeta.com/read/the-bio-belt-growing-the-future-in-rural-america https://www.synbiobeta.com/read/synlogic-announces-positive-top-line-phase-2-data-for-phenylketonuria-pku-synb1934-advances-to-phase-3 https://www.synbiobeta.com/read/arzeda-and-aak-enter-joint-development-agreement-to-create-sustainable-plant-based-oils-for-the-food-industry https://www.synbiobeta.com/read/twist-bioscience-launches-human-sample-id-kit-to-track-whole-blood-samples-through-lab-testing-workflow https://www.synbiobeta.com/read/iarpa-ginkgo-bioworks-and-draper-announce-new-technologies-to-detect-engineered-dna https://www.synbiobeta.com/read/labvantage-solutions-and-biomax-informatics-merge-to-create-innovative-capabilities-for-the-life-science-and-bio-manufacturing-industries https://www.synbiobeta.com/read/sestina-bio-uses-inscriptas-onyx-r-platform-to-develop-microbial-strain-ready-for-scale-up-in-less-than-12-months https://www.synbiobeta.com/read/dna-script-extends-distributorships-to-middle-east-to-expand-access-to-same-day-enzymatic-dna-synthesis https://www.synbiobeta.com/read/codex-dna-announces-plan-to-change-corporate-name-to-telesis-bio https://www.synbiobeta.com/read/lanzatech-produces-ethylene-from-co2-changing-the-way-we-make-products-today https://www.synbiobeta.com/read/labgenius-secures-government-innovation-grant-to-expand-ml-driven-drug-discovery-platform-eva-tm https://www.synbiobeta.com/read/calyxt-announces-agreement-with-evologic-technologies-to-scale-production-of-its-plant-based-ingredients https://www.synbiobeta.com/read/prokarium-strengthens-patent-position-through-notice-of-allowance-of-us-patent-for-immunotherapy-prime-in-combination-with-cell-therapies https://www.synbiobeta.com/read/lanzatech-and-brookfield-form-strategic-partnership-with-an-initial-500-million-commitment https://www.synbiobeta.com/read/snipr-biome-launches-a-non-profit-patent-licensing-program-to-enable-the-field-of-crispr-editing-in-prokaryotes https://www.synbiobeta.com/read/bit-bio-adds-two-new-human-cell-products-to-address-the-translation-gap-and-accelerate-research-and-drug-discovery-for-neurodegenerative-disease https://www.synbiobeta.com/read/bucha-bio-accelerates-manufacturing-plans-for-biobased-materials-with-1-1m-raise https://www.synbiobeta.com/read/arsenal-biosciences-announces-joint-discovery-collaboration-with-genentech-to-identify-features-of-successful-t-cell-therapies-for-oncology https://www.synbiobeta.com/read/danish-synthetic-biology-company-octarine-bio-closes-eu2m-fundraising-co-led-by-dsm-venturing-and-oskare-capital https://www.synbiobeta.com/read/persephone-biosciences-announces-first-participant-enrolled-in-the-argonaut-study-of-gut-microbiome-linked-immune-modulation-in-cancer-treatment-response https://www.synbiobeta.com/read/givaudan-and-lanzatech-announce-their-collaboration-on-developing-sustainable-fragrance-ingredients-from-renewable-carbon https://www.synbiobeta.com/read/colossal-biosciences-spins-out-form-bio-to-revolutionize-computational-life-sciences https://www.synbiobeta.com/read/abcellera-launches-second-phase-of-global-headquarters-expansion-to-advance-capabilities-for-bringing-new-medicines-from-target-to-the-clinic https://www.synbiobeta.com/read/the-australian-research-council-centre-of-excellence-in-synthetic-biology-and-twist-bioscience-partner-to-foster-and-accelerate-synthetic-biology-research-in-australia https://www.synbiobeta.com/read/beam-therapeutics-presents-first-in-vivo-data-demonstrating-potential-of-multiplex-base-editing-approach-to-target-disease-drivers-of-chronic-hepatitis-b-infection https://www.synbiobeta.com/read/codex-dna-debuts-next-generation-automated-synthetic-biology-workstation https://www.synbiobeta.com/read/gamida-cell-appoints-abigail-l-jenkins-as-president-and-chief-executive-officer-bringing-broad-leadership-experience-in-commercializing-innovative-therapies https://www.synbiobeta.com/read/carver-biosciences-launches-with-seed-financing-to-advance-crispr-cas13-based-technologies https://www.synbiobeta.com/read/capstan-therapeutics-launches-with-165-million-to-deliver-on-the-clinical-promise-of-precise-in-vivo-cell-engineering https://www.synbiobeta.com/read/modern-meadow-appoints-catherine-roggero-lovisi-as-ceo https://www.synbiobeta.com/read/arsenal-biosciences-closes-220-million-series-b-financing-to-advance-programmable-cell-therapy-programs-into-clinical-development https://www.synbiobeta.com/read/synlogic-achieves-research-milestone-in-collaboration-with-roche-for-development-of-novel-synthetic-biotic-to-treat-inflammatory-bowel-disease https://www.synbiobeta.com/read/think-bioscience-raises-17m-in-oversubscribed-seed-round-to-develop-small-molecule-drugs-that-hit-undruggable-proteins https://www.synbiobeta.com/read/pivot-bio-launches-the-first-ever-on-seed-nitrogen https://www.synbiobeta.com/read/corteva-agriscience-and-basf-collaborate-to-deliver-the-future-of-weed-control-to-soybean-farmers https://www.synbiobeta.com/read/ginkgo-bioworks-appoints-dr-behzad-mahdavi-as-senior-vice-president-of-biopharma-manufacturing-life-science-tools https://www.synbiobeta.com/read/ayana-bio-announces-appointment-of-frank-jaksch-as-chief-executive-officer https://www.synbiobeta.com/read/a-alpha-bio-announces-collaboration-with-bristol-myers-squibb-to-discover-molecular-glue-targets-for-protein-degradation https://www.synbiobeta.com/read/synlogic-granted-fda-fast-track-designation-for-synb1353-for-the-treatment-of-homocystinuria-hcu https://www.synbiobeta.com/read/conagen-commercializes-scalable-sweetness-enhancers-from-nature https://www.synbiobeta.com/read/codagenix-announces-award-with-the-us-department-of-defense-for-development-of-balanced-tetravalent-dengue-vaccine https://www.synbiobeta.com/read/ginkgo-bioworks-announces-strategic-purchase-of-epidemiological-data-infrastructure-assets https://www.synbiobeta.com/read/ginkgo-bioworks-and-xprescheck-receive-award-to-expand-cdcs-traveler-based-sars-cov-2-genomic-surveillance-program-in-u-s-airports https://www.synbiobeta.com/read/ginkgo-bioworks-and-the-rwanda-development-board-announce-plans-to-develop-and-implement-new-biosecurity-capabilities-in-rwanda https://www.synbiobeta.com/read/synlogic-announces-synthetic-biotic-for-gout-developed-in-partnership-with-ginkgo-bioworks https://www.synbiobeta.com/read/bluestem-biosciences-a-sustainable-chemicals-startup-closes-5-million-pre-seed-funding-to-scale-discovery-through-industrial-anaerobic-fermentation https://www.synbiobeta.com/read/codexis-and-molecular-assemblies-announce-execution-of-commercial-license-and-enzyme-supply-agreement-for-optimized-tdt-enzyme-for-enzymatic-dna-synthesis https://www.synbiobeta.com/read/artisan-launches-star-crispr-tm-to-provide-broad-gene-editing-access-for-drug-discovery-and-development https://www.synbiobeta.com/read/genoa-ventures-announces-second-fund-to-expand-investing-in-the-convergence-of-biology-and-technology https://www.synbiobeta.com/read/berkeley-lights-and-aanika-biosciences-reach-strategic-partnership-milestone-by-identifying-a-commercially-viable-antimicrobial-peptide https://www.synbiobeta.com/read/insempra-announces-strategic-investment-in-solena-materials https://www.synbiobeta.com/read/ginkgo-and-bayer-sign-definitive-agreement-to-build-agricultural-biologicals-r-d-platform-capabilities https://www.synbiobeta.com/read/tetrascience-launches-revolutionary-scientific-data-cloud-unlocking-innovation-and-value-throughout-r-d-manufacturing-and-quality-control https://www.synbiobeta.com/read/mycoworks-commercializes-reishi-tm-the-worlds-first-plastic-free-mycelium-leather-alternative-with-luxury-hatmaker-nick-fouquet https://www.synbiobeta.com/read/ginkgo-bioworks-announces-latest-collaboration-for-beauty-and-personal-care-industry-with-sumitomo-chemical https://www.synbiobeta.com/read/zymergen-expands-agreement-with-octant-to-scale-next-generation-drug-discovery-platform https://www.synbiobeta.com/read/twist-bioscience-launches-monkeypox-virus-synthetic-dna-controls https://www.synbiobeta.com/read/allonnia-discovers-new-pfas-biosensor https://www.synbiobeta.com/read/spiderwort-secures-13-2m-usd-in-series-a-financing-to-accelerate-clinical-trials-of-revolutionary-biomaterials https://www.synbiobeta.com/read/synlogic-initiates-phase-1-study-of-synb1353-for-the-treatment-of-homocystinuria-hcu https://www.synbiobeta.com/read/string-bio-woodside-energy-collaboration-for-sustainable-manufacturing https://www.synbiobeta.com/read/epic-bio-founded-by-crispr-pioneer-launches-to-revolutionize-genetic-medicine-with-epigenetic-engineering https://www.synbiobeta.com/read/stand-forward-stand-sideways-stand-for-something-wndr-r-alpine-launches-first-snowboards-the-belletour-and-the-belleaire https://www.synbiobeta.com/read/biosyntia-closes-a-11-5-million-eur-round-to-launch-worlds-first-bio-based-vitamin-b7 https://www.synbiobeta.com/read/twist-bioscience-opens-new-twist-boston-location-to-expand-antibody-discovery-capacity https://www.synbiobeta.com/read/touchlight-signs-patent-license-agreement-with-pfizer-for-the-use-of-dbdna-for-the-manufacture-of-mrna-based-vaccines-therapeutics-and-gene-therapies https://www.synbiobeta.com/read/materials-innovator-algiknit-closes-13-million-series-a-to-transform-the-textile-industrys-environmental-impact https://www.synbiobeta.com/read/academic-industry-leaders-form-openfold-ai-research-consortium-to-develop-open-source-software-tools-to-understand-biological-systems-and-discover-new-medicines https://www.synbiobeta.com/read/arzeda-announces-collaboration-with-w-l-gore-associates-to-drive-innovation-in-materials-research-with-designer-proteins https://www.synbiobeta.com/read/chinova-bioworks-raises-6-million-in-series-a-investment https://www.synbiobeta.com/read/antheia-announces-new-financing-and-plans-to-construct-pilot-plant-facility-for-biomanufacturing https://www.synbiobeta.com/read/precision-biosciences-announces-50-million-offering-of-common-stock https://www.synbiobeta.com/read/resvita-bio-receives-rare-pediatric-disease-designation-for-rvb-001-as-a-treatment-for-netherton-syndrome https://www.synbiobeta.com/read/affini-t-therapeutics-metagenomi-announce-next-generation-gene-editing-partnership-to-advance-cell-therapies-for-solid-tumor-patients https://www.synbiobeta.com/read/slingshot-biosciences-inc-partners-with-cambridge-bioscience-to-distribute-synthetic-cells-throughout-united-kingdom-and-ireland https://www.synbiobeta.com/read/slingshot-biosciences-inc-partners-with-kem-en-tec-nordic-a-s-to-distribute-synthetic-cells-throughout-denmark-sweden-norway-finland-and-iceland https://www.synbiobeta.com/read/chain-biotech-and-the-university-of-oxford-collaborate-to-tackle-oral-vaccine-inequality https://www.synbiobeta.com/read/cemvita-factory-acquires-biomining-company-solfatara https://www.synbiobeta.com/read/codagenix-completes-dosing-in-phase-1-trial-of-universal-influenza-vaccine https://www.synbiobeta.com/read/pangaia-and-spiber-release-worlds-first-biofabricated-hoodie https://www.synbiobeta.com/read/willow-biosciences-incorporates-inscriptas-onyx-r-platform-to-expand-strain-engineering-capabilities-and-throughput https://www.synbiobeta.com/read/will-co-announces-strategic-collaboration-to-bring-checkerspots-novel-biobased-materials-and-algal-polyurethane-systems-to-european-product-innovators https://www.synbiobeta.com/read/ginkgo-bioworks-and-novo-nordisk-to-collaborate-on-expression-systems-for-pharmaceutical-products https://www.synbiobeta.com/read/dna-script-enables-same-day-q-dpcr-from-design-to-results-with-launch-of-next-generation-syntax-kits-at-agbt https://www.synbiobeta.com/read/ginkgo-bioworks-acquires-bitome-an-integrated-metabolite-monitoring-platform https://www.synbiobeta.com/read/oriciro-announces-series-b2-financing-to-advance-cell-free-dna-technology-for-innovative-therapeutics-and-synthetic-biology https://www.synbiobeta.com/read/latchbio-raises-28m-series-a-to-bring-a-modern-data-analysis-stack-to-biologists https://www.synbiobeta.com/read/solar-biotech-inc-receives-investment-from-ingredion-inc-to-accelerate-the-development-of-its-advanced-synbio-bioprocessing-technologies-and-proprietary-synbio-products-pipeline https://www.synbiobeta.com/read/modern-synthesis-raises-4-1m-to-empower-circular-fashion-with-its-microbial-textile-platform https://www.synbiobeta.com/read/conagens-new-dihydro-resveratrol-made-by-clean-bioconversion-inspires-novel-products-and-drives-market-growth https://www.synbiobeta.com/read/lanzatech-with-the-support-of-danone-discovers-method-to-produce-sustainable-pet-bottles-from-captured-carbon https://www.synbiobeta.com/read/sosvs-indiebio-and-genome-project-write-partner-to-fund-and-advise-startups https://www.synbiobeta.com/read/zymergen-sells-modular-automation-system-to-octant-to-scale-next-generation-drug-discovery-platform https://www.synbiobeta.com/read/future-meat-technologies-expands-executive-leadership-team-continues-momentum-towards-commercialization https://www.synbiobeta.com/read/synbio-coalition-announces-eight-new-members-representing-leading-biotechnology-companies-universities https://www.synbiobeta.com/read/surface-active-foam-fractionation-r-saff-r-technology-now-capable-of-removing-short-chain-perfluoroalkyl-and-polyfluoroalkyl-substances-pfas https://www.synbiobeta.com/read/genscript-launches-gmp-single-strand-and-double-strand-dna-service-for-supporting-gene-and-cell-therapy-development https://www.synbiobeta.com/read/bighat-biosciences-appoints-rob-chess-serial-entrepreneur-to-its-board-of-directors https://www.synbiobeta.com/read/saving-lives-with-living-cells-beckman-coulter-life-sciences-launches-aquios-stem-system-to-provide-a-new-solution-for-stem-cell-analysis https://www.synbiobeta.com/read/evo-foods-and-ginkgo-bioworks-announce-partnership-to-develop-animal-free-egg-products https://www.synbiobeta.com/read/twist-bioscience-enters-into-research-exclusive-option-and-license-agreement-with-astellas-for-antibodies-to-reduce-tumor-microenvironment-mediated-immunosuppression https://www.synbiobeta.com/read/evonetix-granted-patent-for-binary-assembly-method-for-gene-synthesis https://www.synbiobeta.com/read/dab-bios-turbocharged-fermenter-reduces-biomanufacturing-costs-by-50 https://www.synbiobeta.com/read/tierra-biosciences-appoints-michael-nemzek-as-chief-executive-officer https://www.synbiobeta.com/read/edison-releases-global-biopesticides-market-report-feeding-the-world-biological-products-for-sustainable-crop-protection https://www.synbiobeta.com/read/teselagen-biotechnology-launches-open-cloud-based-community-edition-for-designing-dna https://www.synbiobeta.com/read/loliware-introduces-first-of-its-kind-seaweed-pellet-technology-to-replace-plastics https://www.synbiobeta.com/read/personalis-announces-issuance-of-additional-us-patent-related-to-the-next-personal-tm-platform https://www.synbiobeta.com/read/ginkgo-bioworks-to-expand-platform-capabilities-in-agricultural-biologicals-and-launch-flagship-partnership-with-bayer https://www.synbiobeta.com/read/snipr-biome-initiates-first-in-human-clinical-trial-with-snipr001 https://www.synbiobeta.com/read/bridgestone-partners-with-lanzatech-to-pursue-end-of-life-tire-recycling-technologies https://www.synbiobeta.com/read/berkeley-lights-and-vestaron-announce-partnership-to-develop-pesticidal-peptides-utilizing-proprietary-high-throughput-functional-screening-service https://www.synbiobeta.com/read/genscript-debuts-industrys-highest-throughput-dna-synthesis-platform-for-commercial-dna-digital-data-storage https://www.synbiobeta.com/read/fredsense-and-ginkgo-bioworks-announce-partnership-to-develop-water-quality-biosensors https://www.synbiobeta.com/read/sampling-human-raises-2-million-to-support-the-development-of-engineered-cells-for-single-cell-analysis https://www.synbiobeta.com/read/cemvita-factory-partners-with-fluor-to-scale-sustainable-bio-solutions-to-extract-critical-minerals https://www.synbiobeta.com/read/molecular-devices-continues-investment-in-organoid-innovation-center-adding-cell-engineering-capabilities-to-automated-3d-cell-culture-platform https://www.synbiobeta.com/read/dna-script-launches-early-access-program-for-latest-advancements-to-the-syntax-platform-and-enzymatic-dna-synthesis-technology https://www.synbiobeta.com/read/persephone-biosciences-and-ginkgo-bioworks-announce-collaboration-to-develop-novel-therapeutics https://www.synbiobeta.com/read/codexis-and-molecular-assemblies-announce-results-of-first-collaboration-on-a-proprietary-high-performing-dna-polymerase-to-supercharge-fully-enzymatic-dna-synthesis https://www.synbiobeta.com/read/ansa-biotechnologies-closes-oversubscribed-68-million-series-a-financing-to-power-the-next-era-of-dna-enabled-industries https://www.synbiobeta.com/read/checkerspot-and-dic-corporation-announce-joint-development-agreement-to-bring-the-power-of-microalgae-to-skin-care-using-the-wing-tm-platform https://www.synbiobeta.com/read/elanco-and-ginkgo-bioworks-launch-biomedit-a-new-animal-health-company-leveraging-microbiome-technology https://www.synbiobeta.com/read/twist-bioscience-signs-antibody-discovery-collaboration-with-medisix-therapeutics-to-develop-t-cell-therapies https://www.synbiobeta.com/read/pangea-biomed-launches-with-worlds-most-advanced-multi-cancer-response-predictor-increasing-patient-benefits-from-precision-oncology-by-5x https://www.synbiobeta.com/read/ucl-selects-synthace-to-help-make-digital-cloud-based-lab-work-a-reality https://www.synbiobeta.com/read/houston-based-synbio-vc-firm-grows-advisory-team-with-two-new-experts https://www.synbiobeta.com/read/twist-bioscience-and-ginkgo-bioworks-sign-new-collaboration https://www.synbiobeta.com/read/demetrix-and-evonik-sign-supply-agreement-for-cannabinoids https://www.synbiobeta.com/read/dna-script-partners-with-asia-pacific-distributors-as-part-of-global-expansion-to-meet-demand-for-same-day-enzymatic-dna-synthesis https://www.synbiobeta.com/read/evozyne-announces-multi-target-research-collaboration-and-license-agreement-with-takeda-to-develop-next-generation-gene-therapies https://www.synbiobeta.com/read/microba-life-sciences-and-ginkgo-bioworks-announce-partnership-to-discover-novel-live-biotherapeutics https://www.synbiobeta.com/read/evonetix-granted-patent-for-technology-enabling-thermally-controlled-dna-synthesis https://www.synbiobeta.com/read/biobetter-breaks-bottleneck-in-cultivated-meat-with-tobacco-plants https://www.synbiobeta.com/read/beckman-coulter-life-sciences-and-amoydx-sign-application-development-agreement-for-the-biomek-ngenius-system https://www.synbiobeta.com/read/lifemine-therapeutics-announces-175-million-series-c-financing https://www.synbiobeta.com/read/ecovative-announces-partners-to-bring-mycelium-foam-to-the-fashion-industry https://www.synbiobeta.com/read/rootpath-launches-elevating-throughput-of-gene-function-interrogation-by-orders-of-magnitude https://www.synbiobeta.com/read/cemvita-factory-grows-executive-team-biofoundry-leadership https://www.synbiobeta.com/read/powerful-new-cytobank-platform-upgrade-available-from-beckman-coulter-life-sciences https://www.synbiobeta.com/read/twelve-and-lanzatech-partner-to-create-ethanol-from-co2 https://www.synbiobeta.com/read/twist-bioscience-launches-synthetic-rna-positive-controls-for-sars-cov-2-encapsulated-in-imagenes-stainless-steel-capsules https://www.synbiobeta.com/read/genomatica-and-asahi-kasei-partner-on-renewably-sourced-nylon-6-6 https://www.synbiobeta.com/read/polybion-completes-development-of-worlds-first-bacterial-cellulose-biomanufacturing-facility https://www.synbiobeta.com/read/conagen-develops-novel-high-performing-debondable-adhesives-from-natural-ingredients https://www.synbiobeta.com/read/molecular-assemblies-announces-25-8-million-series-b-financing-to-initiate-key-customer-program-for-commercial-access-to-fully-enzymatic-dna-synthesis https://www.synbiobeta.com/read/demetrix-initiates-2022-commercial-manufacturing-campaign https://www.synbiobeta.com/read/ginkgo-bioworks-signs-definitive-agreement-to-acquire-fgen-ag-a-leading-bioengineering-company-and-its-proprietary-ultra-high-throughput-screening-platform https://www.synbiobeta.com/read/strateos-expands-leadership-team-to-meet-increasing-customer-demand-for-its-remote-access-laboratories-and-lab-automation-software https://www.synbiobeta.com/read/berkeley-lights-announces-appointment-of-dr-siddhartha-kadia-as-chief-executive-officer https://www.synbiobeta.com/read/snipr-biome-announces-opening-of-new-bsl2-gmo2-classified-laboratory-in-copenhagen-denmark https://www.synbiobeta.com/read/berkeley-lights-releases-upgrade-to-its-software-suite-for-beacon-r-and-lightning-tm-platforms https://www.synbiobeta.com/read/beckman-coulter-life-sciences-launches-cellmek-sps-a-fully-automated-sample-preparation-system-for-clinical-flow-cytometry https://www.synbiobeta.com/read/allegra-v-15r-benchtop-centrifuge-launched-by-beckman-coulter-life-sciences-during-diamond-year-celebration https://www.synbiobeta.com/read/a-alpha-bio-and-lawrence-livermore-national-laboratory-collaborate-to-accelerate-therapeutic-antibody-discovery-against-emerging-covid-19-variants https://www.synbiobeta.com/read/evonetix-demonstrates-novel-enzymatic-dna-synthesis-method https://www.synbiobeta.com/read/serotiny-and-tessera-therapeutics-enter-into-collaboration-to-engineer-and-optimize-programmable-gene-writer-proteins https://www.synbiobeta.com/read/phytolon-and-ginkgo-bioworks-collaborate-to-take-biological-production-of-vibrant-food-colors-to-the-next-level https://www.synbiobeta.com/read/aanika-biosciences-first-biotech-company-to-receive-bermuda-monetary-authoritys-approval-for-reinsurance-innovation-hub https://www.synbiobeta.com/read/provectus-announces-new-executive-appointment-ushering-in-the-next-stage-of-growth https://www.synbiobeta.com/read/geltor-completes-first-full-scale-commercial-manufacturing-run-of-primacoll-r-for-food-and-beverage https://www.synbiobeta.com/read/study-indicates-that-amsilk-engineered-silk-implant-coatings-can-prevent-infection https://www.synbiobeta.com/read/synthego-raises-200-million-to-accelerate-the-field-of-crispr-based-medicines-from-early-phase-research-to-the-clinic https://www.synbiobeta.com/read/future-meat-technologies-appoints-nicole-johnson-hoffman-as-new-chief-executive-officer https://www.synbiobeta.com/read/what-makes-the-bioeconomy-tick-and-how-can-we-measure-it https://www.synbiobeta.com/read/making-meat-affordable-progress-since-the-330-000-lab-grown-burger https://www.synbiobeta.com/read/lilly-to-supply-up-to-600-000-doses-of-abcellera-discovered-antibody-bebtelovimab-to-the-u-s-government-in-ongoing-effort-to-provide-covid-19-treatments https://www.synbiobeta.com/read/teselagen-secures-contract-from-biomade-to-accelerate-us-biomanufacturing-with-advanced-informatics-and-artificial-intelligence https://www.synbiobeta.com/read/isoplexis-immune-monitoring-helps-identify-early-factors-of-long-covid-in-cell-publication https://www.synbiobeta.com/read/greenlight-biosciences-begins-trading-today-as-nasdaq-grna-on-the-closing-of-its-business-combination-with-environmental-impact-acquisition-corp https://www.synbiobeta.com/read/4q-2021-synthetic-biology-venture-investment-report https://www.synbiobeta.com/read/the-genesis-machine-our-quest-to-rewrite-life-in-the-age-of-synthetic-biology-amy-webb https://www.synbiobeta.com/read/intellia-therapeutics-announces-acquisition-of-rewrite-therapeutics https://www.synbiobeta.com/read/dna-script-joins-wellcome-leap-r3-program-to-advance-rna-products-and-therapies https://www.synbiobeta.com/read/nuclera-raises-42-5m-in-first-close-of-series-b-for-desktop-protein-printer https://www.synbiobeta.com/read/tierra-biosciences-launches-first-ever-online-protein-ordering-platform-for-synthetic-biology-protein-engineering https://www.synbiobeta.com/read/sugarlogix-announces-relaunch-as-namuh https://www.synbiobeta.com/read/industrial-biotech-start-up-cemvita-factory-opens-biofoundry-in-denver-focused-on-sustainable-mining-adding-scientists-engineers-and-innovators https://www.synbiobeta.com/read/solar-biotech-announces-expanded-partnership-with-motif-foodworks https://www.synbiobeta.com/read/mycelium-materials-company-ecovative-launches-forager-to-develop-mushroom-leather-products-and-soft-goods https://www.synbiobeta.com/read/atlast-food-co-reintroduces-itself-as-myforest-tm-foods-co https://www.synbiobeta.com/read/twist-bioscience-signs-collaboration-with-artisan-bio-to-engineer-next-generation-cell-therapeutics https://www.synbiobeta.com/read/prokarium-expands-r-d-capabilities-with-london-biofoundry-to-deepen-microbial-immunotherapy-pipeline https://www.synbiobeta.com/read/kyverna-therapeutics-closes-85-million-series-b-financing-led-by-northpond-ventures https://www.synbiobeta.com/read/roswell-biotechnologies-demonstrates-first-scalable-molecular-electronics-chip-in-peer-review-paper https://www.synbiobeta.com/read/benchsci-raises-63-million-series-c-to-solve-pharmas-biggest-r-d-challenges-with-ai-powered-software-platform https://www.synbiobeta.com/read/mammoth-biosciences-receives-fda-emergency-use-authorization-for-first-crispr-based-high-throughput-covid-19-test https://www.synbiobeta.com/read/altos-labs-launches-with-the-goal-to-transform-medicine-through-cellular-rejuvenation-programming https://www.synbiobeta.com/read/ginkgo-bioworks-announces-acquisition-of-massachusetts-covid-19-testing-provider-project-beacon-covid-19-llc https://www.synbiobeta.com/read/covestro-and-genomatica-produce-important-chemical-raw-material-using-biotechnology https://www.synbiobeta.com/read/an-interview-with-tom-baruch-by-karl-schmieder https://www.synbiobeta.com/read/the-future-of-seafood-starts-in-north-carolina-pearlita-foods-is-bringing-oysters-from-bioreactor-to-table https://www.synbiobeta.com/read/insightful-science-acquires-omiq-to-add-cloud-based-machine-learning-to-its-flow-cytometry-capabilities https://www.synbiobeta.com/read/twist-biosciences-comprehensive-dna-synthesis-capabilities-expanded-as-industry-leading-enzymatic-synthesis-process-unveiled-at-annual-j-p-morgan-healthcare-conference https://www.synbiobeta.com/read/pfizer-and-beam-enter-exclusive-multi-target-research-collaboration-to-advance-novel-in-vivo-base-editing-programs-for-a-range-of-rare-diseases https://www.synbiobeta.com/read/berkeley-lights-and-aanika-biosciences-announce-partnership-to-improve-food-safety-by-commercializing-antimicrobial-peptides-through-proprietary-high-throughput-functional-screening-service https://www.synbiobeta.com/read/bayer-and-mammoth-biosciences-to-collaborate-on-novel-gene-editing-technology https://www.synbiobeta.com/read/absci-announces-research-collaboration-with-merck https://www.synbiobeta.com/read/codex-dna-signs-early-access-collaboration-and-licensing-agreement-with-pfizer-to-further-develop-codex-dnas-novel-enzymatic-dna-synthesis-technology-for-pfizers-use-in-its-research-and-development-of-mrna-based-vaccines-and-biotherapies https://www.synbiobeta.com/read/ginkgo-bioworks-adopts-inscriptas-onyx-digital-genome-engineering-platform-to-continue-accelerating-its-genome-editing-throughput https://www.synbiobeta.com/read/selecta-biosciences-and-ginkgo-bioworks-announce-new-collaboration-to-develop-next-generation-gene-therapy-capsids https://www.synbiobeta.com/read/dna-script-closes-200-million-series-c-financing-with-completion-of-second-tranche https://www.synbiobeta.com/read/inscripta-r-appoints-kristala-prather-phd-to-its-board-of-directors https://www.synbiobeta.com/read/optimvia-and-ginkgo-bioworks-announce-partnership-to-manufacture-biosynthetic-heparin https://www.synbiobeta.com/read/amyris-and-immunitybio-complete-joint-venture-for-next-generation-covid-19-rna-vaccine https://www.synbiobeta.com/read/benjamin-franklin-institute-of-technology-ginkgo-bioworks-to-develop-biotechnology-manufacturing-associates-degree https://www.synbiobeta.com/read/codex-dna-expands-catalog-of-covid-19-tools-with-release-of-full-length-synthetic-genome-for-sars-cov-2-omicron-variant https://www.synbiobeta.com/read/the-synbiobeta-live-conference-is-postponing-to-april-12-14-2022 https://www.synbiobeta.com/read/20n-bio-raises-3-3-million-in-series-seed-funding-to-advance-computational-design-of-new-proteins-for-therapeutics https://www.synbiobeta.com/read/a-alpha-bio-partners-with-kymera-therapeutics-to-discover-novel-interactions-for-molecular-glue-discovery https://www.synbiobeta.com/read/nodexus-inc-emerges-from-stealth-with-30-million-series-a-funding-to-advance-manufacturing-and-expand-commercialization-of-nx-one-platform https://www.synbiobeta.com/read/seaweed-yarnmaker-algiknit-launches-innovation-hub-in-north-carolina-to-scale-production-of-eco-conscious-yarns-for-global-fashion-brands https://www.synbiobeta.com/read/opentrons-subsidiary-neochromosome-and-mekonos-announce-new-partnership-to-advance-cell-engineering-for-personalized-medicine https://www.synbiobeta.com/read/provectus-algae-moves-sustainable-synthetic-biology-biomanufacturing-platform-forward-with-pre-series-a-funding https://www.synbiobeta.com/read/bioeconomy-q3-venture-investment-report-2021 https://www.synbiobeta.com/read/eurofins-clinical-enterprise-launches-new-partnership-with-ginkgo-bioworks-to-support-federally-funded-covid-19-pcr-testing-program https://www.synbiobeta.com/read/the-every-company-closes-oversubscribed-175-million-series-c-round-as-it-drives-scale-up-of-its-b2b-animal-free-protein-platform https://www.synbiobeta.com/read/motif-foodworks-announces-the-commercial-launch-of-hemami-tm-food-tech-earns-generally-recognized-as-safe-gras-status-from-fda https://www.synbiobeta.com/read/cyrus-biotechnology-announces-18m-financing-and-acquisition-of-orthogonal-biologics-to-form-an-integrated-software-driven-pre-clinical-stage-drug-discovery-firm https://www.synbiobeta.com/read/zymochem-completes-4-million-seed-financing https://www.synbiobeta.com/read/nabla-bio-closes-11m-seed-financing-led-by-khosla-ventures-and-zetta-venture-partners https://www.synbiobeta.com/read/eligo-bioscience-announces-successful-outcome-in-us-patent-interference-against-snipr-biome-on-crispr-cas-antimicrobials https://www.synbiobeta.com/read/berkeley-lights-debuts-in-france-as-mimabs-acquires-the-beacon-r-optofluidic-system-for-antibody-discovery https://www.synbiobeta.com/read/synthetic-biologist-marc-salit-named-mitre-fellow https://www.synbiobeta.com/read/oriciro-genomics-launches-new-enzymatic-dna-synthesis-tool-for-commonly-used-vectors https://www.synbiobeta.com/read/codex-dna-announces-commercial-availability-of-automated-mrna-synthesis-kit-with-integrated-capping-technology-for-bioxp-tm-system https://www.synbiobeta.com/read/enginzyme-joins-forces-with-leading-food-processing-company-to-improve-food-beverage-production https://www.synbiobeta.com/read/codex-dna-and-rnaimmune-announce-collaboration-to-optimize-development-of-future-mrna-synthesis-and-delivery-kits https://www.synbiobeta.com/read/cop26-in-review-its-a-race-against-the-clock https://www.synbiobeta.com/read/twist-bioscience-expands-partnership-with-invetx-to-include-discovery-of-best-in-class-antibodies-to-treat-multiple-diseases-in-cats-and-dogs https://www.synbiobeta.com/read/antheia-appoints-zack-mcgahey-as-chief-operating-officer https://www.synbiobeta.com/read/mrna-victoria-and-ginkgo-bioworks-announce-partnership-to-grow-the-bioeconomy-international-biosecurity-capabilities https://www.synbiobeta.com/read/sofinnova-partners-raises-eu150m-for-its-third-industrial-biotech-fund-dedicated-to-environmental-impact https://www.synbiobeta.com/read/crispr-therapeutics-and-viacyte-inc-to-start-clinical-trial-of-the-first-gene-edited-cell-replacement-therapy-for-treatment-of-type-1-diabetes https://www.synbiobeta.com/read/synthace-raises-35m-to-expand-access-to-its-revolutionary-r-d-technology-for-life-changing-research https://www.synbiobeta.com/read/amyris-closes-upsized-offering-of-690-0-million-of-1-50-convertible-senior-notes-due-2026 https://www.synbiobeta.com/read/roswell-biotechnologies-unveils-first-molecular-electronics-chip-to-digitize-biology https://www.synbiobeta.com/read/twist-bioscience-launches-revelar-biotherapeutics-to-develop-and-commercialize-novel-covid-19-and-other-antibody-therapeutics-for-difficult-to-treat-diseases https://www.synbiobeta.com/read/genscript-launches-closed-end-double-stranded-dna-service-for-crispr https://www.synbiobeta.com/read/codex-dna-acquires-eton-bioscience https://www.synbiobeta.com/read/how-science-will-actually-solve-climate-change https://www.synbiobeta.com/read/pheronym-begins-scaling-pest-bio-control-solution-at-lawrence-berkeley-national-laboratory https://www.synbiobeta.com/read/dna-script-to-develop-next-generation-of-enzymatic-dna-synthesis-printers-with-2-2-million-grant-award-from-the-national-human-genome-research-institute-of-the-nih https://www.synbiobeta.com/read/synlogic-and-ginkgo-bioworks-announce-investigational-synthetic-biotic-medicine-for-the-treatment-of-homocystinuria https://www.synbiobeta.com/read/amyris-announces-jv-partnership-with-immunitybio-for-next-generation-covid-19-rna-vaccine https://www.synbiobeta.com/read/bit-bio-raises-in-excess-of-100-million-in-first-close-of-series-b-financing https://www.synbiobeta.com/read/brightseed-receives-grant-to-discover-plant-based-bioactives-that-can-improve-birth-outcomes-and-reduce-global-reliance-on-antibiotics-for-maternal-and-infant-health https://www.synbiobeta.com/read/joyn-bio-announces-opening-of-new-facility-to-develop-engineered-microbes-for-crop-protection https://www.synbiobeta.com/read/the-synbio-innovation-accelerator-a-collaboration-between-codexis-and-casdin-capital-enables-10-million-investment-in-molecular-assemblies-inc https://www.synbiobeta.com/read/meissa-announces-positive-preliminary-clinical-data-on-safety-and-immunogenicity-of-intranasal-covid-19-vaccine https://www.synbiobeta.com/read/arcaea-a-company-launched-on-the-ginkgo-bioworks-platform-announces-78m-series-a-to-build-a-new-foundation-for-the-beauty-industry-through-expressive-biology https://www.synbiobeta.com/read/lygos-successfully-completes-commercial-scale-fermentation-campaign-to-meet-growing-demand-for-bio-based-cannabinoids https://www.synbiobeta.com/read/sphere-fluidics-closes-a-40-million-funding-round-led-by-sofinnova-partners-and-redmile-group https://www.synbiobeta.com/read/selecta-biosciences-and-ginkgo-bioworks-announce-partnership-to-advance-treatments-for-orphan-and-rare-diseases https://www.synbiobeta.com/read/berkeley-lights-announces-gsk-acquires-third-beacon-r-optofluidic-system-to-expand-antibody-therapeutics-development https://www.synbiobeta.com/read/dna-script-raises-165m-in-oversubscribed-series-c-financing-to-accelerate-commercialization-of-enzymatic-dna-printing-platform https://www.synbiobeta.com/read/molecular-assemblies-awarded-nih-phase-i-sbir-grant-to-develop-a-fully-enzymatic-dna-synthesis-process-to-propel-synthetic-biology https://www.synbiobeta.com/read/cellibre-closes-a-bridge-financing-to-accelerate-the-production-of-pure-natural-pharmaceutical-grade-cannabinoids-via-fermentation https://www.synbiobeta.com/read/origin-bio-and-carbocycle-join-forces-to-revolutionize-the-chemical-industry-towards-a-regenerative-future https://www.synbiobeta.com/read/synlogic-announces-nature-publication-demonstrating-novel-application-of-synthetic-biotic-platform https://www.synbiobeta.com/read/london-based-biotech-baccuico-announces-3-8m-seed-round-and-name-change-to-bactobio https://www.synbiobeta.com/read/calyxt-announces-new-strategic-direction-to-provide-sustainable-plant-based-synthetic-biology-solutions-to-expanded-group-of-end-markets-and-diversified-base-of-customers https://www.synbiobeta.com/read/enginzyme-demonstrates-breakthrough-piloting-results-and-opens-the-path-to-commercial-scale https://www.synbiobeta.com/read/moderna-announces-the-launch-of-global-fellowship-program-for-young-researchers-exploring-mrna-medicines https://www.synbiobeta.com/read/q2-2021-report https://www.synbiobeta.com/read/2q-2021-synthetic-biology-venture-investment-report https://www.synbiobeta.com/read/amyris-partners-with-inscripta-to-enhance-development-of-sustainable-ingredients-using-the-onyx-tm-genome-engineering-platform https://www.synbiobeta.com/read/latch-bio-emerges-from-stealth-with-seed-funding-round-led-by-lux-capital https://www.synbiobeta.com/read/greenlight-biosciences-opens-rna-production-facility-for-the-next-generation-of-agricultural-products https://www.synbiobeta.com/read/new-age-meats-raises-25m-in-series-a-funding-to-speed-development-of-cultured-meat https://www.synbiobeta.com/read/fauna-bio-raises-9-million-to-expand-comparative-genomics-platform-for-novel-target-discovery https://www.synbiobeta.com/read/twist-bioscience-internally-discovered-single-domain-antibody-tb202-3-shows-potent-binding-to-multiple-strains-of-sars-cov-2-including-alpha-beta-and-gamma-strains-in-preclinical-studies https://www.synbiobeta.com/read/evonetix-granted-patent-for-dna-data-storage-and-retrieval-method https://www.synbiobeta.com/read/codagenix-announces-safety-and-immunogenicity-data-from-phase-1-covid-19-intranasal-vaccine-trial-and-intent-to-progress-to-phase-2-3-studies https://www.synbiobeta.com/read/twist-bioscience-collaborates-with-deep-learning-experts-deepcdr-on-antibody-library-design https://www.synbiobeta.com/read/persephone-biosciences-inc-announces-collaboration-with-janssen-biotech-inc https://www.synbiobeta.com/read/synlogic-announces-positive-phase-2-data-demonstrating-reduction-in-plasma-phenylalanine-levels-in-patients-with-phenylketonuria https://www.synbiobeta.com/read/abcellera-announces-collaboration-with-moderna-to-discover-therapeutic-antibodies-for-mrna-medicines https://www.synbiobeta.com/read/anjarium-biosciences-raises-chf-55-5m-61m-series-a-financing-to-develop-next-generation-non-viral-gene-therapies https://www.synbiobeta.com/read/riffyn-recognized-as-a-representative-vendor-for-intelligent-process-development-in-2021-gartner-r-market-guide-for-lab-informatics https://www.synbiobeta.com/read/riffyn-identified-in-2021-gartner-r-hype-cycle-tm-for-life-science-manufacturing-quality-and-supply-chain-report-under-two-categories-bioprocessing-informatics-and-enterprise-laboratory-informatics https://www.synbiobeta.com/read/ginkgo-bioworks-ferment-consortium-launches-verb-biotics-a-probiotics-innovation-company-to-address-market-demands-for-effective-probiotics https://www.synbiobeta.com/read/ginkgo-bioworks-ferment-consortium-launches-ayana-bio-to-produce-plant-and-fungal-bioactives-for-herbal-medicines-and-nutraceuticals https://www.synbiobeta.com/read/benchling-expands-into-early-development-market-to-accelerate-delivery-of-breakthrough-products https://www.synbiobeta.com/read/touchlight-extends-funding-round-to-us-125m-as-demand-for-its-dbdna-tm-grows-rapidly https://www.synbiobeta.com/read/ginkgo-bioworks-to-go-public-with-over-1-6-billion-in-proceeds https://www.synbiobeta.com/read/abcellera-acquires-tetragenetics-enhancing-capabilities-to-generate-antibodies-against-high-value-targets https://www.synbiobeta.com/read/biosyntia-and-givaudan-enter-long-term-collaboration-for-sustainable-ingredient-development https://www.synbiobeta.com/read/new-agenus-subsidiary-saponiqx-builds-innovative-adjuvant-platform-and-forms-collaboration-with-ginkgo-bioworks https://www.synbiobeta.com/read/solugen-raises-over-350-million-in-series-c-funding-led-by-baillie-gifford-gic-to-make-carbon-negative-chemicals https://www.synbiobeta.com/read/spiber-inc-raises-jpy-34-4-billion-in-funding-to-strengthen-production-and-sales-network https://www.synbiobeta.com/read/mammoth-biosciences-raises-195-million-to-build-next-generation-crispr-products-in-therapeutics-and-diagnostics https://www.synbiobeta.com/read/amyris-closes-acquisition-of-beauty-labs-combining-synthetic-biology-leadership-with-digital-innovation https://www.synbiobeta.com/read/synbiobeta-2021-is-pushing-to-january-25-27-2022 https://www.synbiobeta.com/read/tantu-and-ginkgo-bioworks-announce-partnership-to-engineer-a-living-biotherapeutic-for-gastrointestinal-healing https://www.synbiobeta.com/read/creative-teams-to-use-biotechnology-to-reimagine-the-future-of-consumer-electronics https://www.synbiobeta.com/read/twelve-and-lanzatech-partner-to-produce-the-worlds-first-polypropylene-from-co2 https://www.synbiobeta.com/read/cambium-biomaterials-announces-partnership-with-ginkgo-bioworks-to-accelerate-industrial-adoption-of-high-performance-biomaterials https://www.synbiobeta.com/read/codex-dna-releases-full-length-synthetic-genome-for-highly-infectious-sars-cov-2-delta-variant https://www.synbiobeta.com/read/teselagen-biotechnology-teams-up-with-igem-to-advance-synthetic-biology-in-developing-countries https://www.synbiobeta.com/read/ginkgo-bioworks-and-givaudan-enter-multi-program-collaboration-to-produce-a-series-of-ingredients https://www.synbiobeta.com/read/provectus-algae-expands-into-new-large-scale-microalgae-biomanufacturing-facility https://www.synbiobeta.com/read/conagen-expands-natural-preservation-by-fermentation https://www.synbiobeta.com/read/amyris-achieves-promising-in-vivo-results-for-intranasal-delivery-of-rna-nlc-vaccine https://www.synbiobeta.com/read/an-open-letter-from-synbiobeta-ceo https://www.synbiobeta.com/read/cronos-group-and-ginkgo-bioworks-announce-achievement-of-equity-milestone-in-partnership-to-produce-cultured-cannabinoids https://www.synbiobeta.com/read/debut-biotech-raises-22-6m-series-a-to-commercialize-high-value-ingredients-from-proprietary-cell-free-biomanufacturing-platform https://www.synbiobeta.com/read/antheia-and-ginkgo-bioworks-announce-partnership-to-accelerate-production-of-essential-medicines-using-synthetic-biology https://www.synbiobeta.com/read/houston-based-cemvita-factory-announces-its-initial-closing-of-series-a-led-by-8090-partners-to-accelerate-industrial-decarbonization https://www.synbiobeta.com/read/atum-announces-issuance-of-us-patents-covering-novel-enzymes-critical-to-genome-engineering-applications https://www.synbiobeta.com/read/berkeley-lights-and-bayer-announce-a-multi-year-agreement-aimed-at-revolutionizing-the-discovery-of-next-generation-traits https://www.synbiobeta.com/read/aldevrons-collaboration-with-ginkgo-bioworks-yields-manufacturing-breakthrough-for-vaccinia-capping-enzyme-used-for-manufacturing-of-mrna-vaccines https://www.synbiobeta.com/read/teselagen-biotechnology-partners-with-agile-biofoundry-to-develop-tools-for-optimizing-fermentation-with-machine-learning https://www.synbiobeta.com/read/bolt-threads-to-leverage-ginkgo-bioworks-platform-for-commercial-strain-optimization-of-b-silk-tm-protein https://www.synbiobeta.com/read/codex-dna-announces-synthetic-biology-collaboration-with-u-s-department-of-agriculture-to-combat-citrus-greening-disease https://www.synbiobeta.com/read/bio-isac-founded-to-protect-and-build-resilience-from-increasing-attacks-on-public-and-private-bioeconomy-infrastructure https://www.synbiobeta.com/read/creo-successfully-completes-commercial-fermentation-run https://www.synbiobeta.com/read/strand-therapeutics-awarded-two-phase-i-nih-sbir-grants-to-advance-programmable-long-lasting-mrna-therapeutics-for-melanoma-and-breast-cancer https://www.synbiobeta.com/read/letter-from-the-editor-leading-the-future-is-never-easy https://www.synbiobeta.com/read/usda-releases-economic-impact-analysis-of-the-u-s-biobased-products-industry https://www.synbiobeta.com/read/vertex-ceo-reshma-kewalramani-md-to-join-ginkgo-bioworks-board-of-directors https://www.synbiobeta.com/read/codexis-and-kalsec-announce-expanded-collaboration-for-supply-of-novel-enzyme-to-sustainably-produce-natural-clean-label-beverage-ingredient https://www.synbiobeta.com/read/motif-foodworks-announces-new-partnerships-to-improve-taste-and-experience-in-plant-based-foods https://www.synbiobeta.com/read/genscript-announces-notice-of-allowance-for-u-s-patent-application-for-sars-cov-2-surrogate-virus-neutralization-kit https://www.synbiobeta.com/read/novonutrients-scaling-up-with-project-funding-plus-9m-in-equity https://www.synbiobeta.com/read/synthace-unveils-first-life-sciences-r-d-cloud-addressing-complexity-speed-reproducibility-for-scientists https://www.synbiobeta.com/read/protera-announces-final-close-of-its-10m-series-a-led-by-sofinnova-partners https://www.synbiobeta.com/read/deep-genomics-raises-180m-in-series-c-financing https://www.synbiobeta.com/read/touchlight-and-vanderbilt-university-medical-center-collaborate-on-darpa-pandemic-prevention-platform-programme-to-develop-synthetic-dna-based-antibody-to-protect-against-emerging-threats https://www.synbiobeta.com/read/prokarium-appoints-kristen-albright-as-chief-executive-officer https://www.synbiobeta.com/read/nobell-foods-raises-75m-series-b-to-introduce-cheese-made-from-plants https://www.synbiobeta.com/read/twist-bioscience-incorporates-molcure-ai-technology-to-augment-therapeutic-antibody-discovery https://www.synbiobeta.com/read/biomx-inc-announces-15-million-registered-direct-offering https://www.synbiobeta.com/read/twist-bioscience-now-shipping-synthetic-rna-positive-controls-for-delta-b-1-617-2-sars-cov-2-variant-for-development-of-accurate-diagnostic-tests https://www.synbiobeta.com/read/xenetic-biosciences-inc-announces-12-5-million-private-placement-priced-at-a-premium-to-market https://www.synbiobeta.com/read/caribou-biosciences-announces-pricing-of-upsized-initial-public-offering https://www.synbiobeta.com/read/berkeley-lights-announces-technology-collaboration-to-accelerate-and-improve-gene-therapy-viral-vector-development-and-manufacturing https://www.synbiobeta.com/read/clexbio-oversubscribes-financing-round-totalling-usd-2-2m-to-develop-engineered-human-blood-vessel-transplants https://www.synbiobeta.com/read/codex-dna-announces-licensing-and-supply-deal-with-trilink-biotechnologies-for-cleancap-r-mrna-capping-technology https://www.synbiobeta.com/read/oriciro-announces-y-1-billion-series-b-financing-to-advance-cell-free-dna-technology-for-innovative-therapeutics-and-synthetic-biology https://www.synbiobeta.com/read/stemson-therapeutics-secures-15m-series-a-funding-to-cure-hair-loss https://www.synbiobeta.com/read/labgenius-announces-research-collaboration-with-ablynx-a-sanofi-company https://www.synbiobeta.com/read/codexis-announces-completion-of-codeevolver-r-license-technology-transfer-with-global-pharmaceutical-leader https://www.synbiobeta.com/read/strateos-launches-its-smartlab-software-platform-to-power-the-digital-transformation-of-life-science-research-laboratories https://www.synbiobeta.com/read/cellares-and-poseida-therapeutics-partner-to-accelerate-cell-therapy-manufacturing https://www.synbiobeta.com/read/provectus-algae-secures-grant-to-advance-r-d-global-commercialisation-of-innovative-synthetic-biology-stack https://www.synbiobeta.com/read/10x-genomics-introduces-new-chromium-x-series-for-single-cell-analysis https://www.synbiobeta.com/read/biology-meets-cloud-computing-and-ai-unilever-partners-with-arzeda-to-harness-the-power-of-computer-designed-enzymes https://www.synbiobeta.com/read/lanzatech-and-lululemon-partner-to-create-the-first-fabric-using-recycled-carbon-emissions https://www.synbiobeta.com/read/fredsense-technologies-raises-2-5m-from-bdc-capital-to-accelerate-their-biologically-based-water-quality-sensors https://www.synbiobeta.com/read/sherlock-biosciences-announces-appointment-of-bryan-dechairo-as-president-and-chief-executive-officer https://www.synbiobeta.com/read/amyris-completes-first-major-license-for-leading-rna-vaccine-advancing-technology-to-human-trials https://www.synbiobeta.com/read/twist-bioscience-acquires-ngs-library-preparation-maker-igenomx https://www.synbiobeta.com/read/antheia-announces-73m-series-b-to-commercialize-synthetic-biology-platform-for-essential-medicines https://www.synbiobeta.com/read/teselagen-biotechnology-releases-new-protein-optimization-toolkit-for-automated-biotherapeutic-drug-design-and-development-2 https://www.synbiobeta.com/read/duke-nus-and-genscript-announce-notice-of-allowance-for-u-s-patent-application-for-sars-cov-2-surrogate-virus-neutralization-test https://www.synbiobeta.com/read/olon-announces-absolute-record-investments-in-technology-platforms-and-r-d-significant-expansion-of-its-high-containment-platform https://www.synbiobeta.com/read/codex-dna-announces-closing-of-initial-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/strand-therapeutics-raises-52m-in-oversubscribed-series-a-round https://www.synbiobeta.com/read/future-meat-technologies-launches-worlds-first-industrial-cultured-meat-production-facility https://www.synbiobeta.com/read/sherlock-biosciences-221b-foundation-enables-global-access-to-covid-19-diagnostics-with-up-to-10-million-tests-per-month https://www.synbiobeta.com/read/anna-biosciences-launches-pioneering-immunotherapeutic-treatment-to-fight-covid-19 https://www.synbiobeta.com/read/zymochem-awarded-4-2-million-from-arpa-e-for-transformational-biomanufacturing-technology https://www.synbiobeta.com/read/benchling-launches-support-for-the-discovery-and-development-of-rna-therapeutics https://www.synbiobeta.com/read/investors-bet-big-with-fungi-alternative-protein-company-enough https://www.synbiobeta.com/read/kytopen-awarded-nih-grant-of-up-to-2m-to-unlock-the-power-of-engineered-natural-killer-nk-cells-via-flowfect-r-platform https://www.synbiobeta.com/read/motif-foodworks-announces-226-million-series-b-funding-round https://www.synbiobeta.com/read/the-221b-foundation-grants-license-to-albot-technologies-to-develop-manufacture-and-distribute-crispr-covid-19-diagnostic-kits-in-india https://www.synbiobeta.com/read/dna-script-announces-the-commercial-launch-of-the-syntax-system-the-first-benchtop-dna-printer-powered-by-enzymatic-synthesis-to-accelerate-molecular-biology-and-genomics-workflows https://www.synbiobeta.com/read/enginzyme-awarded-as-technology-pioneer-2021-by-world-economic-forum https://www.synbiobeta.com/read/absci-announces-acquisition-of-target-discovery-company-totient https://www.synbiobeta.com/read/codex-dna-announces-launch-of-initial-public-offering https://www.synbiobeta.com/read/nautilus-biotechnology-debuts-as-publicly-traded-company-seeks-to-deliver-on-the-untapped-potential-of-the-human-proteome https://www.synbiobeta.com/read/codexis-and-takeda-expand-strategic-collaboration-and-license-agreement-to-discover-additional-gene-therapy-for-a-fourth-rare-genetic-disorder https://www.synbiobeta.com/read/dna-data-storage-alliance-publishes-first-white-paper-launches-website https://www.synbiobeta.com/read/imagindairy-leads-no-cow-guilt-free-dairy-revolution https://www.synbiobeta.com/read/10x-genomics-unlocks-whole-transcriptome-analysis-in-ffpe-tissues-with-new-visium-assay-now-shipping https://www.synbiobeta.com/read/is-tissue-engineering-the-future-of-cruelty-free-fashion https://www.synbiobeta.com/read/synbio-coalition-applauds-senate-passage-of-the-u-s-innovation-and-competition-act https://www.synbiobeta.com/read/ginkgo-bioworks-announces-r-d-collaboration-with-sumitomo-chemical-to-develop-more-sustainable-bio-based-chemicals-for-multiple-industries https://www.synbiobeta.com/read/cronos-group-and-ginkgo-bioworks-amend-agreement-to-accelerate-commercialization-of-cultured-cannabinoids-and-cronos-group-begins-commercial-production-of-cbg https://www.synbiobeta.com/read/centivax-and-u-s-naval-medical-research-center-announce-strategic-partnership-to-initiate-clinical-development-of-a-broad-spectrum-injectable-for-covid-19-with-4-2m-from-the-henry-jackson-foundation https://www.synbiobeta.com/read/finless-foods-announces-new-plant-based-tuna-product https://www.synbiobeta.com/read/berkeley-lights-releases-subscription-based-access-program-and-signs-first-customers https://www.synbiobeta.com/read/sherlock-biosciences-announces-initial-results-of-automation-study-with-nordx-laboratories-on-crispr-based-test-for-sars-cov-2 https://www.synbiobeta.com/read/so-you-want-to-sell-your-genome-as-an-nft-read-this-first https://www.synbiobeta.com/read/survey-1-in-3-u-s-consumers-would-do-all-their-shopping-at-a-sustainable-clothing-store-if-only-one-existed https://www.synbiobeta.com/read/herophilus-appoints-sharath-hegde-ph-d-as-chief-scientific-officer-as-it-scales-drug-discovery-effort-for-complex-brain-diseases https://www.synbiobeta.com/read/hyasynth-announces-production-of-20-rare-cannabinoids-by-fermentation-us-patent-grant-on-novel-biosynthesis-pathway https://www.synbiobeta.com/read/senti-bio-and-bluerock-therapeutics-enter-collaboration-to-develop-gene-circuit-engineered-cell-therapies-for-regenerative-medicine https://www.synbiobeta.com/read/engine-biosciences-announces-43-million-series-a-round-to-decipher-genetic-codes-for-new-medicines-through-machine-learning-and-next-generation-combinatorial-genetics https://www.synbiobeta.com/read/beckman-coulter-life-sciences-launches-next-generation-biolector-xt-microbioreactor https://www.synbiobeta.com/read/origin-bio-secures-15-million-funding-led-by-eqt-ventures-to-help-manufacturers-create-a-more-sustainable-future https://www.synbiobeta.com/read/the-search-for-a-cancer-vaccine-have-we-been-doing-it-all-wrong https://www.synbiobeta.com/read/biogen-and-ginkgo-bioworks-announce-collaboration-and-license-agreement-to-develop-novel-gene-therapy-manufacturing-platform https://www.synbiobeta.com/read/dna-script-advances-evaluation-program-for-the-syntax-system-the-first-benchtop-dna-printer-powered-by-enzymatic-synthesis https://www.synbiobeta.com/read/cultivated-meat-likely-to-make-up-40-of-future-meat-intake https://www.synbiobeta.com/read/teselagen-biotechnology-releases-new-protein-optimization-toolkit-for-automated-biotherapeutic-drug-design-and-development https://www.synbiobeta.com/read/veteran-technology-executive-joins-synthace-to-accelerate-its-mission-to-revolutionize-the-life-science-research-market https://www.synbiobeta.com/read/cardea-bio-partners-with-scentian-bio-to-power-insect-odorant-receptor-enabled-flavor-profiling-product https://www.synbiobeta.com/read/can-microbes-clean-the-worlds-most-polluted-waterways https://www.synbiobeta.com/read/artificial-raises-21-5m-to-accelerate-life-science-breakthroughs https://www.synbiobeta.com/read/motif-foodworks-gains-exclusive-access-to-transformative-plant-based-technologies https://www.synbiobeta.com/read/nuclera-acquires-e-ink-digital-microfluidics-unit https://www.synbiobeta.com/read/ers-genomics-and-genscript-biotech-corporation-sign-crispr-cas9-license-agreement https://www.synbiobeta.com/read/next-on-the-menu-cellular-agriculture-could-domesticate-any-animal-on-the-planet https://www.synbiobeta.com/read/crispr-therapeutics-and-nkarta-announce-global-collaboration-to-develop-gene-edited-cell-therapies-for-cancer https://www.synbiobeta.com/read/omne-possibile-launched-to-harness-transformative-power-of-xna-in-healthcare-information-technology-and-smart-materials https://www.synbiobeta.com/read/dyno-therapeutics-closes-100-million-series-a-financing-led-by-andreessen-horowitz-to-accelerate-ai-powered-gene-therapy-platform https://www.synbiobeta.com/read/the-221b-foundation-and-logicink-announce-license-agreement-to-utilize-sherlock-biosciences-crispr-technology-to-develop-instrument-free-diagnostic-for-covid-19 https://www.synbiobeta.com/read/azitra-appoints-francisco-salva-as-chief-executive-officer https://www.synbiobeta.com/read/codex-dna-releases-long-gene-fragment-cloning-on-the-bioxp-tm-system https://www.synbiobeta.com/read/ginkgo-bioworks-teams-with-quest-diagnostics-to-provide-covid-19-testing-for-k-12-schools-nationwide https://www.synbiobeta.com/read/synlogic-announces-pricing-of-public-offering-of-common-stock https://www.synbiobeta.com/read/the-dna-industry-is-going-cell-free https://www.synbiobeta.com/read/codex-dna-expands-end-to-end-automated-synthetic-biology-workstation-enabling-high-throughput-synthesis-from-dna-sequence-to-biologically-active-mrna https://www.synbiobeta.com/read/dna-script-partners-with-moderna-to-develop-on-demand-vaccines-and-therapeutics-for-darpa https://www.synbiobeta.com/read/modern-meadow-enters-next-phase-of-growth-with-130-million-series-c-funding-and-taps-industry-veteran-anna-bakst-as-ceo https://www.synbiobeta.com/read/dmc-and-conagen-partner-for-commercial-manufacturing-of-l-alanine https://www.synbiobeta.com/read/who-owns-crispr-in-2021-its-even-more-complicated-than-you-think https://www.synbiobeta.com/read/conagens-novel-solution-to-making-natural-capsaicin-by-fermentation-accessible https://www.synbiobeta.com/read/dylan-george-joins-ginkgo-bioworks-to-grow-the-companys-global-biosecurity-efforts https://www.synbiobeta.com/read/nesos-receives-fda-breakthrough-device-designation-for-its-disease-modifying-digital-therapeutic-for-rheumatoid-arthritis https://www.synbiobeta.com/read/edigene-raises-approximately-usd-62-million-in-series-b-plus-financing-and-expands-operation-locations-to-advance-and-scale-up-clinical-translation-of-gene-editing-technologies https://www.synbiobeta.com/read/oxitec-receives-us-6-8-million-from-wellcome-trust-to-advance-scale-up-of-friendly-tm-aedes-aegypti-technology https://www.synbiobeta.com/read/zx-ventures-ab-inbevs-global-innovation-group-partners-with-clara-foods-to-unlock-precision-fermentations-potential-to-meet-global-food-challenges https://www.synbiobeta.com/read/visualizing-the-future-spatialomics-transforms-study-of-gene-expression https://www.synbiobeta.com/read/jellatech-announces-2m-pre-seed-round https://www.synbiobeta.com/read/manus-bio-launches-a-next-generation-natural-zero-calorie-sweetener-in-the-us-under-its-iconic-brand-nutrasweet-natural-tm https://www.synbiobeta.com/read/molecular-assemblies-closes-oversubscribed-24-million-series-a-financing-to-advance-enzymatic-dna-synthesis-toward-initial-commercial-access https://www.synbiobeta.com/read/tetrascience-secures-80-million-series-b-and-accelerates-roll-out-of-the-worlds-only-open-r-d-data-cloud-for-scientific-discovery https://www.synbiobeta.com/read/atlast-raises-40m-to-expand-production-of-whole-cut-plant-based-meat https://www.synbiobeta.com/read/pure-biologics-selects-twist-bioscience-to-expand-phage-display-technology-capabilities https://www.synbiobeta.com/read/benchling-raises-200m-series-e-to-accelerate-biotech-r-d https://www.synbiobeta.com/read/new-coalition-dedicated-to-fostering-american-synthetic-biology-manufacturing-launched-today https://www.synbiobeta.com/read/senti-bio-enters-collaboration-with-spark-therapeutics-to-develop-next-generation-precision-gene-therapies https://www.synbiobeta.com/read/scribe-therapeutics-raises-100m-series-b-financing-to-further-develop-crispr-by-design-platform-and-pipeline-of-breakthrough-genetic-medicines https://www.synbiobeta.com/read/riffyn-launches-riffyn-nexus-v4-2-to-strengthen-bioprocess-data-integrity-with-automated-data-validation https://www.synbiobeta.com/read/living-power-this-bio-battery-is-harnessing-the-power-of-dna https://www.synbiobeta.com/read/helix-announces-partnership-with-ginkgo-bioworks-to-support-back-to-school-covid-19-testing-across-the-western-u-s https://www.synbiobeta.com/read/twist-bioscience-to-provide-antibody-discovery-optimization-and-access-to-library-of-libraries-for-drug-research-to-stanford-university-laboratories https://www.synbiobeta.com/read/amyris-brand-biossance-r-partners-with-reese-witherspoon-to-accelerate-clean-beauty-movement https://www.synbiobeta.com/read/synthego-launches-eclipse-platform-to-accelerate-research-and-development-of-next-generation-medicines https://www.synbiobeta.com/read/making-honey-without-bees-melibio-raises-850-000-pre-seed-round https://www.synbiobeta.com/read/q1-shatters-previous-synthetic-biology-investment-record-signals-projected-2021-investment-of-up-to-36-billion https://www.synbiobeta.com/read/inscripta-announces-the-first-commercial-shipment-of-its-onyx-tm-digital-genome-engineering-platform-and-closes-150-million-in-new-financing https://www.synbiobeta.com/read/corteva-agriscience-collaborates-with-ginkgo-bioworks-to-bolster-crop-protection https://www.synbiobeta.com/read/egenesis-expands-research-collaboration-with-leading-academic-medical-center https://www.synbiobeta.com/read/olive-labs-inc-announces-partnership-with-ginkgo-bioworks-to-scale-covid-response-through-pooled-testing-in-k-12-schools https://www.synbiobeta.com/read/breaking-news-new-kingdom-of-life-discovered https://www.synbiobeta.com/read/amyris-and-dsm-close-significant-strategic-transaction-to-accelerate-the-growth-of-natural-sustainable-ingredients https://www.synbiobeta.com/read/dascena-labs-announces-partnership-with-concentric-by-ginkgo-to-scale-covid-response-through-k-12-classroom-testing https://www.synbiobeta.com/read/phycus-biotechnologies-and-teselagen-biotechnology-partner-to-accelerate-the-production-of-biome-friendly-ingredients-for-cosmetics https://www.synbiobeta.com/read/ecovative-propels-commercial-scale-mycelium-applications-for-textiles-packaging-and-food-with-new-60m-series-d-financing-led-by-viking-global-investors https://www.synbiobeta.com/read/peptone-announces-a-collaboration-with-nvidia-and-verne-global-to-scale-its-ai-driven-protein-engineering-system https://www.synbiobeta.com/read/could-algae-help-solve-indias-pollution-crisis-why-some-scientists-arent-giving-up https://www.synbiobeta.com/read/french-biotech-startup-pili-raises-4meur-to-industrialize-their-sustainable-pigment-biofactories https://www.synbiobeta.com/read/synthace-more-than-doubles-its-annual-recurring-revenue-expands-customer-footprint-with-the-top-pharma-companies-in-2020 https://www.synbiobeta.com/read/twist-bioscience-and-biotia-receive-u-s-fda-emergency-use-authorization-for-first-hybridization-capture-based-next-generation-sequencing-sars-cov-2-assay https://www.synbiobeta.com/read/amfora-raises-6-million-with-investment-from-leaps-by-bayer-and-spruce-capital-partners https://www.synbiobeta.com/read/can-monoclonal-antibodies-cure-alzheimers https://www.synbiobeta.com/read/provectus-algae-appoints-ceo-of-senti-biosciences-to-board-to-aid-advancement-of-high-throughput-synthetic-biology-platform https://www.synbiobeta.com/read/absci-announces-completion-of-125-million-crossover-financing-to-advance-ai-powered-synthetic-biology-drug-creation-platform https://www.synbiobeta.com/read/cd-r-merck-ghi-and-mckesson-ventures-invest-in-innovative-oncology-data-and-informatics-company-m2gen https://www.synbiobeta.com/read/m2gen-announces-new-collaboration-with-merck-to-advance-cancer-therapies https://www.synbiobeta.com/read/algiknit-announces-fundraise-to-turn-ocean-algae-into-scalable-bio-yarns https://www.synbiobeta.com/read/allonnia-announces-evok-innovations-as-strategic-investor-raises-additional-20m-to-develop-and-scale-transformational-waste-management-technologies https://www.synbiobeta.com/read/dmc-demonstrates-full-commercial-scale-at-record-speed https://www.synbiobeta.com/read/teselagen-partners-with-berkeley-labs-advanced-biofuels-and-bioproducts-process-development-unit-to-accelerate-the-bioeconomy https://www.synbiobeta.com/read/synthetic-biology-a-tool-for-marine-conservation https://www.synbiobeta.com/read/amyris-enters-partnership-with-minerva-foods-for-zero-carbon-protein-production https://www.synbiobeta.com/read/deep-branch-announces-eur-8m-series-a-round-led-by-novo-holdings-and-dsm-venturing-paving-the-way-for-commercial-scale-production-facility https://www.synbiobeta.com/read/graphite-bio-secures-150-million-series-b-financing-to-advance-pipeline-of-next-generation-gene-editing-therapies https://www.synbiobeta.com/read/twist-bioscience-begins-shipping-of-synthetic-rna-controls-for-b-1-351-and-p-1-variants https://www.synbiobeta.com/read/lygos-and-the-agile-biofoundry-generate-largest-multi-omics-dataset-to-accelerate-machine-learning-capabilities-for-engineering-strains-for-producing-organic-acids https://www.synbiobeta.com/read/insitro-raises-400-million-in-series-c-financing https://www.synbiobeta.com/read/intellia-therapeutics-presents-preclinical-proof-of-concept-for-crispr-based-in-vivo-editing-of-bone-marrow-at-keystone-esymposium https://www.synbiobeta.com/read/mosaic-and-sound-agriculture-announce-strategic-partnership-to-transform-nutrient-efficiency https://www.synbiobeta.com/read/octarine-bio-announces-closing-of-extended-seed-round-financing-of-1-2-million-usd-with-an-uptick-in-valuation-due-to-significant-investor-demand https://www.synbiobeta.com/read/codex-dna-releases-worlds-first-synthetic-genomes-for-emerging-sars-cov-2-variants https://www.synbiobeta.com/read/deinove-benefits-from-the-support-of-the-french-government-within-the-framework-of-the-france-relance-plan-to-accelerate-the-development-of-new-antimicrobials https://www.synbiobeta.com/read/new-studies-further-the-case-for-cultivated-meat-over-conventional-meat-in-the-race-to-net-zero-emissions https://www.synbiobeta.com/read/delonix-bioworks-closes-usd-14-million-seed-financing https://www.synbiobeta.com/read/pivot-bio-completes-state-of-the-art-lab-and-offices https://www.synbiobeta.com/read/carisma-therapeutics-completes-series-b-financing-totaling-59-million https://www.synbiobeta.com/read/meet-the-heroes-you-never-knew-you-had https://www.synbiobeta.com/read/aleph-farms-and-brf-partner-to-bring-cultivated-meat-to-brazil https://www.synbiobeta.com/read/caribou-biosciences-raises-115m-series-c-financing-to-advance-next-generation-crispr-technologies-and-allogeneic-cell-therapy-pipeline https://www.synbiobeta.com/read/molecular-assemblies-to-provide-enzymatic-synthesis-technology-to-darpa-now-project-for-on-demand-dna-rna-vaccine-manufacturing https://www.synbiobeta.com/read/dna-script-joins-ge-research-collaboration-to-develop-on-demand-vaccines-and-therapeutics-in-response-to-biothreats-for-darpa-now-project https://www.synbiobeta.com/read/wuxi-apptec-completes-acquisition-of-oxgene-to-further-strengthen-cell-and-gene-therapy-service-offerings-for-global-customers https://www.synbiobeta.com/read/twist-bioscience-and-watchmaker-genomics-announce-partnership-to-drive-new-applications-of-high-throughput-genetic-sequencing https://www.synbiobeta.com/read/how-will-the-proteins-of-the-future-be-designed https://www.synbiobeta.com/read/egenesis-announces-125-million-series-c-financing https://www.synbiobeta.com/read/the-meatless-mafia-four-companies-revolutionizing-the-future-of-food https://www.synbiobeta.com/read/amyris-acquiring-costa-brazil-clean-beauty-brand-francisco-costa-to-join-amyris-as-chief-creative-officer https://www.synbiobeta.com/read/miroculus-closes-extension-to-45m-series-b-financing https://www.synbiobeta.com/read/absci-announces-strategic-investment-by-merck-global-health-innovation-fund https://www.synbiobeta.com/read/locus-biosciences-completes-first-of-its-kind-controlled-clinical-trial-for-crispr-enhanced-bacteriophage-therapy https://www.synbiobeta.com/read/phenotypeca-raises-ps300-000-seed-investment-and-strengthens-its-board https://www.synbiobeta.com/read/crispr-clinical-trials-a-2021-update https://www.synbiobeta.com/read/amyris-announces-launch-of-pipette-r-clean-baby-care-brand-in-target-retail-stores-across-north-america https://www.synbiobeta.com/read/pharmaceutical-manufacturing-just-got-an-automation-boost-from-iot https://www.synbiobeta.com/read/beam-therapeutics-announces-acquisition-of-guide-therapeutics https://www.synbiobeta.com/read/dna-script-exclusively-licenses-baseclick-gmbh-technology-to-enable-benchtop-printing-of-modified-dna-on-demand https://www.synbiobeta.com/read/mosa-meat-completes-85m-series-b-investment-round https://www.synbiobeta.com/read/amyris-announces-positive-pre-clinical-results-for-covid-19-rna-vaccine-platform-with-advantaged-manufacturing-storage-and-distribution-characteristics https://www.synbiobeta.com/read/why-killing-animals-for-meat-could-be-a-thing-of-the-past https://www.synbiobeta.com/read/protalix-biotherapeutics-completes-raise-of-approximately-40-million-in-gross-proceeds https://www.synbiobeta.com/read/riffyn-doubles-customers-and-recurring-revenue-for-fourth-straight-year https://www.synbiobeta.com/read/america-your-diet-is-killing-you-why-the-glucose-crisis-will-be-worse-than-the-opioid-crisis https://www.synbiobeta.com/read/excision-biotherapeutics-completes-60-million-financing-to-advance-crispr-based-infectious-disease-programs https://www.synbiobeta.com/read/spt-labtech-acquires-biomicrolab https://www.synbiobeta.com/read/ers-genomics-and-zeclinics-sign-crispr-cas9-license-agreement https://www.synbiobeta.com/read/gamida-cell-announces-75-million-financing-with-highbridge-capital-management https://www.synbiobeta.com/read/microvi-awarded-1-12-million-by-the-national-institutes-of-health-to-develop-precision-biological-processes-with-machine-learning-and-bioinformatics https://www.synbiobeta.com/read/wndr-alpine-receives-b-corp-certification https://www.synbiobeta.com/read/what-can-synthetic-biology-do-better-to-help-end-hunger https://www.synbiobeta.com/read/autolus-announces-closing-of-public-offering-and-full-exercise-of-option-to-purchase-additional-adss https://www.synbiobeta.com/read/evolve-biosystems-announces-major-strategic-investment-from-cargill-and-manna-tree-to-support-innovative-probiotic-that-dramatically-improves-infant-gut-health https://www.synbiobeta.com/read/notch-therapeutics-closes-85-million-series-a-financing-to-develop-pipeline-of-renewable-stem-cell-derived-cancer-immunotherapies https://www.synbiobeta.com/read/abbvie-and-caribou-biosciences-announce-collaboration-and-license-agreement-for-car-t-cell-products https://www.synbiobeta.com/read/enginzyme-extends-series-a-to-eu11-million-to-advance-cell-free-chemical-production-platform-in-funding-round-led-by-swedens-industrifonden https://www.synbiobeta.com/read/new-age-meats-announces-another-2m-in-seed-extension-prior-to-series-a https://www.synbiobeta.com/read/synlogic-appoints-lisa-kelly-croswell-to-its-board-of-directors https://www.synbiobeta.com/read/codexis-announces-expansion-to-new-facility-to-accommodate-next-stage-of-growth https://www.synbiobeta.com/read/lygos-joins-forces-with-flexible-solutions-to-meet-growing-commercial-demand-for-bio-aspartic-tm-acid https://www.synbiobeta.com/read/aquabounty-technologies-inc-announces-closing-of-127-1-million-public-offering-of-common-stock-including-full-exercise-of-overallotment-option https://www.synbiobeta.com/read/cambrian-biopharma-announces-60m-in-financing-to-develop-a-pipeline-of-companies-and-therapeutics-to-treat-diseases-of-aging-coupled-with-a-unique-operational-strategy https://www.synbiobeta.com/read/hoxton-farms-raises-ps2-7m-seed-to-solve-a-fat-problem-for-meat-alternatives https://www.synbiobeta.com/read/berkeley-lights-announces-cfo-transition-and-c-level-additions https://www.synbiobeta.com/read/synthetic-biology-startup-acquires-ai-platform-to-disrupt-the-drug-industry https://www.synbiobeta.com/read/new-synthetic-biology-venture-fund-puts-scientist-founders-first https://www.synbiobeta.com/read/reverie-labs-raises-25m-series-a-round-to-broaden-impact-of-its-computational-kinase-drug-discovery-platform https://www.synbiobeta.com/read/codexis-appoints-dr-esther-martinborough-to-its-board-of-directors https://www.synbiobeta.com/read/nesos-announces-peer-reviewed-validation-of-its-first-of-its-kind-wireless-earbud-for-the-treatment-of-rheumatoid-arthritis https://www.synbiobeta.com/read/absci-enters-biologics-development-collaboration-with-xyphos-biosciences-an-astellas-company https://www.synbiobeta.com/read/geltor-adds-ingredient-science-industry-veterans-to-leadership-team https://www.synbiobeta.com/read/joint-team-from-mit-and-synlogic-named-a-biotechnology-grand-challenge-winner-by-air-force-research-laboratory https://www.synbiobeta.com/read/twist-bioscience-announces-executive-team-appointments https://www.synbiobeta.com/read/ginkgo-bioworks-selected-to-provide-pooled-covid-19-testing-for-massachusetts-k-12-schools https://www.synbiobeta.com/read/the-unexplored-power-of-microbes https://www.synbiobeta.com/read/amyris-announces-breakthrough-clinical-results-for-its-clean-formulation-acne-treatment https://www.synbiobeta.com/read/evozyne-announces-a-strategic-collaboration-for-development-of-novel-biopharmaceutical-therapeutics https://www.synbiobeta.com/read/future-meat-technologies-reduces-cost-of-cultured-chicken-breast-below-10 https://www.synbiobeta.com/read/creo-becomes-first-company-to-achieve-demo-scale-production-of-rare-cannabinoid-cbga https://www.synbiobeta.com/read/synthetic-biology-partners-with-ai-to-delete-food-allergies https://www.synbiobeta.com/read/yield10-bioscience-announces-pricing-of-12-7-million-public-offering https://www.synbiobeta.com/read/lumen-bioscience-receives-carb-x-award-to-develop-preventative-for-deadly-diarrheal-diseases-and-details-broad-potential-of-spirulina-platform https://www.synbiobeta.com/read/split-biosciences-now-parse-biosciences-announces-7m-in-series-a-funding-to-democratize-single-cell-rna-sequencing https://www.synbiobeta.com/read/dna-script-signs-innovation-development-contract-with-french-defence-innovation-agency-to-enable-on-demand-diagnostics-against-emerging-biothreats https://www.synbiobeta.com/read/more-bacon-less-guilt-this-startup-is-taking-on-the-american-classic https://www.synbiobeta.com/read/could-crispr-eradicate-acne https://www.synbiobeta.com/read/synthetic-biology-investment-reached-a-new-record-of-nearly-8-billion-in-2020-what-does-this-mean-for-2021 https://www.synbiobeta.com/read/biotech-startup-droplet-genomics-raises-eu1-million-from-practica-capital-to-commercialize-droplet-microfluidics-technology https://www.synbiobeta.com/read/arcadia-biosciences-rkda-announces-25-1-million-private-placement https://www.synbiobeta.com/read/germin8-ventures-names-dr-ashlie-l-burkart-as-chief-scientific-officer https://www.synbiobeta.com/read/solentim-sets-new-standards-in-productivity-with-the-launch-of-icon-tm-and-studius-tm-accelerating-assurance-rich-workflows-in-the-development-of-new-biologics https://www.synbiobeta.com/read/precigen-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-option-to-purchase-additional-shares https://www.synbiobeta.com/read/inovio-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/editas-medicine-announces-pricing-of-offering-of-common-stock https://www.synbiobeta.com/read/gevo-inc-announces-closing-of-350-million-registered-direct-offering-of-common-stock https://www.synbiobeta.com/read/verve-therapeutics-secures-94-million-in-series-b-financing-to-advance-pipeline-of-gene-editing-medicines-for-cardiovascular-disease https://www.synbiobeta.com/read/strand-therapeutics-and-beigene-enter-into-agreement-to-develop-solid-tumor-immuno-oncology-therapeutics-based-on-strands-next-generation-multi-functional-mrna-technology https://www.synbiobeta.com/read/amyris-acquiring-terasana-brand-to-offer-clean-cannabinoid-consumer-products https://www.synbiobeta.com/read/evolva-launches-l-arabinose-a-natural-sugar-blocker-and-reducing-sugar https://www.synbiobeta.com/read/twist-bioscience-signs-two-biopharma-technology-agreements-to-enable-novel-therapeutics-discovery https://www.synbiobeta.com/read/beam-therapeutics-inc-announces-260-million-common-stock-investment-from-multiple-investors https://www.synbiobeta.com/read/idt-developing-primetime-tm-sars-cov-2-flu-test-for-comprehensive-patient-testing https://www.synbiobeta.com/read/yield10-bioscience-announces-achievement-of-proof-of-concept-milestone-for-producing-pha-bioplastic-in-field-grown-camelina-plants https://www.synbiobeta.com/read/earli-raises-40-million-series-a-funding-led-by-khosla-ventures https://www.synbiobeta.com/read/benchling-doubles-annual-recurring-revenue-arr-for-fourth-straight-year-amid-covid-19-pandemic https://www.synbiobeta.com/read/twist-bioscience-begins-shipping-of-synthetic-rna-controls-for-uk-variant-strain-of-sars-cov-2 https://www.synbiobeta.com/read/axol-bioscience-strengthens-commercial-leadership-team-with-key-appointments https://www.synbiobeta.com/read/protera-strengthens-board-with-appointment-of-dr-oswaldo-da-costa-e-silva-as-non-executive-director https://www.synbiobeta.com/read/mammoth-biosciences-secures-award-to-develop-crispr-based-diagnostics-and-biosurveillance-platforms https://www.synbiobeta.com/read/genscript-submits-application-with-fda-for-use-of-cpass-tm-sars-cov-2-neutralization-antibody-test-in-convalescent-plasma-screening https://www.synbiobeta.com/read/labcentral-launches-labcentral-ignite-new-initiative-to-advance-life-sciences-innovation-by-expanding-and-diversifying-the-talent-base-for-the-biotech-industry https://www.synbiobeta.com/read/codexis-introduces-improved-enzymes-to-further-enhance-tate-lyles-stevia-and-allulose-production https://www.synbiobeta.com/read/vedanta-biosciences-announces-25-million-investment-from-pfizer-inc https://www.synbiobeta.com/read/absci-announces-acquisition-of-deep-learning-company-denovium https://www.synbiobeta.com/read/berkeley-lights-launches-opto-plasma-b-discovery-4-0-to-accelerate-therapeutic-antibody-discovery-against-difficult-targets https://www.synbiobeta.com/read/amyris-creates-partnership-with-jonathan-van-ness-to-launch-leading-clean-haircare-brand https://www.synbiobeta.com/read/conagen-begins-scale-up-of-natural-sustainable-musk-macrocyclic-lactone-fragrance-material https://www.synbiobeta.com/read/editas-medicine-announces-the-fda-has-cleared-initiation-of-the-edit-301-clinical-trial https://www.synbiobeta.com/read/synlogic-outlines-upcoming-clinical-milestones https://www.synbiobeta.com/read/dsm-and-tu-delft-establish-artificial-intelligence-laboratory-to-drive-bioscience-innovation https://www.synbiobeta.com/read/biomatter-designs-raises-eu500k-to-develop-ai-for-generative-protein-design https://www.synbiobeta.com/read/air-protein-announces-32-million-series-a-funding https://www.synbiobeta.com/read/brightseed-announces-preclinical-data-for-phytonutrients-targeting-liver-and-metabolic-health https://www.synbiobeta.com/read/twist-bioscience-supplies-centers-for-disease-control-and-prevention-with-custom-sars-cov-2-synthetic-rna-controls https://www.synbiobeta.com/read/arsenalbio-announces-multi-program-discovery-collaboration-with-bristol-myers-squibb-to-advance-next-generation-t-cell-therapies-for-solid-tumors https://www.synbiobeta.com/read/lifemine-therapeutics-announces-50-million-series-b-financing https://www.synbiobeta.com/read/the-221b-foundation-establishes-coalition-to-control-the-spread-of-covid-19-in-nepal https://www.synbiobeta.com/read/leaps-by-bayer-leads-usd-105-million-series-b-financing-in-senti-bio-to-develop-next-generation-cell-and-gene-therapies-using-advanced-gene-circuit-technology-platform https://www.synbiobeta.com/read/charles-river-laboratories-acquires-distributed-bio https://www.synbiobeta.com/read/indee-labs-announces-successful-early-access-program-launch https://www.synbiobeta.com/read/atomwise-and-futurx-launch-a2i-therapeutics-a-new-immuno-oncology-company-funded-by-leading-biopharma-vcs-and-the-israeli-innovation-authority https://www.synbiobeta.com/read/amyris-to-launch-its-biossance-tm-clean-beauty-brand-in-china-through-partnership-with-superordinary https://www.synbiobeta.com/read/can-synthetic-biology-make-mosquito-borne-diseases-a-thing-of-the-past https://www.synbiobeta.com/read/ginkgo-bioworks-launches-covid-19-pooled-classroom-testing-pilot-for-k-12-schools https://www.synbiobeta.com/read/amyris-announces-bonsucro-certification-sustainable-sugarcane-production-for-clean-ingredients https://www.synbiobeta.com/read/synthetic-biology-for-tennessee-schools-biobuilder-partners-with-niswonger-foundation-on-8-8m-federal-grant-for-stem-education https://www.synbiobeta.com/read/twist-bioscience-to-expand-commercial-capabilities-with-factory-of-the-future https://www.synbiobeta.com/read/amyris-closes-50-million-strategic-transaction https://www.synbiobeta.com/read/arcadia-biosciences-rkda-announces-closing-of-8-0-million-registered-direct-offering-priced-at-the-market https://www.synbiobeta.com/read/gamida-cell-announces-closing-of-75-million-public-offering-including-full-exercise-of-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/gamida-cell-added-to-nasdaq-biotechnology-index https://www.synbiobeta.com/read/lanzatech-and-teselagen-biotechnology-sign-new-multi-year-deal-to-advance-carbon-remediation-via-biological-processes https://www.synbiobeta.com/read/poseida-therapeutics-added-to-nasdaq-biotechnology-index https://www.synbiobeta.com/read/ginkgo-bioworks-acquires-biotechnology-startup-novogys-microbial-engineering-platform https://www.synbiobeta.com/read/lygos-cbx-and-metalabs-partner-to-co-develop-and-commercialize-haircare-products-featuring-cannabinoids https://www.synbiobeta.com/read/draper-signs-agreement-with-kite-to-accelerate-development-of-cancer-immunotherapies https://www.synbiobeta.com/read/eat-just-follows-regulatory-approval-with-historic-first-ever-sale-of-cultured-meat https://www.synbiobeta.com/read/sherlock-biosciences-receives-5-million-grant-to-advance-inspectrtm-platform-for-covid-19-self-test https://www.synbiobeta.com/read/abcellera-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/aquabounty-technologies-inc-announces-closing-of-65-2-million-upsized-public-offering-of-common-stock-including-full-exercise-of-overallotment-option https://www.synbiobeta.com/read/catalog-hires-key-scientists-names-advisory-board-to-advance-dna-computing-and-storage https://www.synbiobeta.com/read/crispr-therapeutics-receives-grant-to-advance-in-vivo-crispr-cas9-gene-editing-therapies-for-hiv https://www.synbiobeta.com/read/genscript-granted-authorization-for-cpass-tm-sars-cov-2-neutralization-antibody-detection-test-in-brazil https://www.synbiobeta.com/read/synlogic-announces-advancement-of-synb1891-to-combination-arm-dosing-with-pd-l1-checkpoint-inhibitor-in-the-on-going-phase-1-study-for-the-treatment-of-solid-tumors-and-lymphoma https://www.synbiobeta.com/read/what-if-you-could-change-your-immune-system-by-wearing-earbuds-meet-the-startup-that-could-make-it-possible https://www.synbiobeta.com/read/building-customer-awareness-for-the-next-biotech-startup-lessons-from-brands-biology https://www.synbiobeta.com/read/the-stunning-pace-of-progress-one-year-in-covid-19-treatments-and-vaccines-are-close-at-hand https://www.synbiobeta.com/read/abcellera-announces-pricing-of-initial-public-offering https://www.synbiobeta.com/read/mosa-meat-backed-by-leading-global-impact-investors-bringing-oversubscribed-round-to-75m https://www.synbiobeta.com/read/sutro-biopharma-announces-closing-of-upsized-144-9-million-public-offering-including-full-exercise-of-the-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/ginkgo-bioworks-and-octant-partner-to-expand-covid-19-testing-capacity-using-next-generation-sequencing-technology https://www.synbiobeta.com/read/intellia-therapeutics-announces-closing-of-201-million-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/deepcell-closes-20-million-series-a-round-to-develop-ai-powered-capture-of-cells-for-precision-medicine https://www.synbiobeta.com/read/pheronym-and-usda-enter-into-5-year-crada https://www.synbiobeta.com/read/twist-bioscience-announces-closing-of-upsized-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/ocean-spray-and-amai-proteins-partner-to-create-the-first-protein-sweetened-reduced-sugar-cranberry-juice https://www.synbiobeta.com/read/sherlock-biosciences-announces-discovery-of-novel-crispr-cas-enzymes-enabling-simple-multiplex-diagnostic-solutions https://www.synbiobeta.com/read/codexis-announces-pricing-of-public-offering-of-common-stock-3 https://www.synbiobeta.com/read/twist-bioscience-announces-pricing-of-a-300-million-upsized-public-offering-of-common-stock https://www.synbiobeta.com/read/biobuilder-founder-and-executive-director-featured-as-2020-mwm-trailblazer-award-winner https://www.synbiobeta.com/read/sherlock-biosciences-strengthens-intellectual-property-portfolio-in-crispr-based-diagnostics-through-exclusive-license-agreement-with-tolo-biotech https://www.synbiobeta.com/read/codex-dna-releases-new-synthetic-genomes-for-the-fight-against-covid-19 https://www.synbiobeta.com/read/riffyn-selected-as-the-digital-backbone-of-biomade-network-to-advance-domestic-biomanufacturing-innovation https://www.synbiobeta.com/read/amyris-delivers-record-black-friday-sales https://www.synbiobeta.com/read/lygos-and-high-beauty-sign-agreement-to-co-develop-and-commercialize-cosmetic-products-containing-rare-cannabinoids https://www.synbiobeta.com/read/codexis-and-casdin-capital-launch-synbio-innovation-accelerator https://www.synbiobeta.com/read/keep-warm-this-winter-with-a-sweater-made-from-brewed-protein-the-breakthrough-sustainable-material-inspired-by-spider-silk https://www.synbiobeta.com/read/arzeda-expands-applications-of-its-protein-design-platform-and-advances-towards-commercial-deployment-of-designer-enzymes-for-sustainable-food-nutrition-ingredients https://www.synbiobeta.com/read/genomatica-to-scale-bio-nylon-50-fold-with-aquafil-to-meet-surging-brand-demand https://www.synbiobeta.com/read/ginkgo-bioworks-funds-expansion-of-rapid-antigen-test-manufacturing-with-access-bio-in-new-jersey https://www.synbiobeta.com/read/twist-bioscience-and-biotia-announce-research-use-only-availability-of-first-hybridization-capture-based-next-generation-sequencing-sars-cov-2-assay-for-characterization-and-surveillance-of-the-virus https://www.synbiobeta.com/read/abcellera-expands-technology-stack-with-acquisition-of-trianni-for-90-million https://www.synbiobeta.com/read/innovation-can-feed-the-growing-appetite-for-a-sustainable-food-system https://www.synbiobeta.com/read/manus-bio-raises-75m-in-series-b-financing-to-expand-biomanufacturing-platform-for-natural-ingredients https://www.synbiobeta.com/read/one-company-was-the-first-to-produce-a-key-component-of-the-covid-19-pcr-test-and-it-has-now-provided-52-million-tests https://www.synbiobeta.com/read/64x-bio-emerges-from-stealth-to-drive-an-evolution-in-cell-and-gene-therapy-manufacturing https://www.synbiobeta.com/read/beckman-coulter-life-sciences-acquires-microbioreactor-manufacturer-m2p-labs https://www.synbiobeta.com/read/precigen-announces-dosing-of-first-patients-with-ultracar-t-r-cells-manufactured-using-proprietary-ultraporator-tm-system-in-ongoing-prgn-3005-and-prgn-3006-phase-1-clinical-trials https://www.synbiobeta.com/read/can-we-recreate-every-human-cell-type-in-the-body-this-uk-startup-thinks-so https://www.synbiobeta.com/read/twist-bioscience-expands-infectious-disease-product-line-adding-comprehensive-viral-panel https://www.synbiobeta.com/read/european-synthetic-biology-company-octarine-raises-1-8m-usd-in-funding-and-enters-pre-clinical-studies-with-novel-improved-cannabinoid-and-psychedelic-derivatives https://www.synbiobeta.com/read/twist-bioscience-illumina-and-western-digital-form-alliance-with-microsoft-to-advance-data-storage-in-dna https://www.synbiobeta.com/read/intellia-therapeutics-receives-grant-to-develop-curative-crispr-cas9-in-vivo-sickle-cell-disease-treatments https://www.synbiobeta.com/read/locus-biosciences-signs-contract-with-carb-x-to-advance-14-million-precision-medicine-program-to-develop-crphage-tm-product-targeting-klebsiella-pneumoniae-infections https://www.synbiobeta.com/read/goldwin-releases-worlds-first-sweater-knitted-with-innovative-fabric-produced-through-microbial-fermentation https://www.synbiobeta.com/read/ambrx-closes-200-million-in-crossover-financing-with-leading-healthcare-investors-to-advance-its-clinical-and-preclinical-pipeline-of-precision-biologics https://www.synbiobeta.com/read/intellia-therapeutics-doses-first-patient-in-landmark-crispr-cas9-clinical-trial-of-ntla-2001-for-the-treatment-of-transthyretin-amyloidosis https://www.synbiobeta.com/read/where-biology-and-computers-combine-trillions-await-those-who-can-scale-up-an-interview-with-lattice-automation-co-founder-doug-densmore https://www.synbiobeta.com/read/cell-free-technology-comes-of-age-biobits-is-changing-the-way-we-teach-biology https://www.synbiobeta.com/read/cytek-biosciences-completes-series-d-funding-round https://www.synbiobeta.com/read/egenesis-announces-research-collaboration-with-leading-academic-medical-center https://www.synbiobeta.com/read/synthace-and-ipsen-partner-to-accelerate-novel-therapeutic-development-through-automation https://www.synbiobeta.com/read/cell-based-collagen-company-looks-to-disrupt-traditional-supply-chains-for-a-better-world https://www.synbiobeta.com/read/bill-gates-backed-ginkgo-bioworks-has-a-new-40-million-spinout-using-synthetic-biology-to-clean-wastewater https://www.synbiobeta.com/read/these-crispr-edited-seeds-are-planting-a-sustainable-future-for-the-agricultural-industry https://www.synbiobeta.com/read/u-k-startup-just-closed-21-million-series-b-to-engineer-cancer-attacking-microbes https://www.synbiobeta.com/read/lygos-joins-biomade-network-to-advance-sustainable-and-reliable-bioindustrial-manufacturing-technologies https://www.synbiobeta.com/read/lesaffre-and-recombia-biosciences-to-advance-innovative-gene-editing-technology-through-a-strategic-partnership https://www.synbiobeta.com/read/twist-bioscience-collaborates-with-beyond-earth-to-launch-artwork-stored-in-dna-into-space https://www.synbiobeta.com/read/gentibio-expands-leadership-team-and-partnership-with-migal-to-help-advance-development-of-engineered-regulatory-t-cell-therapies https://www.synbiobeta.com/read/labgenius-has-closed-an-oversubscribed-15m-extension-round https://www.synbiobeta.com/read/mammoth-biosciences-signs-agreements-with-milliporesigma-and-hamilton-company-targeting-commercialization-of-high-throughput-crispr-based-sars-cov-2-test https://www.synbiobeta.com/read/inscripta-appoints-sri-kosaraju-as-president-and-ceo https://www.synbiobeta.com/read/lanzatech-total-and-loreal-announce-a-worldwide-premiere-the-production-of-the-first-cosmetic-plastic-bottle-made-from-industrial-carbon-emissions https://www.synbiobeta.com/read/prokarium-closes-21m-series-b-financing-round-and-strengthens-board https://www.synbiobeta.com/read/hyasynth-completes-key-commercialization-milestone-for-cannabinoid-biosynthesis-receives-2-5-million-payment https://www.synbiobeta.com/read/lygos-announces-the-launch-of-lygos-cbx-tm-a-new-low-cost-industrial-scale-cannabinoid-production-company https://www.synbiobeta.com/read/allonnia-launches-from-ginkgo-bioworks-ferment-consortium-with-40m-series-a-to-address-critical-problems-in-waste-remediation-with-synthetic-biology-appoints-nicole-richards-as-ceo https://www.synbiobeta.com/read/leaps-by-bayer-leads-usd-17-million-series-b-financing-in-biotech-company-azitra https://www.synbiobeta.com/read/opencell-works-with-government-of-jersey-to-provide-on-island-testing https://www.synbiobeta.com/read/amyris-and-the-infectious-disease-research-institute-enter-into-exclusive-license-for-novel-rna-vaccine-platform-beginning-with-covid-19-vaccine https://www.synbiobeta.com/read/carbon-negative-food-made-from-thin-air-this-science-fiction-idea-may-be-a-reality-sooner-than-you-think https://www.synbiobeta.com/read/microvi-expands-reach-to-areas-hit-hardest-with-nitrate-pollution-in-central-valley-of-california https://www.synbiobeta.com/read/renew-biopharma-announces-new-executive-leadership-to-drive-its-drug-discovery-program https://www.synbiobeta.com/read/amyris-and-arzeda-enter-into-development-collaboration-agreement https://www.synbiobeta.com/read/australian-startup-raises-3-25-million-with-synthetic-biology-algal-platform https://www.synbiobeta.com/read/natural-infant-formula-on-the-horizon-how-to-copy-what-nature-put-in-mothers-milk https://www.synbiobeta.com/read/how-genetic-modification-of-microbes-that-help-make-foods-can-contribute-to-a-more-stable-and-delicious-food-chain https://www.synbiobeta.com/read/dr-amy-liao-receives-the-wallace-a-coulter-award-for-healthcare-innovation https://www.synbiobeta.com/read/twist-bioscience-and-neogene-announce-broad-strategic-partnership-for-next-generation-personalized-t-cell-therapies https://www.synbiobeta.com/read/absci-ceo-sean-mcclain-named-as-an-entrepreneur-of-the-year-r-2020-pacific-northwest-region-award-winner https://www.synbiobeta.com/read/synthegos-crispr-platform-enables-faster-identification-of-potential-coronavirus-treatment https://www.synbiobeta.com/read/the-social-dilemma-what-can-the-biotech-industry-learn-from-the-failures-of-the-social-media-industry https://www.synbiobeta.com/read/u-s-patent-office-grants-renew-biopharma-pivotal-patent-for-cannabinoid-biosynthesis https://www.synbiobeta.com/read/sestina-bio-launches-engineering-biology-at-the-level-of-single-cells https://www.synbiobeta.com/read/chai-launches-first-saliva-based-covid-19-surveillance-test-kit-to-help-schools-and-businesses-reopen-safely https://www.synbiobeta.com/read/with-300-million-in-new-funding-zymergen-aims-to-sustainably-transform-the-3-trillion-chemical-and-materials-industry https://www.synbiobeta.com/read/newlight-technologies-completes-45mm-series-f-expansion-finance-round https://www.synbiobeta.com/read/recombinetics-inc-merges-with-makana-therapeutics-to-accelerate-xenotransplantation https://www.synbiobeta.com/read/a-living-night-light-made-from-microbes-could-be-all-the-rage-this-christmas https://www.synbiobeta.com/read/jennifer-doudnas-new-gene-editing-company-launches-with-a-20-million-round-to-develop-genetic-medicines https://www.synbiobeta.com/read/youve-heard-of-computer-aided-design-what-about-computer-aided-biology https://www.synbiobeta.com/read/a-new-approach-to-a-deadly-breast-cancer-offers-hope-to-the-black-women-it-affects-most https://www.synbiobeta.com/read/could-a-chief-biology-officer-make-your-company-more-profitable https://www.synbiobeta.com/read/how-one-unassuming-little-protein-makes-coronavirus-a-killer https://www.synbiobeta.com/read/bioeconomy-powerhouse-berkeley-lights-nearly-triples-since-ipo-now-valued-at-3-9-billion https://www.synbiobeta.com/read/synthego-pioneers-next-generation-crispr-light-control-technology https://www.synbiobeta.com/read/synthace-announces-the-launch-of-new-product-helping-scientists-execute-and-scale-key-assays https://www.synbiobeta.com/read/open-book-extracts-and-lygos-sign-mou-to-co-develop-and-commercialize-nutraceutical-supplement-products-containing-rare-cannabinoids https://www.synbiobeta.com/read/atomwise-receives-a-2-3m-grant-to-develop-new-therapies-for-drug-resistant-malaria-and-tuberculosis https://www.synbiobeta.com/read/adm-and-spiber-to-partner-on-production-of-innovative-biobased-polymers https://www.synbiobeta.com/read/scribe-therapeutics-to-collaborate-with-biogen-to-develop-crispr-based-genetic-medicines-for-neurological-diseases-including-amyotrophic-lateral-sclerosis https://www.synbiobeta.com/read/scribe-therapeutics-unveils-fully-integrated-platform-for-engineering-breakthrough-crispr-based-genetic-medicines https://www.synbiobeta.com/read/sandia-helps-safeguard-biological-data-threatened-during-covid-19-pandemic https://www.synbiobeta.com/read/amyris-delivering-sustainable-alternative-to-shark-squalene-adjuvant-enabling-vaccines-for-all-with-no-sharks-killed https://www.synbiobeta.com/read/black-veatch-experts-on-demand-service-to-offer-food-beverage-biotechnology-and-bioenergy-expertise https://www.synbiobeta.com/read/oriciro-launches-worlds-first-cell-free-amplification-technology-for-large-circular-dna https://www.synbiobeta.com/read/beam-therapeutics-announces-pricing-of-public-offering-of-common-stock https://www.synbiobeta.com/read/conagen-wins-synbiobeta-award-for-non-gmo-human-milk-oligosaccharide-and-human-lactoferrin https://www.synbiobeta.com/read/idt-expands-global-footprint-with-launch-of-idt-china https://www.synbiobeta.com/read/logicbio-therapeutics-announces-proposed-public-offering-of-common-stock https://www.synbiobeta.com/read/machine-learning-and-synthetic-biology-used-to-optimize-a-cellular-factory-for-industrially-relevant-products https://www.synbiobeta.com/read/ansa-biotechnologies-partners-with-teselagen-biotechnology-to-enable-commercial-production-of-dna-products https://www.synbiobeta.com/read/riffyn-and-imperial-college-partner-to-build-digital-foundations-to-accelerate-synthetic-biology-research https://www.synbiobeta.com/read/1-5-billion-invested-in-alternative-proteins-in-2020-including-a-record-435-million-in-the-next-pillar-fermentation https://www.synbiobeta.com/read/amyris-pipette-clean-baby-brand-selected-by-alibaba-for-accelerated-entry-into-china-for-singles-day-sales https://www.synbiobeta.com/read/moderna-and-vertex-establish-new-collaboration-to-treat-cystic-fibrosis-using-gene-editing https://www.synbiobeta.com/read/amyris-continues-market-adoption-of-its-sweetener-with-approval-by-health-canada https://www.synbiobeta.com/read/debut-biotechnology-awarded-1m-from-air-force-research-lab-to-leverage-cell-free-continuous-biomanufacturing-in-aerospace-applications https://www.synbiobeta.com/read/ansa-biotechnologies-raises-9-2-million-in-combined-seed-and-pre-seed-financing https://www.synbiobeta.com/read/sherlock-biosciences-launches-the-221b-foundation-to-address-the-covid-19-pandemic-and-equity-in-stem https://www.synbiobeta.com/read/synlogic-appoints-david-hava-ph-d-as-chief-scientific-officer https://www.synbiobeta.com/read/synthetic-biology-versus-coronavirus-three-women-in-a-cutting-edge-field-using-biological-engineering-to-save-lives https://www.synbiobeta.com/read/synthetic-biology-startups-raised-3-billion-in-the-first-half-of-2020 https://www.synbiobeta.com/read/could-fermentation-power-the-future-of-plant-based-foods-motif-foodworks-thinks-yes https://www.synbiobeta.com/read/evonetix-and-analog-devices-collaborate-on-third-generation-dna-synthesis-platform https://www.synbiobeta.com/read/dna-based-data-storage-and-computation-provider-catalog-founded-by-mit-scientists-raises-10-million https://www.synbiobeta.com/read/biopharma-leaders-unite-to-stand-with-science https://www.synbiobeta.com/read/demetrix-is-scaling-the-cannabinoid-industry https://www.synbiobeta.com/read/zymergen-takes-aim-at-3-trillion-chemical-materials-industry-with-300-million-in-new-funding https://www.synbiobeta.com/read/the-drug-supply-chain-is-broken-a-new-breakthrough-paves-the-way-for-on-demand-plant-based-medicines https://www.synbiobeta.com/read/how-do-we-safely-reopen-schools-and-work-cheap-fast-testing-enabled-by-a-5-million-xprize https://www.synbiobeta.com/read/demetrix-begins-demo-scale-production-of-rare-cannabinoids https://www.synbiobeta.com/read/biomx-enters-collaboration-with-boehringer-ingelheim-with-the-goal-of-discovering-microbiome-based-biomarkers-for-inflammatory-bowel-disease https://www.synbiobeta.com/read/twist-bioscience-announces-potent-sars-cov-2-neutralizing-data-from-covid-19-therapeutic-antibody-program https://www.synbiobeta.com/read/new-paper-demonstrates-most-advanced-example-of-engineering-integrated-systems-for-biosynthesis https://www.synbiobeta.com/read/sherlock-biosciences-announces-clinical-data-from-dartmouth-hitchcock-healths-pilot-study-of-sherlock-tm-crispr-sars-cov-2-kit https://www.synbiobeta.com/read/amyris-scales-first-fermentation-based-cannabinoid https://www.synbiobeta.com/read/genscript-biotech-corporation-signs-exclusive-agreement-with-ph-biotech-firm-to-distribute-faster-more-accurate-and-more-affordable-immunity-tests-for-covid-19 https://www.synbiobeta.com/read/how-a-newly-public-synthetic-biology-company-pivoted-to-the-pandemic-up-close-and-personal-with-twist-bioscience https://www.synbiobeta.com/read/yield10-bioscience-announces-closing-of-4-0-million-public-offering-including-exercise-of-the-over-allotment-option-and-concurrent-1-7-million-private-placement https://www.synbiobeta.com/read/a-virtual-drug-discovery-company-with-no-lab-of-its-own-partners-with-roche-to-fight-cancers-in-the-brain https://www.synbiobeta.com/read/the-rush-for-hand-sanitizers-is-a-boom-for-hand-moisturizers-this-startup-has-a-solution-for-both https://www.synbiobeta.com/read/codex-dna-demonstrates-momentum-toward-mission-of-building-worlds-first-vaccine-printer-and-global-vaccine-network https://www.synbiobeta.com/read/yield10-bioscience-announces-pricing-of-5-2-million-public-offering-and-concurrent-private-placement https://www.synbiobeta.com/read/indee-labs-awarded-grant-from-the-national-institute-of-allergy-and-infectious-diseases https://www.synbiobeta.com/read/provivi-r-announces-regulatory-approval-of-first-sprayable-pheromone-product-for-the-control-of-fall-armyworm-in-brazil https://www.synbiobeta.com/read/can-technology-make-more-natural-pesticides-zymergen-fmc-partnership-offers-a-peek-into-the-future-of-crop-protection https://www.synbiobeta.com/read/twist-bioscience-synthetic-dna-stores-new-netflix-original-series-biohackers https://www.synbiobeta.com/read/conagens-novel-non-gmo-human-milk-oligosaccharide-paves-the-way-for-advancing-nutrition-in-next-generation-infant-formulas https://www.synbiobeta.com/read/checkerspot-closes-36-million-series-b-round https://www.synbiobeta.com/read/ingenza-meets-a-key-milestone-in-the-deployment-of-novel-cost-effective-covid-19-vaccine-technology https://www.synbiobeta.com/read/fmc-corporation-collaborates-with-zymergen-to-accelerate-discovery-of-breakthrough-crop-protection-technologies https://www.synbiobeta.com/read/codex-dna-launches-new-automated-synthetic-biology-workstation-for-commercial-use https://www.synbiobeta.com/read/more-talent-rushes-to-the-synthetic-biology-gold-mine-venture-capitalist-mitchell-mutz-leaves-roche-to-join-codon-capital https://www.synbiobeta.com/read/labshares-newton-announces-next-launch-labshares-winner https://www.synbiobeta.com/read/lygos-successfully-validates-novel-fermentation-process-for-sustainable-and-rare-cannabinoids https://www.synbiobeta.com/read/precigen-announces-first-patient-dosed-in-phase-i-ii-study-of-first-in-class-prgn-2009-adenoverse-tm-immunotherapy-to-treat-hpv-associated-cancers https://www.synbiobeta.com/read/automated-biology-is-now-an-affordable-reality https://www.synbiobeta.com/read/kalion-inc-receives-nsf-phase-ii-sbir-grant-to-develop-bio-based-glucaric-acid https://www.synbiobeta.com/read/novome-biotechnologies-expands-therapeutic-focus-and-platform-capabilities-with-acquisition-of-preclinical-projects-and-intellectual-property-from-caribou-biosciences-and-license-to-crispr-cas9-foundational-patent-portfolio https://www.synbiobeta.com/read/sherlock-biosciences-announces-research-collaboration-with-dartmouth-hitchcock-health-to-launch-study-of-crispr-based-test-for-sars-cov-2 https://www.synbiobeta.com/read/precigen-actobio-announces-positive-topline-results-from-phase-1b-study-of-ag019-actobiotics-tm-a-novel-therapy-designed-to-address-the-underlying-cause-of-type-1-diabetes https://www.synbiobeta.com/read/new-cyrus-biotechnology-antibody-structure-prediction-software-nextgen-outperforms-schrodinger-and-other-software-in-third-party-test https://www.synbiobeta.com/read/search-funds-a-new-model-for-innovation-in-the-synthetic-biology-industry https://www.synbiobeta.com/read/two-unicorns-shaping-the-future-of-the-synthetic-biology-industry https://www.synbiobeta.com/read/emerald-bioscience-raises-approximately-7-0-million-in-upsized-registered-offering https://www.synbiobeta.com/read/optimizepress-48486 https://www.synbiobeta.com/read/will-programming-a-cell-ever-be-as-easy-as-programming-an-app https://www.synbiobeta.com/read/catalent-enters-into-strategic-partnership-with-editas-medicine-to-support-gene-editing-medicine-pipeline https://www.synbiobeta.com/read/elo-life-systems-announces-strategic-partnership-with-dole-food-company-with-the-goal-of-saving-the-cavendish-banana https://www.synbiobeta.com/read/have-your-cake-and-eat-it-too-so-long-as-theyre-gmo-5-reasons-gmo-should-be-on-your-shopping-list https://www.synbiobeta.com/read/abcellera-provides-covid-19-program-update-with-the-start-of-phase-3-clinical-trials-and-the-expansion-of-its-covid-19-antibody-database https://www.synbiobeta.com/read/carisma-therapeutics-announces-fda-clearance-of-ind-application-for-first-ever-engineered-macrophage-immunotherapy https://www.synbiobeta.com/read/mantra-bio-announces-25-million-series-a-financing-to-develop-next-generation-targeted-therapeutics-based-on-platform-for-engineering-targeted-exosome-vehicles https://www.synbiobeta.com/read/versant-ventures-launches-bright-peak-therapeutics https://www.synbiobeta.com/read/your-car-is-more-plastic-than-you-know-this-company-may-soon-be-brewing-its-parts-with-biology https://www.synbiobeta.com/read/a-next-generation-infant-formula-the-closest-to-mothers-milk-yet-made-with-biology https://www.synbiobeta.com/read/despite-coronavirus-85-of-americans-are-thinking-about-sustainability-as-much-as-or-more-than-ever https://www.synbiobeta.com/read/new-age-meats-raises-2m-seed-extension-to-continue-developing-cultivated-pork https://www.synbiobeta.com/read/a-new-test-may-show-whether-your-immune-system-can-neutralize-the-coronavirus https://www.synbiobeta.com/read/synlogic-announces-promotion-of-antoine-tony-awad-to-chief-operating-officer-and-additions-to-leadership-team https://www.synbiobeta.com/read/survey-americans-embrace-sustainability-despite-covid-19-upheaval https://www.synbiobeta.com/read/twist-bioscience-launches-two-sars-cov-2-antibody-panels-to-expedite-research-for-covid-19 https://www.synbiobeta.com/read/cabaletta-bio-and-artisan-bio-announce-gene-editing-research-and-collaboration-agreement-to-develop-next-generation-caar-t-cell-therapies https://www.synbiobeta.com/read/manus-bio-and-stk-bio-ag-technologies-announce-partnership-to-develop-and-commercialize-pipeline-of-next-generation-biopesticides https://www.synbiobeta.com/read/dna-script-expands-series-b-to-89m https://www.synbiobeta.com/read/amyris-and-the-infectious-disease-research-institute-partner-to-advance-novel-rna-vaccine-platform-beginning-with-covid-19-application https://www.synbiobeta.com/read/robot-that-prints-new-skin-could-revolutionise-burns-treatment https://www.synbiobeta.com/read/synthetic-protein-design-and-production-publication-confirms-evozynes-revolutionary-technology https://www.synbiobeta.com/read/genscript-announces-publication-of-clinical-data-on-new-method-for-detecting-covid-19-neutralizing-antibodies-in-nature-biotechnology https://www.synbiobeta.com/read/twist-bioscience-appoints-erin-smith-senior-vice-president-government-affairs-and-public-policy https://www.synbiobeta.com/read/inventor-and-science-luminary-john-warner-joins-zymergen-to-accelerate-green-chemistry https://www.synbiobeta.com/read/tropic-biosciences-partners-with-basf-to-develop-innovative-traits-for-growers https://www.synbiobeta.com/read/twist-bioscience-launches-synthetic-controls-for-respiratory-viruses https://www.synbiobeta.com/read/berkeley-lights-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/abcellera-announces-agreement-with-alloy-therapeutics-to-integrate-access-to-atx-gx-tm-humanized-mice-platform-for-antibody-discovery-programs https://www.synbiobeta.com/read/renaissance-bioscience-appoints-victor-dusik-as-director https://www.synbiobeta.com/read/life-sciences-heavyweight-dr-joe-keegan-joins-fast-growing-nucleras-board-as-non-executive-director https://www.synbiobeta.com/read/berkeley-lights-announces-pricing-of-initial-public-offering https://www.synbiobeta.com/read/twist-bioscience-customer-vanderbilt-university-medical-center-vumc-announces-publication-of-positive-preclinical-results-on-neutralizing-antibodies-as-a-potential-therapy-for-preventing-and-treating-covid-19 https://www.synbiobeta.com/read/twist-bioscience-partners-with-invetx-to-deliver-best-in-class-antibody-therapeutics-for-dogs-and-cats https://www.synbiobeta.com/read/sab-biotherapeutics-closes-series-b-funding https://www.synbiobeta.com/read/glympse-bio-announces-46-7-million-series-b-financing https://www.synbiobeta.com/read/amyris-launches-plant-derived-sustainable-silica-for-clean-beauty-applications https://www.synbiobeta.com/read/cambridge-crops-rebrands-as-mori-and-raises-12-million-in-series-a-funding-to-combat-food-waste https://www.synbiobeta.com/read/bioconsortia-welcomes-dr-damian-curtis-to-lead-new-gene-editing-and-synthetic-biology-platform-for-next-generation-biopesticides-biostimulants-and-fertilizers https://www.synbiobeta.com/read/new-england-biolabs-r-podcast-video-series-spotlights-scientists-working-to-fight-sars-cov-2-virus https://www.synbiobeta.com/read/codex-dna-releases-new-synthetic-sars-cov-2-genome-for-covid-19-vaccine-and-therapeutic-research https://www.synbiobeta.com/read/indiebios-arvind-gupta-joins-mayfield-will-lead-new-alliance-using-capitalism-and-biology-to-do-good-in-the-world https://www.synbiobeta.com/read/fishcakes-in-space-how-one-biotech-startup-is-fermenting-far-out-food https://www.synbiobeta.com/read/synbiobeta-annual-membership https://www.synbiobeta.com/read/telum-therapeutics-raises-eu-4-1-million-in-its-first-round-of-financing-to-advance-the-development-of-new-synthetic-biology-based-therapies-for-the-treatment-of-infectious-diseases-caused-by-multi-resistant-bacteria https://www.synbiobeta.com/read/perfect-day-expands-series-c-to-300-million-led-by-cpp-investments-after-breakthroughs-in-animal-free-dairy-production-capabilities https://www.synbiobeta.com/read/new-england-biolabs-sars-cov-2-rapid-colorimetric-lamp-assay-kit-enables-visual-detection-of-novel-coronavirus-in-30-minutes https://www.synbiobeta.com/read/as-some-startup-vcs-hunker-down-others-are-finding-new-ways-to-fund-the-next-aws-of-biology https://www.synbiobeta.com/read/takeda-partners-with-twist-bioscience-to-expand-biologics-discovery-capabilities https://www.synbiobeta.com/read/evonik-launches-food-supplement-medox-r-with-plant-pigments-from-scandinavian-bilberries-in-pharmacies-all-over-germany https://www.synbiobeta.com/read/say-goodbye-to-moldy-bread-ai-driven-biotech-startup-is-fermenting-natural-ingredients-to-double-bakery-shelf-life https://www.synbiobeta.com/read/synthetic-biology-and-americas-future-new-opportunities-for-working-with-the-u-s-government https://www.synbiobeta.com/read/biossance-announces-clean-academy-impact-award-and-partnership-with-oceana https://www.synbiobeta.com/read/from-wtf-to-wfh-building-a-digital-backbone-for-faster-cheaper-better-science-in-a-decentralized-world-2 https://www.synbiobeta.com/read/a-20-minute-covid-19-test-using-crispr-gene-editing-technology-coming-soon-to-your-doctors-office-supermarket-and-workplace https://www.synbiobeta.com/read/carb-x-funds-eligo-bioscience-to-develop-crispr-based-therapeutics-derived-from-bacteriophages-to-kill-superbugs-and-prevent-deadly-infections-in-transplant-patients https://www.synbiobeta.com/read/neoleukin-therapeutics-announces-pricing-of-76-2-million-public-offering https://www.synbiobeta.com/read/twist-bioscience-adds-respiratory-virus-panel-to-infectious-disease-product-line https://www.synbiobeta.com/read/sherlock-biosciences-and-binx-health-announce-global-partnership-to-develop-first-crispr-based-point-of-care-test-for-covid-19 https://www.synbiobeta.com/read/bay-area-covid-fighting-startup-files-for-100m-ipo https://www.synbiobeta.com/read/pharmas-dirty-secret-and-the-synthetic-biology-startup-offering-a-new-approach https://www.synbiobeta.com/read/if-biology-can-build-it-they-will-come-ginkgo-bioworks-is-laying-the-foundation-for-the-4-trillion-bioeconomy https://www.synbiobeta.com/read/a-new-way-of-making-dna-is-about-to-revolutionize-the-biotech-industry https://www.synbiobeta.com/read/boost-biomes-announces-close-of-series-a-and-co-development-agreement-with-lead-investor-yara-international-for-biostimulants-products https://www.synbiobeta.com/read/dotmatics-acquires-biobright-to-accelerate-laboratory-data-automation-for-the-lab-of-the-future https://www.synbiobeta.com/read/berkeley-lights-announces-opto-tm-antigen-presenting-bead-kit-to-accelerate-the-expansion-of-antigen-specific-t-cells-used-to-develop-cell-based-therapies https://www.synbiobeta.com/read/idt-launches-gblocks-tm-hifi-improving-on-industry-leading-products-for-synthetic-biology https://www.synbiobeta.com/read/amyris-partners-with-ab-mauri-north-america-to-reduce-sugar-in-baking-products-using-purecane-tm-sweetener https://www.synbiobeta.com/read/preclinical-data-for-prgn-3005-ultracar-t-r-demonstrate-superior-expansion-and-persistence-of-ultracar-t-compared-to-traditional-car-t https://www.synbiobeta.com/read/codexis-and-molecular-assemblies-partner-to-transform-the-field-of-dna-synthesis https://www.synbiobeta.com/read/agrospheres-awarded-75-000-from-cit-crcf https://www.synbiobeta.com/read/codagenix-announces-the-synthesis-and-preliminary-safety-of-scalable-live-attenuated-vaccine-candidate-against-covid-19 https://www.synbiobeta.com/read/theres-a-new-fermented-zero-calories-sugar-on-the-market-and-it-actually-tastes-like-real-sugar https://www.synbiobeta.com/read/netflix-pandemic-star-just-showed-his-covid-19-antibody-drug-works-in-hamsters-how-quickly-could-it-treat-humans https://www.synbiobeta.com/read/praj-and-lygos-to-co-develop-advanced-lactic-acid-yeast-technology-for-bio-based-products https://www.synbiobeta.com/read/computer-aided-biology-the-metadata-responsibility https://www.synbiobeta.com/read/genomatica-celebrates-third-epa-award-win-with-brontide-tm-natural-butylene-glycol https://www.synbiobeta.com/read/cambium-biomaterials-and-the-us-navy-produce-breakthrough-in-bio-based-fire-resistant-composite-materials-for-aerospace-space-transport-and-other-unmet-advanced-material-needs https://www.synbiobeta.com/read/deep-tech-startups-vs-covid-19-with-khosla-ventures-fifty-years-and-sosv https://www.synbiobeta.com/read/conamax-tm-promising-antibody-based-therapy-breakthroughs-are-brewing-at-conagen https://www.synbiobeta.com/read/pheronym-wins-225-000-nsf-grant-for-commercializing-nematode-pheromones-for-eco-friendly-pest-control-in-agriculture https://www.synbiobeta.com/read/synthace-and-tecan-announce-collaboration-to-accelerate-purification-optimization-in-process-development-through-augmented-lab-automation https://www.synbiobeta.com/read/biosyntia-secures-commercial-in-licensing-rights-to-natural-isoflavonoids-through-global-partnership https://www.synbiobeta.com/read/could-franchises-create-a-small-business-boom-in-synthetic-biology https://www.synbiobeta.com/read/swiftscale-achieves-key-milestone-in-faster-manufacturing-process-for-covid-19-treatments https://www.synbiobeta.com/read/protera-closes-5-6m-series-a-financing-led-by-sofinnova-partners https://www.synbiobeta.com/read/investing-in-these-8-bioeconomy-sectors-could-create-up-to-1-6m-jobs-lost-to-covid https://www.synbiobeta.com/read/from-wtf-to-wfh-building-a-digital-backbone-for-faster-cheaper-better-science-in-a-decentralized-world https://www.synbiobeta.com/read/sherlock-biosciences-and-integrated-dna-technologies-idt-announce-strategic-partnership-for-manufacturing-crispr-sars-cov-2-diagnostic-and-research-products https://www.synbiobeta.com/read/amyris-raises-200-million-from-private-placement https://www.synbiobeta.com/read/if-software-is-eating-the-world-biology-is-going-to-rebuild-it-zymergen-ceo-josh-hoffman-on-the-coming-bioeconomy https://www.synbiobeta.com/read/intellia-therapeutics-announces-closing-of-115-million-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares https://www.synbiobeta.com/read/tropic-biosciences-raises-28-5-million-series-b-financing-to-transform-the-massive-tropical-agriculture-industry https://www.synbiobeta.com/read/twist-bioscience-to-join-proteona-in-global-alliance-to-protect-immunocompromised-patients-from-covid-19-infection https://www.synbiobeta.com/read/codexis-and-alphazyme-partner-to-offer-novel-enzymes-to-life-science-and-diagnostic-markets https://www.synbiobeta.com/read/modular-bioscience-acquires-exclusive-license-to-university-of-illinois-urbana-champaign-artificial-restriction-enzyme-technology https://www.synbiobeta.com/read/how-california-can-lead-the-global-bioeconomy-a-conversation-with-zymergen-ceo-josh-hoffman https://www.synbiobeta.com/read/this-synthetic-biology-company-is-on-the-cusp-of-using-live-engineered-bacteria-as-a-cancer-drug https://www.synbiobeta.com/read/publication-in-nature-communications-highlights-the-preclinical-development-of-synb1891-and-its-potential-as-a-dual-innate-immune-activator-to-stimulate-an-immune-response-in-difficult-to-treat-tumors https://www.synbiobeta.com/read/regeneron-and-intellia-therapeutics-expand-collaboration-to-develop-crispr-cas9-based-treatments https://www.synbiobeta.com/read/new-mckinsey-report-sees-a-4-trillion-gold-rush-in-this-one-hot-sector-whos-selling-picks-and-shovels https://www.synbiobeta.com/read/fda-lists-beckman-coulter-life-sciences-rna-extraction-kit-for-use-in-eua-authorized-covid-19-test https://www.synbiobeta.com/read/lexagene-places-pre-commercial-instrument-for-covid-19-testing https://www.synbiobeta.com/read/ginkgo-bioworks-to-build-infrastructure-for-rapid-epidemic-response-with-70mm-investment https://www.synbiobeta.com/read/mission-bio-launches-first-automated-custom-panel-designer-for-mouse-genomes-and-crispr-editing-to-accelerate-breakthroughs-in-cancer-research https://www.synbiobeta.com/read/mike-kamdar-the-future-of-dna-writing-and-the-business-of-biology https://www.synbiobeta.com/read/renaissance-bioscience-corp-to-receive-r-d-funding-to-advance-its-yeast-based-rnai-biopesticide-and-biotherapeutics-technology https://www.synbiobeta.com/read/scientists-use-virtual-reality-to-refine-new-ai-generated-drugs-for-covid-19 https://www.synbiobeta.com/read/abcellera-announces-multi-year-antibody-discovery-collaboration-with-lilly https://www.synbiobeta.com/read/amyris-launches-safe-alternative-to-talc-based-baby-powder https://www.synbiobeta.com/read/atomwise-partners-with-global-research-teams-to-pursue-broad-spectrum-treatments-against-covid-19-and-future-coronavirus-outbreaks https://www.synbiobeta.com/read/sherlock-biosciences-launches-innovation-lab-to-develop-covid-19-diagnostics-with-7-5-million-grant-from-open-philanthropy https://www.synbiobeta.com/read/wuxi-biologics-closes-land-deal-to-build-state-of-the-art-biologics-production-facility-in-the-united-states https://www.synbiobeta.com/read/opencell-partners-with-kings-college-and-opentrons-to-create-affordable-shipping-container-covid-19-testing-lab https://www.synbiobeta.com/read/synlogic-announces-termination-of-abbvie-collaboration-agreement https://www.synbiobeta.com/read/built-with-biology-summit-propose-a-breakout-session https://www.synbiobeta.com/read/synbiobeta-covid-19-town-hall-serological-tests-qpcr-antibodies-and-vaccines https://www.synbiobeta.com/read/egenesis-strengthens-production-capabilities-with-acquisition-of-icbiotec https://www.synbiobeta.com/read/octant-launches-polypharmacology-drug-discovery-engine-for-complex-diseases-with-30-million-series-a-financing-led-by-andreessen-horowitz https://www.synbiobeta.com/read/the-eight-little-mice-that-could-be-the-key-to-ending-the-pandemic https://www.synbiobeta.com/read/prellis-biologics-inc-generates-300-human-antibodies-that-bind-the-sars-cov2-virus-pursues-development-of-a-treatment-and-preventative-therapy-for-covid-19-infection https://www.synbiobeta.com/read/centivax-antibodies-neutralize-the-pandemic-coronavirus-independently-confirmed-by-three-research-laboratories-usamriid-stanford-and-utmb-gnl https://www.synbiobeta.com/read/idt-broadens-capacity-and-customer-support-of-covid-19-products-with-new-manufacturing-facility https://www.synbiobeta.com/read/duke-nus-genscript-and-a-star-launch-first-in-the-world-sars-cov-2-serology-test-to-detect-neutralising-antibodies-without-need-of-containment-facility-or-specimen https://www.synbiobeta.com/read/a-coronavirus-vaccine-candidate-in-six-days-this-company-is-fast-tracking-vaccine-development-with-the-first-fully-automated-gene-synthesis-platform https://www.synbiobeta.com/read/enzymicals-and-syngulon-sign-a-non-exclusive-license-agreement-on-the-use-of-syngulons-antibiotic-free-technology-to-produce-enzymes https://www.synbiobeta.com/read/five-things-big-pharma-and-its-investors-could-learn-from-synthetic-biology https://www.synbiobeta.com/read/bay-area-biotech-incubator-opens-extensive-new-lab-facility-paving-way-for-entrepreneurs-and-their-innovation https://www.synbiobeta.com/read/preventing-another-pandemic-might-be-as-simple-as-trying-alternative-meat https://www.synbiobeta.com/read/eric-schmidts-five-insights-about-navigating-coronavirus-that-every-business-leader-needs-to-hear-now https://www.synbiobeta.com/read/the-new-diagnostics-marketplace-in-a-post-covid-19-world https://www.synbiobeta.com/read/its-time-to-build-with-biology https://www.synbiobeta.com/read/primordial-genetics-and-denovium-collaborate-to-impact-the-diagnosis-prevention-treatment-of-human-diseases https://www.synbiobeta.com/read/synbiobeta-live-the-covid-19-vaccine-report https://www.synbiobeta.com/read/sherlock-biosciences-receives-fda-emergency-use-authorization-for-crispr-sars-cov-2-rapid-diagnostic https://www.synbiobeta.com/read/twist-bioscience-identifies-competitive-antibodies-for-sars-cov-2 https://www.synbiobeta.com/read/grail-announces-390-million-series-d-financing https://www.synbiobeta.com/read/abcellera-receives-175-6-million-from-the-government-of-canada-to-discover-solutions-for-covid-19-and-build-a-manufacturing-facility-for-antibody-drugs https://www.synbiobeta.com/read/apple-founder-zoom-bombs-meeting-to-thank-covid-19-scientists https://www.synbiobeta.com/read/the-future-of-manufacturing-is-built-with-biology-or-how-this-biotech-startup-is-challenging-the-trillion-dollar-global-chemical-industry https://www.synbiobeta.com/read/pivot-bio-raises-100-million-to-transform-agriculture-economics https://www.synbiobeta.com/read/register-now-for-the-built-with-biology-summit-june-3-2020 https://www.synbiobeta.com/read/exploring-coronavirus-in-virtual-reality-insights-for-fighting-todays-pandemic-and-the-next https://www.synbiobeta.com/read/synbiobeta-live-can-humanity-build-a-global-antibody-defense-barrier-against-future-pandemics https://www.synbiobeta.com/read/berkeley-lights-launches-two-new-capabilities-in-the-opto-cell-therapy-development-1-0-workflow-to-accelerate-the-creation-of-effective-cancer-immunotherapies https://www.synbiobeta.com/read/why-biotechs-goal-should-not-be-to-feed-the-world https://www.synbiobeta.com/read/the-data-organ-paradromics-ceo-matt-angle-on-the-future-of-the-brain-computer-interface https://www.synbiobeta.com/read/opentrons-partners-with-zymo-research-to-offer-an-affordable-automated-covid-19-testing-platform https://www.synbiobeta.com/read/official-launch-of-luminity-r-deinoves-new-cosmetic-active-ingredient-for-a-radiant-complexion https://www.synbiobeta.com/read/fujifilm-diosynth-biotechnologies-enters-strategic-partnership-with-oxgene-tm-to-address-supply-bottlenecks-in-gene-therapy-development-and-manufacturing https://www.synbiobeta.com/read/ablexis-alivamab-discovery-services-and-berkeley-lights-collaborate-to-identify-a-diverse-panel-of-anti-sars-cov-2-human-antibodies https://www.synbiobeta.com/read/enginzyme-secures-eu6-4-million-series-a-financing-round-led-by-sofinnova-partners https://www.synbiobeta.com/read/precigen-announces-clearance-of-ind-to-initiate-phase-i-ii-study-for-first-in-class-prgn-2009-adenoverse-tm-immunotherapy-to-treat-hpv-positive-hpv-solid-tumors https://www.synbiobeta.com/read/molecular-assemblies-appoints-todd-c-peterson-to-board-of-directors https://www.synbiobeta.com/read/twist-bioscience-expands-flexibility-of-clonal-genes-for-pharmaceutical-biotechnology-and-industrial-chemical-research https://www.synbiobeta.com/read/amyris-receives-approval-to-sell-its-fermented-sugarcane-reb-m-in-brazil-and-canada https://www.synbiobeta.com/read/mammoth-biosciences-announces-peer-reviewed-validation-of-its-rapid-crispr-based-covid-19-diagnostic https://www.synbiobeta.com/read/inspired-by-nature-zymergen-brews-high-performance-bio-electronics https://www.synbiobeta.com/read/licensing-of-patient-derived-covid-19-neutralizing-antibodies-to-hisun-pharma-for-co-development-and-clinical-use https://www.synbiobeta.com/read/ginkgo-bioworks-provides-support-on-process-optimization-to-moderna-for-covid-19-response https://www.synbiobeta.com/read/idt-announces-expansion-of-coronavirus-products-begins-accepting-pre-orders-for-new-covid-19-primer-probe-panel-in-ratios-set-forth-in-who-charite-berlin-test https://www.synbiobeta.com/read/amyris-experiences-very-strong-sales-start-with-pipette-hand-sanitizer-for-the-whole-family https://www.synbiobeta.com/read/geltor-announces-first-biocompatible-elastin-for-skincare-market https://www.synbiobeta.com/read/synbiobeta-live-covid-19-antibodies-roundtable https://www.synbiobeta.com/read/synbiobeta-live-investing-in-times-of-turmoil-neurotech-and-happiness https://www.synbiobeta.com/read/is-coronavirus-in-the-nyc-subway-how-swabbing-doors-and-trains-is-shaping-the-fight-against-covid-19 https://www.synbiobeta.com/read/sgi-dna-is-now-codex https://www.synbiobeta.com/read/zymergen-reimagines-electronics-with-breakthrough-bio-fabricated-materials https://www.synbiobeta.com/read/amyris-scales-up-in-response-to-high-need-for-its-hand-sanitizer-and-wipe-products https://www.synbiobeta.com/read/berkeley-lights-expands-its-platform-and-introduces-the-optoseq-tm-3-mrna-library-kit https://www.synbiobeta.com/read/biomx-announces-positive-topline-data-from-phase-1-study-for-lead-candidate-bx001-for-acne-prone-skin https://www.synbiobeta.com/read/fda-accepts-investigational-new-drug-application-for-crispr-cas9-based-sickle-cell-disease-therapeutic-candidate-developed-under-collaboration-with-intellia-therapeutics https://www.synbiobeta.com/read/conagen-receives-a-strategic-investment-from-sumitomo-chemical https://www.synbiobeta.com/read/gevo-tightens-belt-plans-to-push-forward-with-project-funding-amid-covid-19-layoffs https://www.synbiobeta.com/read/thermo-fisher-scientific-launches-new-acrometrix-coronavirus-2019-covid-19-rna-control-ruo https://www.synbiobeta.com/read/timeline-shows-3-paths-to-covid-19-treatment-and-prevention-infographic https://www.synbiobeta.com/read/genofab-inc-partners-with-decisions-llc-the-leading-provider-of-business-automation-and-business-rule-software-to-accelerate-biomedical-research-projects https://www.synbiobeta.com/read/growcab-selected-as-winner-in-the-tff-x-beta-space-space-colonisation-prize https://www.synbiobeta.com/read/synlogic-provides-summary-of-impact-of-covid-19-on-clinical-program-progress-and-operational-activities https://www.synbiobeta.com/read/amyris-launches-leading-hand-sanitizer-and-receives-initial-positive-result-for-vaccine-adjuvant https://www.synbiobeta.com/read/twist-bioscience-synthetic-sars-cov-2-rna-controls-added-to-fda-website-as-reference-materials https://www.synbiobeta.com/read/twist-bioscience-partners-with-vanderbilt-university-medical-center-to-supply-critical-products-and-identify-antibody-therapeutics-for-covid-19 https://www.synbiobeta.com/read/atum-provides-covid-19-diagnostic-and-therapeutic-developers-free-access-to-its-protein-synthesis-platform https://www.synbiobeta.com/read/infant-formula-evolves-and-advances-in-nutrition https://www.synbiobeta.com/read/thermo-fisher-scientific-receives-ce-mark-for-its-diagnostic-test-to-detect-covid-19 https://www.synbiobeta.com/read/berkeley-lights-announces-the-global-emerging-pathogen-antibody-discovery-consortium-gepad-to-attack-covid-19-and-other-viruses https://www.synbiobeta.com/read/indiebio-announces-coronavirus-initiative https://www.synbiobeta.com/read/natures-fynd-begins-production-raises-80-million-series-b-to-commercialize-a-new-to-the-world-protein https://www.synbiobeta.com/read/as-zymergen-buys-enevolv-biological-manufacturing-is-ready-to-transform-how-industry-makes-everything-from-airplanes-to-air-jordans https://www.synbiobeta.com/read/codexis-signs-strategic-collaboration-and-license-agreement-with-takeda-to-advance-novel-gene-therapies-for-rare-genetic-disorders https://www.synbiobeta.com/read/commercial-launch-of-biome-oleoactif-r-new-cosmetic-active-co-developed-by-deinove-and-hallstar-france https://www.synbiobeta.com/read/with-its-coronavirus-rapid-paper-test-strip-this-crispr-startup-wants-to-help-halt-a-pandemic https://www.synbiobeta.com/read/roosterbio-partners-with-senti-biosciences-to-rapidly-translate-gene-circuit-cell-therapy-into-the-clinic https://www.synbiobeta.com/read/running-your-pharma-company-out-of-a-starbucks-drug-discovery-moves-to-the-cloud https://www.synbiobeta.com/read/evonik-achieves-major-biotech-breakthrough-with-a-new-animal-free-and-fermentation-based-collagen-platform https://www.synbiobeta.com/read/sigilon-therapeutics-announces-80-3-million-series-b-financing-to-advance-shielded-living-therapeutics-tm-to-the-clinic https://www.synbiobeta.com/read/twist-announces-availability-of-next-generation-sequencing-target-enrichment-panel-for-sars-cov-2-covid-19-research https://www.synbiobeta.com/read/inovio-receives-new-5-million-grant-to-accelerate-scale-up-of-smart-delivery-device-for-its-covid-19-vaccine https://www.synbiobeta.com/read/willow-biosciences-announces-cannabinoid-scale-up-and-expedited-path-to-commercialization https://www.synbiobeta.com/read/zbiotics-worlds-first-maker-of-genetically-engineered-probiotics-raises-2-3m-to-bring-additional-gmo-probiotics-to-the-world https://www.synbiobeta.com/read/twist-bioscience-announces-availability-of-synthetic-sars-cov-2-rna-controls https://www.synbiobeta.com/read/deinove-passes-the-2nd-milestone-of-the-agir-program-and-receives-eu1-5m-from-bpifrance https://www.synbiobeta.com/read/octarine-bio-ivs-receives-funding-from-vaekstfonden-to-develop-biosynthetic-platform-for-cannabinoid-and-psychedelic-tryptamine-derivatives https://www.synbiobeta.com/read/food-from-thin-air-the-forgotten-space-tech-that-could-feed-planet-earth https://www.synbiobeta.com/read/nasa-is-quietly-funding-this-project-to-understand-how-synthetic-biology-can-support-human-life-in-space https://www.synbiobeta.com/read/synbiobeta-covid-19-town-hall-2-building-the-synthetic-biology-tool-stack-for-detecting-sars-cov-2 https://www.synbiobeta.com/read/berkeley-lights-launches-cell-line-development-2-0-workflow-to-find-top-clones-for-complex-antibody-therapeutics https://www.synbiobeta.com/read/with-15m-series-a-culture-biosciences-is-growing-cells-in-the-cloud https://www.synbiobeta.com/read/amyris-expands-distribution-of-purecane-baking-sweetener-on-amazon-strong-early-sales https://www.synbiobeta.com/read/idt-launches-alt-r-tm-hdr-design-tool-and-templates https://www.synbiobeta.com/read/amyris-discovers-major-breakthrough-in-cbd-delivery https://www.synbiobeta.com/read/the-great-digital-shift-where-synthetic-biology-biomanufacturing-and-biopharma-combine https://www.synbiobeta.com/read/berkeley-lights-launches-t-cell-receptor-sequencing-kit-to-increase-efficiency-of-t-cell-receptor-discovery https://www.synbiobeta.com/read/mycoworks-raises-17m-series-a-to-meet-growing-demand-for-reishi-tm https://www.synbiobeta.com/read/meet-the-companies-waging-war-on-sugar-and-diabetes-with-synthetic-biology https://www.synbiobeta.com/read/synbiobeta-podcast-how-dna-synthesis-is-powering-the-fourth-manufacturing-revolution https://www.synbiobeta.com/read/biomanufacturing-and-bioinformatics-innovator-natures-toolbox-raises-13m-in-series-a-funding-round https://www.synbiobeta.com/read/what-squirrels-can-teach-us-about-why-when-and-how-to-use-gene-drives https://www.synbiobeta.com/read/agragene-raises-1-2-million-in-seed-round-financing-from-ospraie-ag-science https://www.synbiobeta.com/read/how-industrial-enzymes-have-changed-your-life-in-more-ways-than-you-know https://www.synbiobeta.com/read/evonetix-raises-30-million-usd-ps23-million-gbp https://www.synbiobeta.com/read/will-synthetic-biology-be-in-the-toolbox-of-bps-new-climate-neutral-ceo https://www.synbiobeta.com/read/the-new-space-race-meet-the-investors-building-a-new-space-settlement-industry https://www.synbiobeta.com/read/dna-script-presents-new-data-demonstrating-the-feasibility-of-the-companys-enzymatic-synthesis-technology https://www.synbiobeta.com/read/researchers-worldwide-are-using-berkeley-lights-beacon-platform-to-combat-covid-19 https://www.synbiobeta.com/read/cepheid-and-sherlock-biosciences-establish-collaboration-on-new-genexpert-tests-for-infectious-diseases-and-oncology-leveraging-crispr-technology https://www.synbiobeta.com/read/deinove-expands-its-range-of-cosmetic-active-ingredients https://www.synbiobeta.com/read/caribou-biosciences-and-promab-biotechnologies-announce-sale-and-assignment-agreement-for-humanized-scfv-targeting-bcma https://www.synbiobeta.com/read/sgi-dna-equipping-researchers-with-critical-tools-to-combat-coronavirus-disease-covid-2019 https://www.synbiobeta.com/read/idt-launches-xgen-prism-dna-library-prep-kit https://www.synbiobeta.com/read/adisseo-and-calysta-establish-a-joint-venture-to-commercialize-feedkind-r-an-innovative-feed-solution-for-aquaculture https://www.synbiobeta.com/read/twist-bioscience-announces-pricing-of-upsized-130-0-million-public-offering-of-common-stock https://www.synbiobeta.com/read/goodwin-launches-new-initiative-to-support-emerging-life-sciences-ecosystem https://www.synbiobeta.com/read/as-coronavirus-spreads-house-bound-chinese-students-are-causing-an-online-ed-tech-boom https://www.synbiobeta.com/read/bio-nylon-is-the-new-green-how-one-company-is-fermenting-a-10-billion-market https://www.synbiobeta.com/read/xenetic-biosciences-inc-strengthens-expertise-to-advance-xcart-development-program-with-appointment-of-cell-therapy-expert-maksim-mamonkin-ph-d-to-scientific-advisory-board https://www.synbiobeta.com/read/sphere-fluidics-expands-commercial-operations-to-increase-supply-of-pico-surf-surfactant-for-droplet-microfluidics https://www.synbiobeta.com/read/cibus-achieves-critical-milestones-for-two-new-gene-edited-traits-that-increase-productivity-for-rice-farmers https://www.synbiobeta.com/read/beam-therapeutics-announces-multiple-scientific-advances-in-its-base-editing-technology-platforms https://www.synbiobeta.com/read/twist-bioscience-market-cap-up-18-to-1-1b-on-settlement-of-legal-dispute-with-agilent-2 https://www.synbiobeta.com/read/indiebios-class-nine-archetypes-of-engineering-biology https://www.synbiobeta.com/read/beam-therapeutics-announces-closing-of-initial-public-offering https://www.synbiobeta.com/read/synthetic-biology-is-shaking-up-these-5-industries-some-of-them-might-surprise-you https://www.synbiobeta.com/read/bayer-meiogenix-collaborate-to-accelerate-agricultural-innovation-through-the-development-of-unique-technologies https://www.synbiobeta.com/read/twist-bioscience-market-cap-up-18-to-1-1b-on-settlement-of-legal-dispute-with-agilent https://www.synbiobeta.com/read/the-synthetic-biology-companies-racing-to-fight-coronavirus https://www.synbiobeta.com/read/chinas-plan-to-beat-the-u-s-in-the-trillion-dollar-global-bioeconomy https://www.synbiobeta.com/read/how-asias-smartest-businessman-plans-to-power-a-clean-planet-with-synthetic-biology https://www.synbiobeta.com/read/aemetis-awarded-4-1-million-grant-for-biogas-upgrading-unit-to-produce-pipeline-quality-renewable-natural-gas https://www.synbiobeta.com/read/precigen-completes-series-of-transactions-to-solidify-healthcare-focus https://www.synbiobeta.com/read/sgi-dna-launches-vmax-tm-x2-the-most-innovative-product-in-the-competent-cells-market-since-the-discovery-of-e-coli https://www.synbiobeta.com/read/carbios-enters-joint-development-agreement-with-novozymes-to-produce-its-proprietary-enzyme-for-complete-recycling-of-pet-plastics-and-fibers https://www.synbiobeta.com/read/mammoth-biosciences-raises-45-million-to-build-next-generation-crispr-products-for-therapeutics-and-diagnostics https://www.synbiobeta.com/read/synlogic-appoints-dr-michael-burgess-to-its-board-of-directors https://www.synbiobeta.com/read/motif-foodworks-partners-with-the-university-of-massachusetts-amherst-to-optimize-formulation-processes-for-plant-based-food-proteins https://www.synbiobeta.com/read/abcellera-is-mobilizing-a-response-to-the-novel-coronavirus-outbreak-as-part-of-its-darpa-p3-program https://www.synbiobeta.com/read/the-crispr-platform-for-next-generation-therapeutics-and-diagnostics https://www.synbiobeta.com/read/arbor-biosciences-and-lgc-biosearch-technologies-partner-on-marker-discovery-and-genotyping-in-agrigenomics https://www.synbiobeta.com/read/inovio-selected-by-cepi-to-develop-vaccine-against-new-coronavirus https://www.synbiobeta.com/read/genomatica-hits-industry-first-milestone-in-nylon-sustainability https://www.synbiobeta.com/read/partnership-between-locus-ag-and-nori-sets-the-stage-for-monetizing-carbon-farming https://www.synbiobeta.com/read/berkeley-lights-launches-culture-station-to-increase-capacity-of-its-beacon-r-and-lightning-tm-optofluidic-platforms https://www.synbiobeta.com/read/correcting-and-replacing-idt-offers-preferred-pricing-and-early-access-to-complete-portfolio-of-coronavirus-research-tools https://www.synbiobeta.com/read/on-india-trade-mission-california-lt-gov-eleni-kounalakis-seeks-to-grow-the-economy-and-protect-the-environment https://www.synbiobeta.com/read/opening-up-the-world-of-automation-with-opentrons-the-evolution-of-automation-adoption-in-biology https://www.synbiobeta.com/read/an-interview-with-ginkgo-bioworks-reshma-shetty-on-co-founding-synthetic-biologys-first-unicorn https://www.synbiobeta.com/read/opentrons-and-swift-launch-plug-play-ngs-library-preparation-automation-workstation https://www.synbiobeta.com/read/twist-bioscience-announces-completion-of-50-million-registered-direct-offering-priced-at-the-market https://www.synbiobeta.com/read/benchling-unifies-hardware-with-software-to-maximize-lab-automation-investments https://www.synbiobeta.com/read/beam-therapeutics-promotes-giuseppe-ciaramella-ph-d-to-president-and-chief-scientific-officer https://www.synbiobeta.com/read/microvi-signs-contract-to-bring-clean-drinking-water-to-rural-communities-in-california https://www.synbiobeta.com/read/the-future-of-agriculture-the-convergence-of-tech-and-bio-bringing-better-food-to-market https://www.synbiobeta.com/read/free-labxchange-science-education-accelerator-launched-by-amgen-foundation-and-harvards-faculty-of-arts-and-sciences https://www.synbiobeta.com/read/berkeley-lights-launches-next-generation-b-cell-workflow-to-accelerate-therapeutic-antibody-discovery https://www.synbiobeta.com/read/ebsco-information-services-partners-with-protocols-io-investing-in-open-and-reproducible-research https://www.synbiobeta.com/read/biotech-2020-and-the-decade-of-the-bioeconomy https://www.synbiobeta.com/read/the-american-bioeconomy-ian-watson-at-synbiobeta-2019 https://www.synbiobeta.com/read/algentech-granted-us-patent-for-a-key-genome-editing-technology https://www.synbiobeta.com/read/iarpa-announces-launch-of-the-molecular-information-storage-program https://www.synbiobeta.com/read/ambrx-and-sino-biopharma-announce-collaboration-to-develop-two-next-generation-biologics https://www.synbiobeta.com/read/avidea-technologies-utilizes-genscripts-synthesized-neoantigen-peptides-for-novel-personalized-cancer-vaccine https://www.synbiobeta.com/read/lockheed-martin-is-reprogramming-cells-to-bioproduce-new-materials https://www.synbiobeta.com/read/lygos-acquires-librede-to-accelerate-cannabinoid-production-for-consumer-nutraceutical-and-pharmaceutical-products https://www.synbiobeta.com/read/twist-bioscience-announces-strategic-collaboration-with-schrodinger-for-drug-discovery https://www.synbiobeta.com/read/genscript-and-genopis-enter-into-strategic-partnership-agreement-for-manufacture-service-of-gmp-plasmids https://www.synbiobeta.com/read/twist-bioscience-selected-as-dna-synthesis-provider-for-dna-data-storage-project-under-intelligence-advanced-research-projects-activity-iarpa-molecular-information-storage-mist-program https://www.synbiobeta.com/read/iarpa-funds-team-involving-dna-script-the-broad-institute-and-harvard-university-for-dna-data-storage-research-and-development https://www.synbiobeta.com/read/meissa-vaccines-receives-u-s-fda-fast-track-designation-for-respiratory-syncytial-virus-vaccine-mv-012-968 https://www.synbiobeta.com/read/horizon-discovery-to-provide-access-to-novel-base-editing-technology https://www.synbiobeta.com/read/artisan-bio-announces-global-research-and-discovery-collaboration-agreement-with-takeda-to-develop-next-generation-cell-therapy-products https://www.synbiobeta.com/read/emendo-biotherapeutics-raises-61-million-to-advance-next-generation-genome-editing-therapeutics https://www.synbiobeta.com/read/the-end-of-the-flu-can-we-immunize-the-world-against-a-seasonal-killer https://www.synbiobeta.com/read/new-scientific-advisory-board-adds-70-years-of-r-d-expertise-to-turbines-simulation-first-drug-discovery-mission https://www.synbiobeta.com/read/synthego-adopts-good-manufacturing-practices-for-highest-quality-genome-engineering-for-clinical-applications https://www.synbiobeta.com/read/arbor-biosciences-and-curio-genomics-expand-partnership-to-provide-end-to-end-genomic-solutions-for-plant-research-development https://www.synbiobeta.com/read/biomotiv-and-atomwise-sign-ai-partnership-to-transform-therapeutic-development https://www.synbiobeta.com/read/absci-closes-15-4-m-in-series-d-funding-to-accelerate-growth-and-scale-disruptive-protein-printingtm-technology-announces-exclusive-co-marketing-partnership-with-kbi-biopharma https://www.synbiobeta.com/read/codagenix-raises-20-million-in-series-b-funding-for-continued-development-of-rsv-influenza-and-oncolytic-virus-products https://www.synbiobeta.com/read/kyverna-therapeutics-secures-25-million-series-a-funding-from-key-investors-and-enters-into-strategic-collaboration-with-gilead-sciences https://www.synbiobeta.com/read/evonetix-collaborates-with-imec-to-scale-up-chip-based-technology-production-for-third-generation-dna-synthesis-platform https://www.synbiobeta.com/read/amyris-provides-update-achieves-record-fourth-quarter-2019-product-shipments-clean-beauty-produces-breakout-performance https://www.synbiobeta.com/read/editas-medicine-and-sandhill-therapeutics-inc-announce-collaboration-to-develop-engineered-cell-medicines-to-treat-cancer https://www.synbiobeta.com/read/aspect-biosystems-announces-us-20-million-series-a-financing-to-advance-its-leading-platform-for-3d-bioprinting-of-human-tissue https://www.synbiobeta.com/read/will-concord-be-the-bay-areas-next-tech-hub https://www.synbiobeta.com/read/how-the-cloud-can-solve-life-sciences-big-data-problem https://www.synbiobeta.com/read/bayer-and-azitra-partner-to-harness-the-human-skin-microbiome-as-a-source-for-new-natural-skin-care-products-for-sensitive-and-eczema-prone-skin https://www.synbiobeta.com/read/european-synthetic-biology-company-octarine-receives-funding-to-develop-biosynthetic-platform-for-cannabinoid-and-psilocybin-derivatives https://www.synbiobeta.com/read/codexis-and-nestle-health-science-sign-development-agreement-to-advance-therapeutic-candidate-towards-clinical-studies-and-extend-strategic-collaboration-agreement https://www.synbiobeta.com/read/logicbio-therapeutics-announces-collaboration-with-takeda-to-develop-new-genome-editing-candidate-lb-301-for-the-treatment-of-crigler-najjar-syndrome https://www.synbiobeta.com/read/new-age-meats-raises-2-7m-seed-round-led-by-ff-venture-capital https://www.synbiobeta.com/read/synlogic-outlines-upcoming-milestones-for-clinical-programs-and-unveils-new-preclinical-pipeline-programs https://www.synbiobeta.com/read/eli-lilly-and-company-in-collaboration-with-strateos-inc-launch-remote-controlled-robotic-cloud-lab https://www.synbiobeta.com/read/locus-biosciences-initiates-worlds-first-controlled-clinical-trial-for-a-crispr-enhanced-bacteriophage-therapy https://www.synbiobeta.com/read/the-azitra-approach-treating-disease-targets-with-microbial-darts https://www.synbiobeta.com/read/snipr-biome-strengthens-lead-in-crispr-based-medicines-to-treat-microbiomes https://www.synbiobeta.com/read/novome-biotechnologies-raises-33-million-series-a-financing-and-appoints-blake-wise-as-chief-executive-officer https://www.synbiobeta.com/read/rootpath-raises-11-million-series-a-to-accelerate-clinical-translation-of-its-proprietary-synthetic-immunology-platform https://www.synbiobeta.com/read/debut-biotechnology-closes-2-6m-seed-round-to-bring-continuous-biomanufacturing-of-high-value-molecules-to-pharma https://www.synbiobeta.com/read/precigen-receives-fda-orphan-drug-designation-for-prgn-3006-ultracar-t-tm-in-patients-with-acute-myeloid-leukemia-aml https://www.synbiobeta.com/read/how-aquaculture-innovation-can-save-seafood https://www.synbiobeta.com/read/is-californias-salad-bowl-the-next-silicon-valley https://www.synbiobeta.com/read/with-crispr-prime-gene-therapies-are-one-step-closer-to-curing-millions https://www.synbiobeta.com/read/codexis-announces-license-agreement-with-roche-for-enzyme-used-in-next-generation-sequencing https://www.synbiobeta.com/read/intrexon-to-achieve-175m-cash-goal-appoints-helen-sabzevari-phd-as-new-president-and-ceo-and-will-change-name-to-precigen-to-reflect-healthcare-focus https://www.synbiobeta.com/read/amyris-announces-successful-shipment-of-first-fermentation-derived-cannabinoid-to-lavvan-and-provides-business-updates https://www.synbiobeta.com/read/lodo-therapeutics-names-serial-biotech-entrepreneur-dale-pfost-as-ceo-and-adds-top-industry-veterans-to-leadership-team https://www.synbiobeta.com/read/four-ways-synthetic-biology-can-help-lego-bricks-go-green https://www.synbiobeta.com/read/benchling-more-than-doubles-customer-base-for-the-second-consecutive-year https://www.synbiobeta.com/read/exploring-solutions-to-climate-change-with-synthetic-biology https://www.synbiobeta.com/read/mammoth-biosciences-strengthens-executive-management-with-biotech-veterans-peter-nell-and-ted-tisch https://www.synbiobeta.com/read/berkeley-lights-makes-debut-in-korea-as-samsung-biologics-adopts-the-beacon-r-optofluidic-platform-for-cell-line-development https://www.synbiobeta.com/read/dmc-biotech-total-series-a-fundraising-closes-with-11-3-million https://www.synbiobeta.com/read/cell-free-is-growing-up https://www.synbiobeta.com/read/synbiobetas-most-popular-articles-of-2019 https://www.synbiobeta.com/read/synlogic-bridging-study-data-with-solid-oral-formulation-of-synb1618-a-synthetic-biotic-approach-to-treat-phenylketonuria-demonstrate-improved-tolerability-over-early-liquid-formulation-and-guide-to-next-stage-of-clinical-development https://www.synbiobeta.com/read/genedit-and-editas-medicine-enter-into-exclusive-license-and-collaboration-agreement-for-nanoparticle-gene-therapy-delivery https://www.synbiobeta.com/read/bp-and-arzeda-announce-collaboration-expansion https://www.synbiobeta.com/read/charles-river-announces-strategic-partnership-with-bit-bio-increasing-portfolio-of-translational-drug-discovery-technologies https://www.synbiobeta.com/read/genscript-releases-precision-mutant-library-services-for-drug-development-and-synthetic-biology https://www.synbiobeta.com/read/twist-bioscience-and-pandion-therapeutics-expand-antibody-optimization-collaboration https://www.synbiobeta.com/read/the-microbiology-of-desire-a-microbes-view-of-the-world https://www.synbiobeta.com/read/a-year-in-review-nobel-laureate-frances-arnold-at-synbiobeta-2019 https://www.synbiobeta.com/read/inscripta-raises-125m-in-series-d-financing-to-accelerate-commercialization-of-revolutionary-digital-genome-engineering-platform https://www.synbiobeta.com/read/the-kids-are-alright-synthetic-biologys-training-grounds-now-have-a-twist https://www.synbiobeta.com/read/thermo-fisher-scientific-opens-90-million-viral-vector-manufacturing-site-in-massachusetts https://www.synbiobeta.com/read/codexis-announces-the-publication-with-merck-of-an-efficient-enzymatic-cascade-process-for-synthesis-of-investigational-anti-hiv-agent-islatravir https://www.synbiobeta.com/read/cyrus-biotechnology-and-the-broad-institute-of-mit-and-harvard-launch-multi-target-collaboration-to-develop-optimized-crispr-gene-editing-technology https://www.synbiobeta.com/read/why-people-are-the-cornerstone-for-successful-scale-up https://www.synbiobeta.com/read/ginkgo-bioworks-joins-the-ellen-macarthur-foundations-circular-economy-100-ce100-network https://www.synbiobeta.com/read/prokarium-announces-mhra-acceptance-to-run-phase-i-trial-of-lead-vaccine-against-enteric-fever https://www.synbiobeta.com/read/molecule-maker-arzeda-wants-to-grow-phone-screens-that-wont-scratch https://www.synbiobeta.com/read/synthetic-biology-the-inheritance-of-my-generation https://www.synbiobeta.com/read/cellink-launches-new-bioinks-to-further-strengthen-the-companys-bioink-portfolio https://www.synbiobeta.com/read/pairwise-teams-achieve-key-collaboration-milestones-early-accelerating-product-development https://www.synbiobeta.com/read/manus-bio-facility-to-produce-next-generation-natural-ingredients https://www.synbiobeta.com/read/fermenting-the-future-of-healthy-aging https://www.synbiobeta.com/read/can-synthetic-biology-inspire-the-next-wave-of-ai https://www.synbiobeta.com/read/the-scientist-who-first-showed-us-the-double-helix-a-personal-look-at-rosalind-franklin https://www.synbiobeta.com/read/gore-tex-is-betting-big-on-synthetic-biology https://www.synbiobeta.com/read/caribou-biosciences-announces-new-methods-to-harness-type-i-crispr-cas-systems-for-genome-engineering-in-human-cells https://www.synbiobeta.com/read/sick-of-pesticides-remember-death-in-the-time-of-cholera https://www.synbiobeta.com/read/sgi-dna-launches-gibson-assembly-r-rapidamp-tm-technology-for-its-bioxp-tm-gene-builder https://www.synbiobeta.com/read/novonutrients-joins-chevron-technology-ventures-catalyst-program https://www.synbiobeta.com/read/ask-a-vc https://www.synbiobeta.com/read/former-google-ceo-eric-schmidt-talks-synthetic-biology https://www.synbiobeta.com/read/turbine-secures-eu3-million-eur-seed-fund-to-expand-the-potential-of-simulation-first-drug-discovery https://www.synbiobeta.com/read/innovative-wellness-ingredient-company-purissima-announces-launch https://www.synbiobeta.com/read/x-37-announces-14-5-million-series-a https://www.synbiobeta.com/read/recap-of-the-igem-2019-giant-jamboree https://www.synbiobeta.com/read/raytheon-developing-microscopic-bomb-detector https://www.synbiobeta.com/read/cruelty-free-beauty-products-biodesigned-in-silicon-valley https://www.synbiobeta.com/read/university-of-birmingham-spin-out-secures-ps2m-to-develop-medical-diagnostic-technology https://www.synbiobeta.com/read/building-the-human-spinal-cord-atlas https://www.synbiobeta.com/read/dna-script-to-open-u-s-office-in-south-san-francisco-to-support-commercialization-of-the-companys-industry-leading-enzymatic-synthesis-technology https://www.synbiobeta.com/read/twist-biopharma-implements-genedata-biologics-to-advance-synthetic-biology-driven-antibody-discovery https://www.synbiobeta.com/read/egenesis-announces-100-million-series-b-financing https://www.synbiobeta.com/read/cultured-meat-startup-because-animals-closes-seed-round https://www.synbiobeta.com/read/shape-therapeutics-inc-raises-35-5m-series-a-financing-led-by-nea-and-announces-the-formation-of-a-world-class-scientific-advisory-board-to-advance-a-first-in-class-rna-editing-gene-therapy-platform-focused-on-curing-genetic-diseases https://www.synbiobeta.com/read/connell-delivers-innovative-products-to-customers-with-geltor-distribution-agreement https://www.synbiobeta.com/read/fast-forward-10-years-from-now-what-does-the-crispr-genome-editing-field-look-like-to-you https://www.synbiobeta.com/read/digitizing-biology-and-scaling-precision-medicine-companies-the-role-of-enabling-technology-and-the-right-capital https://www.synbiobeta.com/read/the-cssbi-an-index-tracking-performance-of-the-synthetic-biology-industry https://www.synbiobeta.com/read/better-than-nature-why-fermenting-vanilla-is-good-for-consumers-the-environment-and-the-economy https://www.synbiobeta.com/read/how-neural-nets-will-personalize-medicine-meet-the-startup-thats-changing-how-we-find-new-drugs https://www.synbiobeta.com/read/british-biotech-company-sees-hope-in-reducing-mosquito-borne-diseases-and-deaths-with-gmos https://www.synbiobeta.com/read/beam-therapeutics-announces-collaboration-and-exclusive-license-agreement-with-prime-medicine-for-prime-editing-technology https://www.synbiobeta.com/read/evonetix-expands-facilities-and-relocates-to-central-cambridge-uk https://www.synbiobeta.com/read/tetrascience-secures-investment-from-waters-corporation-joining-floodgate-capital-first-round-underscore-vc-founder-collective-and-y-combinator-in-8m-series-a https://www.synbiobeta.com/read/pioneers-of-cellular-reprogramming-and-cell-therapies-join-bit-bio https://www.synbiobeta.com/read/how-automation-and-machine-learning-help-explore-the-dark-corners-of-the-genome https://www.synbiobeta.com/read/the-medicine-cabinet-of-the-future-if-you-can-imagine-a-drug-this-company-can-make-it https://www.synbiobeta.com/read/forget-the-grow-room-and-the-plant-companies-can-now-brew-cannabis-like-beer https://www.synbiobeta.com/read/if-every-governor-were-like-gavin-newsom-the-bioeconomy-would-be-booming-nationally-here-are-5-reasons-why https://www.synbiobeta.com/read/how-to-spot-a-synthetic-biology-unicorn https://www.synbiobeta.com/read/can-we-redesign-the-modern-city-with-synthetic-biology-could-we-grow-our-houses-instead-of-building-them https://www.synbiobeta.com/read/are-you-trying-to-buy-sustainably-but-discouraged-by-all-the-confusing-words-on-the-product-ingredients-list-you-are-not-alone https://www.synbiobeta.com/read/cars-carbon-and-chlamydomonas-how-these-five-synthetic-biology-companies-will-disrupt-the-automotive-industry https://www.synbiobeta.com/read/with-great-power-comes-great-responsibility-meet-alexander-titus-the-department-of-defenses-head-of-biotechnology https://www.synbiobeta.com/read/gelita-geltor-sign-letter-of-intent-to-commercialize-first-animal-free-biodesigned-collagen-for-dietary-supplements-a-market-with-huge-growth-potential https://www.synbiobeta.com/read/synthego-launches-high-throughput-induced-pluripotent-stem-cell-genome-engineering https://www.synbiobeta.com/read/thermo-fisher-scientific-launches-cell-culture-media-as-first-to-remain-stable-when-stored-at-room-temperature https://www.synbiobeta.com/read/science-exchange-raises-capital-to-advance-innovative-outsourced-r-d-platform-to-drive-biopharma-productivity https://www.synbiobeta.com/read/uki2s-innovate-accelerator-reaches-entrepreneurial-start-ups-in-all-parts-of-the-uk https://www.synbiobeta.com/read/teewinot-announces-availability-of-cannabinol-for-commercial-cannabinoid-market https://www.synbiobeta.com/read/arsenalbio-launches-with-85-million-series-a-financing-to-advance-new-paradigm-to-discover-and-develop-immune-cell-therapies https://www.synbiobeta.com/read/corteva-agriscience-to-create-challenge-grants-to-advance-climate-positive-agriculture https://www.synbiobeta.com/read/crispr-therapeutics-and-ksq-therapeutics-announce-license-agreement-to-advance-companies-respective-cell-therapy-programs-in-oncology https://www.synbiobeta.com/read/editas-medicine-and-askbio-enter-strategic-research-collaboration-to-explore-in-vivo-delivery-of-genome-editing-medicines-to-treat-neurological-diseases https://www.synbiobeta.com/read/codexis-protein-engineering-forum-highlights-progress-and-future-direction-of-the-field https://www.synbiobeta.com/read/andrew-alliance-announces-partnership-with-brooks-life-sciences-enabling-their-consumables-to-be-added-to-its-groundbreaking-onelab-software https://www.synbiobeta.com/read/thought-for-food-launches-the-2019-tff-challenge-calling-on-the-next-generation-of-changemakers-to-create-breakthrough-solutions-for-sustainable-and-inclusive-food-systems https://www.synbiobeta.com/read/azitra-completes-14-million-series-a-financing https://www.synbiobeta.com/read/provivi-r-raises-85m-to-fight-pests-with-pheromones https://www.synbiobeta.com/read/dna-is-the-future-for-data-storage-that-future-is-coming-very-soon https://www.synbiobeta.com/read/watch-kevin-ness-keynote-during-synbiobeta-2019-digital-genome-engineering-unlocking-the-unlimited-potential-of-biology https://www.synbiobeta.com/read/are-we-doing-enough-about-biosecurity-looking-to-tech-and-one-another-for-how-to-protect-human-health-and-prosperity-in-the-bioeconomy https://www.synbiobeta.com/read/how-to-support-women-in-synthetic-biology https://www.synbiobeta.com/read/how-inscriptas-onyx-platform-is-making-creativity-the-biologists-only-limiting-factor https://www.synbiobeta.com/read/basf-and-biomillenia-join-forces-in-microbiome-research-to-promote-healthy-skin https://www.synbiobeta.com/read/top-synthetic-biology-news-from-academic-labs-in-2019 https://www.synbiobeta.com/read/the-good-food-institute-awards-4-5m-to-fill-gaps-in-plant-based-and-cultivated-meat-science-in-2019 https://www.synbiobeta.com/read/korro-bio-launched-to-advance-groundbreaking-new-approach-to-nucleic-acid-editing https://www.synbiobeta.com/read/settling-space-requires-new-ways-of-thinking https://www.synbiobeta.com/read/a-first-timers-take-on-synbiobeta2019-we-can-actually-build-and-are-building-a-better-world https://www.synbiobeta.com/read/here-are-10-emerging-tech-platforms-building-tomorrows-breakthroughs https://www.synbiobeta.com/read/editas-medicine-and-maxcyte-announce-clinical-and-commercial-license-agreement-for-engineered-cell-medicines https://www.synbiobeta.com/read/leading-by-example-how-aquabounty-oxford-biomedica-and-berkeley-lights-have-successfully-brought-products-to-market https://www.synbiobeta.com/read/arbor-biosciencestm-launches-bulk-offerings-of-cell-free-expression-systems https://www.synbiobeta.com/read/conagens-vertical-integration-rapidly-commercializes-unprecedented-flavors-and-fragrances https://www.synbiobeta.com/read/the-structure-of-data-not-dna-will-forge-the-bioeconomy https://www.synbiobeta.com/read/goldwin-x-spiber-x-loaded-boards-joint-research-and-development https://www.synbiobeta.com/read/industrial-microbes-and-opus-12-awarded-1m-to-turn-waste-gas-into-valuable-chemicals https://www.synbiobeta.com/read/basf-strengthens-biotechnology-footprint-to-enter-natural-f-f-ingredients-market https://www.synbiobeta.com/read/renew-biopharma-announces-landmark-patent-in-cannabinoid-biosynthesis-ceo-to-speak-today-at-synbiobeta https://www.synbiobeta.com/read/gibson-assembly-r-advances-field-of-dna-digital-data-storage https://www.synbiobeta.com/read/ginkgo-bioworks-and-berkeley-lights-bring-unprecedented-speed-and-scale-to-synthetic-biology-with-150mm-collaboration https://www.synbiobeta.com/read/inscripta-launches-the-worlds-first-benchtop-platform-for-digital-genome-engineering https://www.synbiobeta.com/read/twist-bioscience-showcases-new-innovation-lab-at-synbiobeta-2019 https://www.synbiobeta.com/read/biomx-presents-in-vivo-data-on-bacteriophage-delivery-to-intra-tumor-bacteria https://www.synbiobeta.com/read/crop-plants-of-the-future-will-fix-nitrogen-using-synthetic-biology https://www.synbiobeta.com/read/molecular-assemblies-announces-12-2-m-series-a-financing-to-advance-enzymatic-dna-synthesis-for-life-sciences-and-data-storage https://www.synbiobeta.com/read/art-meet-bio-bio-meet-art-designing-a-sustainable-future https://www.synbiobeta.com/read/david-h-witte-to-lead-mbp-titan-llc https://www.synbiobeta.com/read/sherlock-biosciences-awarded-contract-from-u-s-defense-threat-reduction-agency-to-support-the-development-of-ultra-fast-ultra-sensitive-diagnostics https://www.synbiobeta.com/read/eric-schmidt-george-church-frances-arnold-to-explore-frontiers-of-tech-and-biology-at-synbiobeta-2019 https://www.synbiobeta.com/read/the-age-of-waste-is-how-our-era-will-be-remembered-these-5-synthetic-biology-companies-are-changing-that https://www.synbiobeta.com/read/with-food-security-becoming-one-of-our-biggest-challenges-for-humankinds-survival-whats-on-the-menu-for-the-9-billion-people-inhabiting-the-world-by-2050 https://www.synbiobeta.com/read/why-this-synthetic-biology-stock-has-doubled-since-ipo https://www.synbiobeta.com/read/genscript-partners-with-harvard-university-to-develop-ultra-safe-cells-resistant-to-natural-viruses https://www.synbiobeta.com/read/dna-spells-tomorrow-how-dna-tech-will-impact-our-world https://www.synbiobeta.com/read/revolutionizing-large-size-dna-amplification-a-q-a-with-oriciro-genomics-seiji-hirasaki https://www.synbiobeta.com/read/can-synthetic-biology-make-insulin-faster-better-and-cheaper https://www.synbiobeta.com/read/nobelist-frances-arnold-is-nudging-nature-to-make-your-world-greener-one-small-evolution-at-a-time https://www.synbiobeta.com/read/youtube-video-whats-your-biostrategy-how-investors-and-business-leaders-can-plan-to-thrive-in-the-coming-bioeconomy https://www.synbiobeta.com/read/heres-a-must-read-before-tonights-party-the-worlds-first-gmo-probiotic-is-here-to-end-all-hangovers-and-it-works https://www.synbiobeta.com/read/modern-meadow-secures-strategic-funding-from-evonik-to-scale-the-next-generation-of-biofabricated-materials https://www.synbiobeta.com/read/synthetic-biology-unicorn-ginkgo-bioworks-raises-an-additional-290-million https://www.synbiobeta.com/read/why-california-leads-the-synthetic-biology-industry-and-how-your-state-can-cash-in-too https://www.synbiobeta.com/read/meet-five-synthetic-biology-companies-using-ai-to-engineer-biology https://www.synbiobeta.com/read/lygos-secures-strategic-investment-from-cj-cheiljedang-to-accelerate-growth-in-bioengineering-industries https://www.synbiobeta.com/read/ginkgo-bioworks-offers-its-cell-programming-platform-to-the-next-generation-of-biotech-startups https://www.synbiobeta.com/read/pasteur-vs-possibility-the-ever-changing-face-of-the-laboratory https://www.synbiobeta.com/read/would-you-buy-a-bag-made-of-mushroom-leather-a-jacket-made-with-spider-silk-the-future-of-the-fashion-industry-is-here-and-its-made-with-biology https://www.synbiobeta.com/read/genome-editing-biotech-edigene-raises-11-m-in-series-pre-b2-financing-and-forms-research-collaboration-to-develop-allogeneic-t-cell-therapeutics-for-cancer https://www.synbiobeta.com/read/arcadia-biosciences-announces-closing-of-10-million-registered-direct-offering-priced-at-the-market https://www.synbiobeta.com/read/your-vegan-diet-and-paper-straws-arent-going-to-save-the-planet-but-these-3-policies-can https://www.synbiobeta.com/read/meet-the-8-tech-titans-investing-in-synthetic-biology https://www.synbiobeta.com/read/boston-tech-investors-launch-petri-accelerator-to-fund-synthetic-biology-entrepreneurs https://www.synbiobeta.com/read/there-is-more-money-in-the-borneo-rainforests-biodiversity-than-in-its-deforestation https://www.synbiobeta.com/read/probiotics-2-0-your-gut-microbiome-is-getting-a-tech-upgrade https://www.synbiobeta.com/read/synthetic-biology-is-disrupting-personal-care-making-it-more-sustainable-and-more-personal https://www.synbiobeta.com/read/synthetic-biology-has-raised-12-4-billion-here-are-five-sectors-it-will-soon-disrupt https://www.synbiobeta.com/read/watch-this-two-minute-synthetic-biology-video-is-a-far-out-vision-of-the-future https://www.synbiobeta.com/read/the-growth-and-bottlenecks-of-synthetic-biology-say-hello-to-berkeley-lights https://www.synbiobeta.com/read/plugging-into-the-immunology-matrix https://www.synbiobeta.com/read/lightcast-discovery-raises-ps1-3m-in-seed-financing-to-expand-pilot-studies https://www.synbiobeta.com/read/minipcr-bio-tm-launches-biobits-tm-system-for-synthetic-biology-and-stem-education https://www.synbiobeta.com/read/new-culture-announces-the-closing-of-its-3-5m-seed-funding-led-by-evolv-ventures https://www.synbiobeta.com/read/synbiobeta-podcast-how-an-artist-becomes-an-investor-and-advisor-to-the-worlds-greatest-technology-companies https://www.synbiobeta.com/read/probiotics-2-0-synthetic-biology-jumps-into-the-human-gut https://www.synbiobeta.com/read/meet-the-company-using-microbes-to-revolutionize-how-we-care-for-our-land-our-animals-and-our-own-selves https://www.synbiobeta.com/read/opentrons-launches-the-worlds-most-fully-affordable-thermocycler https://www.synbiobeta.com/read/sgi-dna-secures-25-million-series-a-financing-to-support-commercial-launch https://www.synbiobeta.com/read/poised-for-growth-how-to-scale-a-microbiome-engineering-company https://www.synbiobeta.com/read/synlogic-announces-appointments-of-new-cmo-head-of-regulatory-affairs-and-cfo-departure https://www.synbiobeta.com/read/inscripta-appoints-jim-lalonde-to-lead-microbial-digital-genome-engineering-business-and-portfolio-strategy https://www.synbiobeta.com/read/lygos-upgrades-technology-capabilities-to-accelerate-microbial-cell-factory-development-timelines https://www.synbiobeta.com/read/gevo-announces-breakthrough-development-of-low-carbon-no-particulate-renewable-diesel https://www.synbiobeta.com/read/bio-inspired-design-working-group https://www.synbiobeta.com/read/spibers-biomaterials-stack-from-new-production-facility-to-fashion-runway https://www.synbiobeta.com/read/synbiobeta-podcast-how-this-household-name-is-beating-climate-change-and-making-great-products https://www.synbiobeta.com/read/the-ingredient-driving-beauty-industry-innovation-biology https://www.synbiobeta.com/read/new-this-ski-season-a-jacket-brewed-from-spider-silk https://www.synbiobeta.com/read/meet-the-synthetic-biology-company-engineering-your-immune-system https://www.synbiobeta.com/read/trade-deal-or-not-china-is-investing-big-in-synthetic-biology https://www.synbiobeta.com/read/engineering-the-future-of-biotherapeutics https://www.synbiobeta.com/read/inscripta-expands-management-team-with-appointment-of-three-senior-bioinformatics-and-computational-biology-experts https://www.synbiobeta.com/read/biomx-announces-in-house-phage-manufacturing-facility https://www.synbiobeta.com/read/webinar-whats-your-biostrategy-how-investors-and-business-leaders-can-plan-to-thrive-in-the-coming-bioeconomy https://www.synbiobeta.com/read/synbiobeta-podcast-the-mycelium-revolution-how-a-mushroom-can-make-food-plastic-and-more https://www.synbiobeta.com/read/making-machine-learning-in-science-an-everyday-reality https://www.synbiobeta.com/read/azitra-inc-appoints-mark-sampson-ph-d-as-chief-scientific-officer https://www.synbiobeta.com/read/cyrus-biotechnology-offers-cryoem-services-based-on-first-in-class-peer-reviewed-rosetta-software-methods https://www.synbiobeta.com/read/the-alliance-for-regenerative-medicine-releases-statement-of-principles-on-genome-editing https://www.synbiobeta.com/read/sgi-dna-launches-multi-tile-assembly-cloning-mtac-application-for-its-bioxp-tm-3200-system https://www.synbiobeta.com/read/sphere-fluidics-introduces-latest-version-of-cyto-mine-studio-software-suite https://www.synbiobeta.com/read/ranomics-launches-q-strands-dna-fragment https://www.synbiobeta.com/read/right-now-right-this-very-minute-is-the-time-to-prepare-for-synbiobeta-2019 https://www.synbiobeta.com/read/sphere-fluidics-expands-into-additional-facility-at-granta-park-in-cambridge-uk https://www.synbiobeta.com/read/pivot-bio-offers-u-s-corn-farmers-an-alternative-to-chemical-nitrogen-fertilizer-announces-2020-sales-season https://www.synbiobeta.com/read/advanced-bionutrition-and-greenlight-biosciences-announce-collaboration https://www.synbiobeta.com/read/biotech-conagen-acquires-production-platform-of-therapeutic-proteins https://www.synbiobeta.com/read/wild-earth-launches-worlds-first-high-protein-meat-free-dog-food-at-superzoo https://www.synbiobeta.com/read/novalis-lifesciences-launches-its-first-life-science-investment-fund-with-85-million https://www.synbiobeta.com/read/crispr-clinical-trials-a-2019-update https://www.synbiobeta.com/read/how-twist-bioscience-doubled-its-stock-price-in-nine-months https://www.synbiobeta.com/read/codexis-doses-first-subjects-in-phase-1a-trial-of-cdx-6114-6115 https://www.synbiobeta.com/read/global-bioenergies-receives-three-additional-fundings-from-the-european-union-further-supporting-its-strategy-of-feedstock-diversification-2 https://www.synbiobeta.com/read/transcriptic-appoints-life-science-industry-veteran-jeff-finer-m-d-ph-d-to-board-of-directors-2 https://www.synbiobeta.com/read/living-colors-biotech-dyes-help-the-textile-industry-go-green-2 https://www.synbiobeta.com/read/turning-the-tide-for-horseshoe-crabs-new-hope-for-an-ancient-species-2 https://www.synbiobeta.com/read/scripps-research-chemist-floyd-romesberg-receives-prestigious-royal-society-of-chemistry-award-2 https://www.synbiobeta.com/read/amsilk-co-founder-thomas-scheibel-named-finalist-for-european-inventor-award-2 https://www.synbiobeta.com/read/ers-genomics-licenses-crispr-cas9-genome-editing-patents-to-evotec-2 https://www.synbiobeta.com/read/synlogic-doses-first-patient-in-phase-1b-2a-trial-of-synb1020-for-treatment-of-hyperammonemia-in-patients-with-cirrhosis-2 https://www.synbiobeta.com/read/neil-goldsmith-joins-unibios-board-of-directors-2 https://www.synbiobeta.com/read/arbor-biotechnologies-discovers-new-crispr-system-utilizing-its-discovery-platform-2 https://www.synbiobeta.com/read/md-anderson-and-berkeley-lights-launch-optera-therapeutics-to-accelerate-development-of-cell-therapies-for-cancer-2 https://www.synbiobeta.com/read/monsanto-and-pairwise-announce-r-d-collaboration-to-accelerate-innovation-in-agriculture-with-gene-editing-2 https://www.synbiobeta.com/read/bio-is-beautiful-an-interview-with-vivid-biology-founder-claudia-stocker-2 https://www.synbiobeta.com/read/synbiobeta-podcast-how-to-spot-a-synthetic-biology-unicorn-with-ali-tamaseb-of-dcvc https://www.synbiobeta.com/read/actobio-therapeutics-tm-receives-ind-green-light-for-new-antigen-specific-immunotherapy-study-aimed-at-improving-celiac-patients-tolerance-of-gluten https://www.synbiobeta.com/read/synlogic-discontinues-development-of-synb1020-to-treat-hyperammonemia https://www.synbiobeta.com/read/yield10-bioscience-expands-research-license-with-bayer-for-evaluation-of-a-novel-c3004-yield-trait-gene-in-soybean https://www.synbiobeta.com/read/carverrs-new-supply-chain-sandbox https://www.synbiobeta.com/read/5-reasons-jeff-bezos-should-bet-big-on-synthetic-biology https://www.synbiobeta.com/read/gene-editing-reborn-a-conversation-with-inscriptas-richard-fox https://www.synbiobeta.com/read/verdeca-receives-usda-approval-of-hb4-r-drought-tolerant-soybeans https://www.synbiobeta.com/read/idt-launches-opools-tm-oligo-pools-the-longest-highest-fidelity-and-ready-to-use-custom-oligo-pools-on-the-market https://www.synbiobeta.com/read/cyrus-biotechnology-significantly-expands-customer-engagement-through-biotherapeutic-partnerships-and-fee-for-service-scientific-consulting https://www.synbiobeta.com/read/motif-ingredients-rebrands-to-motif-foodworks-raises-27-5-million-to-fuel-animal-free-ingredients-r-d https://www.synbiobeta.com/read/agilent-introduces-revolutionary-real-time-cell-analyzer https://www.synbiobeta.com/read/deep-science-ventures-launches-europes-first-venture-building-programme-for-food-agriculture https://www.synbiobeta.com/read/zbiotics-functional-beverage-featuring-the-worlds-first-genetically-engineered-probiotic-now-available https://www.synbiobeta.com/read/conagen-expands-portfolio-beyond-gamma-decalactone-to-20-new-non-gmo-lactones https://www.synbiobeta.com/read/biodesign-here-now-at-the-london-design-festival https://www.synbiobeta.com/read/calling-life-science-innovators-dont-miss-your-chance-for-a-golden-ticket-to-labcentral https://www.synbiobeta.com/read/synbiobeta-podcast-building-indias-synthetic-biology-industry-with-santanu-dasgupta https://www.synbiobeta.com/read/askbio-acquires-synpromics-ltd-and-expands-its-gene-therapy-technology-portfolio https://www.synbiobeta.com/read/dna-data-storage-is-about-to-go-viral https://www.synbiobeta.com/read/start-codon-partners-with-clustermarket-and-science-entrepreneur-club-to-support-life-science-and-healthcare-start-ups https://www.synbiobeta.com/read/corteva-agriscience-to-invest-in-evogenes-agriculture-biologicals-subsidiary-lavie-bio https://www.synbiobeta.com/read/crispr-therapeutics-provides-business-update-and-reports-second-quarter-2019-financial-results https://www.synbiobeta.com/read/gevos-low-carbon-renewable-isobutanol-program-a-success-in-lowering-greenhouse-gas-emissions-in-seattles-fleet-vehicles https://www.synbiobeta.com/read/synthorx-reports-second-quarter-financial-results https://www.synbiobeta.com/read/codexis-reports-second-quarter-2019-financial-results https://www.synbiobeta.com/read/intrexon-reports-second-quarter-and-first-half-2019-financial-results https://www.synbiobeta.com/read/synlogic-reports-second-quarter-2019-financial-results-and-provides-program-updates https://www.synbiobeta.com/read/five-companies-building-the-tools-and-tech-for-humans-to-thrive-off-planet https://www.synbiobeta.com/read/how-fungi-will-give-form-to-the-future-of-food-a-conversation-with-ecovatives-eben-bayer https://www.synbiobeta.com/read/eurofins-genomics-us-expands-gene-synthesis-capabilities-with-acquisition-of-blue-heron-biotech https://www.synbiobeta.com/read/molecular-assemblies-expands-board-of-directors https://www.synbiobeta.com/read/novo-holdings-invests-72-million-in-sustainable-products-leader-lanzatech https://www.synbiobeta.com/read/synbiobeta-podcast-the-role-of-creativity-and-design-in-biotechnology-with-christina-agapakis https://www.synbiobeta.com/read/research-roundup-artificial-cells-respond-to-their-environment-protein-nanowires-and-a-new-crispr-algorithm https://www.synbiobeta.com/read/synthetic-biologys-lego-kit-brought-to-you-by-arzeda-teselagen-twist-bioscience-and-labcyte https://www.synbiobeta.com/read/opentrons-publishes-revolutionary-new-guide-for-adding-automation-to-your-lab https://www.synbiobeta.com/read/twist-bioscience-reports-third-quarter-fiscal-2019-financial-results-and-highlights-commercial-and-operational-progress https://www.synbiobeta.com/read/human-tissue-engineering-company-prellis-biologics-raises-8-7-million-series-a-round-announces-first-animal-transplant-of-its-3d-printed-tissue https://www.synbiobeta.com/read/mammoth-biosciences-awarded-key-patents-for-novel-crispr-diagnostics-methods https://www.synbiobeta.com/read/joyn-bio-joins-the-international-phytobiomes-alliance https://www.synbiobeta.com/read/customem-changes-name-to-puraffinity-and-announces-successful-fundraise-to-accelerate-its-growth https://www.synbiobeta.com/read/gevo-begins-field-trials-to-amplify-soil-carbon-sequestration-using-locus-ag-r-probiotics https://www.synbiobeta.com/read/synbiobeta-podcast-investing-at-the-frontiers-of-life-science-innovation https://www.synbiobeta.com/read/labtwin-partners-with-ca-based-biotech-shared-laboratory-community-and-incubator-bonneville-labs-and-lab-launch-give-biotech-startups-access-to-worlds-first-voice-and-ai-powered-digital-lab-assistant https://www.synbiobeta.com/read/one-lab-in-germany-is-using-robots-to-advance-computer-aided-synthetic-biology https://www.synbiobeta.com/read/sangamo-announces-nature-biotechnology-publication-of-new-strategies-for-optimizing-the-specificity-of-gene-editing-nucleases https://www.synbiobeta.com/read/in-research-news-this-week-smart-cell-therapies-new-base-editing-technology-synthetic-cells-and-more https://www.synbiobeta.com/read/viewpoint-building-a-proactive-culture-around-biosecurity-will-accelerate-biotechnology-not-limit-it https://www.synbiobeta.com/read/animal-free-beef-was-just-a-start-synthetic-biology-is-set-to-bring-us-dairy-egg-products-and-more https://www.synbiobeta.com/read/twist-bioscience-launches-long-oligos-to-fuel-drug-development-dna-data-storage-and-gene-editing-research https://www.synbiobeta.com/read/call-for-bio-belt-ambassadors https://www.synbiobeta.com/read/biosecurity-is-economic-security https://www.synbiobeta.com/read/does-blockchain-have-a-place-in-synthetic-biology https://www.synbiobeta.com/read/reacting-is-no-longer-good-enough-new-who-foresight-unit-aims-to-anticipate-advances-in-life-sciences https://www.synbiobeta.com/read/benchling-raises-34-5m-series-c-to-fuel-life-sciences-r-d https://www.synbiobeta.com/read/twist-bioscience-enhances-dna-storage-capabilities-through-agreement-with-imagene-sa https://www.synbiobeta.com/read/one-year-later-how-far-have-we-come-toward-building-the-business-of-biodesign https://www.synbiobeta.com/read/getting-started-building-synthetic-biology-companies-in-the-us-and-the-uk https://www.synbiobeta.com/read/better-than-disneyland-why-duane-clark-believes-space-habitation-is-something-worth-investing-in https://www.synbiobeta.com/read/how-biomanufacturing-can-make-living-on-mars-a-reality https://www.synbiobeta.com/read/a-game-of-genomes-uk-synthetic-biology-research-centers https://www.synbiobeta.com/read/gmo-doesnt-cut-it-why-synthetic-biology-needs-better-labeling-of-industrial-microbes https://www.synbiobeta.com/read/closing-the-loop-with-computer-aided-biology https://www.synbiobeta.com/read/synthetic-biology-investing-in-an-age-of-open-platforms https://www.synbiobeta.com/read/five-ways-buildings-of-the-future-will-use-biotech-to-become-living-things https://www.synbiobeta.com/read/joyn-bio-and-newleaf-symbiotics-join-forces-in-75m-deal https://www.synbiobeta.com/read/synbiobeta-webinar-crispr-enabled-trackable-engineering-create-bringing-genome-engineering-to-the-bench https://www.synbiobeta.com/read/synthetic-biology-news-from-the-lab-bench-4 https://www.synbiobeta.com/read/ambrx-to-receive-milestone-payment-from-bristol-myers-squibb-for-the-initiation-of-phase-1-clinical-trial-of-a-long-acting-relaxin-derivative https://www.synbiobeta.com/read/milliporesigma-and-broad-institute-announce-crispr-license-framework-to-encourage-innovation https://www.synbiobeta.com/read/evogene-amends-its-collaboration-agreement-with-bayer-to-include-genome-editing-targets https://www.synbiobeta.com/read/how-chemical-sensing-plants-may-help-secure-a-safe-healthy-future https://www.synbiobeta.com/read/these-37-synthetic-biology-companies-raised-1-2b-this-quarter https://www.synbiobeta.com/read/protein-design-101-an-introduction-to-protein-design-for-synthetic-biology-with-alexandre-zanghellini https://www.synbiobeta.com/read/arbor-biosciences-partners-with-curio-genomics-for-analysis-of-iwgsc-wheat-exome https://www.synbiobeta.com/read/tackling-the-future-of-sustainability-at-the-2019-biodesign-challenge-summit https://www.synbiobeta.com/read/cibus-issued-new-patent-for-increasing-efficiency-of-gene-editing-in-plants https://www.synbiobeta.com/read/microgravity-biomedicines-next-frontier https://www.synbiobeta.com/read/synlogic-reports-positive-top-line-data-from-phase-1-2a-study-of-synb1618-in-patients-with-phenylketonuria-and-guides-to-next-phase-of-development https://www.synbiobeta.com/read/university-of-california-granted-u-s-crispr-cas9-patent-related-to-production-of-genetically-modified-cells https://www.synbiobeta.com/read/casebia-highlights-novel-research-in-gene-editing-therapeutics-for-hemophilia-a https://www.synbiobeta.com/read/synthetic-biology-news-from-the-lab-bench-3 https://www.synbiobeta.com/read/rethinking-sustainable-agriculture-creative-solutions-from-unexpected-places https://www.synbiobeta.com/read/braskem-renews-partnership-with-france-based-startup-specializing-in-development-of-microorganisms https://www.synbiobeta.com/read/demetrix-secures-50-million-in-series-a-funding-to-provide-cannabinoids-to-pharmaceutical-supplement-and-consumer-product-companies https://www.synbiobeta.com/read/basf-is-collaborating-with-riffyn-on-white-biotechnology-r-d https://www.synbiobeta.com/read/how-to-tell-your-synthetic-biology-story-with-ben-kellogg-of-bwk-the-synbiobeta-podcast https://www.synbiobeta.com/read/dmc-biotechnologies-inc-announces-first-close-of-10-3m-series-a-financing-led-by-sofinnova-partners https://www.synbiobeta.com/read/arcis-biotechnology-and-opentrons-sign-distribution-agreement https://www.synbiobeta.com/read/synthetic-biology-news-from-the-lab-bench-2 https://www.synbiobeta.com/read/company-accelerates-the-development-of-new-academic-labs https://www.synbiobeta.com/read/synthetic-biology-gets-a-makeover-with-evonetixs-dna-synthesis-technology https://www.synbiobeta.com/read/cancer-vaccine-firm-oxford-vacmedix-announces-collaboration-innovate-uk-grant https://www.synbiobeta.com/read/dyadic-extends-research-and-development-agreement-with-vtt https://www.synbiobeta.com/read/hiv-eliminated-from-the-genomes-of-living-animals-excision-biotherapeutics-advancing-the-innovation-to-clinical-development https://www.synbiobeta.com/read/your-future-dna-hard-drive-will-use-enzymes https://www.synbiobeta.com/read/how-labgenius-is-scaling-ai-mediated-discovery-through-automation https://www.synbiobeta.com/read/building-dna-on-a-chip-a-novel-approach-to-gene-synthesis https://www.synbiobeta.com/read/crispr-gets-a-transposon-upgrade https://www.synbiobeta.com/read/synthetic-biology-news-from-the-lab-bench-1 https://www.synbiobeta.com/read/vedanta-biosciences-announces-first-patient-enrolled-in-ve416-phase-1b-2-food-allergy-clinical-study https://www.synbiobeta.com/read/actobio-therapeutics-tm-progresses-ag019-to-next-stage-of-a-phase-ib-iia-clinical-study-for-the-treatment-of-type-1-diabetes https://www.synbiobeta.com/read/a-new-toolkit-to-accelerate-ocean-conservation-ocean-genomics-horizon-scan https://www.synbiobeta.com/read/riffyn-hits-enterprise-grade-compliance-and-security-milestones https://www.synbiobeta.com/read/aromyx-corp-closes-3-million-investment-to-grow-its-team-and-continue-development-of-sensory-platform-to-digitally-measure-taste-and-smell https://www.synbiobeta.com/read/how-procter-gamble-is-saving-water-reducing-carbon-emissions-and-eliminating-plastic-use-one-soluble-swatch-at-a-time https://www.synbiobeta.com/read/how-synthetic-biology-is-dyeing-the-future-of-fashion https://www.synbiobeta.com/read/this-design-exchange-consortium-could-accelerate-the-synthetic-biology-industry https://www.synbiobeta.com/read/geltor-ceo-alex-lorestanis-take-on-a-future-shaped-by-biodesigned-products https://www.synbiobeta.com/read/biobright-and-philips-collaborate-on-new-ai-to-improve-the-patient-and-clinician-experience https://www.synbiobeta.com/read/biodesign-here-now-showcases-the-innovators-designing-a-more-sustainable-future-with-biology https://www.synbiobeta.com/read/genscript-launches-enhanced-genbrick-gene-synthesis-service-for-building-synthetic-genomes https://www.synbiobeta.com/read/technology-is-ready-to-confront-climate-change-are-we https://www.synbiobeta.com/read/could-carbon-sequestration-be-the-future-of-agriculture https://www.synbiobeta.com/read/synthetic-biology-for-sustainable-cities https://www.synbiobeta.com/read/why-carbon-recycling-could-be-synthetic-biologys-crowning-achievement https://www.synbiobeta.com/read/john-conway-former-head-of-data-sciences-and-ai-at-astra-zeneca-joins-riffyn-as-chief-commercial-officer https://www.synbiobeta.com/read/pairwise-partners-with-universities-usda-and-psi-to-study-opportunities-for-berry-improvements-through-gene-editing https://www.synbiobeta.com/read/how-can-you-help-shape-u-s-science-over-the-next-decade-here-are-some-big-ideas https://www.synbiobeta.com/read/roadmap-encourages-federal-investment-in-synthetic-biology-research https://www.synbiobeta.com/read/casdin-capital-invests-50-million-in-codexis-to-accelerate-strategic-growth-initiatives https://www.synbiobeta.com/read/inscripta-to-present-first-data-from-its-digital-genome-engineering-technology-at-upcoming-synthetic-biology-conference https://www.synbiobeta.com/read/cannabinoid-fermentation-report https://www.synbiobeta.com/read/ginkgo-bioworks-new-chairman-marijn-dekkers-on-technology-marketing-and-the-synthetic-biology-consumer https://www.synbiobeta.com/read/cpi-to-showcase-results-from-biostreamline-project-developing-novel-biotherapeutics https://www.synbiobeta.com/read/intrexon-corporation-and-surterra-wellness-partner-in-100m-deal-to-advance-commercial-scale-fermentation-based-cannabinoid-production https://www.synbiobeta.com/read/aldevron-now-utilizing-berkeley-lights-beacon-r-platform https://www.synbiobeta.com/read/larry-peck-former-vp-at-autodesk-joins-riffyn-as-vice-president-of-engineering https://www.synbiobeta.com/read/motif-ingredients-appoints-michele-fite-as-chief-commercial-officer https://www.synbiobeta.com/read/senti-biosciences-announces-dr-laurent-fischer-as-new-independent-board-member https://www.synbiobeta.com/read/groundbreaking-pili-leader-in-the-production-of-biotech-dyes-secures-additional-4million-to-accelerate-the-development-of-its-products https://www.synbiobeta.com/read/synlogic-and-ginkgo-bioworks-establish-transformational-platform-collaboration-for-the-accelerated-development-of-novel-synthetic-biotic-tm-medicines https://www.synbiobeta.com/read/synthetic-biology-culture-and-the-stirrings-of-innovation-from-old-japan https://www.synbiobeta.com/read/why-you-should-look-to-tokyo-for-the-cell-free-amplification-of-large-genome-scale-dna https://www.synbiobeta.com/read/arbor-biosciencestm-launches-crispr-based-mitochondrial-dna-depletion-kits https://www.synbiobeta.com/read/berkeley-lights-inc-and-amyris-announce-collaboration-to-speed-testing-of-microbial-strains https://www.synbiobeta.com/read/sphere-fluidics-closes-a-4-8-million-usd-ps3-7-million-funding-round https://www.synbiobeta.com/read/along-came-spiber-how-synthetic-proteins-are-weaving-a-new-era-in-materials https://www.synbiobeta.com/read/riffyn-enters-multi-year-contract-with-novozymes-for-r-d-data-analytics https://www.synbiobeta.com/read/strateos-combines-transcriptic-and-3scan-to-become-premier-drug-discovery-technology-partner-for-the-pharmaceutical-industry https://www.synbiobeta.com/read/riffyn-hits-a-home-run-in-2019 https://www.synbiobeta.com/read/strand-therapeutics-announces-6-million-seed-financing-to-advance-its-programmable-mrna-therapeutics-platform https://www.synbiobeta.com/read/synthego-introduces-the-next-generation-of-crispr-knockout-technology-with-the-gene-knockout-kit-v2 https://www.synbiobeta.com/read/lygos-awarded-2-million-grant-to-develop-artificial-intelligence-and-machine-learning-technologies-to-revive-u-s-biomanufacturing https://www.synbiobeta.com/read/intrexon-announces-advances-in-non-browning-greenvenus-tm-romaine-lettuce https://www.synbiobeta.com/read/oxitec-successfully-completes-first-field-deployment-of-2nd-generation-friendly-tm-aedes-aegypti-technology https://www.synbiobeta.com/read/scientist-com-partners-with-5am-ventures-to-create-an-r-d-marketplace-for-biotech-startups https://www.synbiobeta.com/read/triple-green-threat-why-cannabinoids-are-synbios-next-big-market https://www.synbiobeta.com/read/idt-launches-ultra-high-performance-crispr-cas12a-enzyme https://www.synbiobeta.com/read/conagen-announces-formation-of-scientific-advisory-board https://www.synbiobeta.com/read/international-cannabis-biotii-and-y-combinator-backed-biotech-innovator-to-build-bioworks-foundry https://www.synbiobeta.com/read/research-associate-immunology-indee-labs-berkeley-california https://www.synbiobeta.com/read/a-alpha-bio-receives-gates-foundation-grant-to-develop-drugs-for-infectious-diseases https://www.synbiobeta.com/read/cyrus-biotechnology-integrates-dna-rna-support-into-its-rosetta-based-protein-design-platform https://www.synbiobeta.com/read/riffyn-raises-a-15m-series-b-to-accelerate-its-growth-in-life-sciences-r-d https://www.synbiobeta.com/read/atum-licenses-exclusive-access-to-proprietary-gene-coding-algorithm-for-plant-based-recombinant-protein-expression-to-medicago https://www.synbiobeta.com/read/intellia-therapeutics-names-laura-sepp-lorenzino-ph-d-chief-scientific-officer https://www.synbiobeta.com/read/technology-startup-kytopen-raises-3-6-million-seed-round https://www.synbiobeta.com/read/amyris-announces-the-execution-of-strategic-supply-agreements-with-raizen-the-largest-sugar-producer-in-the-world https://www.synbiobeta.com/read/twist-bioscience-strengthens-board-with-semiconductor-and-storage-expert-nelson-c-chan https://www.synbiobeta.com/read/us-patent-grants-strengthen-snipr-biomes-approach-to-enhance-immunooncology-outcomes-by-microbiome-modulation https://www.synbiobeta.com/read/food-for-thought-what-is-being-vegan-vegetarian-in-the-era-of-cellular-agriculture https://www.synbiobeta.com/read/the-alternative-protein-boom-from-beyond-burger-to-shrimp-feed https://www.synbiobeta.com/read/highres-biosolutions-and-tetrascience-integrate-technology-to-provide-r-d-labs-with-next-generation-lab-automation https://www.synbiobeta.com/read/collaboration-of-four-biotech-companies-showcases-high-throughput-dna-assembly-platform-for-diverse-applications https://www.synbiobeta.com/read/crown-laboratories-acquires-xycrobe-tm-therapeutics-inc-an-innovator-in-skin-microbiome-technology https://www.synbiobeta.com/read/solugen-inc-secures-32-million-in-series-b-funding https://www.synbiobeta.com/read/wild-earth-closes-series-a-with-11-million-from-veginvest-bits-x-bites-vectr-p-o-v-and-m-ventures https://www.synbiobeta.com/read/indee-labs-announces-formation-of-strategic-advisory-board https://www.synbiobeta.com/read/denovium-and-maxygen-enter-into-partnership-in-artificial-intelligence https://www.synbiobeta.com/read/scaling-the-green-tech-revolution-lanzatech-goes-industrial-size https://www.synbiobeta.com/read/a-two-for-one-punch-how-mango-materials-turns-waste-methane-into-biodegradable-materials https://www.synbiobeta.com/read/deinove-is-now-ready-to-start-phase-ii-clinical-trial-for-its-antibiotic-compound-dnv3837 https://www.synbiobeta.com/read/dna-script-raises-38-5-million-in-series-b-financing https://www.synbiobeta.com/read/lonza-chooses-synpromics-novel-inducible-promoter-platform-to-manufacture-biopharmaceuticals https://www.synbiobeta.com/read/renaissance-bioscience-files-pct-patent-application-for-yeast-based-rna-bioactive-molecule-production-and-delivery-technology-platform https://www.synbiobeta.com/read/amyris-to-videocast-its-exclusive-annual-industry-forum-biodisrupt-2019 https://www.synbiobeta.com/read/ginkgo-bioworks-acquires-warp-drive-bios-genome-mining-platform-for-discovery-and-development-of-novel-classes-of-antibiotics https://www.synbiobeta.com/read/codexis-announces-codeevolver-r-technology-transfer-and-license-agreement-with-global-pharmaceutical-leader https://www.synbiobeta.com/read/microvi-mne-treats-ethanol-plant-wastewater-maximizing-water-reuse https://www.synbiobeta.com/read/meet-crisprs-new-small-molecule-inhibitor https://www.synbiobeta.com/read/the-new-kids-on-the-block-first-time-synthetic-biology-investors-focused-on-cleantech https://www.synbiobeta.com/read/indistinguishable-from-magic-meet-berkeley-lights https://www.synbiobeta.com/read/oxford-genetics-and-cell-and-gene-therapy-catapult-collaborate-to-develop-scalable-gene-therapy-manufacturing-processes https://www.synbiobeta.com/read/vedanta-biosciences-closes-extended-45-5-million-series-c-financing https://www.synbiobeta.com/read/agrimetis-r-receives-second-us-patent-to-produce-more-technologically-advanced-safer-tool-against-weeds https://www.synbiobeta.com/read/calysta-and-thai-union-offer-world-first-taste-of-commercial-shrimp-fed-feedkind-protein https://www.synbiobeta.com/read/agilent-announces-unique-portfolio-to-advance-immunotherapy https://www.synbiobeta.com/read/c3j-therapeutics-and-ampliphi-biosciences-announce-successful-completion-of-merger-and-formation-of-bacteriophage-company-armata-pharmaceuticals-inc https://www.synbiobeta.com/read/dowdupont-board-of-directors-approves-corteva-distribution-and-announces-effectiveness-of-form-10-registration-statement-for-corteva https://www.synbiobeta.com/read/londons-synbitech-takes-on-the-challenge-of-building-a-multibillion-dollar-synthetic-biology-industry https://www.synbiobeta.com/read/twist-bioscience-announces-pricing-of-78-8-million-public-offering-of-common-stock https://www.synbiobeta.com/read/the-city-of-seattles-fleet-vehicles-to-use-gevos-renewable-isobutanol-to-lower-greenhouse-gas-emissions https://www.synbiobeta.com/read/how-delicious-beyond-meat-up-163-on-first-day-of-trading https://www.synbiobeta.com/read/how-molecular-assemblies-is-using-enzymatic-dna-to-enable-dna-data-storage https://www.synbiobeta.com/read/yield10-bioscience-signs-exclusive-worldwide-license-with-university-of-missouri-for-advanced-technology-used-to-boost-oil-content-in-crops https://www.synbiobeta.com/read/synthetic-biology-investment-in-the-midwest-topped-the-bay-area-in-q1 https://www.synbiobeta.com/read/twist-bioscience-announces-proposed-public-offering-of-common-stock https://www.synbiobeta.com/read/the-impending-data-storage-crisis-and-how-dna-will-fix-it https://www.synbiobeta.com/read/beam-therapeutics-presents-data-on-multiplex-base-editing-for-engineered-car-t-cells-at-american-society-of-gene-and-cell-therapy-22nd-annual-meeting https://www.synbiobeta.com/read/thermo-fisher-scientific-completes-acquisition-of-brammer-bio https://www.synbiobeta.com/read/genscript-biotech-remd-biotherapeutics-inc-reached-a-strategic-collaboration-to-develop-several-bispecific-antibodies https://www.synbiobeta.com/read/new-england-biolabs-r-launches-myneb-tm-a-first-of-its-kind-voice-activated-digital-lab-assistant-for-alexa https://www.synbiobeta.com/read/the-class-of-2019-five-synthetic-biology-companies-to-watch-this-year https://www.synbiobeta.com/read/betaspace-webinar-series-a-five-year-plan-to-settle-the-solar-system-using-the-mojave-as-an-analog-site https://www.synbiobeta.com/read/ecovia-expands-fermentation-capacity-for-production-of-biobased-ingredients-materials https://www.synbiobeta.com/read/codexis-signs-multi-year-enzyme-supply-and-licensing-agreement-with-tate-lyle-for-the-manufacture-of-tasteva-r-m-stevia-sweetener https://www.synbiobeta.com/read/amyris-announces-closing-of-34-million-private-placement https://www.synbiobeta.com/read/givaudan-to-acquire-cosmetics-business-of-amsilk https://www.synbiobeta.com/read/international-space-station-tests-a-new-approach-to-fight-the-growing-threat-of-antibiotic-resistance https://www.synbiobeta.com/read/biology-unlocked-emerging-applications-of-cell-free-systems https://www.synbiobeta.com/read/microvi-wins-breakthrough-technology-company-of-the-year-at-global-water-awards-in-london https://www.synbiobeta.com/read/idt-and-igem-partnership-helps-young-researchers-break-free-and-innovate-in-synthetic-biology https://www.synbiobeta.com/read/nanocellect-biomedical-begins-distribution-to-europe https://www.synbiobeta.com/read/precigen-opens-gene-and-cell-therapy-manufacturing-facility-in-germantown-maryland https://www.synbiobeta.com/read/codagenix-inc-announces-award-of-1m-us-army-contract-for-continued-development-of-contemporary-balanced-dengue-vaccine https://www.synbiobeta.com/read/twist-bioscience-announces-synthetic-dna-biosecurity-publication-in-frontiers https://www.synbiobeta.com/read/clara-foods-secures-series-b-financing-led-by-ingredion-and-inks-global-commercial-partnership https://www.synbiobeta.com/read/exxonmobil-and-synthetic-genomics-appearing-on-season-2-of-emmy-nominated-tomorrows-world-today https://www.synbiobeta.com/read/navan-closes-seed-funding-round https://www.synbiobeta.com/read/sherlock-biosciences-announces-close-of-series-a-round-with-additional-investment-led-by-northpond-ventures-and-baidu-ventures https://www.synbiobeta.com/read/poseida-therapeutics-raises-142-million-in-series-c-financing https://www.synbiobeta.com/read/start-codon-founded-in-cambridge-uk-to-deliver-premier-life-science-and-healthcare-business-acceleration-program https://www.synbiobeta.com/read/you-can-have-the-green-new-deal-and-your-hamburger-too https://www.synbiobeta.com/read/cb-therapeutics-announces-closing-of-the-latest-round-of-equity-funding-for-scaling-up-biosynthesis-research-and-production https://www.synbiobeta.com/read/synbiobetas-first-green-new-deal-town-hall-sweeping-visions-growing-consensus https://www.synbiobeta.com/read/autolus-announces-closing-of-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-american-depositary-shares https://www.synbiobeta.com/read/biomica-initiates-pre-clinical-studies-in-its-immuno-oncology-program https://www.synbiobeta.com/read/japan-ministry-of-environment-issues-regulatory-policy-guidance-that-would-bring-benefits-of-new-plant-breeding-technologies-to-japans-farmers-food-industry-and-consumers https://www.synbiobeta.com/read/amyris-completes-sale-of-vitamin-e-royalty-to-dsm https://www.synbiobeta.com/read/lygos-appoints-bryce-dille-as-vice-president-of-finance https://www.synbiobeta.com/read/novel-antibiotics-deinove-signs-an-agreement-with-the-institut-pasteur-to-explore-the-potential-of-new-targeted-strains https://www.synbiobeta.com/read/precision-biosciences-announces-dosing-of-first-patient-in-off-the-shelf-car-t-cell-therapy-phase-1-2a-clinical-trial https://www.synbiobeta.com/read/dndi-and-atomwise-collaborate-to-advance-drug-development-using-ai-for-neglected-diseases https://www.synbiobeta.com/read/joyn-bio-opens-new-plant-sciences-facility-to-accelerate-testing-of-engineered-microbes-for-agriculture https://www.synbiobeta.com/read/sumitomo-chemical-and-zymergen-announce-partnership-to-develop-renewable-specialty-materials https://www.synbiobeta.com/read/polartec-and-kraig-biocraft-laboratories-to-bring-first-spider-silk-fabrics-to-the-performance-apparel-market https://www.synbiobeta.com/read/icc-makes-strategic-investment-in-disruptive-biosynthesis-research-cfn-media https://www.synbiobeta.com/read/inari-broadens-plant-breeding-toolkit-through-exclusive-agreement-with-cold-spring-harbor-lab https://www.synbiobeta.com/read/oxitec-signs-new-multi-year-development-agreement-to-apply-2nd-generation-technology-to-control-soybean-looper https://www.synbiobeta.com/read/librede-inc-receives-patent-for-tetrahydrocannabinolic-acid-thca-production-in-yeast https://www.synbiobeta.com/read/checkerspot-raises-13m-series-a-to-produce-biotech-enabled-performance-materials https://www.synbiobeta.com/read/the-best-kept-secret-in-drug-discovery-has-a-twist https://www.synbiobeta.com/read/how-distributed-bio-cso-jake-glanville-is-engineering-the-cell-for-the-21st-century https://www.synbiobeta.com/read/decoding-the-immune-system-cogen-immunemedicines-ceo-jose-carlos-gutierrez-on-changing-the-paradigm-of-antigen-based-therapies https://www.synbiobeta.com/read/dyadic-announces-uplisting-to-the-nasdaq-capital-market https://www.synbiobeta.com/read/edigene-raises-15-million-in-series-b-funding https://www.synbiobeta.com/read/cibus-issued-new-patent-covering-its-gene-editing-technologies-in-plants https://www.synbiobeta.com/read/lonza-launches-gs-piggybac-tm-a-unique-and-versatile-cell-line-engineering-technology https://www.synbiobeta.com/read/molecular-assemblies-receives-honorable-mention-for-fast-companys-2019-world-changing-ideas-awards https://www.synbiobeta.com/read/uconn-researchers-see-promising-early-results-in-drug-discovery-partnership-with-ai-biotech-company https://www.synbiobeta.com/read/rewriting-genomes-to-understand-life https://www.synbiobeta.com/read/a-modern-day-david-and-goliath-how-lygos-ceo-eric-steen-is-tackling-the-petrochemical-industry https://www.synbiobeta.com/read/twist-bioscience-adopts-battelles-threatseq-tm-dna-screening-web-service-for-advanced-biosecurity https://www.synbiobeta.com/read/azitra-receives-ongoing-support-for-its-netherton-development-program-from-the-national-science-foundation-nsf https://www.synbiobeta.com/read/meet-the-25-synthetic-biology-companies-that-raised-652m-this-quarter https://www.synbiobeta.com/read/roosterbio-and-gencure-sign-multiple-agreements-to-advance-regenerative-medicine-startups https://www.synbiobeta.com/read/twist-bioscience-customized-libraries-for-biologics-discovery-highlighted-at-pegs-boston-2019 https://www.synbiobeta.com/read/azitra-demonstrates-feasibility-of-engineering-the-skin-microbiome-to-treat-serious-skin-conditions https://www.synbiobeta.com/read/oxitec-advances-self-limiting-fall-armyworm-control-solution-to-next-phase-of-development https://www.synbiobeta.com/read/genscript-launches-beta-testing-program-for-new-precision-mutant-library-services https://www.synbiobeta.com/read/nohbo-launches-eco-friendly-personal-care-drops-made-with-genomaticas-natural-brontide-butylene-glycol https://www.synbiobeta.com/read/how-culture-biosciences-ceo-will-patrick-is-striving-to-make-running-bioreactors-as-easy-as-running-code-on-a-server https://www.synbiobeta.com/read/making-the-impossible-possible-scaling-from-discovery-to-manufacturing-with-conagen https://www.synbiobeta.com/read/absci-develops-game-changing-12-week-cell-line-optimization-workflow-and-adds-two-new-members-to-its-executive-team https://www.synbiobeta.com/read/synthetic-biology-breaks-out-of-the-cell https://www.synbiobeta.com/read/twist-bioscience-and-lakepharma-form-strategic-collaboration-to-provide-antibody-discovery-and-development-services https://www.synbiobeta.com/read/inscripta-adds-20m-to-its-105m-series-c-to-create-crispr-powered-gene-editing-tools https://www.synbiobeta.com/read/inscripta-completes-20m-expansion-of-series-c-financing-increasing-total-round-to-105-5m https://www.synbiobeta.com/read/intrexon-intensifies-focus-on-healthcare-forms-two-units-and-streamlines-management https://www.synbiobeta.com/read/amfora-licenses-gene-editing-technology https://www.synbiobeta.com/read/genetically-modified-tequila-bacterium-produces-cannabinoids-from-sugar-farmako-applies-for-a-worldwide-patent https://www.synbiobeta.com/read/news-digest-268-mammutys-100m-series-a-and-the-future-of-food https://www.synbiobeta.com/read/c3j-therapeutics-announces-issuance-of-u-s-patent-covering-synthetic-bacteriophage https://www.synbiobeta.com/read/actobio-therapeutics-tm-ceo-pieter-rottiers-on-the-potential-to-cure-disease-with-living-medicines https://www.synbiobeta.com/read/why-now-is-the-time-for-programmable-living-medicines-insights-from-jim-collins-aoife-brennan-and-jason-kelly https://www.synbiobeta.com/read/senti-biosciences-ceo-tim-lu-talks-about-the-challenges-facing-cell-therapies-and-how-we-can-overcome-them https://www.synbiobeta.com/read/synthetic-biologist-wendell-lim-talks-about-using-living-cells-to-raise-the-bar-on-cancer-therapy https://www.synbiobeta.com/read/why-automation-in-space-is-a-critical-investment https://www.synbiobeta.com/read/genscript-launches-single-stranded-dna-service-for-crispr-based-gene-editing https://www.synbiobeta.com/read/covestro-and-genomatica-launch-partnership-for-sustainable-growth https://www.synbiobeta.com/read/synthetic-biologys-latest-unicorn-mammuty-closes-100m-series-a-for-cell-based-meats-from-extinct-animals https://www.synbiobeta.com/read/asimov-selected-by-darpa-to-develop-artificial-intelligence-design-engine-for-synthetic-biology https://www.synbiobeta.com/read/geltor-unveils-first-biodesigned-human-collagen-for-skincare-market https://www.synbiobeta.com/read/meissa-vaccines-closes-3-4-million-financing-to-advance-rsv-vaccine-to-clinic https://www.synbiobeta.com/read/news-digest-267-the-sporting-green-synbio-meets-sports-george-church-35m-for-sherlock-bio https://www.synbiobeta.com/read/how-agritech-will-slow-or-even-reverse-climate-change https://www.synbiobeta.com/read/biotechnology-meets-fashion-and-sports-performance-trends-in-the-apparel-industry https://www.synbiobeta.com/read/can-synthetic-biology-usher-in-the-next-generation-of-anti-doping-measures https://www.synbiobeta.com/read/crispr-superathletes-the-future-of-bioengineered-performance-humans https://www.synbiobeta.com/read/sherlock-biosciences-launches-to-provide-better-faster-and-more-affordable-diagnostic-testing-worldwide-through-engineering-biology https://www.synbiobeta.com/read/deinove-passes-the-first-milestone-of-the-agir-program-and-receives-eu1-5m-from-bpifrance https://www.synbiobeta.com/read/tropic-biosciences-launches-breakthrough-geigs-tm-platform-to-combat-global-crop-protection-challenges-by-combining-gene-editing-and-rnai-technologies https://www.synbiobeta.com/read/news-digest-266-who-owns-crispr-exploring-the-synthetic-biology-ip-landscape-with-mintz-sponsored-by-mintz https://www.synbiobeta.com/read/the-7-rebelbio-companies-making-science-fiction-for-real https://www.synbiobeta.com/read/benson-hill-biosystems-acquires-schillinger-genetics-expanding-high-quality-soybean-options https://www.synbiobeta.com/read/3bar-biologics-and-pivot-bio-help-farmers-increase-crop-productivity-and-decrease-need-for-fertilizer https://www.synbiobeta.com/read/with-the-recent-patent-news-who-owns-crispr-now https://www.synbiobeta.com/read/amyris-finalizes-cannabinoid-development-licensing-and-commercialization-agreement-containing-300-million-of-r-d-and-milestone-payments-and-a-long-term-royalty-stream https://www.synbiobeta.com/read/nature-publishing-group-study-highlights-potential-of-indee-labs-technology-as-an-alternative-to-current-gene-modified-cell-therapy-manufacturing https://www.synbiobeta.com/read/arcadia-biosciences-receives-fda-approval-for-sonova-r-gla-safflower-oil-in-cat-food https://www.synbiobeta.com/read/global-bioenergies-greets-the-french-parliaments-proposal-aiming-to-promote-a-french-bio-jet-fuel-industry https://www.synbiobeta.com/read/how-do-you-make-judgments-about-gm-foods https://www.synbiobeta.com/read/news-digest-265-leading-women-in-synbio-ge-salmon-and-cell-based-foods-leap-regulatory-bounds-synbiobeta-early-bird-ends-friday https://www.synbiobeta.com/read/yield10-bioscience-announces-pricing-of-2-9-million-registered-direct-offering https://www.synbiobeta.com/read/ge-salmons-20-year-upstream-struggle-to-market https://www.synbiobeta.com/read/usda-fda-announcement-brings-cell-based-meat-one-step-closer-to-u-s-supermarkets https://www.synbiobeta.com/read/here-are-the-stories-in-their-own-words-of-five-women-of-synthetic-biology https://www.synbiobeta.com/read/butagaz-and-global-bioenergies-announce-their-first-delivery-of-bio-isobutene-a-bio-sourced-gas-to-the-heracles-winery https://www.synbiobeta.com/read/the-long-view-with-synthetic-biology-ip-veteran-terri-shieh-newton https://www.synbiobeta.com/read/lygos-awarded-three-innovation-research-grants-to-advance-applications-for-its-portfolio-of-sustainable-specialty-biochemicals https://www.synbiobeta.com/read/federal-agencies-release-framework-for-advancing-the-bioeconomy https://www.synbiobeta.com/read/synlogic-announces-achievement-of-milestone-in-collaboration-to-develop-synthetic-biotic-tm-medicines-to-treat-inflammatory-bowel-disease https://www.synbiobeta.com/read/cyrus-biotechnology-announces-release-of-antibody-structure-prediction-software-for-biologics-drug-development-and-discovery https://www.synbiobeta.com/read/new-sentiall-r-co-polymer-platform-from-corbion-to-unlock-value-in-multiple-industries https://www.synbiobeta.com/read/beam-therapeutics-secures-135-million-in-series-b-financing-to-advance-base-editing-platform-and-expand-pipeline-of-precision-genetic-medicines https://www.synbiobeta.com/read/news-digest-264-synbio-startup-playbook-plus-ursheet-parikh-vern-norviel-charlie-silver-janice-chen-sponsored-by-mayfield https://www.synbiobeta.com/read/can-synthetic-biology-help-vanderbilt-university-medical-center-researchers-develop-therapeutic-antibodies-in-only-90-days https://www.synbiobeta.com/read/intrexon-and-surterra-wellness-to-collaborate-on-botticelli-tm-next-generation-plant-propagation-for-cannabis-cultivation https://www.synbiobeta.com/read/the-next-industrial-revolution-computational-biology-bioplatforms https://www.synbiobeta.com/read/procarta-announces-eu1-5-million-investment-for-new-class-of-antibiotics-to-combat-antimicrobial-resistance https://www.synbiobeta.com/read/evogene-announces-establishment-of-ag-biologicals-subsidiary-lavie-bio-ltd https://www.synbiobeta.com/read/joint-venture-to-bring-eversweet-tm-sweeteners-to-market-faster-is-finalized https://www.synbiobeta.com/read/arcadia-biosciences-a-leader-in-advanced-agricultural-breeding-and-gene-optimization-announces-new-business-unit-dedicated-to-cannabis https://www.synbiobeta.com/read/eight-no-nonsense-dos-and-donts-for-your-next-pitch https://www.synbiobeta.com/read/sample-slide-leaf-focus https://www.synbiobeta.com/read/the-four-key-elements-to-scaling-health-it-startups https://www.synbiobeta.com/read/the-ethics-of-democratizing-diagnostics-with-next-gen-crispr https://www.synbiobeta.com/read/finding-a-needle-in-the-cancer-haystack https://www.synbiobeta.com/read/wsgrs-norviel-has-this-ip-advice-for-synthetic-biology-startups https://www.synbiobeta.com/read/introduction-to-synthetic-biology-course https://www.synbiobeta.com/read/news-digest-263-synbio-in-india-ginkgos-90m-new-spin-out-motif-takes-on-food-tech https://www.synbiobeta.com/read/synthego-to-award-1m-in-crispr-tools-to-genome-innovators https://www.synbiobeta.com/read/dna-script-announces-worlds-first-enzymatic-synthesis-of-a-high-purity-200-nucleotide-strand-of-dna https://www.synbiobeta.com/read/ginkgo-bets-on-future-food-tech-with-spin-out-motif-ingredients https://www.synbiobeta.com/read/powering-a-clean-planet-with-synthetic-biology https://www.synbiobeta.com/read/how-one-company-is-using-greenhouse-gas-to-mitigate-world-hunger https://www.synbiobeta.com/read/jugaad-epitomized-a-deep-dive-into-indias-synthetic-biology-scene https://www.synbiobeta.com/read/lygos-partners-with-leading-materials-scientists-at-the-university-of-massachusetts-to-expand-applications-of-its-bio-malonic-tm-acid-product-family https://www.synbiobeta.com/read/news-digest-262-why-2019-is-the-year-of-living-medicines-nestle-codexis-14m-for-phylagen https://www.synbiobeta.com/read/living-medicines-ginkgos-machine-to-disrupt-the-pharma-industry https://www.synbiobeta.com/read/knipbio-earns-gras-green-light-from-fda-for-novel-aquafeed-protein https://www.synbiobeta.com/read/caribou-biosciences-announces-expansion-of-scientific-advisory-board https://www.synbiobeta.com/read/inari-adds-powerful-plant-breeding-tools-through-exclusive-license-to-ucla-epigenetics-patents https://www.synbiobeta.com/read/synlogic-appoints-patricia-n-hurter-ph-d-to-board-of-directors https://www.synbiobeta.com/read/living-medicines-engineering-the-microbiome https://www.synbiobeta.com/read/amyris-is-selected-by-nih-grant-recipient-idri-to-engineer-molecules-for-vaccine-adjuvant-applications https://www.synbiobeta.com/read/codexis-announces-nestle-health-science-exercises-option-for-exclusive-global-license-to-cdx-6114-for-the-management-of-phenylketonuria https://www.synbiobeta.com/read/a-bold-strategy-for-saving-our-world https://www.synbiobeta.com/read/phylagen-secures-14m-to-bring-transparency-to-global-supply-chains-through-microbiome-analytics https://www.synbiobeta.com/read/news-digest-260-digital-biology-newsletter-2-cell-free-webinar-seattles-synbio-protein-design-in-the-cloud-labcytes-acquisition https://www.synbiobeta.com/read/news-digest-261-synthetic-biology-in-china-space-crispr-babies-pivots-field-day-culture-biosciences-5-5m https://www.synbiobeta.com/read/news-digest-259-amsilks-omega-watch-7m-for-lygos-and-sphere-early-bird-ends-tomorrow https://www.synbiobeta.com/read/why-pivot-bios-new-field-data-is-a-boon-for-sustainable-agriculture https://www.synbiobeta.com/read/why-china-is-primed-to-be-the-ultimate-synbio-market https://www.synbiobeta.com/read/culture-biosciences-secures-5-5m-to-pioneer-biomanufacturing-as-a-service https://www.synbiobeta.com/read/ethos-chocolate-a-pro-gmo-chocolate-brand-launches-to-demystify-gmo-farming https://www.synbiobeta.com/read/the-crispr-twins-bioethics-for-the-gene-editing-age https://www.synbiobeta.com/read/codexis-secures-multi-year-technology-upgrade-package-for-its-codeevolver-protein-engineering-platform-license-with-merck https://www.synbiobeta.com/read/global-bioenergies-first-production-of-isobutene-from-wheat-straw-at-demo-scale https://www.synbiobeta.com/read/cibus-launches-new-seed-brand-falco-tm-bringing-change-and-choice-to-north-american-canola-growers https://www.synbiobeta.com/read/twist-bioscience-announces-appointment-of-martin-kunz-as-senior-vice-president-operations https://www.synbiobeta.com/read/idt-backs-innovative-synthetic-biology-start-ups-with-grant-awards https://www.synbiobeta.com/read/amino-labs-and-mindfuel-partner-to-scale-synthetic-biology-stem-education-for-k-12 https://www.synbiobeta.com/read/pivot-bio-proven-outperforms-chemical-fertilizer https://www.synbiobeta.com/read/beckman-coulter-life-sciences-acquires-labcyte-to-expand-laboratory-automation-business https://www.synbiobeta.com/read/seattles-synthetic-biology-space-is-booming-here-are-6-reasons-why https://www.synbiobeta.com/read/why-the-future-of-protein-design-rests-on-cloud-computing-and-machine-learning https://www.synbiobeta.com/read/azitras-clinical-study-of-azt-04-for-cosmetic-use-completes-enrollment https://www.synbiobeta.com/read/syngulon-announces-the-issuance-by-the-uspto-of-a-second-patent-covering-the-use-of-bacteriocin-immunity-for-the-controlled-growth-of-microorganisms https://www.synbiobeta.com/read/how-the-synbio-stack-is-allowing-startups-to-flourish-in-the-land-of-biotech-giants https://www.synbiobeta.com/read/sphere-fluidics-closes-2-million-usd-c-ps1-5-million-gbp-investment-round https://www.synbiobeta.com/read/how-the-damp-lab-is-using-the-synthetic-biology-stack-to-make-research-fast-scalable-and-reproducible https://www.synbiobeta.com/read/building-a-protein-killer-app-with-the-synthetic-biology-wheel https://www.synbiobeta.com/read/gevo-announces-breakthrough-development-of-renewable-isoprene-a-key-chemical-building-block-for-producing-rubber-and-rubber-products https://www.synbiobeta.com/read/dupont-breaks-ground-on-new-european-headquarters-for-industrial-biosciences-in-the-netherlands https://www.synbiobeta.com/read/renaissance-bioscience-corp-partners-with-mitacs-in-a-million-dollar-project-to-test-precision-yeast-based-rnai-technologies-for-environmentally-friendly-agricultural-biopesticides-and-medical-biotherapeutics https://www.synbiobeta.com/read/twist-bioscience-receives-iso-13485-2016-and-9001-2015-certifications-of-its-quality-management-systems-for-ngs-target-enrichment-panels https://www.synbiobeta.com/read/yield10-bioscience-initiates-early-development-program-in-corn-to-evaluate-novel-traits https://www.synbiobeta.com/read/news-digest-258-the-bioautomation-age-green-new-deal-for-synbio-and-bioscience-in-space-sponsored-by-labcyte https://www.synbiobeta.com/read/novonutrients-recruits-biotechnologist-christopher-oakes-as-vice-president-charged-with-business-development-and-product-marketing https://www.synbiobeta.com/read/british-defense-tech-meet-synthetic-spider-silk https://www.synbiobeta.com/read/green-new-deal-town-hall-meeting-february-5 https://www.synbiobeta.com/read/is-there-a-place-for-biologists-in-the-age-of-automation https://www.synbiobeta.com/read/lg-technology-ventures-makes-strategic-investment-in-lygos https://www.synbiobeta.com/read/going-viral-synthetic-biology-and-the-green-new-deal https://www.synbiobeta.com/read/gevo-working-with-san-francisco-international-airport-consortium-to-advance-sustainable-aviation-fuel https://www.synbiobeta.com/read/horizon-discovery-extends-crispr-screening-service-to-primary-human-t-cells https://www.synbiobeta.com/read/crispr-therapeutics-and-probiogen-sign-collaboration-and-license-agreement-to-develop-novel-in-vivo-delivery-technologies https://www.synbiobeta.com/read/editas-medicine-announces-chief-executive-officer-transition https://www.synbiobeta.com/read/yield10-bioscience-reports-encouraging-results-from-2018-field-tests-of-c3003-and-announces-advancement-of-c3003-into-commercial-development-for-canola https://www.synbiobeta.com/read/evonetix-appoints-stephanie-brooking-as-head-of-product-management https://www.synbiobeta.com/read/egenesis-appoints-industry-veteran-paul-sekhri-as-president-and-chief-executive-officer https://www.synbiobeta.com/read/evogene-and-tmg-announce-collaboration-to-develop-nematode-resistant-soybean-through-genome-editing https://www.synbiobeta.com/read/from-fruit-flies-to-boy-scouts-a-brief-history-of-science-in-space https://www.synbiobeta.com/read/precision-biosciences-announces-formation-of-scientific-advisory-board-with-anderson-kantarjian-schinazi-and-turtle https://www.synbiobeta.com/read/why-automated-liquid-handling-is-a-key-technology-for-any-synthetic-biology-company-a-q-a-with-labcytes-chris-grimley https://www.synbiobeta.com/read/news-digest-257-5-hottest-synbio-job-markets-the-top-10-skills-synthetic-biologists-need-now https://www.synbiobeta.com/read/news-digest-256-the-internet-of-synthetic-biology-things-measuring-what-matters-greenlight-biosciences-announces-50m https://www.synbiobeta.com/read/news-digest-255-what-is-the-future-of-dna-synthesis-the-next-generation-of-natural-sweeteners https://www.synbiobeta.com/read/arbor-biosciences-and-the-iwgsc-partner-on-wheat-exome https://www.synbiobeta.com/read/genomatica-produces-the-first-600-tons-of-brontide-natural-butylene-glycol https://www.synbiobeta.com/read/absci-establishes-new-collaboration-with-sanofi https://www.synbiobeta.com/read/inovios-dna-encoded-monoclonal-antibody-dmab-tm-platform-leaps-forward-with-first-in-human-trial https://www.synbiobeta.com/read/solentim-and-atum-announce-technology-collaboration-to-enable-rapid-high-expression-stable-cell-line-development https://www.synbiobeta.com/read/the-five-hottest-synthetic-biology-job-markets-in-the-world https://www.synbiobeta.com/read/the-top-10-skills-synthetic-biologists-will-need-for-2019 https://www.synbiobeta.com/read/why-synthetic-biology-investors-need-to-look-beyond-silicon-valley-and-boston https://www.synbiobeta.com/read/asimov-appoints-synthetic-biology-pioneer-james-j-collins-as-inaugural-member-of-scientific-advisory-board https://www.synbiobeta.com/read/in-synthetic-biology-its-not-only-what-you-measure-but-how-you-share-it https://www.synbiobeta.com/read/greenlight-biosciences-announces-50-million-funding-round https://www.synbiobeta.com/read/sigilon-therapeutics-and-mit-announce-research-collaboration-to-advance-programmable-living-therapeutics-for-serious-chronic-diseases https://www.synbiobeta.com/read/synthetic-biology-and-reproducibility-meet-on-the-internet-of-things https://www.synbiobeta.com/read/twist-bioscience-enhances-genes-product-offering-with-longer-genes-and-offers-access-to-its-application-programming-interface https://www.synbiobeta.com/read/measuring-what-matters-a-q-a-with-agilents-darlene-solomon https://www.synbiobeta.com/read/ampliphi-biosciences-and-c3j-therapeutics-agree-to-merge https://www.synbiobeta.com/read/vertex-and-arbor-biotechnologies-establish-collaboration-to-discover-novel-proteins-to-advance-discovery-of-gene-editing-therapies https://www.synbiobeta.com/read/new-cell-free-expression-system-runs-on-linear-dna https://www.synbiobeta.com/read/berkeley-lights-announces-collaboration-with-university-of-pennsylvania-to-advance-car-t-therapeutics https://www.synbiobeta.com/read/locus-biosciences-enters-a-collaboration-and-license-agreement-with-johnson-johnson-innovation-to-develop-crispr-cas3-bacteriophage-therapeutics https://www.synbiobeta.com/read/sana-biotechnology-launches-focusing-on-engineering-cells-to-create-a-new-class-of-medicines https://www.synbiobeta.com/read/synlogic-progresses-clinical-and-preclinical-pipeline-and-outlines-2019-catalysts https://www.synbiobeta.com/read/vedanta-biosciences-raises-27-million-series-c-financing-to-advance-clinical-pipeline-of-microbiome-derived-product-candidates https://www.synbiobeta.com/read/how-sweet-it-is-the-next-generation-of-natural-zero-calorie-sweeteners https://www.synbiobeta.com/read/the-future-of-dna-synthesis https://www.synbiobeta.com/read/novo-nordisk-purchases-berkeley-lights-beacon-r-optofluidic-platform-for-cell-line-development-and-antibody-discovery https://www.synbiobeta.com/read/zymergen-appoints-jens-peter-clausen-as-senior-vice-president-global-manufacturing https://www.synbiobeta.com/read/news-digest-254-these-98-synthetic-biology-companies-raised-3-8-billion-in-2018 https://www.synbiobeta.com/read/evonetix-establishes-scientific-advisory-board https://www.synbiobeta.com/read/intrexon-and-merck-kgaa-darmstadt-germany-announce-agreement-realizing-precigens-vision-for-full-developmental-autonomy-of-its-car-t-program https://www.synbiobeta.com/read/in-the-first-year-of-release-inscriptas-mad7-crispr-enzyme-is-widely-adopted-by-the-gene-editing-community https://www.synbiobeta.com/read/zymergen-raises-400m-to-deliver-ai-enabled-biology-to-global-bio-based-industry https://www.synbiobeta.com/read/crispr-is-stuck-and-this-company-can-fix-it https://www.synbiobeta.com/read/mission-bio-raises-30m-to-scale-the-first-ever-platform-aimed-at-predicting-and-preventing-cancer-relapse-with-single-cell-genomics https://www.synbiobeta.com/read/these-98-synthetic-biology-companies-raised-3-8-billion-in-2018 https://www.synbiobeta.com/read/intrexon-and-aquabounty-receive-regulatory-exemption-in-development-of-gene-edited-tilapia-for-more-sustainable-production https://www.synbiobeta.com/read/here-are-2018s-top-articles-on-synbiobeta https://www.synbiobeta.com/read/four-synthetic-biology-startups-to-watch-in-2019 https://www.synbiobeta.com/read/cathay-industrial-biotech-invests-an-additional-usd-500-million-to-expand-its-production-capacity-for-new-bio-based-materials https://www.synbiobeta.com/read/synthetic-biology-start-up-colorifix-raises-3m-series-a-round-to-scale-its-revolutionary-textile-dyeing-solution https://www.synbiobeta.com/read/digest-253-1-2-billion-in-1-week-moderna-604m-ipo-zymergen-400m-synthorx-131m-ipo-synthace-25-6m-elemental-machines-9m-genedit-8-5m-our-early-bird-ends-friday https://www.synbiobeta.com/read/biomx-enters-collaboration-with-johnson-johnson-innovation-for-discovery-of-microbiome-based-biomarkers-for-ibd https://www.synbiobeta.com/read/zymergen-announces-400-million-in-series-c-funding-led-by-the-softbank-vision-fund https://www.synbiobeta.com/read/the-ladder-of-proof-how-vcs-see-your-startup https://www.synbiobeta.com/read/computer-aided-biology-pioneer-synthace-secures-25-6-million-in-series-b-funding https://www.synbiobeta.com/read/how-to-win-in-the-bioeconomy-a-peek-at-rob-carlsons-playbook https://www.synbiobeta.com/read/synlogic-expands-capabilities-in-manufacturing-with-the-appointment-of-head-of-technical-operations-and-establishment-of-in-house-production-of-clinical-trial-material-for-its-synthetic-biotictm-medicines https://www.synbiobeta.com/read/knipbio-touts-success-in-comprehensive-rainbow-trout-feed-trial https://www.synbiobeta.com/read/precision-biosciences-and-durham-stem-students-lead-launch-of-first-genome-editing-experiment-into-space https://www.synbiobeta.com/read/amyris-celebrates-launch-of-new-zero-calorie-naturally-derived-sweetener https://www.synbiobeta.com/read/cellink-and-prellis-biologics-inc-sign-partnership-to-commercialize-high-resolution-holographic-bioprinting-technology-for-micro-printing https://www.synbiobeta.com/read/berkeley-lights-launches-plasma-b-cell-antibody-discovery-workflow-on-the-beacon-r-optofluidic-platform https://www.synbiobeta.com/read/intellia-therapeutics-and-novartis-expand-cell-therapy-collaboration-to-pursue-crispr-cas9-based-genome-editing-in-additional-stem-cell-population https://www.synbiobeta.com/read/renmatix-and-gevo-sign-a-joint-development-agreement-to-evaluate-the-commercial-feasibility-of-creating-cellulosic-hydrocarbons-for-global-renewable-jet-fuel-and-gasoline-markets https://www.synbiobeta.com/read/ecovias-azuragel-tm-superabsorbent-awarded-100-usda-certified-biobased-product-label https://www.synbiobeta.com/read/news-digest-252-igem-teams-find-success-with-lab-automation-and-cell-free-expression-tips-for-building-your-biotech-startup-team-12-5-2018 https://www.synbiobeta.com/read/uniqure-incorporates-novel-synthetic-promoter-developed-by-synpromics-in-new-preclinical-target https://www.synbiobeta.com/read/top-tips-for-building-your-biotech-startup-team https://www.synbiobeta.com/read/winning-igem-team-uses-opentrons-to-create-a-3x-faster-chassis-for-genetic-engineering https://www.synbiobeta.com/read/amyris-partners-with-camil-alimentos-to-deliver-zero-calorie-sweetener-made-from-sugarcane-to-brazilian-consumers https://www.synbiobeta.com/read/gevo-technology-mitigates-effects-of-climate-change-identified-in-us-government-report https://www.synbiobeta.com/read/amyris-partners-with-givaudan-to-introduce-a-tabletop-application-for-its-zero-calorie-naturally-sourced-sweetener https://www.synbiobeta.com/read/cell-free-expression-platforms-enable-new-possibilities-at-igem-and-beyond https://www.synbiobeta.com/read/global-bioenergies-receives-letters-of-intent-for-purchases-covering-the-capacity-of-its-first-plant-project-ibn-one-a-joint-venture-with-cristal-union https://www.synbiobeta.com/read/oxitec-transitioning-friendly-tm-self-limiting-mosquitoes-to-2nd-generation-technology-platform-paving-way-to-new-scalability-performance-and-cost-breakthroughs https://www.synbiobeta.com/read/lumen-bioscience-announces-issuance-of-us-patent-for-genetic-modification-of-spirulina https://www.synbiobeta.com/read/news-digest-251-betaspace-the-space-settlement-issue https://www.synbiobeta.com/read/precision-biosciences-receives-fda-authorization-to-initiate-clinical-study-of-gene-edited-cancer-immunotherapy https://www.synbiobeta.com/read/twist-bioscience-appoints-experienced-technology-executive-jan-johannessen-to-board-of-directors https://www.synbiobeta.com/read/space-lab-3-0-imagining-the-future-of-science-in-space https://www.synbiobeta.com/read/farming-on-mars-a-future-for-synthetic-biology-off-earth https://www.synbiobeta.com/read/betaspace-the-innovation-ecosystem-for-our-on-and-off-planet-future https://www.synbiobeta.com/read/moving-to-mars-biomaterials-point-the-way https://www.synbiobeta.com/read/deinove-will-market-a-2nd-proprietary-carotenoid-based-cosmetic-active-ingredient-in-2019 https://www.synbiobeta.com/read/microvi-partners-with-elemental-excelerator-to-bring-clean-water-to-disadvantaged-communities-in-california https://www.synbiobeta.com/read/synthetic-life-made-from-scratch https://www.synbiobeta.com/read/from-brain-prostheses-to-the-3d-brain-ed-boyden-on-the-future-of-neuroscience https://www.synbiobeta.com/read/news-digest-250-p-g-biomaterials-challenge-synthetic-neurobiology-and-more https://www.synbiobeta.com/read/2-million-us-department-of-energy-grant-awarded-for-collaborative-project-to-develop-economical-bio-based-fuel-additive https://www.synbiobeta.com/read/microvi-mne-implemented-at-thames-water-wastewater-treatment-plant-in-uk-to-demonstrate-ammonia-removal-in-cold-temperatures https://www.synbiobeta.com/read/perfect-day-adm-sign-jda-to-jointly-develop-and-commercialize-animal-free-dairy-proteins https://www.synbiobeta.com/read/torrey-pines-investments-i2020-accelerator-to-advance-snap-bios-selective-kinase-inhibitor-platform-for-treatment-of-endodermal-cancers-and-autoimmune-diseases https://www.synbiobeta.com/read/news-digest-248-twists-ipo-indiebios-demo-day-synlogics-new-data-and-ginkgos-de-extinct-scent https://www.synbiobeta.com/read/news-digest-249-neuroscience-and-ai-pivot-and-ginkgo-news https://www.synbiobeta.com/read/news-digest-247-twists-ipo-ginkgos-bioworks4-igems-winners-and-geltors-series-a https://www.synbiobeta.com/read/biobricks-foundation-announces-publication-of-openmta-in-nature-biotechnology https://www.synbiobeta.com/read/five-must-dos-for-potential-biotech-start-ups https://www.synbiobeta.com/read/transcriptic-selected-to-oversee-robotic-cloud-lab-platform-for-lillys-san-diego-biotechnology-center https://www.synbiobeta.com/read/calyxt-and-s-w-seed-company-announce-milestone-in-alfalfa-seed-development-program https://www.synbiobeta.com/read/re-introducing-crispr-the-google-search-of-the-genome https://www.synbiobeta.com/read/mosa-meat-raises-eu7-5m-to-commercialise-cultured-meat https://www.synbiobeta.com/read/agbiome-llc-secures-series-c-funding https://www.synbiobeta.com/read/dna-script-awarded-2-7m-in-innovation-grants-from-bpifrance-total-financing-raised-to-date-is-27m https://www.synbiobeta.com/read/labcyte-to-support-gp-write-project-under-new-agreement-with-center-of-excellence-for-engineering-biology https://www.synbiobeta.com/read/penn-announces-publication-of-clinically-relevant-genome-editing-in-primates-using-precisions-arcus-platform https://www.synbiobeta.com/read/dr-craig-behnke-joins-lumen-bioscience-as-svp-production-and-development https://www.synbiobeta.com/read/evolva-announces-oliver-walker-to-succeed-simon-waddington-as-ceo https://www.synbiobeta.com/read/genscript-to-launch-new-platform-to-save-up-to-a-billion-usd-for-worldwide-research-community https://www.synbiobeta.com/read/synthace-expands-uk-presence-relocates-to-new-white-city-life-sciences-hub https://www.synbiobeta.com/read/codexis-doses-first-subjects-in-phase-1a-trial-of-cdx-6114 https://www.synbiobeta.com/read/global-bioenergies-receives-three-additional-fundings-from-the-european-union-further-supporting-its-strategy-of-feedstock-diversification https://www.synbiobeta.com/read/transcriptic-appoints-life-science-industry-veteran-jeff-finer-m-d-ph-d-to-board-of-directors https://www.synbiobeta.com/read/living-colors-biotech-dyes-help-the-textile-industry-go-green https://www.synbiobeta.com/read/turning-the-tide-for-horseshoe-crabs-new-hope-for-an-ancient-species https://www.synbiobeta.com/read/scripps-research-chemist-floyd-romesberg-receives-prestigious-royal-society-of-chemistry-award https://www.synbiobeta.com/read/amsilk-co-founder-thomas-scheibel-named-finalist-for-european-inventor-award https://www.synbiobeta.com/read/ers-genomics-licenses-crispr-cas9-genome-editing-patents-to-evotec https://www.synbiobeta.com/read/synlogic-doses-first-patient-in-phase-1b-2a-trial-of-synb1020-for-treatment-of-hyperammonemia-in-patients-with-cirrhosis https://www.synbiobeta.com/read/monsanto-and-pairwise-announce-r-d-collaboration-to-accelerate-innovation-in-agriculture-with-gene-editing https://www.synbiobeta.com/read/neil-goldsmith-joins-unibios-board-of-directors https://www.synbiobeta.com/read/arbor-biotechnologies-discovers-new-crispr-system-utilizing-its-discovery-platform https://www.synbiobeta.com/read/md-anderson-and-berkeley-lights-launch-optera-therapeutics-to-accelerate-development-of-cell-therapies-for-cancer https://www.synbiobeta.com/read/bio-is-beautiful-an-interview-with-vivid-biology-founder-claudia-stocker https://www.synbiobeta.com/read/maxygen-relaunches-in-sunnyvale-to-offer-well-established-molecular-breeding-technology-with-new-collaborative-vision https://www.synbiobeta.com/read/the-search-for-high-oleic-oils https://www.synbiobeta.com/read/algiknit-closes-2-2m-seed-round-to-develop-kelp-derived-yarn https://www.synbiobeta.com/read/partnering-with-procter-and-gamble-joining-together-to-change-the-world https://www.synbiobeta.com/read/synthetic-biology-and-the-brain-bryan-johnson-and-ed-boyden-on-the-neobiological-revolution https://www.synbiobeta.com/read/elo-life-systems-launches-australian-subsidiary-in-queensland https://www.synbiobeta.com/read/genomatica-names-viachem-distributor-for-brontide-natural-butylene-glycol-in-north-america https://www.synbiobeta.com/read/kraig-biocraft-laboratories-begins-scale-up-of-second-generation-dragon-silk https://www.synbiobeta.com/read/geneious-prime-released-with-new-functionality-for-streamlining-cloning-workflows https://www.synbiobeta.com/read/ginkgo-bioworks-and-glycosyn-llc-announce-14mm-deal-to-scale-production-of-human-milk-oligosaccharides https://www.synbiobeta.com/read/dna-script-creates-u-s-subsidiary-and-expands-executive-team-in-the-u-s https://www.synbiobeta.com/read/pivot-bio-bayer-announce-research-collaboration-to-enhance-soybean-inoculant https://www.synbiobeta.com/read/synlogic-presents-preclinical-data-from-first-synthetic-biotictm-clinical-candidate-in-immuno-oncology-at-the-society-for-immunotherapy-of-cancers-sitc-33rd-annual-meeting https://www.synbiobeta.com/read/vedanta-biosciences-announces-preclinical-data-on-microbiome-derived-immuno-oncology-candidate https://www.synbiobeta.com/read/can-we-go-carbon-negative https://www.synbiobeta.com/read/ers-genomics-licenses-crispr-gene-editing-technology-to-definigen-to-develop-human-cell-models-to-support-the-preclinical-development-of-therapeutics https://www.synbiobeta.com/read/cyrus-biotechnology-and-openeye-scientific-software-announce-collaboration-and-cheminformatics-integration-to-expedite-new-drug-design-and-development-with-cyrus-bench-platform https://www.synbiobeta.com/read/introducing-element-d-the-latest-addition-to-the-elemental-machines-platform https://www.synbiobeta.com/read/charles-river-and-distributed-bio-enter-exclusive-partnership-to-create-an-integrated-antibody-discovery-and-development-platform https://www.synbiobeta.com/read/training-the-next-synthetic-biologists https://www.synbiobeta.com/read/twist-bioscience-corporation-announces-pricing-of-initial-public-offering https://www.synbiobeta.com/read/a-big-ipo-for-synthetic-biology-twist-rings-the-nasdaq-bell-today https://www.synbiobeta.com/read/engineered-cell-therapies-for-the-21st-century https://www.synbiobeta.com/read/elpis-biomed-human-cell-models-could-potentially-replace-animal-experiments-in-drug-discovery https://www.synbiobeta.com/read/u-s-patent-office-grants-second-charpentier-doudna-patent-covering-crispr-cas9-gene-editing https://www.synbiobeta.com/read/geltor-announces-series-a-funding-from-cultivian-sandbox-ventures https://www.synbiobeta.com/read/news-digest-246-synthego-raises-110m-the-new-culture-of-responsibility-and-re-awakening-the-ag-microbiome https://www.synbiobeta.com/read/deinove-to-collaborate-with-calibr-to-explore-broadly-the-anti-infectious-potentials-of-its-bacterial-collection https://www.synbiobeta.com/read/janssen-biotech-and-touchlight-announce-collaboration https://www.synbiobeta.com/read/intrexon-announces-the-formation-of-bioinformatics-hub-in-munich https://www.synbiobeta.com/read/ginkgo-bioworks-opens-bioworks4-adds-new-tools-for-the-rapid-genetic-engineering-of-mammalian-cells https://www.synbiobeta.com/read/twist-bioscience-adds-ray-tabibiazar-m-d-as-senior-vice-president-corporate-development-and-business-strategy https://www.synbiobeta.com/read/international-student-teams-industry-leaders-executives-and-investors-descend-upon-boston-for-the-igem-giant-jamboree-synthetic-biologys-largest-innovation-event https://www.synbiobeta.com/read/senti-biosciences-announces-dr-gary-lee-as-chief-scientific-officer https://www.synbiobeta.com/read/tweaking-just-a-few-genes-in-wild-plants-can-create-new-food-crops-but-lets-get-the-regulation-right https://www.synbiobeta.com/read/synthetic-biology-investors-are-a-mix-of-life-sciences-and-traditional-technology-investors https://www.synbiobeta.com/read/1k-gene-therapy-is-one-step-closer-with-synthegos-110m-funding-round https://www.synbiobeta.com/read/synthego-receives-110m-in-funding-to-accelerate-global-access-to-genome-engineering https://www.synbiobeta.com/read/riffyn-wins-pistoia-alliance-presidents-startup-challenge-2018 https://www.synbiobeta.com/read/synpromics-promoter-technology-moves-closer-to-the-clinic https://www.synbiobeta.com/read/amyris-successfully-producing-its-new-zero-calorie-natural-sweetener-at-industrial-scale https://www.synbiobeta.com/read/news-digest-245-berkeley-lights-raises-95-million-a-new-openmta-for-synthetic-biology-and-more https://www.synbiobeta.com/read/news-digest-244-a-clash-of-tech-titans-and-the-first-nobel-for-synthetic-biology-plus-meet-staph-epidermidis-sponsored-by-conagen https://www.synbiobeta.com/read/op-ed-synthetic-biology-and-the-new-culture-of-responsibility https://www.synbiobeta.com/read/dmc-biotechnologies-inc-announces-that-breakthrough-energy-ventures-bev-has-joined-capricorn-venture-partners-in-participating-in-their-series-seed-round https://www.synbiobeta.com/read/pivot-bio-re-awakening-the-agricultural-microbiome https://www.synbiobeta.com/read/labcyte-introduces-the-echo-650-and-655-liquid-handlers https://www.synbiobeta.com/read/synpromics-unveils-next-generation-liver-selective-and-tunable-promoter-platform https://www.synbiobeta.com/read/selexis-and-berkeley-lights-collaborate-to-accelerate-cell-line-development-with-the-beacon-optofluidic-platform https://www.synbiobeta.com/read/the-economist-intelligence-unit-and-corteva-agriscience-tm-agriculture-division-of-dowdupont-release-2018-global-food-security-index-findings https://www.synbiobeta.com/read/let-your-kid-be-a-hero-a-genetic-engineering-hero https://www.synbiobeta.com/read/oxitec-to-develop-2nd-friendly-tm-mosquito-strain-designed-to-combat-malaria-spreading-mosquitoes https://www.synbiobeta.com/read/ampliphi-biosciences-announces-pricing-of-6-6-million-underwritten-public-offering https://www.synbiobeta.com/read/ers-genomics-and-syngulon-sign-license-agreement-on-crispr-cas9-genome-editing-patents-for-industrial-applications https://www.synbiobeta.com/read/inovios-ebola-vaccine-provides-100-protection-and-elicits-long-lasting-immune-responses-in-preclinical-studies https://www.synbiobeta.com/read/berkeley-lights-closes-95-million-funding-round-to-expedite-commercial-expansion-and-platform-development-for-cell-therapy https://www.synbiobeta.com/read/canopy-biosciences-announces-catalog-of-genetically-engineered-cell-lines-and-lysates https://www.synbiobeta.com/read/evonetix-wins-best-emerging-synthetic-biology-company-at-the-obn-awards https://www.synbiobeta.com/read/biobricks-foundation-announces-openmta-in-nature-biotech https://www.synbiobeta.com/read/mars-taps-benson-hills-crop-design-platform-to-help-protect-cacao-from-climate-change https://www.synbiobeta.com/read/organic-farming-with-gene-editing-an-oxymoron-or-a-tool-for-sustainable-agriculture https://www.synbiobeta.com/read/perkinelmer-launches-asset-genius-tm-system-for-remote-laboratory-monitoring https://www.synbiobeta.com/read/a-clash-of-titans-diy-bio-met-the-homebrew-computer-club-at-synbiobeta-2018 https://www.synbiobeta.com/read/global-bioenergies-reaches-87-of-yield-target-in-isobutene-process https://www.synbiobeta.com/read/meet-staph-epidermidis-gatekeeper-of-healthy-skin https://www.synbiobeta.com/read/news-digest-243-synbiobeta-day-3-twist-86-3m-ipo-pivot-bios-70m-genomaticas-90m https://www.synbiobeta.com/read/news-digest-242-download-our-program-guide-sutros-ipo-14-awesome-workshops-sponsored-by-synthego https://www.synbiobeta.com/read/news-digest-241-targeting-breast-cancer-with-crispr-the-new-neuro-scaling-up-industrial-fermentation-and-more-sponsored-by-twist-bioscience https://www.synbiobeta.com/read/highlights-of-synbiobeta-2018-day-3-twist-86-3m-ipo-pivot-bios-70m-genomaticas-90m https://www.synbiobeta.com/read/highlights-of-synbiobeta-day-2-neobiological-revolution-bio-is-not-another-app-living-medicines-and-biosecurity https://www.synbiobeta.com/read/highlights-of-day-1-of-synbiobeta-2018-mushroom-stage-the-homebrew-computer-club-meets-diybio-engineering-biology-awards https://www.synbiobeta.com/read/a-nobel-prize-for-evolutionary-biology https://www.synbiobeta.com/read/twist-bioscience-files-for-86-3m-ipo https://www.synbiobeta.com/read/dna-script-announces-worlds-first-enzymatic-synthesis-of-a-high-purity-150-nucleotide-strand-of-dna https://www.synbiobeta.com/read/ecovative-announces-mycoflex-tm-the-next-generation-mycelium-biofabrication-platform https://www.synbiobeta.com/read/arzeda-and-bp-sign-collaborative-joint-development-agreement https://www.synbiobeta.com/read/pivot-bio-closes-70-million-series-b-financing-to-deliver-first-and-only-clean-alternative-to-synthetic-nitrogen-fertilizer-for-u-s-corn-farmers https://www.synbiobeta.com/read/evonetix-partner-with-lionix-international-to-enable-dna-synthesis-at-scale https://www.synbiobeta.com/read/platelet-biogenesis-and-scaled-biolabs-to-collaborate-to-optimize-platelet-production-platform https://www.synbiobeta.com/read/synthace-launches-ground-breaking-new-whitepaper-computer-aided-biology-delivering-biotechnology-in-the-21st-century https://www.synbiobeta.com/read/technology-roadmap-poised-to-revolutionize-discovery-at-the-intersection-of-semiconductors-and-synthetic-biology https://www.synbiobeta.com/read/riffyn-launches-open-access-for-scientists-at-non-profits https://www.synbiobeta.com/read/arzeda-leverages-scalable-synthetic-biology-resources-to-drive-computational-protein-design-platform https://www.synbiobeta.com/read/marilene-pavan-to-speak-at-synbiobeta-2018 https://www.synbiobeta.com/read/twb-contributes-to-the-development-of-synthetic-biology-in-france https://www.synbiobeta.com/read/cambridge-consultants-and-catalog-reveal-plans-for-scalable-dna-data-encoding-machine https://www.synbiobeta.com/read/synbicite-launches-new-five-year-strategy https://www.synbiobeta.com/read/bio-platforms-the-future-of-innovation-and-collaboration https://www.synbiobeta.com/read/genomatica-completes-90-million-financing-to-drive-technologies-for-more-sustainable-everyday-products https://www.synbiobeta.com/read/brooks-automation-steps-further-into-the-life-sciences-through-its-recent-acquisition-of-genewiz https://www.synbiobeta.com/read/battery-ventures-acquires-ttp-labtech-limited-global-leader-in-liquid-handling-sample-management-technologies https://www.synbiobeta.com/read/protect-the-ocean-applying-synthetic-biology-based-on-systems-thinking https://www.synbiobeta.com/read/the-arch-mission-foundation-announces-digital-data-stored-in-dna-added-to-lunar-library-tm-creating-groundbreaking-archive-of-knowledge-on-the-moon https://www.synbiobeta.com/read/amyris-enters-into-extensive-collaboration-agreement-with-leading-chinese-pharmaceutical-company-yifan-pharmaceutical-co-ltd https://www.synbiobeta.com/read/touchlight-genetics-synthesizing-the-dna-of-the-future https://www.synbiobeta.com/read/vonnie-estes-named-pma-vice-president-of-technology https://www.synbiobeta.com/read/how-crispr-is-fighting-breast-cancer https://www.synbiobeta.com/read/the-fourth-annual-engineering-biology-awards-recognize-excellence-in-the-synthetic-biology-industry-at-synbiobeta-2018 https://www.synbiobeta.com/read/news-digest-240-how-these-synbio-startups-are-transforming-agriculture-making-dna-at-scale-and-more-sponsored-by-codexis https://www.synbiobeta.com/read/news-digest-239-synbiobeta-awards-live-at-10am-biopharma-and-synthetic-biology-sponsored-by-mayfield-fund https://www.synbiobeta.com/read/how-one-company-is-revolutionizing-fermentation-from-design-to-industrial-production https://www.synbiobeta.com/read/on-solving-the-brain-ed-boyden-and-the-new-neuroscience https://www.synbiobeta.com/read/calyxt-appoints-ceo-jim-blome-former-president-ceo-of-bayer-cropscience-lp https://www.synbiobeta.com/read/intrexon-announces-advances-in-production-of-medical-cannabis https://www.synbiobeta.com/read/scotland-makes-its-mark-in-mammalian-synthetic-biology https://www.synbiobeta.com/read/discovering-detectr-the-crispr-based-platform-for-disease-detection https://www.synbiobeta.com/read/bristol-based-company-breaks-records-for-a-uk-biodesign-exit https://www.synbiobeta.com/read/how-this-synbio-startup-is-transforming-agriculture-feeding-the-world-and-cleaning-up-the-planet https://www.synbiobeta.com/read/how-manchesters-synbiochem-is-harnessing-the-power-of-synthetic-biology-to-scale-up-the-production-of-chemicals-and-materials https://www.synbiobeta.com/read/steve-wozniak-vs-george-church-the-original-homebrew-computer-club-meets-diybio https://www.synbiobeta.com/read/thermo-fisher-scientific-releases-gene-synthesis-and-genome-editing-products-in-china https://www.synbiobeta.com/read/how-one-company-is-empowering-synthetic-biology-by-making-high-fidelity-dna-at-scale https://www.synbiobeta.com/read/variantfind-tm-by-ranomics-announces-distribution-agreement-with-axil-scientific https://www.synbiobeta.com/read/asilomar-bio-rebrands-as-sound-agriculture https://www.synbiobeta.com/read/maxygen-appoints-steven-b-riedmuller-as-chief-executive-officer https://www.synbiobeta.com/read/thermo-fisher-scientific-expands-genome-editing-ip-portfolio https://www.synbiobeta.com/read/building-synthetic-biology-companies-at-scale-practical-advice-from-seasoned-investors-and-entrepreneurs https://www.synbiobeta.com/read/ecovia-renewables-awarded-500-000-phase-iib-nsf-grant-to-develop-high-performing-and-eco-friendly-superabsorbent-biopolymers https://www.synbiobeta.com/read/inovio-develops-novel-h3n2-influenza-dna-vaccine-that-generates-cross-reactive-responses-and-provides-complete-protection-against-lethal-preclinical-challenges https://www.synbiobeta.com/read/biobright-and-beckman-coulter-announce-a-strategic-partnership-to-bring-enhanced-technical-support-capabilities-to-instruments https://www.synbiobeta.com/read/evonetix-makes-key-appointments-to-support-development-of-novel-gene-synthesis-technology https://www.synbiobeta.com/read/molecular-assemblies-expands-patent-portfolio-in-enzymatic-dna-synthesis https://www.synbiobeta.com/read/the-challenges-of-big-green-scaling-sustainability-at-procter-gamble https://www.synbiobeta.com/read/atomwise-enters-into-an-evaluation-agreement-with-pfizer https://www.synbiobeta.com/read/crispr-therapeutics-and-viacyte-announce-strategic-collaboration-to-develop-gene-edited-stem-cell-derived-therapy-for-diabetes https://www.synbiobeta.com/read/launching-the-synbiobeta-digital-biology-newsletter-issue-1 https://www.synbiobeta.com/read/news-digest-238-dna-data-storage-synbiobetas-annual-synthetic-biology-investment-report-and-more-sponsored-by-data-collective https://www.synbiobeta.com/read/news-digest-237-airbus-bets-big-on-spider-silk-bolt-threads-new-bag-women-in-synbio-and-more-sponsored-by-ginkgo-bioworks https://www.synbiobeta.com/read/news-digest-236-pivot-bios-nitrogen-producing-microbes-ginkgos-cultured-cannabinoids-and-more-sponsored-by-pivot-bio https://www.synbiobeta.com/read/how-to-make-dna-data-storage-a-commercially-viable-solution-and-bring-physical-data-ownership-back https://www.synbiobeta.com/read/from-magnetic-tape-to-the-dna-hard-drive-entering-the-next-frontier-with-dna-data-storage https://www.synbiobeta.com/read/plant-sensory-systems-receives-notice-of-allowance-from-uspto-for-patent-on-taurine-production https://www.synbiobeta.com/read/gilead-sciences-and-precision-biosciences-announce-collaboration-to-develop-therapies-against-hepatitis-b-virus-using-arcus-genome-editing https://www.synbiobeta.com/read/why-is-global-aeronautics-leader-airbus-partnering-with-synthetic-biology-startup-amsilk https://www.synbiobeta.com/read/amsilk-announces-partnership-with-airbus-to-develop-the-next-generation-of-composite-fibers-for-lightweight-high-performance-planes https://www.synbiobeta.com/read/synvitrobio-rebrands-as-tierra-biosciences-announces-2-6m-seed-round-to-discover-unexplored-areas-of-biology https://www.synbiobeta.com/read/how-uk-taxes-are-fueling-a-new-synthetic-biology-industry https://www.synbiobeta.com/read/doulix-and-sirion-biotech-release-worlds-first-online-adeno-associated-virus-design-and-production-tool https://www.synbiobeta.com/read/why-biotech-is-failing-women-and-how-we-can-do-better https://www.synbiobeta.com/read/the-story-of-synthetic-biology-is-still-being-written-dont-leave-the-women-out-this-time https://www.synbiobeta.com/read/usda-and-fda-announce-joint-public-meeting-on-use-of-animal-cell-culture-technology-to-develop-products-derived-from-livestock-and-poultry https://www.synbiobeta.com/read/knipbio-announces-success-with-third-single-cell-protein-product https://www.synbiobeta.com/read/large-scale-demonstration-of-groundbreaking-wastewater-treatment-technology-shows-full-nitrogen-removal-in-less-than-two-hours https://www.synbiobeta.com/read/yield10-bioscience-reports-promising-seed-yield-results-for-novel-yield-trait-c3004-in-growth-chamber-studies-in-camelina https://www.synbiobeta.com/read/benson-hill-biosystems-raises-60-million-to-improve-food-and-ingredients https://www.synbiobeta.com/read/atum-and-adm-extend-joint-development-agreement https://www.synbiobeta.com/read/inscripta-announces-strategic-acquisition-of-solana-biosciences https://www.synbiobeta.com/read/pvp-biologics-announces-first-in-human-clinical-trials-for-a-novel-therapeutic-for-celiac-disease https://www.synbiobeta.com/read/scale-up-photanol-bv-to-build-demonstration-plant-at-akzonobel-site-in-delfzijl https://www.synbiobeta.com/read/experiment-2-0-reshaping-the-scientific-enterprise-by-rethinking-your-data https://www.synbiobeta.com/read/towards-data-driven-biotechnology https://www.synbiobeta.com/read/precision-biosciences-announces-collaboration-with-university-of-pennsylvania-to-develop-genome-editing-therapeutics https://www.synbiobeta.com/read/cronos-group-and-ginkgo-bioworks-announce-a-landmark-partnership-to-produce-cultured-cannabinoids https://www.synbiobeta.com/read/teewinot-life-sciences-corporation-announced-today-grant-of-a-u-s-patent-with-claims-to-cannabinoid-formulations https://www.synbiobeta.com/read/bluebird-bio-and-gritstone-oncology-announce-strategic-collaboration-to-develop-novel-cancer-cell-therapies https://www.synbiobeta.com/read/synlogic-reports-positive-interim-phase-1-2a-data-demonstrating-safety-tolerability-and-proof-of-mechanism-in-healthy-volunteers-for-synb1618-in-development-for-the-management-of-phenylketonuria-pku https://www.synbiobeta.com/read/news-digest-234-what-are-the-defining-milestones-from-the-last-20-years-of-synthetic-biology-sponsored-by-synbicite https://www.synbiobeta.com/read/news-digest-235-the-lab-is-getting-smarter-cheaper-and-more-agile-free-genes-project-makes-dna-freely-available-to-the-world-sponsored-by-labcyte https://www.synbiobeta.com/read/free-genes-project-makes-dna-freely-available-to-the-world https://www.synbiobeta.com/read/amyris-gets-green-light-for-commercial-sales-of-its-new-natural-zero-calorie-sweetener https://www.synbiobeta.com/read/horizon-discovery-announces-collaboration-with-major-pharmaceutical-company-on-single-cell-rnaseq-linked-crispr-screening https://www.synbiobeta.com/read/nuleaf-launches-equity-crowdfunding-campaign-on-seedinvest https://www.synbiobeta.com/read/aromyx-corp-announces-recruitment-of-top-cell-biology-scientists https://www.synbiobeta.com/read/the-synbio-stack-part-1 https://www.synbiobeta.com/read/news-digest-233-ginkgos-new-creative-resident-data-storage-in-dna-recombinetics-raises-34m-amyris-46m-and-more-sponsored-by-genscript https://www.synbiobeta.com/read/white-dog-labs-announces-remarkable-health-benefits-for-shrimp-aquaculture https://www.synbiobeta.com/read/amyris-announces-successful-closing-of-secondary-offering https://www.synbiobeta.com/read/fair-shares https://www.synbiobeta.com/read/new-crop-innovators-partner-to-unlock-intrinsic-yield-and-sustainability-genes-conserved-within-multiple-crop-species https://www.synbiobeta.com/read/promega-commits-3-million-to-revive-restore-science-fund-supporting-catalytic-research-bridging-biotech-and-conservation https://www.synbiobeta.com/read/the-magnificent-seven-life-science-startups-hitting-london-this-summer https://www.synbiobeta.com/read/molecular-assemblies-announces-first-storage-and-retrieval-of-information-with-enzymatic-dna-synthesis https://www.synbiobeta.com/read/genetically-modified-mosquitoes-may-be-best-weapon-for-curbing-disease-transmission https://www.synbiobeta.com/read/recombinetics-closes-34-million-in-series-a-funding https://www.synbiobeta.com/read/ideas-conversations-and-resident-creativity-an-interview-with-ginkgo-bioworks-christina-agapakis https://www.synbiobeta.com/read/news-digest-232-rewriting-dna-with-enzymatic-synthesis-todays-report-and-webinar-on-chemicals-and-materials-sponsored-by-molecular-assemblies https://www.synbiobeta.com/read/news-digest-231-new-chemicals-and-materials-report-living-medicines-p-g-embraces-the-biobased-future-sponsored-by-p-g https://www.synbiobeta.com/read/molecular-assemblies-rewriting-synthetic-biology-with-enzymatic-dna-synthesis https://www.synbiobeta.com/read/atum-receives-patent-to-expand-and-integrate-transposon-based-technologies-for-protein-pharmaceutical-development https://www.synbiobeta.com/read/correcting-sickle-cell-causing-mutation-with-efficient-crispr-cas9-genome-editing https://www.synbiobeta.com/read/bluenalu-raises-4-5-million-to-launch-cellular-aquaculture https://www.synbiobeta.com/read/living-medicines-accessing-the-cancer-fighting-power-within-your-body https://www.synbiobeta.com/read/synthetic-genomics-announces-changes-to-its-board-of-directors https://www.synbiobeta.com/read/bactevo-announces-addition-to-scientific-advisory-board-and-company-name-change https://www.synbiobeta.com/read/procter-gamble-embraces-the-bio-based-future https://www.synbiobeta.com/read/synlogic-publishes-preclinical-data-supporting-development-of-synb1618-a-synthetic-biotic-tm-medicine-as-a-potential-treatment-for-phenylketonuria https://www.synbiobeta.com/read/teneobio-and-poseida-expand-their-partnership-to-develop-unidabs-tm-for-advanced-car-t-therapies https://www.synbiobeta.com/read/yield10-bioscience-signs-research-license-agreement-covering-crispr-cas9-genome-editing-technology-with-the-broad-institute-and-pioneer https://www.synbiobeta.com/read/inari-secures-40-million-in-series-b-funding-to-expand-its-development-of-transformational-plant-breeding-technologies https://www.synbiobeta.com/read/news-digest-230-opentrons-synbiobetalive-today-pivot-bios-launch-partner-with-p-g-sponsored-by-p-g https://www.synbiobeta.com/read/nsw-health-funds-indee-labs-first-preclinical-study-into-gene-modified-cell-therapy-manufacturing-for-blood-cancer https://www.synbiobeta.com/read/the-assembly-line-of-the-future-automation-dna-construction-and-synthetic-biology https://www.synbiobeta.com/read/uki2s-announces-seed-investment-in-cagen-a-pioneering-synthetic-biology-company-using-protein-nanocages https://www.synbiobeta.com/read/os-fund-raising-250m-to-support-entrepreneurs-building-deep-tech-to-solve-global-problems https://www.synbiobeta.com/read/oxford-genetics-signs-major-supply-and-licensing-agreement-for-crispr-engineered-mammalian-cell-lines https://www.synbiobeta.com/read/pivot-bio-advances-toward-commercial-launch-of-first-sustainable-nitrogen-product https://www.synbiobeta.com/read/azitra-awarded-nih-sbir-grant-to-develop-microbiome-based-therapeutic-for-netherton-syndrome https://www.synbiobeta.com/read/egenesis-announces-global-collaboration-with-qihan-biotech-to-address-global-shortage-of-organs-with-xenotransplantation https://www.synbiobeta.com/read/adding-to-the-microbial-toolbox-optimizing-skin-microbes-to-treat-skin-disease https://www.synbiobeta.com/read/synthace-appoints-susan-shiff-phd-mba-to-board-of-directors https://www.synbiobeta.com/read/news-digest-229-85-4-m-for-sutro-23-m-for-mammoth-biosciences-peter-thiel-wild-earth-crispr-crops-hurdles-and-space-bioprinters-sponsored-by-the-open-philanthropy-project https://www.synbiobeta.com/read/scibac-awarded-up-to-3-76m-by-carb-x-to-develop-hybrid-microbes-as-a-drug-for-c-diff https://www.synbiobeta.com/read/mammoth-biosciences-raises-23-million-led-by-mayfield-to-bring-worlds-first-crispr-based-disease-detection-platform-to-everyday-life https://www.synbiobeta.com/read/sutro-biopharma-announces-85-4-million-series-e-round https://www.synbiobeta.com/read/wild-earth-closes-seed-funding-round-with-450k-investment-from-founders-fund-and-peter-thiel https://www.synbiobeta.com/read/gm-crop-ruling-shows-why-the-eus-laws-are-wholly-inadequate https://www.synbiobeta.com/read/scientist-com-recognized-as-san-diegos-second-fastest-growing-company https://www.synbiobeta.com/read/amyris-biossance-brand-executes-significant-expansion-with-agreement-to-launch-across-all-668-sephora-inside-jcpenney-stores https://www.synbiobeta.com/read/news-digest-228-indiebio-nyc-crispr-diagnostics-5-must-dos-for-biotech-start-ups-opentrons-on-synbiobetalive-sponsored-by-corteva-agriscience https://www.synbiobeta.com/read/how-to-grow-crops-on-mars-if-we-are-to-live-on-the-red-planet https://www.synbiobeta.com/read/doulix-launches-new-dna-assembly-tool-perfect-for-igem-students https://www.synbiobeta.com/read/news-digest-227-meet-azitra-and-the-skin-microbiome-newco-a-alpha-bio-lygos-15-5m-and-inscriptas-new-patents-sponsored-by-azitra https://www.synbiobeta.com/read/locus-biosciences-acquires-epibiomes-high-throughput-discovery-platform-to-enhance-its-global-leadership-in-crispr-engineered-phage-therapeutics https://www.synbiobeta.com/read/codexis-appoints-dr-hicham-alaoui-veteran-drug-discoverer-as-vice-president-biotherapeutics-research-development https://www.synbiobeta.com/read/lygos-raises-15-5-million-to-accelerate-delivery-of-clean-and-sustainable-biology-based-performance-materials https://www.synbiobeta.com/read/investment-fuels-cutting-edge-synthetic-biology-in-uk https://www.synbiobeta.com/read/inscripta-granted-patents-for-crispr-gene-editing-systems https://www.synbiobeta.com/read/your-skin-the-new-frontier-in-microbial-medicine https://www.synbiobeta.com/read/news-digest-226-food-2-0-manus-bios-19-4m-series-a-synthace-expands-uk-presence-and-more https://www.synbiobeta.com/read/butanova-awarded-with-commercial-evaluation-grant https://www.synbiobeta.com/read/vedanta-biosciences-receives-award-from-the-crohns-colitis-foundation-to-advance-a-microbiome-derived-therapeutic-program-for-interception-and-treatment-of-inflammatory-bowel-disease https://www.synbiobeta.com/read/food-2-0-three-companies-that-are-changing-the-way-we-eat https://www.synbiobeta.com/read/gene-drives-accelerate-evolution-but-we-need-brakes https://www.synbiobeta.com/read/news-digest-225-synbio-q2-funding-tops-925m-todays-synbicite-webinar-john-oliver-on-gene-editing https://www.synbiobeta.com/read/these-33-synthetic-biology-companies-just-raised-925-million-read-synbiobetas-2018-q2-funding-update https://www.synbiobeta.com/read/john-oliver-on-gene-editing-stop-freaking-out-and-lets-be-careful https://www.synbiobeta.com/read/manus-bio-raises-19-4-million-series-a-financing-to-accelerate-product-commercialization-and-expands-board-of-directors https://www.synbiobeta.com/read/yield10-bioscience-begins-field-testing-of-novel-yield-trait-gene-c3003-and-novel-trait-gene-c3008-in-oilseed-crops https://www.synbiobeta.com/read/checkerspot-raises-5m-to-bring-new-high-performance-sustainable-materials-from-microalgae https://www.synbiobeta.com/read/evonetix-awarded-innovate-uk-funding-for-ps1-3-million-1-75m-gene-synthesis-project https://www.synbiobeta.com/read/life-sciences-industry-veteran-todd-r-nelson-named-sgi-dna-ceo-to-lead-spin-out-from-synthetic-genomics https://www.synbiobeta.com/read/how-to-show-consumers-the-benefits-of-genetically-modified-foods https://www.synbiobeta.com/read/deinove-enters-into-collaboration-with-biomerieux-to-discover-new-antibiotics https://www.synbiobeta.com/read/ginkgo-bioworks-announces-biosecurity-initiative-using-deep-learning-to-reduce-the-global-threat-of-biological-weapons-and-infectious-disease https://www.synbiobeta.com/read/amyris-and-bgi-agree-to-joint-venture-to-develop-products-to-improve-human-health-in-greater-china https://www.synbiobeta.com/read/prellis-biologics-achieves-unprecedented-speed-and-resolution-in-3d-printing-of-human-tissue-with-capillaries https://www.synbiobeta.com/read/ecovative-partners-with-cnc-exotic-mushrooms-to-reach-eu-market https://www.synbiobeta.com/read/global-bioenergies-successfully-moves-its-c3-process-to-demo-scale https://www.synbiobeta.com/read/iarpa-awards-draper-multi-year-7-8-million-contract-to-improve-biodetection-security https://www.synbiobeta.com/read/news-digest-202-12-3m-for-evonetix-and-10m-for-engine-bio-synbiobeta-early-bird-ends-today https://www.synbiobeta.com/read/news-digest-203-crispr-at-davos-the-top-eighteen-technologies-and-free-genes https://www.synbiobeta.com/read/news-digest-204-terraforming-mars-self-cleaning-teeth-how-to-convince-people-to-love-gmos-and-more https://www.synbiobeta.com/read/news-digest-205-hexafly-raises-1-3m-to-farm-insects-biotech-needs-better-stories-and-more https://www.synbiobeta.com/read/news-digest-206-senti-bio-raises-53m-inscripta-55-5m-perfect-day-24-7m-prokarium-10m-boost-biomes-2m https://www.synbiobeta.com/read/news-digest-207-living-medicines-living-paints-and-living-foundries-are-all-on-the-rise https://www.synbiobeta.com/read/news-digest-208-idts-1-9b-acquisition-melinda-gates-on-tech-meets-bio https://www.synbiobeta.com/read/news-digest-211-synbiobeta-q1-breaks-650m-trump-appoints-elizabeth-holmes-to-fda https://www.synbiobeta.com/read/news-digest-210-opentrons-10m-for-lab-of-the-future-synbiobeta-early-bird-ends-next-week-sponsored-by-opentrons https://www.synbiobeta.com/read/news-digest-212-twist-50m-for-dna-data-storage-synbiobeta-early-bird-ends-friday https://www.synbiobeta.com/read/news-digest-213-five-companies-raise-207m-aligning-business-with-ocean-philanthropy https://www.synbiobeta.com/read/news-digest-214-what-can-synthetic-biologists-learn-from-zuckerbergs-mistakes https://www.synbiobeta.com/read/news-digest-215-saving-our-oceans-plus-stella-mccartney-partnership-with-colorifix-bolt https://www.synbiobeta.com/read/news-digest-216-synthorx-raises-63m-new-startup-mammoth-uses-crispr-to-tackle-diagnostics https://www.synbiobeta.com/read/news-digest-217-synbiobetalive-and-riffyn-power-up-your-machine-learning-and-azitras-skin-microbiome-funding https://www.synbiobeta.com/read/news-digest-218-87m-for-base-editing-technology-3m-for-pilis-biopigments-dna-data-storage https://www.synbiobeta.com/read/news-digest-219-join-us-in-90-minutes-for-synbiobeta-live-learn-why-you-need-be-a-data-company-else-youre-not-going-to-survive-the-future https://www.synbiobeta.com/read/news-digest-220-opiates-from-yeast-gene-editing-for-ag-synbiobeta-is-hiring-early-bird-ends-tomorrow https://www.synbiobeta.com/read/news-digest-221-live-demo-with-amyris-labcyte-off-the-shelf-biocontainment-absci-12m-round https://www.synbiobeta.com/read/news-digest-222-ginkgo-turns-10-dna-scripts-milestone-crispr-stocks-plunge https://www.synbiobeta.com/read/news-digest-223-faster-dna-synthesis-benchling-raises-14-5m-crispr-patents-and-more https://www.synbiobeta.com/read/news-digest-224-join-us-live-at-amyris-today-early-bird-ends-friday-5-companies-raise-278m https://www.synbiobeta.com/read/news-digest-209-meet-joyn-bio-from-ginkgo-bayer-vegan-pets-and-feng-zhangs-crispr-newco-sponsored-by-riffyn https://www.synbiobeta.com/read/news-digest-201-memoriesindna-synbiobeta-early-bird-ends-wed-synthetic-viruses-and-more https://www.synbiobeta.com/read/news-digest-200-biotech-revenue-reaches-370b-indiebios-new-class-genomaticas-bio-nylon https://www.synbiobeta.com/read/news-digest-199-y-combinator-bio-synbiobeta-2018-raw-water https://www.synbiobeta.com/read/news-digest-198-bolt-threads-raises-123m-can-crispr-save-the-worlds-chocolate https://www.synbiobeta.com/read/news-digest-197-these-fifty-synthetic-biology-companies-raised-1-7b-in-2017 https://www.synbiobeta.com/read/from-cell-culture-to-table-culture-food-tech-comes-alive https://www.synbiobeta.com/read/twist-bioscience-expands-executive-team-with-industry-veterans https://www.synbiobeta.com/read/synlogic-presents-new-preclinical-data-from-synthetic-biotic-tm-immuno-oncology-program-at-focis-2018 https://www.synbiobeta.com/read/can-you-change-the-world-with-100-000-bp-of-dna-this-company-wants-to-help https://www.synbiobeta.com/read/precision-biosciences-raises-110m-to-advance-arcus-genome-editing-programs https://www.synbiobeta.com/read/synthetic-genomics-appoints-reinhard-j-ambros-ph-d-former-global-head-of-the-novartis-venture-fund-to-board-of-directors https://www.synbiobeta.com/read/the-sky-is-not-the-limit-what-synthetic-biologists-can-learn-from-astronaut-scott-kelly https://www.synbiobeta.com/read/green-biologics-announces-launch-of-first-bio-based-acetone-nail-polish-remover https://www.synbiobeta.com/read/helping-plants-remove-natural-toxins-could-boost-crop-yields-by-47-percent https://www.synbiobeta.com/read/nematodes-in-space-pheronym-wins-grant-for-eco-friendly-pest-control-for-interstellar-agriculture https://www.synbiobeta.com/read/gevo-and-avfuel-enter-into-renewable-jet-fuel-supply-agreement https://www.synbiobeta.com/read/checkerspot-closes-5-million-series-seed-financing https://www.synbiobeta.com/read/knipbio-awarded-sbir-phase-i-grant-to-investigate-effect-of-dietary-components-on-fish-health https://www.synbiobeta.com/read/modern-meadow-awarded-as-technology-pioneer-by-world-economic-forum https://www.synbiobeta.com/read/synthace-named-a-2018-cool-vendor-in-life-sciences-by-gartner https://www.synbiobeta.com/read/the-new-pharma-synthetic-biology-reimagines-drug-development https://www.synbiobeta.com/read/crispr-therapeutics-intellia-therapeutics-and-caribou-biosciences-announce-grant-of-u-s-patent-for-crispr-cas9-genome-editing https://www.synbiobeta.com/read/oxitec-to-apply-new-generation-of-self-limiting-mosquito-technology-to-malaria-spreading-mosquitoes https://www.synbiobeta.com/read/targeted-sequencing-changes-the-ngs-game https://www.synbiobeta.com/read/kraig-biocraft-laboratories-deploys-new-spider-silk-dna-synthesis-methodology https://www.synbiobeta.com/read/amyris-announces-signing-of-major-ucp-in-porto-aicep-consortium-project-agreement-valued-at-50-million https://www.synbiobeta.com/read/japanese-patent-office-grants-broad-claims-covering-crispr-cas9-gene-editing-technology https://www.synbiobeta.com/read/lumen-wins-triple-funding-boost-to-advance-development-of-low-cost-therapeutics-for-newborns-and-infants-in-developing-countries https://www.synbiobeta.com/read/roosterbio-inc-becomes-industry-partner-in-nsf-funded-public-private-cell-manufacturing-technologies-initiative https://www.synbiobeta.com/read/benchling-raises-14-5m-from-benchmark-to-advance-life-sciences-research https://www.synbiobeta.com/read/genscript-supports-the-development-of-a-novel-hiv-vaccine https://www.synbiobeta.com/read/ginkgo-bioworks-marks-10-year-anniversary-with-igem-partnership https://www.synbiobeta.com/read/sense-and-sustainability-where-does-synthetic-biology-fit https://www.synbiobeta.com/read/garments-of-interdependence-natsai-audrey-chieza-on-fashion-design-and-synthetic-biology https://www.synbiobeta.com/read/synlogic-presents-preclinical-data-from-synthetic-biotictm-medicine-synb1618-for-the-treatment-of-phenylketonuria https://www.synbiobeta.com/read/deinove-and-oleos-expand-their-collaboration-with-the-support-of-the-occitanie-region https://www.synbiobeta.com/read/eforfuel-fuels-from-co2-and-electricity https://www.synbiobeta.com/read/new-england-biolabs-r-scientists-push-the-limits-of-golden-gate-assembly https://www.synbiobeta.com/read/lumen-bioscience-wins-usda-grant-to-develop-oral-vaccine-to-protect-farmed-fish https://www.synbiobeta.com/read/open-cell-is-transforming-shipping-containers-into-lab-space-in-london https://www.synbiobeta.com/read/white-dog-labs-israel-and-advancebio-announce-collaboration-on-a-new-clostridia-based-technology https://www.synbiobeta.com/read/synthego-launches-engineered-cells-product-portfolio-as-next-step-in-delivering-genome-engineering-access-to-all-scientists https://www.synbiobeta.com/read/open-cell-launches-shipping-container-labs-at-shepherds-bush-market-to-accelerate-biotech-start-up-businesses https://www.synbiobeta.com/read/senti-biosciences-announces-curt-herberts-as-new-chief-financial-officer-and-chief-business-officer https://www.synbiobeta.com/read/atomwise-expands-its-groundbreaking-artificial-intelligence-screening-program-to-support-academic-projects-worldwide https://www.synbiobeta.com/read/nitto-partners-with-mbc-biolabs-for-a-new-san-carlos-life-science-startup-incubator https://www.synbiobeta.com/read/programmed-for-safety-how-synvivia-is-commercializing-biocontainment-technology https://www.synbiobeta.com/read/recombinetics-and-semex-form-alliance-to-improve-animal-well-being https://www.synbiobeta.com/read/absci-raises-oversubscribed-12m-series-c-to-fuel-commercialization-of-its-groundbreaking-protein-expression-platform https://www.synbiobeta.com/read/knipbio-announces-high-performance-aquafeed-ingredient https://www.synbiobeta.com/read/isolation-and-recombinant-expression-of-key-enzyme-for-opioid-production https://www.synbiobeta.com/read/synbiobeta-is-hiring https://www.synbiobeta.com/read/berkeley-lights-and-tpg-biologics-enter-into-a-strategic-collaboration-for-cell-line-development https://www.synbiobeta.com/read/oxitec-launches-field-trial-in-brazil-for-next-generation-addition-to-friendly-tm-mosquitoes-platform https://www.synbiobeta.com/read/microvi-demonstrates-unprecedented-removal-of-hazardous-organic-compounds-in-drinking-water-through-nih-grant https://www.synbiobeta.com/read/scientists-are-engineering-organisms-to-create-new-materials https://www.synbiobeta.com/read/yield10-bioscience-exercises-option-with-university-of-missouri-to-obtain-exclusive-worldwide-license-to-advanced-technologies-for-oilseed-crops https://www.synbiobeta.com/read/shouting-from-the-ivory-tower-we-need-more-stem-friendly-public-figures-to-give-science-a-voice https://www.synbiobeta.com/read/rebelbio-answers-londons-call-offering-more-investment-support-for-biotech-start-ups https://www.synbiobeta.com/read/biosyntia-raises-eu4-million-in-series-a-financing-to-advance-its-microbe-engineering-technology-and-bio-based-product-pipeline https://www.synbiobeta.com/read/a-new-story-for-science-entrepreneurship https://www.synbiobeta.com/read/calysta-partners-with-nofima-for-trials-to-promote-sustainable-seafood https://www.synbiobeta.com/read/amyris-sustainable-lubricants-joint-venture-company-novvi-and-chevron-enter-agreement-to-develop-and-bring-to-market-new-renewable-base-oil-technologies https://www.synbiobeta.com/read/intellia-therapeutics-announces-wt1-as-its-first-cell-therapy-target-following-presentation-of-early-data-at-the-american-society-of-gene-and-cell-therapy-21st-annual-meeting https://www.synbiobeta.com/read/nih-awards-grant-to-lumen-bioscience-for-cost-effective-oral-malaria-vaccine https://www.synbiobeta.com/read/indee-labs-closes-2-6m-in-seed-funding-from-founders-funds-ff-science-and-main-sequence-ventures https://www.synbiobeta.com/read/pivot-bio-reports-significant-growth-and-expansion-of-leadership-team https://www.synbiobeta.com/read/why-the-future-will-be-written-in-dna-an-interview-with-twist-biosciences-bill-peck https://www.synbiobeta.com/read/beam-therapeutics-founded-by-gene-editing-pioneers-to-create-precision-genetic-medicines-with-base-editing https://www.synbiobeta.com/read/pili-leader-in-the-production-of-biotech-dyes-obtains-3-million-in-funding-to-accelerate-the-development-of-its-first-products https://www.synbiobeta.com/read/are-programmable-plants-the-future-of-farming https://www.synbiobeta.com/read/beam-therapeutics-launched-to-develop-harvard-base-editing-technology-toward-precision-genetic-medicines https://www.synbiobeta.com/read/bactevo-enters-drug-discovery-agreement-with-boehringer-ingelheim https://www.synbiobeta.com/read/custom-built-dna-could-be-used-as-a-sensor-probe https://www.synbiobeta.com/read/amyris-collaborates-with-firmenich-to-develop-disruptive-bio-based-fragrance-ingredient https://www.synbiobeta.com/read/the-story-of-life-on-earth-part-i https://www.synbiobeta.com/read/azitra-secures-2-15-million-convertible-debt-financing-led-jointly-by-bios-partners-and-connecticut-innovations https://www.synbiobeta.com/read/synpromics-awarded-ps1-9m-grant-from-scottish-enterprise https://www.synbiobeta.com/read/five-amazing-ways-redesigning-biological-cells-could-help-us-fight-cancer https://www.synbiobeta.com/read/harvards-wyss-institute-partners-with-cellectis-to-recode-the-human-genome https://www.synbiobeta.com/read/ultra-safe-cells-resistant-to-natural-viruses-announced-as-first-gp-write-grand-scale-project https://www.synbiobeta.com/read/vegan-pet-food-a-billion-dollar-industry https://www.synbiobeta.com/read/bio-botanica-inc-partners-with-genomatica-to-create-new-extract-line-made-with-brontide-butylene-glycol https://www.synbiobeta.com/read/yield10-addresses-application-of-metabolic-engineering-to-increase-crop-yield-in-paper-published-in-plant-science https://www.synbiobeta.com/read/molecular-devices-and-fortebio-combine-to-create-new-biologics-solutions-business-unit-to-drive-integrated-workflow-offerings-for-drug-discovery-and-development https://www.synbiobeta.com/read/synthorx-announces-63-million-series-c-financing-to-advance-a-pipeline-of-synthorin-tm-cytokines https://www.synbiobeta.com/read/renaissance-bioscience-partners-with-mitacs-for-1-44-million-project https://www.synbiobeta.com/read/synthace-appoints-bob-wiederhold-as-chairman-of-its-board-of-directors https://www.synbiobeta.com/read/mammoth-biosciences-launches-to-develop-worlds-first-crispr-based-detection-platform https://www.synbiobeta.com/read/zymeworks-and-celgene-expand-bispecific-antibody-collaboration https://www.synbiobeta.com/read/braskem-begins-operation-in-boston-to-strengthen-its-renewable-chemicals-strategy https://www.synbiobeta.com/read/high-tech-algae-farming-industry-gets-boost-with-introduction-of-bipartisan-algae-agriculture-act-of-2018 https://www.synbiobeta.com/read/porton-pharma-solutions-and-codexis-launch-global-partnership https://www.synbiobeta.com/read/synpromics-awarded-innovate-uk-grant-to-evaluate-its-inducible-promoter-platform-in-collaboration-with-lonza-pharma-biotech https://www.synbiobeta.com/read/alexandria-launchlabs-the-premier-life-science-startup-platform-to-open-in-fall-2018-at-the-alexandria-center-at-one-kendall-square-in-the-heart-of-east-cambridge https://www.synbiobeta.com/read/berkeley-lights-announces-new-agreement-with-sanofi-for-beacon-r-optofluidic-platform https://www.synbiobeta.com/read/inocucor-15-9m-final-close-of-series-b-financing-brings-series-b-total-to-54-4m https://www.synbiobeta.com/read/twist-bioscience-accelerates-global-expansion-with-strategic-asia-pacific-distribution-agreements https://www.synbiobeta.com/read/indee-labs-secures-funding-to-develop-unique-gene-therapy-manufacturing-technology-in-australia https://www.synbiobeta.com/read/global-bioenergies-and-skynrg-announce-their-collaboration-on-astm-certification-of-a-bio-isobutene-feedstock-and-conversion-process-for-the-production-of-sustainable-aviation-fuel https://www.synbiobeta.com/read/labcyte-reaches-agreement-with-merck-to-supply-acoustic-mass-spectrometry-equipment https://www.synbiobeta.com/read/the-future-is-now-indiebios-demo-day-reflection https://www.synbiobeta.com/read/deinove-and-greentech-announce-the-launch-of-hebelys-r-the-first-cosmetic-active-ingredient-resulting-from-their-collaboration https://www.synbiobeta.com/read/synthetic-biologists-can-learn-from-zuckerbergs-mistakes https://www.synbiobeta.com/read/metalytics-debuts-worlds-most-advanced-metabolic-flux-analysis-offering-coremfa-r https://www.synbiobeta.com/read/darpa-awards-ginkgo-bioworks-and-transcriptic-9-5m-to-bring-ai-into-the-lab https://www.synbiobeta.com/read/inovio-awarded-up-to-56-million-from-cepi-to-advance-dna-vaccines-against-lassa-fever-and-mers https://www.synbiobeta.com/read/to-go-green-synthetic-biologists-should-think-blue https://www.synbiobeta.com/read/ecovia-renewables-announces-major-partnership-raises-1-million-in-seed-financing https://www.synbiobeta.com/read/gilson-and-synthace-announce-collaboration-aiming-to-make-biological-research-more-efficient-and-reproducible-at-analytica-2018 https://www.synbiobeta.com/read/science-exchange-and-ranomics-collaborate-to-offer-online-access-to-their-variantfindtm-mutagenesis-platform https://www.synbiobeta.com/read/codexis-announces-pricing-of-public-offering-of-common-stock-2 https://www.synbiobeta.com/read/first-car-driving-with-global-bioenergies-renewable-gasoline https://www.synbiobeta.com/read/poseida-raises-30-5-million-in-series-b-financing https://www.synbiobeta.com/read/synlogic-announces-registered-direct-offering-of-common-stock https://www.synbiobeta.com/read/ocean-of-awe-aligning-business-and-philanthropy-to-build-a-better-world https://www.synbiobeta.com/read/on-the-steps-between-scientist-and-founder-an-interview-with-fatma-kaplan https://www.synbiobeta.com/read/impossible-foods-announces-114-million-convertible-note-as-startup-prepares-for-rapid-expansion-in-the-us-and-overseas https://www.synbiobeta.com/read/new-england-biolabs-r-launches-lessons-from-lab-life-tm-podcast https://www.synbiobeta.com/read/agilent-and-biotek-join-forces-to-create-an-integrated-metabolic-analysis-and-imaging-platform https://www.synbiobeta.com/read/national-corn-growers-association-names-lygos-winner-of-international-award-for-its-bio-malonate-tm-manufacturing-technology https://www.synbiobeta.com/read/open-philanthropy-project-awards-11-3m-to-uws-institute-for-protein-design https://www.synbiobeta.com/read/3f-bio-ltd-confirms-a-ps6-16m-series-a-financing-round https://www.synbiobeta.com/read/dna-script-awarded-5-5m-in-innovation-grants-from-the-european-commission-and-bpifrance-total-financing-to-date-is-24m https://www.synbiobeta.com/read/green-biologics-partners-with-kingsford-r-charcoal-to-launch-new-ecolight-tm-natural-charcoal-lighter-fluid https://www.synbiobeta.com/read/kraig-biocraft-laboratories-successfully-produces-recombinant-spider-silk-cocoons-from-new-line-of-hybrid-silkworms https://www.synbiobeta.com/read/join-our-team-of-writers https://www.synbiobeta.com/read/twist-bioscience-completes-50-million-financing-to-fuel-advancement-of-digital-storage-in-dna-and-drug-discovery https://www.synbiobeta.com/read/synthetic-biology-companies-raised-over-650-million-in-q1-setting-the-pace-for-another-record-breaking-year https://www.synbiobeta.com/read/trump-taps-elizabeth-holmes-to-lead-fda https://www.synbiobeta.com/read/can-bacteria-in-clothing-really-make-an-athlete-faster https://www.synbiobeta.com/read/sgi-dna-launches-automated-gene-libraries-for-accelerated-drug-discovery-and-development-research https://www.synbiobeta.com/read/building-the-business-of-biodesign https://www.synbiobeta.com/read/jennifer-doudna-to-advise-crispr-start-up-synthego https://www.synbiobeta.com/read/let-a-thousand-foundries-bloom-opentrons-lab-of-the-future https://www.synbiobeta.com/read/opentrons-releases-next-gen-lab-robot-closes-10m-seed-funding-round https://www.synbiobeta.com/read/usda-biobased-economy-report-indicates-potential-for-rural-prosperity-with-renewable-chemicals https://www.synbiobeta.com/read/chain-to-explore-manufacturing-of-novel-medicines https://www.synbiobeta.com/read/aobiome-therapeutics-reports-positive-clinical-safety-results-for-first-in-class-microbiome-targeted-therapy-for-intranasal-delivery https://www.synbiobeta.com/read/genomatica-brings-its-naturally-sourced-brontide-tm-butylene-glycol-to-europe https://www.synbiobeta.com/read/monsanto-and-agrimetis-announce-global-licensing-agreement-to-drive-novel-insect-control-solutions https://www.synbiobeta.com/read/ampliphi-biosciences-announces-closing-of-registered-direct-offering-of-common-stock https://www.synbiobeta.com/read/bayer-collaborates-with-greater-sacramento-in-new-incubator-space https://www.synbiobeta.com/read/deinove-expands-its-innovative-antibiotic-portfolio-by-signing-a-license-option-agreement-with-redx-pharma https://www.synbiobeta.com/read/starting-with-mother-natures-designs-will-speed-up-critical-development-of-new-antibiotics https://www.synbiobeta.com/read/what-and-who-is-synthetic-biology https://www.synbiobeta.com/read/pairwise-raises-25m-series-a-financing-to-accelerate-crop-innovation https://www.synbiobeta.com/read/pivot-bio-announces-pre-commercial-launch-of-nitrogen-producing-microbes-to-improve-crop-nutrition-and-yields https://www.synbiobeta.com/read/be-your-own-data-scientist-its-easier-than-you-think https://www.synbiobeta.com/read/cambridge-consultants-reveals-a-vision-for-the-use-of-pha-bioplastics-in-convenience-food-packaging https://www.synbiobeta.com/read/bayer-and-ginkgo-bioworks-unveil-joint-venture-joyn-bio-and-establish-operations-in-boston-and-west-sacramento https://www.synbiobeta.com/read/cargill-officially-starts-producing-its-next-generation-sweetener-eversweet https://www.synbiobeta.com/read/wild-earth-introduces-cultured-clean-protein-for-30b-pet-food-market https://www.synbiobeta.com/read/dupont-tate-lyle-bio-products-expanding-bio-based-propanediol-production-in-tennessee https://www.synbiobeta.com/read/autolus-to-support-uk-network-of-advanced-therapies-treatment-centres https://www.synbiobeta.com/read/key-milestone-reached-in-the-audi-global-bioenergies-partnership https://www.synbiobeta.com/read/living-ink-technologies-awarded-phase-ii-grant-from-national-science-foundation-to-develop-algae-ink-tm https://www.synbiobeta.com/read/u-s-epa-awards-600-000-to-help-two-california-small-businesses-develop-environmental-technologies https://www.synbiobeta.com/read/duponts-microbiome-venture-announces-second-strategic-partnership https://www.synbiobeta.com/read/oxford-3d-bio-printer-company-oxsybio-secures-ps10m-series-a-led-by-woodford https://www.synbiobeta.com/read/synlogic-presents-clinical-and-preclinical-data-from-synthetic-biotic-tm-medicine-programs-for-treatment-of-inborn-errors-of-metabolism-at-annual-meeting-of-the-society-for-inherited-metabolic-disorders https://www.synbiobeta.com/read/autolus-announces-confidential-submission-of-draft-registration-statement-for-potential-initial-public-offering-in-the-united-states https://www.synbiobeta.com/read/melinda-gates-on-the-promise-and-peril-of-biotechnology https://www.synbiobeta.com/read/epa-opens-public-comment-period-for-oxitecs-experimental-use-permit-application-for-friendly-tm-mosquitoes-in-florida-keys https://www.synbiobeta.com/read/the-garden-where-science-art-and-philosophy-converge-an-interview-with-scientist-poet-peter-bickerton https://www.synbiobeta.com/read/twist-bioscience-expands-north-american-presence-with-office-in-san-diego-california https://www.synbiobeta.com/read/exploring-the-frontiers-of-microbiome-and-drug-development https://www.synbiobeta.com/read/danaher-to-acquire-integrated-dna-technologies https://www.synbiobeta.com/read/modern-meadow-partners-with-evonik-to-grow-fermentation-processes-to-commercial-scale https://www.synbiobeta.com/read/atomwise-raises-45-million-series-a-to-become-the-preferred-artificial-intelligence-partner-for-the-global-pharmaceutical-industry https://www.synbiobeta.com/read/exxonmobil-and-synthetic-genomics-algae-biofuels-program-targets-10-000-barrels-per-day-by-2025 https://www.synbiobeta.com/read/bioengineers-today-emphasize-the-crucial-ingredient-dr-frankenstein-forgot-responsibility https://www.synbiobeta.com/read/a-new-day-dawns-for-roosterbio-inc-fitci-graduate https://www.synbiobeta.com/read/living-medicines-using-gut-microbes-to-treat-disease https://www.synbiobeta.com/read/european-patent-office-grants-2nd-charpentier-doudna-patent-covering-crispr-cas9-gene-regulation-applications https://www.synbiobeta.com/read/polytech-and-amsilk-announce-start-of-joint-international-clinical-study-for-silk-coated-medical-implants https://www.synbiobeta.com/read/c3j-therapeutics-bolsters-antimicrobial-r-d-program-acquires-engineered-bacteriophage-assets-from-synthetic-genomics https://www.synbiobeta.com/read/integrated-dna-technologies-inc-announces-winners-of-the-idt-sustainability-award-supporting-innovation-in-biodiversity-research https://www.synbiobeta.com/read/perfect-day-on-its-way-to-bringing-animal-free-dairy-to-store-shelves https://www.synbiobeta.com/read/inscripta-raises-55-5-million-to-advance-gene-editing-technology https://www.synbiobeta.com/read/on-the-future-of-gene-and-cell-based-therapies-senti-bios-timothy-lu https://www.synbiobeta.com/read/boost-biomes-launches-with-2-05m-seed-funding-to-develop-microbiome-based-products https://www.synbiobeta.com/read/dyadic-international-inc-announces-research-and-development-collaboration-with-mitsubishi-tanabe-pharma-corporation-to-produce-two-target-proteins-in-c1 https://www.synbiobeta.com/read/indiebios-class-six-presents-next-gen-therapies-event-recap https://www.synbiobeta.com/read/senti-biosciences-secures-53-million-series-a-to-build-the-future-of-gene-and-cell-based-therapies https://www.synbiobeta.com/read/kite-a-gilead-company-and-sangamo-therapeutics-announce-collaboration-to-develop-next-generation-engineered-cell-therapies-for-the-treatment-of-cancer https://www.synbiobeta.com/read/molecular-devices-launches-the-imagexpress-pico-system https://www.synbiobeta.com/read/two-issued-u-s-patents-granted-to-cellectis-for-crispr-use-in-t-cells https://www.synbiobeta.com/read/deinove-announces-the-success-of-its-cosmetic-active-ingredients-production-process-industrialization https://www.synbiobeta.com/read/riffyn-awarded-its-first-us-patent-for-experiment-design-and-data-analytics https://www.synbiobeta.com/read/brissynbio-connect-12th-april-2018-tickets-now-available https://www.synbiobeta.com/read/prokarium-secures-10-million-investment-from-saudi-swedish-and-korean-investors-for-clinical-development-of-revolutionary-thermostable-vaccines https://www.synbiobeta.com/read/atum-and-just-biotherapeutics-team-up-to-accelerate-drug-discovery https://www.synbiobeta.com/read/benson-hill-biosystems-receives-patent-for-novel-crispr-technology https://www.synbiobeta.com/read/cargill-precision-biosciences-team-up-to-develop-next-generation-of-low-saturate-high-oleic-canola-oil https://www.synbiobeta.com/read/here-there-will-be-dragons-beyond-the-map-of-synbio-with-kim-de-mora https://www.synbiobeta.com/read/lgc-acquires-lucigen-strengthening-its-reagents-offering-to-the-genomics-market https://www.synbiobeta.com/read/techaccel-initiates-protein-engineering-project-with-uc-davis-to-improve-wheat-yield https://www.synbiobeta.com/read/knipbio-announces-breakthrough-aquafeed-ingredient-development https://www.synbiobeta.com/read/rebelbio-partners-with-clustermarket-to-support-startups-with-state-of-the-art-resources https://www.synbiobeta.com/read/composite-biopesticides-exponentially-better-results-for-effective-safe-and-eco-friendly-pest-control https://www.synbiobeta.com/read/twist-bioscience-launches-exome-and-custom-target-enrichment-solutions-for-genomics-and-clinical-researchers-conducting-next-generation-sequencing https://www.synbiobeta.com/read/synlogic-presents-data-from-immuno-oncology-development-program-demonstrating-potent-anti-tumor-immunity-following-administration-of-novel-sting-agonist-producing-synthetic-biotic-tm-medicine https://www.synbiobeta.com/read/biotech-needs-better-external-innovation-networks-and-think-tanks-part-i https://www.synbiobeta.com/read/dyadic-international-inc-announces-research-and-development-collaboration-to-produce-an-active-ingredient-in-c1 https://www.synbiobeta.com/read/amyris-aprinnova-joint-venture-launches-pharmaceutical-grade-neossance-squalane-usp-opens-new-market-among-fda-regulated-products https://www.synbiobeta.com/read/inovio-and-the-wistar-institute-receive-more-than-4-6-million-in-r-d-funding-to-advance-vaccines-against-tuberculosis-malaria https://www.synbiobeta.com/read/techaccel-makes-science-advancement-investment-in-plant-biotechnology-startup-plastomics-inc https://www.synbiobeta.com/read/case-western-reserve-and-sangamo-therapeutics-announce-11-million-nih-grant-for-study-of-gene-edited-t-cells-for-viral-eradication-of-hiv https://www.synbiobeta.com/read/bioamber-inc-announces-pricing-of-us-10-million-underwritten-public-offering https://www.synbiobeta.com/read/ttp-labtechs-global-launch-of-dragonfly-discovery-at-slas-2018 https://www.synbiobeta.com/read/inscripta-adds-world-renowned-protein-engineering-ai-expert-to-executive-team https://www.synbiobeta.com/read/labcyte-introduces-new-acoustic-sample-management-solution https://www.synbiobeta.com/read/qb3-953-unites-life-science-facility-under-new-mbc-biolabs-name https://www.synbiobeta.com/read/customem-wins-transformational-eu1-4m-ps1-2m-grant-from-horizon-2020 https://www.synbiobeta.com/read/abbvie-and-mbc-biolabs-team-up-to-support-life-science-startups-in-the-san-francisco-bay-area https://www.synbiobeta.com/read/future-shock-what-the-world-economic-forum-had-to-say-about-crispr https://www.synbiobeta.com/read/bio-succinic-acid-demonstrates-substantial-benefits-toward-growth-performance-in-animal-feed-commercial-trial https://www.synbiobeta.com/read/synlogic-announces-underwriters-option-exercise-in-full https://www.synbiobeta.com/read/amyris-biossance-starts-2018-with-over-300-retail-sales-growth-now-available-across-sephora-canada-stores https://www.synbiobeta.com/read/dsm-and-evonik-establish-veramaris-joint-venture https://www.synbiobeta.com/read/lux-research-names-top-transformational-technologies-reshaping-the-world https://www.synbiobeta.com/read/responsible-and-sustainable-synthetic-biology-in-africa https://www.synbiobeta.com/read/deinove-and-oleos-partners-in-the-development-of-a-new-cosmetic-active-ingredient https://www.synbiobeta.com/read/engine-biosciences-raises-10-million-in-seed-financing-to-accelerate-drug-discovery-using-genomics-and-artificial-intelligence https://www.synbiobeta.com/read/biomx-licenses-novel-bacterial-targets-for-the-treatment-of-inflammatory-bowel-disease https://www.synbiobeta.com/read/sphere-fluidics-expands-cyto-mine-sales-team-and-distribution-in-us-europe-and-asia https://www.synbiobeta.com/read/dna-script-and-dynamic-combinatorial-chemistry-enter-exclusive-partnership-to-enable-enzymatically-synthesized-dna https://www.synbiobeta.com/read/evonetix-raises-12-3-million-usd-ps9-million-gbp-to-advance-development-of-its-highly-novel-gene-synthesis-platform https://www.synbiobeta.com/read/tyson-foods-invests-in-cultured-meat-with-stake-in-memphis-meats https://www.synbiobeta.com/read/inovio-pharmaceuticals-published-universal-flu-vaccine-data-demonstrates-protective-responses-against-all-major-lethal-h1n1-influenza-viruses-from-the-last-100-years-in-animal-models https://www.synbiobeta.com/read/kraig-biocraft-laboratories-expands-material-performance-testing-procedures https://www.synbiobeta.com/read/synthego-launches-powerful-crispr-analysis-software-to-make-world-class-genome-engineering-accessible https://www.synbiobeta.com/read/teewinot-life-sciences-corporations-subsidiary-teewinot-technologies-ltd-announced-today-grant-of-a-new-patent-with-broad-claims-to-biosynthetic-production-of-cannabinoid-pharmaceuticals https://www.synbiobeta.com/read/nanome-partners-with-science-exchange-to-offer-virtual-reality-drug-design-tools-and-blockchain-solutions-to-scientists https://www.synbiobeta.com/read/labcytes-acoustic-droplet-ejection-technology-is-miniaturizing-high-throughput-assembly https://www.synbiobeta.com/read/modern-meadow-taps-former-shinola-and-michael-kors-executives-to-drive-growth-in-2018 https://www.synbiobeta.com/read/synpromics-announces-new-partnership-with-ucl-to-develop-novel-gene-therapies-for-blood-based-disorders https://www.synbiobeta.com/read/synthetic-virus-to-tackle-antimicrobial-resistance https://www.synbiobeta.com/read/aquafil-and-genomatica-join-forces-for-bio-nylon-target-more-sustainable-apparel-carpets-and-fibers https://www.synbiobeta.com/read/exclusive-in-france-butagaz-and-global-bioenergies-present-the-first-bottles-of-bio-sourced-gas https://www.synbiobeta.com/read/intrexon-announces-closing-of-public-offering-of-common-stock-and-exercise-of-option-by-underwriters https://www.synbiobeta.com/read/synlogic-announces-proposed-public-offering-of-common-stock https://www.synbiobeta.com/read/lanzatech-and-teselagen-sign-deal-to-use-artificial-intelligence-to-further-the-sustainable-bioeconomy https://www.synbiobeta.com/read/introducing-indiebio-class-six https://www.synbiobeta.com/read/thought-for-food-launches-its-2018-global-challenge-calling-on-youth-to-tackle-food-security https://www.synbiobeta.com/read/knipbio-achieves-key-scale-up-milestone https://www.synbiobeta.com/read/biobright-sanger-institute-aim-to-cut-drug-development-time https://www.synbiobeta.com/read/dupont-industrial-biosciences-and-wools-of-new-zealand-announce-materials-collaboration https://www.synbiobeta.com/read/genes-in-space-stem-competition-launches https://www.synbiobeta.com/read/amyris-announces-over-25-million-in-grants https://www.synbiobeta.com/read/distributed-bio-announces-superhuman-platform-license-agreement-with-pfizer-inc https://www.synbiobeta.com/read/new-england-biolabs-supports-creation-of-labcentral-learning-lab https://www.synbiobeta.com/read/building-biotech-on-the-success-of-semiconductors-an-interview-with-customarray-ceo-brooke-anderson-about-genscripts-recent-acquisition https://www.synbiobeta.com/read/riffyn-opens-boston-office-to-meet-accelerating-demand-for-digital-transformation-in-biotech-and-pharmaceutical-r-d https://www.synbiobeta.com/read/rebelbio-launches-a-new-biotech-cohort-in-london https://www.synbiobeta.com/read/estimation-of-a-69-reduction-in-greenhouse-gases-emissions-for-fully-renewable-etbe-compared-to-fossil-gasoline https://www.synbiobeta.com/read/manus-bio-awarded-funding-to-develop-novel-production-method-for-artemisinin https://www.synbiobeta.com/read/ampliphi-biosciences-announces-pricing-of-4-0-million-public-offering-of-common-stock https://www.synbiobeta.com/read/inovio-pharmaceuticals-and-the-parker-institute-for-cancer-immunotherapy-establish-clinical-development-collaboration-to-evaluate-novel-cancer-immunotherapy-combinations https://www.synbiobeta.com/read/bell-biosystems-inc-announces-pre-clinical-results-of-major-in-vivo-safety-study-milestone https://www.synbiobeta.com/read/science-exchange-partners-with-lab-launch-to-help-its-startups-advance-scientific-innovations https://www.synbiobeta.com/read/we-scientists-need-to-comment-on-the-raw-water-fad https://www.synbiobeta.com/read/how-to-close-the-gap-between-technological-creation-and-commercialization-fast https://www.synbiobeta.com/read/adapsyn-bioscience-completes-financing-to-advance-its-small-molecule-natural-product-platform-and-pipeline-announces-research-collaboration-with-pfizer-inc https://www.synbiobeta.com/read/dmc-biotechnologies-inc-announces-first-close-of-1-75m-equity-financing-led-by-leuven-belgium-based-capricorn-venture-partners https://www.synbiobeta.com/read/battelle-tapped-to-help-u-s-government-prevent-the-intentional-or-accidental-creation-of-synthetic-biological-threats https://www.synbiobeta.com/read/inocucor-raises-9-5-million-usd-12-1-million-cad-in-series-b-second-close-led-by-pontifax-agtech-raising-total-proceeds-of-series-b-financing-to-38-5-million-usd-50-9-million-cad https://www.synbiobeta.com/read/international-gene-synthesis-consortium-updates-screening-protocols-for-synthetic-dna-products-and-services https://www.synbiobeta.com/read/a-biological-solution-to-carbon-capture-and-recycling https://www.synbiobeta.com/read/renew-biopharma-launches-pre-clinical-drug-discovery-program-with-indiana-university-bloomingtons-gill-center-for-biomolecular-science-using-cannabinoids-grown-in-microalgae https://www.synbiobeta.com/read/zymergen-acquires-metagenomics-company-radiant-genomics https://www.synbiobeta.com/read/in-growing-algae-for-biofuels-it-matters-who-used-the-water-last https://www.synbiobeta.com/read/jet-fuel-from-sugarcane-its-not-a-flight-of-fancy https://www.synbiobeta.com/read/the-libraries-of-the-future-will-be-made-of-dna https://www.synbiobeta.com/read/global-bioenergies-and-clariant-unveil-development-of-new-bio-based-cosmetics-polymer-for-more-natural-formulations https://www.synbiobeta.com/read/these-fifty-synthetic-biology-companies-raised-1-7b-in-2017 https://www.synbiobeta.com/read/clean-meat-start-up-supermeat-pecks-up-3m-in-seed-funding-partners-with-industry-leaders https://www.synbiobeta.com/read/legend-biotech-announces-closing-of-global-strategic-lcar-b38m-car-t-cell-immunotherapy-collaboration-with-janssen https://www.synbiobeta.com/read/yield10-bioscience-announces-closing-of-14-5-million-public-offering https://www.synbiobeta.com/read/juno-therapeutics-and-thermo-fisher-scientific-announce-car-t-manufacturing-partnership https://www.synbiobeta.com/read/deinove-launches-the-industrial-production-of-its-first-carotenoid https://www.synbiobeta.com/read/genscript-biotech-acquires-customarray-to-expand-synthetic-biology-product-portfolio https://www.synbiobeta.com/read/arzeda-strengthens-board-of-directors-with-addition-of-biotechnology-veteran-william-baum https://www.synbiobeta.com/read/accelerate-fund-ii-invests-in-fredsense-portable-water-testing-for-rapid-affordable-results-at-source https://www.synbiobeta.com/read/vcs-please-dont-let-the-past-hold-the-future-hostage https://www.synbiobeta.com/read/flagship-pioneering-announces-capital-raise-of-618mm https://www.synbiobeta.com/read/first-genomic-platform-powered-by-the-blockchain-raises-2-million-in-funding-backed-by-illumina-veterans https://www.synbiobeta.com/read/inscripta-releases-new-unique-crispr-gene-editing-enzyme-free-to-use-for-all-researchers https://www.synbiobeta.com/read/biomx-acquires-rondinx-to-boost-microbiome-discovery-and-development-capabilities https://www.synbiobeta.com/read/breakout-labs-partners-with-science-exchange-to-empower-its-portfolio-companies-with-external-research-innovations https://www.synbiobeta.com/read/an-exclusive-interview-with-helge-bastian-about-the-uncommon-collaboration-between-foldit-synbio-and-a-confectionery-powerhouse https://www.synbiobeta.com/read/genetic-circuits-startup-asimov-raises-seed-round-led-by-andreessen-horowitz https://www.synbiobeta.com/read/silicon-valley-sees-a-future-in-circuits-made-of-dna https://www.synbiobeta.com/read/why-eco-friendly-solutions https://www.synbiobeta.com/read/designer-proteins-that-package-genetic-material-could-help-deliver-gene-therapy https://www.synbiobeta.com/read/synthego-introduces-first-crispr-guaranteed-editing-genome-engineering-solution https://www.synbiobeta.com/read/leveraging-the-power-of-biology-for-manufacturing-ginkgo-bioworks-raises-275-million-in-series-d-funding https://www.synbiobeta.com/read/ginkgo-bioworks-launches-new-organism-foundry-supported-by-275-million-in-series-d-funding https://www.synbiobeta.com/read/innovating-in-uncharted-waters-an-interview-with-alexander-nielsen-about-novozymes-open-innovation-initiative-helloscience https://www.synbiobeta.com/read/sgi-dna-expands-advanced-protein-expression-product-suite-with-vmax-tm-express-chemically-competent-cells https://www.synbiobeta.com/read/touchlight-receives-grant-funding-for-dna-templated-nanowire-inks-project https://www.synbiobeta.com/read/vertex-and-crispr-therapeutics-to-co-develop-and-co-commercialize-ctx001-as-crispr-cas9-gene-edited-treatment-for-sickle-cell-disease-and-v-thalassemia https://www.synbiobeta.com/read/yield10-bioscience-grants-research-license-to-monsanto-to-evaluate-two-novel-yield-traits-in-soybean https://www.synbiobeta.com/read/new-release-geneious-biologics-gives-deeper-insight-into-big-data https://www.synbiobeta.com/read/5-wild-biotech-products-that-will-touch-our-lives-in-the-near-future https://www.synbiobeta.com/read/ers-genomics-licenses-crispr-cas9-genome-editing-patents-to-charles-river https://www.synbiobeta.com/read/ge-aviation-testing-100-gevo-atj-fuel https://www.synbiobeta.com/read/gilead-sciences-and-kite-to-acquire-cell-design-labs https://www.synbiobeta.com/read/synlogic-and-ginkgo-bioworks-announce-collaboration-as-first-step-toward-building-an-unprecedented-discovery-engine-for-novel-living-medicines-in-neurological-and-liver-disorders https://www.synbiobeta.com/read/algae-could-feed-and-fuel-planet-with-aid-of-new-hi-tech-tool https://www.synbiobeta.com/read/obsidian-therapeutics-announces-49-5-million-series-a-financing-to-develop-controllable-cell-and-gene-therapy-products https://www.synbiobeta.com/read/editas-medicine-inc-announces-pricing-of-50-million-offering-of-common-stock https://www.synbiobeta.com/read/from-trash-to-tank-upcycling-of-landfill-to-fuel-demonstrated-in-japan https://www.synbiobeta.com/read/lumen-raises-13m-for-new-biotech-production-platform https://www.synbiobeta.com/read/koch-biological-solutions-and-asilomar-bio-agree-to-exclusive-commercial-license-of-leading-yield-enhancement-technology https://www.synbiobeta.com/read/nanocellect-biomedical-raises-10m-in-series-b-funding-led-by-illumina-ventures https://www.synbiobeta.com/read/easy-bake-oven-for-biology-dna-playground-official-release-genetic-engineering-is-now-childs-play https://www.synbiobeta.com/read/opinion-the-gop-tax-bill-could-derail-synthetic-biology https://www.synbiobeta.com/read/precision-crispr-engineering-startup-guide-biosci-named-runner-up-in-idt-synthetic-biology-grant-contest https://www.synbiobeta.com/read/humanitarian-diagnostics-startup-helispot-takes-home-first-ever-idt-synthetic-biology-grant-award https://www.synbiobeta.com/read/scientists-at-tsri-and-synthorx-create-the-first-semi-synthetic-organism-to-encode-and-translate-expanded-genetic-information-into-a-novel-protein-with-different-non-natural-amino-acids https://www.synbiobeta.com/read/provivi-inc-announces-31-5-million-series-b-financing-round https://www.synbiobeta.com/read/arzeda-officially-closes-series-a-with-total-15-2-million-to-revolutionize-chemical-production-with-protein-design https://www.synbiobeta.com/read/how-machine-learning-is-changing-synthetic-biology https://www.synbiobeta.com/read/inovio-pharmaceuticals-syncon-r-tert-cancer-immunotherapy-combined-with-checkpoint-inhibitor-synergistically-shrinks-tumor-and-improves-survival-in-preclinical-tumor-model https://www.synbiobeta.com/read/intrexon-announces-key-management-appointments https://www.synbiobeta.com/read/worlds-first-bio-tetris-played-with-cell-free-expressed-protein https://www.synbiobeta.com/read/sphere-fluidics-and-geneva-biotech-receive-eurostars-genome-editing-grant https://www.synbiobeta.com/read/expanded-genome-editing-tool-kit-supports-every-step-in-researchers-workflow https://www.synbiobeta.com/read/first-batch-delivered-to-loreal-by-global-bioenergies https://www.synbiobeta.com/read/synpromics-announces-collaboration-with-ucl-to-develop-revolutionary-gene-therapy-for-parkinsons-disease https://www.synbiobeta.com/read/labgenius-locks-down-3-66m-from-top-tier-investors-to-harness-evolution https://www.synbiobeta.com/read/laura-shawver-ph-d-appointed-ceo-of-synthorx https://www.synbiobeta.com/read/renewable-chemicals-accelerate-advance-into-mainstream-chemical-industry https://www.synbiobeta.com/read/deinove-and-greentech-are-making-progress-in-the-co-development-of-their-cosmetic-active-ingredient https://www.synbiobeta.com/read/dupont-launches-robust-fermentation-solution-synerxia-r-thrive https://www.synbiobeta.com/read/lygos-reaches-major-technical-milestone-scaling-bio-malonic-tm-manufacturing-process-in-partnership-with-nrel https://www.synbiobeta.com/read/make-science-great-again-for-the-general-public https://www.synbiobeta.com/read/pollution-to-products-synthetic-biology-the-path-to-a-carbon-smart-future https://www.synbiobeta.com/read/dsm-expands-strategic-alliance-with-amyris-and-acquires-brazilian-production-facility-from-amyris https://www.synbiobeta.com/read/why-scientists-cant-do-business https://www.synbiobeta.com/read/evolva-and-northumbria-university-to-collaborate-in-studies-on-human-health-benefits-of-veri-te-tm-resveratrol https://www.synbiobeta.com/read/oxford-genetics-licenses-snapfast-tm-expression-vectors-to-twist-bioscience https://www.synbiobeta.com/read/autolus-announces-publication-of-a-unique-therapeutic-approach-for-treatment-of-patients-with-t-cell-lymphomas-in-nature-medicine https://www.synbiobeta.com/read/food-evolution-explores-the-science-and-real-world-implications-of-gmos https://www.synbiobeta.com/read/snapgene-and-synbio-technologies-partner-to-streamline-construct-design-and-synthesis https://www.synbiobeta.com/read/crispr-therapeutics-and-casebia-collaborate-with-curevac-on-mrna-for-gene-editing-programs https://www.synbiobeta.com/read/synbio-technologies-to-be-first-dna-manufacturer-listed-on-national-equities-exchange-and-quotation-neeq https://www.synbiobeta.com/read/ers-genomics-and-cellecta-inc-sign-license-agreement-on-crispr-cas9-genome-editing-patents-for-tools-and-services https://www.synbiobeta.com/read/evolva-announces-the-successful-completion-of-the-chf-86-million-rights-offering-and-private-placement https://www.synbiobeta.com/read/npl-and-imperial-college-london-launch-a-new-virtual-lab-to-establish-the-uk-centre-for-engineering-biology-metrology-and-standards https://www.synbiobeta.com/read/changing-the-landscape-of-whats-possible-an-exclusive-interview-with-sean-osullivan https://www.synbiobeta.com/read/zymergen-announces-expansion-with-new-office-in-seattle https://www.synbiobeta.com/read/mars-and-partners-launch-uncommon-collaboration-to-crowdsource-gaming-solutions-that-solve-aflatoxin https://www.synbiobeta.com/read/usda-to-re-engage-stakeholders-on-revisions-to-biotechnology-regulations https://www.synbiobeta.com/read/frost-sullivan-commends-sphere-fluidics-for-its-innovative-single-cell-analysis-platform-solution https://www.synbiobeta.com/read/ontario-genomics-invests-in-renewable-chemicals https://www.synbiobeta.com/read/bristol-myers-squibb-biolabs-announce-founding-sponsorship-in-support-of-promising-biotech-companies-in-new-york https://www.synbiobeta.com/read/intellia-therapeutics-announces-proposed-public-offering-of-common-stock https://www.synbiobeta.com/read/synthetic-sex-in-yeast-promises-safer-medicines-for-people https://www.synbiobeta.com/read/vedanta-biosciences-to-advance-cancer-immunotherapy-candidates-based-on-microbiome-derived-live-biotherapeutics-that-induce-cd8-t-cells https://www.synbiobeta.com/read/arcturus-therapeutics-and-synthetic-genomics-announce-strategic-alliance-to-develop-next-generation-vaccines-and-therapeutics https://www.synbiobeta.com/read/knipbio-pledges-support-for-uns-sustainable-development-goal-to-conserve-and-sustainably-use-ocean-resources https://www.synbiobeta.com/read/poseida-awarded-19-8-million-cirm-grant-to-support-clinical-trial-of-p-bcma-101-a-t-stem-cell-memory-car-t-therapy-for-multiple-myeloma https://www.synbiobeta.com/read/aobiome-therapeutics-reports-positive-efficacy-results-from-phase-2b-clinical-trial-of-ammonia-oxidizing-bacteria-aob-for-the-treatment-of-acne-vulgaris https://www.synbiobeta.com/read/synthetic-genomics-and-ceva-enter-agreement-to-develop-commercialize-next-generation-vaccines-for-animal-health https://www.synbiobeta.com/read/synthetic-genomics-partners-with-duke-human-vaccine-institute-on-darpa-pandemic-prevention-platform-program https://www.synbiobeta.com/read/h-r-makes-equity-investment-in-novvi-and-its-high-performance-renewable-base-oil-technology https://www.synbiobeta.com/read/george-church-joins-nucleras-scientific-advisory-board https://www.synbiobeta.com/read/synlogic-receives-orphan-drug-designation-for-synb1618-a-synthetic-biotictm-medicine-for-the-treatment-of-phenylketonuria https://www.synbiobeta.com/read/takeaways-from-synbiobeta-sf-2017 https://www.synbiobeta.com/read/do-deep-tech-investments-actually-make-money https://www.synbiobeta.com/read/elemental-machines-doubles-support-for-labcentral https://www.synbiobeta.com/read/deinove-confirms-the-launch-of-its-first-cosmetic-active-ingredient-during-the-first-half-of-2018-and-targets-the-very-dynamic-segment-of-anti-aging-skincare https://www.synbiobeta.com/read/qb3-signs-partnership-with-science-exchange https://www.synbiobeta.com/read/benson-hill-biosystems-launches-the-first-fully-enabling-genome-editing-system-for-crop-improvement https://www.synbiobeta.com/read/intrexon-and-arch-pharmalabs-collaborate-on-fermentative-production-of-an-api-to-replace-existing-process-sourced-from-animals https://www.synbiobeta.com/read/toolgen-and-rebelbio-announce-the-agreement-for-collaboration-using-toolgens-crispr-cas9-ip https://www.synbiobeta.com/read/beyond-biofuels-berkeley-lab-facility-a-catalyst-for-broader-bio-based-economy https://www.synbiobeta.com/read/intrexon-corporation-enters-into-100-million-preferred-stock-equity-facility https://www.synbiobeta.com/read/intrexon-crop-protection-achieves-milestone-in-development-of-pioneering-self-limiting-fall-armyworm-solution https://www.synbiobeta.com/read/amsilk-and-interpolymer-announce-production-and-distribution-partnership https://www.synbiobeta.com/read/ingenza-advances-inable-r-biomanufacturing-technologies-in-collaboration-with-syngenta https://www.synbiobeta.com/read/micro-solutions-for-a-macro-problem-how-marine-algae-could-help-feed-the-world https://www.synbiobeta.com/read/science-exchange-honored-by-goldman-sachs-for-entrepreneurship https://www.synbiobeta.com/read/dupont-pioneer-and-broad-institute-of-mit-and-harvard-join-forces-to-enable-democratic-access-to-crispr-licensing-in-agriculture https://www.synbiobeta.com/read/synthego-receives-intel-capital-investment-to-advance-crispr-bioinformatics https://www.synbiobeta.com/read/walking-the-fine-line-between-academia-and-industry https://www.synbiobeta.com/read/a-deep-dive-into-biobuilder https://www.synbiobeta.com/read/teselagen-building-the-information-technology-backbone-for-synthetic-biology https://www.synbiobeta.com/read/lygos-partners-with-agile-biofoundry-and-u-s-department-of-energy-to-accelerate-bioproduct-r-d-and-commercialization https://www.synbiobeta.com/read/simpath-licenses-novel-ornl-system-for-enhanced-synthetic-biology https://www.synbiobeta.com/read/illumina-ventures-closes-230-million-fund https://www.synbiobeta.com/read/oxford-biotrans-raises-ps2-1-million https://www.synbiobeta.com/read/genomatica-wins-icis-innovation-award-for-geno-bg-tm-process https://www.synbiobeta.com/read/warp-drive-bio-forms-strategic-collaboration-to-advance-novel-classes-of-antibiotics-to-combat-multi-drug-resistant-bacterial-infections https://www.synbiobeta.com/read/codexis-and-nestle-health-science-enter-into-healthcare-focused-protein-engineering-platform-partnership https://www.synbiobeta.com/read/riffyn-introduces-first-of-kind-scientific-development-environment-to-address-100b-of-lost-productivity-in-scientific-r-d https://www.synbiobeta.com/read/oxitec-do-brasil-receives-prestigious-award-for-innovation-and-impact https://www.synbiobeta.com/read/los-alamos-national-laboratory-to-collaborate-with-gevo-to-develop-missile-fuel https://www.synbiobeta.com/read/department-of-energys-national-labs-to-collaborate-with-gevo-to-optimize-ethanol-to-olefins-eto-catalyst-performance https://www.synbiobeta.com/read/synlogic-strengthens-leadership-team-with-appointment-of-chief-operating-officer-and-chief-human-resources-officer https://www.synbiobeta.com/read/amyris-appoints-chief-operating-officer-to-support-continued-strong-growth https://www.synbiobeta.com/read/double-helix-technologies-teams-up-with-agilent-technologies-to-offer-the-surevector-cloning-system https://www.synbiobeta.com/read/guangdong-evergreen-feed-industry-co-wins-f3-fish-free-feed-prize https://www.synbiobeta.com/read/calyxt-and-s-ws-gene-edited-alfalfa-plant-designated-as-non-regulated-by-usda https://www.synbiobeta.com/read/feedkind-r-protein-can-enable-blue-economy-and-increase-global-food-security https://www.synbiobeta.com/read/synpromics-announced-as-best-emerging-uk-synthetic-biotech-company-at-obn-awards-2017 https://www.synbiobeta.com/read/kraig-biocraft-laboratories-to-open-new-biotechnology-research-and-production-center https://www.synbiobeta.com/read/transfer-of-regulatory-jurisdiction-for-oxitecs-self-limiting-friendly-tm-aedes-in-the-united-states https://www.synbiobeta.com/read/synthego-and-thermo-fisher-scientific-align-to-manufacture-and-distribute-synthetic-guide-rna-products-for-crispr-genome-engineering https://www.synbiobeta.com/read/j-craig-venter-institute-led-team-awarded-5-year-10-7-m-grant-from-u-s-department-of-energy-to-optimize-metabolic-networks-in-diatoms-enabling-next-generation-biofuels-and-bioproducts https://www.synbiobeta.com/read/cambridge-consultants-to-develop-custom-dna-at-lightning-speeds https://www.synbiobeta.com/read/arzeda-and-teselagen-partner-to-advance-biodesign-technologies-for-industrial-biotechnology https://www.synbiobeta.com/read/gevo-to-supply-jet-fuel-to-virgin-australia-at-brisbane-airport-in-australia-flights-expected-to-be-flown-through-the-end-of-2018 https://www.synbiobeta.com/read/usda-announces-support-to-grow-the-bioeconomy https://www.synbiobeta.com/read/agile-biofoundry-announces-new-projects https://www.synbiobeta.com/read/ginkgo-bioworks-taps-transcriptics-robotics-software-to-further-accelerate-automation-in-organism-design https://www.synbiobeta.com/read/twist-bioscience-to-provide-one-billion-base-pairs-of-synthetic-dna-to-ginkgo-bioworks-to-support-expansion-into-new-industries https://www.synbiobeta.com/read/crispr-therapeutics-announces-promotion-of-samarth-kulkarni-ph-d-to-chief-executive-officer https://www.synbiobeta.com/read/three-new-mega-raises-put-synbio-on-track-for-record-breaking-year-of-funding https://www.synbiobeta.com/read/rna-sequencing-better-and-faster-with-amaryllis-nucleics https://www.synbiobeta.com/read/intellia-therapeutics-demonstrates-sustained-and-durable-genome-editing-with-crispr-cas9-in-one-year-animal-study https://www.synbiobeta.com/read/in-a-nutshell-synthetic-biology-from-drawing-board-to-commercialization https://www.synbiobeta.com/read/first-product-bottling-at-the-global-bioenergies-leuna-demo-plant https://www.synbiobeta.com/read/novozymes-invites-collaboration-on-global-challenges https://www.synbiobeta.com/read/george-church-lab-spinout-gro-biosciences-secures-2-1-million-in-seed-funding https://www.synbiobeta.com/read/knipbio-announces-first-commercial-scale-purchase-order-for-premium-fishmeal-alternative https://www.synbiobeta.com/read/twist-bioscience-and-collaborators-microsoft-university-of-washington-preserve-archive-quality-audio-recordings-for-memory-of-the-world https://www.synbiobeta.com/read/learning-from-nature-to-develop-new-organisms-that-replace-technology-with-biology https://www.synbiobeta.com/read/meet-dr-jenny-rooke-biotech-investor-with-deep-life-science-expertise https://www.synbiobeta.com/read/autolus-secures-us-80-million-series-c-funding https://www.synbiobeta.com/read/modern-meadow-launches-zoa-the-first-ever-biofabricated-leather-material-brand https://www.synbiobeta.com/read/egenesis-appoints-jodie-morrison-as-chief-executive-officer-and-president https://www.synbiobeta.com/read/amyris-enters-into-second-major-product-development-and-production-agreement-with-royal-dsm https://www.synbiobeta.com/read/eligo-bioscience-secures-20-million-series-a-from-khosla-ventures-and-seventure-to-bring-precision-medicine-to-the-microbiome https://www.synbiobeta.com/read/investing-in-biological-solutions-to-human-problems https://www.synbiobeta.com/read/signature-science-awarded-contract-from-iarpa-for-the-development-of-new-computational-tools-to-screen-dna-sequences-to-detect-biological-threats https://www.synbiobeta.com/read/capital-cell-europes-first-dedicated-life-sciences-crowdfunding-platform-opens-to-uk-investors https://www.synbiobeta.com/read/protein-is-the-killer-app-for-synthetic-biology https://www.synbiobeta.com/read/upgrading-biosafety-and-biosecurity-open-philanthropy-awards-700k-for-diybio https://www.synbiobeta.com/read/provenance-biofabrics-and-ucsf-to-harness-advances-in-synthetic-biology-to-build-leather https://www.synbiobeta.com/read/mammoth-diagnostics-to-develop-new-diagnostic-tests-using-oligo-pools-from-twist-bioscience https://www.synbiobeta.com/read/synthetic-biology-and-immunotherapy-to-bring-more-effective-cell-therapies-for-cancer https://www.synbiobeta.com/read/meet-laura-adam-an-expert-in-design-automation-in-synthetic-biology https://www.synbiobeta.com/read/ecovative-design-collaborating-with-danielle-trofe-design-to-launch-grow-a-grow-it-yourself-lamp-made-with-mushroom-r-materials https://www.synbiobeta.com/read/benchling-announces-groundbreaking-workflow-results-management-solution-to-organize-optimize-and-measure-biologics-r-d https://www.synbiobeta.com/read/molecular-devices-and-cytena-partner-to-launch-the-cloneselect-single-cell-printer https://www.synbiobeta.com/read/oxitec-to-build-state-of-the-art-mosquito-egg-production-unit https://www.synbiobeta.com/read/sgi-dna-and-biocat-announce-distribution-partnership-for-vmax-tm-express-protein-expression-platform https://www.synbiobeta.com/read/a-new-enzymatic-approach-to-dna-synthesis-could-be-the-next-breakthrough-in-synthetic-biology https://www.synbiobeta.com/read/the-future-trades-in-genes-how-dna-synthesis-is-shaping-the-new-bio-economy https://www.synbiobeta.com/read/new-bioinspired-materials-why-amsilk-is-betting-on-bioengineered-silk-polymers https://www.synbiobeta.com/read/gsk-astrazeneca-and-labcyte-form-alliance-to-develop-acoustic-mass-spectrometry-a-novel-sample-handling-technology-for-ms-based-drug-discovery https://www.synbiobeta.com/read/sir-andrew-witty-former-ceo-of-gsk-joins-synthego-advisory-board https://www.synbiobeta.com/read/synpromics-announces-gene-therapy-research-partnership-with-solid-biosciences https://www.synbiobeta.com/read/meet-dr-terri-shieh-newton-life-sciences-patent-attorney https://www.synbiobeta.com/read/from-fish-stem-cells-to-sustainable-seafood-the-story-of-finless-foods https://www.synbiobeta.com/read/from-the-lab-to-the-marketplace-creating-business-opportunities-for-synthetic-biologists https://www.synbiobeta.com/read/eating-methane-and-plastics-and-staring-into-a-greener-world https://www.synbiobeta.com/read/four-women-who-are-transforming-the-biologists-toolbox https://www.synbiobeta.com/read/green-biologics-renewable-chemicals-granted-kosher-and-halal-certification https://www.synbiobeta.com/read/3rd-annual-engineering-biology-award-winners-announced https://www.synbiobeta.com/read/meet-jacob-glanville-a-scientist-and-entrepreneur-pioneering-the-next-generation-of-biomedicine https://www.synbiobeta.com/read/berkeley-lights-announces-strategic-project-with-bayer-focused-on-cell-line-development-and-antibody-discovery https://www.synbiobeta.com/read/lifemine-therapeutics-launches-with-55-million-series-a-financing https://www.synbiobeta.com/read/synthace-raises-ps7-3m-to-accelerate-biotechnology-to-enable-faster-breakthroughs https://www.synbiobeta.com/read/horizon-discovery-announces-launch-of-genome-wide-crispri-and-crispra-screening-services https://www.synbiobeta.com/read/elemental-machines-wins-masstlc-leadership-award-for-innovative-technology-of-the-year-iot https://www.synbiobeta.com/read/guesstimating-the-size-of-the-global-array-synthesis-market https://www.synbiobeta.com/read/how-to-restore-our-oceans-with-biotechnology-meet-biocellection https://www.synbiobeta.com/read/sugars-worth-getting-addicted-to-meet-sugarlogix https://www.synbiobeta.com/read/why-m-ventures-is-investing-in-synthetic-biology-companies-meet-andreas-jurgeit https://www.synbiobeta.com/read/unleashing-the-power-of-engineered-proteins-the-possibilities-are-endless https://www.synbiobeta.com/read/a-200m-dollar-mistake-why-its-best-to-be-patient-with-crispr https://www.synbiobeta.com/read/sean-osullivan-at-indiebios-5th-demo-day https://www.synbiobeta.com/read/greenlight-biosciences-announces-series-d-financing-unveils-rna-strategy https://www.synbiobeta.com/read/the-agir-project-carried-out-by-the-deinove-group-is-granted-eu14-6-million-by-the-investments-for-the-future-program-ifp-operated-by-bpifrance-to-develop-new-antibiotics https://www.synbiobeta.com/read/bayer-and-ginkgo-bioworks-join-forces-for-sustainable-agriculture-forming-new-company-with-usd-100-million-series-a https://www.synbiobeta.com/read/arcadia-biosciences-to-accelerate-agricultural-trait-development-with-crispr-cas9 https://www.synbiobeta.com/read/benson-hill-biosystems-launches-novel-genome-editing-crispr-3-0-technology https://www.synbiobeta.com/read/bioeconomy-fund-1-completes-8-3m-of-investments-in-six-companies-that-are-building-critical-infrastructure-for-the-21st-century-global-economy https://www.synbiobeta.com/read/dna-script-raises-eu11-million-13-million-in-series-a-financing-led-by-illumina-ventures-to-advance-development-of-its-dna-synthesis-technology https://www.synbiobeta.com/read/agrimetis-announces-publication-of-l-glufosinate-patent-application https://www.synbiobeta.com/read/chain-awarded-ps0-5m-grant-funding-to-develop-healthcare-platform https://www.synbiobeta.com/read/evolva-awarded-contract-by-us-government-to-advance-novel-pest-control-product https://www.synbiobeta.com/read/oxford-genetics-supports-significant-growth-with-new-u-s-office https://www.synbiobeta.com/read/synpromics-expands-facilities-to-meet-demand-for-revolutionary-gene-control-technology https://www.synbiobeta.com/read/next-generation-dna-synthesis-dna-script-raises-13m-series-a-round-led-by-illumina-ventures https://www.synbiobeta.com/read/indiebio-is-about-to-debut-its-fifth-graduating-class-of-new-startups https://www.synbiobeta.com/read/khosla-and-church-how-two-legends-see-the-future-of-ai-enhanced-synthetic-biology https://www.synbiobeta.com/read/nothing-to-hide-an-interview-with-hadyn-parry https://www.synbiobeta.com/read/technology-legends-george-church-and-vinod-khosla-to-take-stage https://www.synbiobeta.com/read/a-biotechnology-platform-to-feed-the-fish-that-feed-us https://www.synbiobeta.com/read/metabolic-engineering-is-a-scientific-art-meet-oliver-yu-ceo-of-conagen https://www.synbiobeta.com/read/sam-altman-and-jason-kelly-at-the-intersection-between-tech-and-deep-biology https://www.synbiobeta.com/read/from-methane-to-bioplastics-the-mango-materials-story https://www.synbiobeta.com/read/seafood-innovation-contest-to-develop-fish-free-fish-oil-launches https://www.synbiobeta.com/read/knipbio-reports-success-in-using-its-bioengineering-platform-to-advance-development-of-fish-feed-alternatives https://www.synbiobeta.com/read/slaves-to-nitrogen https://www.synbiobeta.com/read/meet-adam-clore-idts-synthetic-biology-veteran https://www.synbiobeta.com/read/ranomics-launches-variantfind-tm-a-dna-library-synthesis-platform https://www.synbiobeta.com/read/oxitecs-innovative-solution-to-tackle-growing-diamondback-moth-pest-issue-begins-field-trials https://www.synbiobeta.com/read/the-untold-story-of-john-cumbers-and-the-founding-of-synbiobeta https://www.synbiobeta.com/read/venture-valuations-biotechgate-collaborates-with-california-life-sciences-association-clsa-to-connect-californias-life-sciences-sector https://www.synbiobeta.com/read/science-exchange-signs-on-as-labcentral-sponsor-to-support-life-science-and-biotech-startups-with-outsourced-r-d-services https://www.synbiobeta.com/read/biological-eye-candy-at-synbiobeta-san-francisco-2017 https://www.synbiobeta.com/read/evolva-announces-major-restructuring-for-next-phase-of-its-development https://www.synbiobeta.com/read/agbiome-howler-fungicide-receives-epa-registration https://www.synbiobeta.com/read/synlogic-completes-merger-with-mirna-therapeutics https://www.synbiobeta.com/read/dow-agrosciences-and-teselagen-expanding-advanced-biodesign-platform-for-ag https://www.synbiobeta.com/read/kraig-biocraft-laboratories-delivers-first-fiber-sample-to-medical-application-firm-for-performance-and-suitability-testing https://www.synbiobeta.com/read/ibm-your-computer-can-help-scientists-study-connection-between-body-bacteria-and-autoimmune-diseases https://www.synbiobeta.com/read/bioxp-tm-genomic-workstation-makes-european-debut-at-vib-research-institute-in-belgium https://www.synbiobeta.com/read/crispr-therapeutics-announces-collaboration-with-massachusetts-general-hospital-to-research-use-of-crispr-cas9-in-t-cell-cancer-therapies https://www.synbiobeta.com/read/from-spider-silk-shoes-to-algae-fuel-welcome-to-the-new-age-of-biotech https://www.synbiobeta.com/read/new-report-proposes-framework-to-identify-vulnerabilities-posed-by-synthetic-biology https://www.synbiobeta.com/read/oxford-genetics-secures-ps7-5-million-investment https://www.synbiobeta.com/read/singularity-university-announces-new-and-updated-programs-to-prepare-leaders-for-disruptive-times-identify-strategic-opportunities-achieve-high-impact-growth-and-build-a-better-world https://www.synbiobeta.com/read/egenesis-study-addressing-cross-species-viral-transmission-concern-in-xenotransplantation-published-in-science https://www.synbiobeta.com/read/modern-meadow-moves-headquarters-into-state-of-the-art-facility-in-new-jersey https://www.synbiobeta.com/read/embryonic-editing-therapies-still-seem-unlikely-despite-crispr-progress https://www.synbiobeta.com/read/four-reasons-to-attend-synthetic-biology-conference-synbiobeta-sf-2017 https://www.synbiobeta.com/read/genomatica-introduces-next-process-technology https://www.synbiobeta.com/read/synthorx-appoints-marcos-milla-ph-d-as-senior-vice-president-of-research https://www.synbiobeta.com/read/performance-plants-announces-key-advancement-of-drought-tolerant-cotton-in-bayer-crop-science-product-development-collaboration https://www.synbiobeta.com/read/oxford-biomedica-announces-a-ps2-million-two-year-collaboration-co-funded-by-innovate-uk https://www.synbiobeta.com/read/scientist-com-and-indiebio-create-next-generation-innovation-marketplace-to-accelerate-early-stage-biotech-research https://www.synbiobeta.com/read/molecular-assemblies-recognized-as-a-leader-in-innovation https://www.synbiobeta.com/read/agilis-biotherapeutics-and-gene-therapy-research-institution-enter-into-strategic-partnership https://www.synbiobeta.com/read/idt-launches-first-cas9-enzyme-that-drastically-reduces-crispr-off-target-effects-without-significant-loss-of-on-target-activity https://www.synbiobeta.com/read/swedish-wellness-innovator-nutrinovate-to-formulate-healthy-ageing-skin-care-line-with-evolvas-veri-te-tm-resveratrol https://www.synbiobeta.com/read/at-t-connects-elemental-machines-smart-labs https://www.synbiobeta.com/read/horizon-discovery-announces-release-of-high-quality-well-annotated-cho-genome-sequence-to-drive-innovation-in-bioproduction https://www.synbiobeta.com/read/swayana-brings-carbon-recycling-to-south-africa https://www.synbiobeta.com/read/u-s-army-exercises-contract-option-with-kraig-biocraft-laboratories-awarding-additional-funding-to-develop-and-deliver-spider-silk-technology https://www.synbiobeta.com/read/colorifix-reinventing-the-color-wheel-of-the-textile-industry https://www.synbiobeta.com/read/imminent-approval-of-novartis-car-t-cell-therapy-is-a-long-awaited-win-for-the-industry-and-the-world https://www.synbiobeta.com/read/verdezyne-groundbreaking-ceremony-in-malaysia-commemorates-initiation-of-the-worlds-first-biobased-ddda-plant https://www.synbiobeta.com/read/biologics-the-pricey-drugs-transforming-medicine https://www.synbiobeta.com/read/modern-meadow-reveals-the-technologies-behind-its-biofabricated-leather-materials https://www.synbiobeta.com/read/22-synthetic-biology-companies-have-raised-half-a-billion-dollars-in-2017 https://www.synbiobeta.com/read/storing-data-in-dna-brings-nature-into-the-digital-universe https://www.synbiobeta.com/read/can-synthetic-biology-make-our-oceans-more-sustainable https://www.synbiobeta.com/read/ginkgo-bioworks-and-kerry-announce-new-technology-partnership https://www.synbiobeta.com/read/praj-gevo-joint-development-agreement-to-enter-commercialization-phase https://www.synbiobeta.com/read/vaude-launches-footwear-range-containing-biosuccinium-r https://www.synbiobeta.com/read/amyris-biossance-launches-in-sephora-canada-stores https://www.synbiobeta.com/read/cyrus-biotechnology-announces-8m-financing-to-expand-computational-drug-discovery-software-platform https://www.synbiobeta.com/read/swissaustral-and-ginkgo-bioworks-partner-to-develop-improved-industrial-enzymes https://www.synbiobeta.com/read/synthego-announces-worlds-first-modified-synthetic-sgrna-libraries-for-arrayed-whole-genome-crispr-screening https://www.synbiobeta.com/read/calyxt-announces-pricing-of-56-0-million-initial-public-offering https://www.synbiobeta.com/read/cellectis-granted-patent-for-crispr-use-in-t-cells https://www.synbiobeta.com/read/the-story-behind-the-non-browning-apple-an-interview-with-neal-carter https://www.synbiobeta.com/read/lygos-appoints-industry-expert-johan-van-walsem-as-coo-to-lead-commercial-operations-and-manufacturing https://www.synbiobeta.com/read/bgi-genomics-announces-pricing-of-initial-public-offering https://www.synbiobeta.com/read/a-vibrant-synthetic-biology-ecosystem-has-developed-in-the-uk-promising-new-jobs-and-valuable-technology https://www.synbiobeta.com/read/modern-meadow-to-unveil-its-creative-materials-platform-at-fall-exhibition https://www.synbiobeta.com/read/stella-mccartney-and-bolt-threads-announce-a-new-partnership-focused-on-sustainable-fashion-and-luxury-materials-development https://www.synbiobeta.com/read/the-rise-of-the-robot-scientist https://www.synbiobeta.com/read/3-futureoffood-trends-in-2017 https://www.synbiobeta.com/read/when-the-pest-becomes-the-pesticide-genetically-reprogramming-mosquitoes-moths-and-more https://www.synbiobeta.com/read/arzeda-raises-12-million-in-series-a-round-of-funding-led-by-os-fund https://www.synbiobeta.com/read/bgene-genetics-announces-the-acquisition-of-cad4bio https://www.synbiobeta.com/read/amyris-enters-into-first-product-development-and-production-agreement-with-royal-dsm-for-food-and-nutrition-molecule https://www.synbiobeta.com/read/crispr-therapeutics-and-neon-therapeutics-enter-research-collaboration https://www.synbiobeta.com/read/oxitec-launching-friendly-tm-aedes-project-in-juiz-de-fora-brazil https://www.synbiobeta.com/read/calyxt-announces-proposed-initial-public-offering-of-100-0-million https://www.synbiobeta.com/read/us-patent-granted-to-azargen-biotechnologies-for-synthetic-promoter-technology https://www.synbiobeta.com/read/sphere-fluidics-limited-and-partners-win-major-innovateuk-grant-to-develop-the-worlds-first-desktop-genome-editing-system https://www.synbiobeta.com/read/the-solution-to-the-human-organ-shortage-may-be-found-in-pigs-literally https://www.synbiobeta.com/read/customem-wins-ps100k-1st-prize-in-bio-start-competition https://www.synbiobeta.com/read/synthego-launches-crispr-pioneers-program-to-expand-genome-engineering-research-worldwide https://www.synbiobeta.com/read/indianoil-and-lanzatech-sign-a-statement-of-intent-to-construct-worlds-first-refinery-off-gas-to-bioethanol-production-facility-in-india https://www.synbiobeta.com/read/quintara-biosciences-partners-with-twist-bioscience-to-launch-new-gene-fragment-and-cloning-services-qblocks-and-qgenes https://www.synbiobeta.com/read/twist-bioscience-collaborates-with-synbio-technologies-to-supply-long-dna-to-customers https://www.synbiobeta.com/read/horizon-discovery-takes-exclusive-license-for-novel-transposon-based-gene-editing-technology-platform https://www.synbiobeta.com/read/indiebio-backed-startups-gain-exclusive-access-to-customized-science-exchange-outsourced-r-d-platform-helping-to-level-playing-field-with-larger-biopharma-companies https://www.synbiobeta.com/read/crispr-a-present-day-guide-to-the-current-crispr-innovation-landscape https://www.synbiobeta.com/read/oxitecs-friendly-tm-aedes-mosquito-receives-positive-evaluation-for-european-standard-in-relation-to-human-health-and-the-environment https://www.synbiobeta.com/read/neil-goldsmith-stepping-down-as-ceo-and-board-member-of-evolva https://www.synbiobeta.com/read/flagship-pioneering-announces-launch-of-sigilon-therapeutics-to-harness-the-full-power-of-cell-therapeutics https://www.synbiobeta.com/read/green-biologics-achieves-reach-certification-sets-sights-on-europe https://www.synbiobeta.com/read/genomatica-delivers-on-plant-performance-guarantees https://www.synbiobeta.com/read/science-exchange-raises-28m-in-series-c-funding https://www.synbiobeta.com/read/ecovative-design-awarded-9-1-million-u-s-department-of-defense-research-contract https://www.synbiobeta.com/read/ecovative-design-awarded-9-1-million-u-s-department-of-defense-research-contract-to-develop-scale-a-new-generation-of-living-building-materials https://www.synbiobeta.com/read/dupont-pioneer-secures-exclusive-rights-to-ers-genomics-crispr-cas-patent-portfolio-for-agriculture https://www.synbiobeta.com/read/at-synbiobeta-sf-2017-a-fireside-chat-with-george-church-on-how-biology-meets-artificial-intelligence https://www.synbiobeta.com/read/the-bio-side-of-big-data-mimetics-uncovers-hidden-patterns-in-agbio-food-and-pharma https://www.synbiobeta.com/read/amyris-partners-with-queensland-on-biofutures-acceleration-program-in-next-step-toward-planned-development-of-biorefinery https://www.synbiobeta.com/read/novel-biomaterial-that-filters-out-harmful-micropollutants-wins-science-award https://www.synbiobeta.com/read/synlogic-receives-fast-track-designation-in-u-s-for-lead-candidate-synb1020 https://www.synbiobeta.com/read/second-microbial-and-plant-systems-modulated-by-secondary-metabolite-meeting-joint-genome-institute https://www.synbiobeta.com/read/crispr-therapeutics-announces-patent-for-crispr-cas-genome-editing-in-china https://www.synbiobeta.com/read/dr-una-ryan-joins-elemental-machines-board-of-directors https://www.synbiobeta.com/read/intellia-therapeutics-announces-patent-for-crispr-cas-genome-editing-in-china https://www.synbiobeta.com/read/synlogic-tm-doses-first-subject-in-phase-1-trial-of-novel-class-of-synthetic-biotic-tm-medicines https://www.synbiobeta.com/read/vonnie-estes-to-receive-2017-rosalind-franklin-award https://www.synbiobeta.com/read/exxonmobil-and-synthetic-genomics-report-breakthrough-in-algae-biofuel-research https://www.synbiobeta.com/read/twist-bioscience-and-biobricks-foundation-announce-unique-partnership https://www.synbiobeta.com/read/twist-bioscience-and-the-biobricks-foundation-announce-partnership-to-provide-10-000-public-benefit-genes-to-the-synthetic-biology-community https://www.synbiobeta.com/read/alexandria-launchlabs-nycs-premier-life-science-startup-platform-celebrates-grand-opening-and-awards-inaugural-100-000-entrepreneurship-prize https://www.synbiobeta.com/read/eligo-bioscience-awarded-as-technology-pioneer-by-world-economic-forum https://www.synbiobeta.com/read/sb7-0-the-seventh-international-meeting-on-synthetic-biology-days-1-and-2 https://www.synbiobeta.com/read/twist-bioscience-adds-27-million-to-its-2017-financing https://www.synbiobeta.com/read/james-collins-to-keynote-at-synbiobeta-sf-2017 https://www.synbiobeta.com/read/selling-half-baked-cakes-by-emilia-diaz-founder-of-kaitek-labs https://www.synbiobeta.com/read/intellia-therapeutics-and-san-raffaele-university-and-research-hospital-to-combine-crispr-cas9-genome-editing-with-enhanced-cell-therapies-to-fight-cancer https://www.synbiobeta.com/read/cell-design-labs-announces-issuance-of-broad-patent-for-chimeric-notch-synnotch-tm-receptor-to-treat-cancer-and-other-diseases https://www.synbiobeta.com/read/living-ink-raises-funds-from-colorados-aia-for-sustainable-algal-ink https://www.synbiobeta.com/read/synlogic-meets-first-discovery-milestone-in-partnership-with-abbvie https://www.synbiobeta.com/read/integrated-dna-technologies-launches-new-grant-program-aimed-at-synthetic-biology-startups https://www.synbiobeta.com/read/deinove-and-flint-hills-resources-enter-the-second-stage-of-their-partnership-in-animal-feed https://www.synbiobeta.com/read/show-me-the-money-5-biotech-ready-vcs https://www.synbiobeta.com/read/atum-and-horizon-discovery-announce-collaboration-and-technology-cross-license-to-simplify-and-speed-bioproduction-cell-line-development https://www.synbiobeta.com/read/intrexons-head-of-environment-sector-joins-brazil-investment-forum-to-discuss-importance-of-vector-control-and-economic-impact-of-vector-borne-diseases https://www.synbiobeta.com/read/labcyte-moves-global-headquarters-to-60-000-square-foot-building-in-san-jose https://www.synbiobeta.com/read/sb7-0-will-address-the-role-of-synthetic-biology-in-security https://www.synbiobeta.com/read/synthetic-genomics-launches-cgmp-suite-for-pharmaceutical-quality-manufacturing-of-synthetic-dna-for-advaxis-clinical-trials https://www.synbiobeta.com/read/metabolic-explorer-presents-its-new-development-project-and-discloses-its-new-ambitions https://www.synbiobeta.com/read/thermo-fisher-scientific-strengthens-portfolio-of-endotoxin-free-plasmid-dna-isolation-kits https://www.synbiobeta.com/read/nucelis-and-fermic-enter-partnership-to-bring-naturally-sourced-specialty-ingredients-to-market https://www.synbiobeta.com/read/digital-to-biological-converter-for-on-demand-production-of-biologics-developed-by-synthetic-genomics-inc https://www.synbiobeta.com/read/biomx-raises-24-million-in-series-a-funding-to-develop-microbiome-therapeutics https://www.synbiobeta.com/read/gevos-isobutanol-cleared-for-use-in-on-road-vehicles-in-arizona https://www.synbiobeta.com/read/intrexon-appoints-dr-mark-carnegie-brown-as-ceo-of-oxitec https://www.synbiobeta.com/read/horizon-discovery-announces-new-gene-editing-technology-platform-for-research-and-therapeutic-applications https://www.synbiobeta.com/read/sb7-0-panel-will-address-the-biodiversity-crisis-and-how-synbio-can-help https://www.synbiobeta.com/read/ginkgo-bioworks-and-robertet-announce-successful-commercial-scale-fermentation-of-flavor-and-fragrance-cultured-ingredient https://www.synbiobeta.com/read/amyris-on-track-to-double-revenue-for-vitamin-e-partnership-with-nenter-announces-exclusive-vitamin-a-license-with-royal-dsm https://www.synbiobeta.com/read/argonne-national-laboratory-and-national-renewable-energy-laboratory-receive-funding-to-support-the-blending-of-gevos-isobutanol-with-gasoline https://www.synbiobeta.com/read/atum-licenses-gene-design-software-to-thermo-fisher-scientific https://www.synbiobeta.com/read/synlogic-and-mirna-therapeutics-agree-to-merger https://www.synbiobeta.com/read/synthego-first-to-offer-over-100-000-genomes-in-powerful-new-crispr-software https://www.synbiobeta.com/read/johnson-johnson-innovation-announces-40-resident-companies-now-at-jlabs-toronto https://www.synbiobeta.com/read/caribou-biosciences-announces-grant-of-a-key-crispr-cas9-genome-editing-patent-in-europe https://www.synbiobeta.com/read/cellectis-patent-encompassing-broad-uses-of-gene-editing-technologies-maintained-by-uspto https://www.synbiobeta.com/read/rebelbio-launches-the-fourth-generation-of-startups-a-look-at-the-first-five https://www.synbiobeta.com/read/two-new-start-up-plans-win-brissynbios-first-synthetic-biology-entrepreneurship-competition https://www.synbiobeta.com/read/fda-extends-comment-period-on-genome-editing-tech-for-plants-and-animals https://www.synbiobeta.com/read/huvepharma-to-utilize-intrexons-proprietary-fungal-expression-platform-to-produce-key-animal-feed-enzyme https://www.synbiobeta.com/read/royal-dsm-to-make-equity-investment-in-amyris-with-the-purpose-of-establishing-a-long-term-relationship https://www.synbiobeta.com/read/evolva-signs-two-new-distributor-agreements-in-europe-for-veri-tetm https://www.synbiobeta.com/read/amyris-announces-much-better-than-expected-sales-of-farnesene-to-meet-accelerated-demand-for-liquid-farnesene-rubber-by-global-tire-brands https://www.synbiobeta.com/read/opentrons-launches-2x-faster-ot-one-s-line-of-personal-pipetting-robots https://www.synbiobeta.com/read/sb7-0-session-3-art-critical-design-critique-our-world https://www.synbiobeta.com/read/calysta-completes-40-million-series-d-financing https://www.synbiobeta.com/read/caribou-biosciences-and-dupont-pioneer-develop-new-method-to-comprehensively-map-the-off-target-activity-of-crispr-cas9-across-entire-genomes https://www.synbiobeta.com/read/intellia-therapeutics-and-crispr-therapeutics-announce-u-s-patent-covering-crispr-cas9-ribonucleoprotein-complexes https://www.synbiobeta.com/read/renewable-energy-group-closes-financing-on-24-million-upgrade-to-ralston-biorefinery https://www.synbiobeta.com/read/calysta-cargill-officially-break-ground-on-nouritech-a-new-feed-production-plant-in-memphis https://www.synbiobeta.com/read/amyris-announces-industrial-production-of-leading-healthy-sweetener-product-in-2018 https://www.synbiobeta.com/read/amyris-announces-key-advancements-under-darpa-multi-year-technology-investment-agreement-enables-development-of-industrial-scale-fermentation-process-for-virtually-any-biological-molecule https://www.synbiobeta.com/read/building-with-biology-researchers-discuss-advances-in-bioproduction-at-sb7-0 https://www.synbiobeta.com/read/twist-bioscience-appoints-chief-ethics-and-compliance-officer https://www.synbiobeta.com/read/sb7-0-session-1-translating-ideas-into-impact https://www.synbiobeta.com/read/global-bioenergies-announces-first-success-in-scaling-up-the-isobutene-process-in-the-leuna-demo-plant https://www.synbiobeta.com/read/panel-on-synthetic-cells-will-kick-off-sb7-0-conference https://www.synbiobeta.com/read/modular-genetics-surfactants-awarded-100-usda-certified-biobased-content-r-and-palm-oil-free-r-certification https://www.synbiobeta.com/read/7th-international-meeting-on-synthetic-biology-takes-fresh-look-at-opportunities-and-challenges https://www.synbiobeta.com/read/kraig-biocraft-laboratories-expands-domestic-spider-silk-production-capacity https://www.synbiobeta.com/read/synpromics-raises-ps5-2m-of-new-investment https://www.synbiobeta.com/read/crispr-therapeutics-and-casebia-therapeutics-announce-exclusive-development-and-option-agreement-with-stridebio https://www.synbiobeta.com/read/amyris-agrees-to-exclusive-china-manufacturing-with-blue-california-enabling-continued-record-product-revenue-growth-into-asian-markets https://www.synbiobeta.com/read/twist-bioscience-expands-agreement-to-pursue-higher-density-digital-data-storage-on-dna-with-microsoft-and-university-of-washington https://www.synbiobeta.com/read/watch-the-fireside-chat-with-christine-gould-and-thomas-bostick-at-synbiobeta-london-2017 https://www.synbiobeta.com/read/forget-transistors-data-storage-goes-biological-thanks-to-microsoft-university-of-washington-and-twist-bioscience https://www.synbiobeta.com/read/watch-drew-endys-keynote-at-synbiobeta-london-2017 https://www.synbiobeta.com/read/codexis-announces-pricing-of-public-offering-of-common-stock https://www.synbiobeta.com/read/u-s-epa-awards-300-000-to-east-bay-small-business-that-harnesses-microbes-for-green-chemistry https://www.synbiobeta.com/read/intellia-therapeutics-announces-european-patent-offices-decision-to-grant-crispr-cas9-genome-editing-technology-patent https://www.synbiobeta.com/read/twist-bioscience-ceo-named-distinguished-alumnus-of-the-university-of-houston-college-of-natural-sciences-and-mathematics https://www.synbiobeta.com/read/atum-launches-cell-line-development-service https://www.synbiobeta.com/read/synbiobeta-and-ginkgo-bioworks-collaborate-to-make-the-synthetic-biology-community-more-diverse-and-inclusive https://www.synbiobeta.com/read/highlights-of-day-2-of-synbiobeta-london-2017 https://www.synbiobeta.com/read/highlights-of-day-1-of-synbiobeta-london-2017 https://www.synbiobeta.com/read/twist-bioscience-to-present-at-synbiobeta-london-2017 https://www.synbiobeta.com/read/syngenta-good-growth-plan-annual-update-programs-to-improve-farm-sustainability-more-than-double-their-reach https://www.synbiobeta.com/read/new-cloud-based-perkinelmer-signals-tm-notebook-helps-scientists-accelerate-drug-discovery-research https://www.synbiobeta.com/read/amyris-enables-launch-of-new-high-performance-tackifier-from-cray-valley-featuring-sustainably-sourced-resin-technology https://www.synbiobeta.com/read/biosyntia-and-fgen-to-collaborate-on-development-of-vitamin-production-strain https://www.synbiobeta.com/read/bp-and-dupont-joint-venture-butamax-r-announces-next-step-in-commercialization-of-bio-isobutanol-with-acquisition-of-ethanol-facility-in-kansas https://www.synbiobeta.com/read/intrexon-ziopharm-and-merck-kgaa-darmstadt-germany-advancing-next-generation-non-viral-car-t-platform-empowered-by-membrane-bound-il-15-under-rheoswitch-therapeutic-system-control https://www.synbiobeta.com/read/plos-offers-protocols-io-author-tools-to-improve-experimental-methods-reporting https://www.synbiobeta.com/read/data-collective-partners-with-dr-john-cumbers-founder-of-synbiobeta-to-launch-pre-seed-and-seed-stage-synthetic-biology-venture-fund https://www.synbiobeta.com/read/engineering-the-future-new-partnership-set-to-transform-the-engineering-of-biology https://www.synbiobeta.com/read/european-intellectual-property-firm-keltie-expands-to-irish-technology-hub https://www.synbiobeta.com/read/synthego-awards-synthetic-sgrna-grant-to-university-of-oxford-for-crispr-research-applications-in-the-uk https://www.synbiobeta.com/read/evolva-announces-long-term-commercial-agreement-with-cargill https://www.synbiobeta.com/read/oxitecs-friendly-tm-aedes-achieves-81-suppression-of-wild-aedes-aegypti-in-cecap-eldorado-piracicaba-in-second-year-of-project https://www.synbiobeta.com/read/codexis-signs-second-multi-year-agreement-in-food-industry-with-tate-lyle https://www.synbiobeta.com/read/egf-advances-synthetic-dna-assembly-using-fully-automated-workflow-with-integrated-colony-picking-from-molecular-devices https://www.synbiobeta.com/read/why-the-uk-is-a-great-place-to-start-a-synthetic-biology-company https://www.synbiobeta.com/read/genewiz-to-launch-single-cell-rna-seq-services-at-aacr https://www.synbiobeta.com/read/crispr-therapeutics-announces-european-patent-for-crispr-cas-gene-editing https://www.synbiobeta.com/read/sgi-dna-launches-automated-next-generation-sequencing-library-construction-kits-for-the-bioxp-tm-3200-system-to-expand-the-capabilities-of-the-genomic-workstation https://www.synbiobeta.com/read/twist-bioscience-raises-33-million https://www.synbiobeta.com/read/deinove-enters-the-cosmetic-ingredients-market-with-greentech-with-the-objective-of-a-commercial-launch-by-end-of-2018 https://www.synbiobeta.com/read/meet-these-french-synbio-startups-and-organizations https://www.synbiobeta.com/read/basf-licenses-crispr-cas9-genome-editing-technology-from-the-broad-institute https://www.synbiobeta.com/read/genscript-partners-with-igem-to-expand-synthetic-biology-community-in-china https://www.synbiobeta.com/read/lightning-talks-at-synbiobeta-london-will-showcase-international-synbio-scene https://www.synbiobeta.com/read/agrimetis-announces-publication-of-spinosyn-analog-patent-applications https://www.synbiobeta.com/read/cell-design-labs-announces-issuance-of-broad-patent-for-programmable-car-t-cells-to-treat-cancer-and-other-diseases https://www.synbiobeta.com/read/deinove-now-has-a-catalog-of-active-extracts-identified-for-cosmetic-applications https://www.synbiobeta.com/read/how-darpa-is-leading-the-debate-on-biosecurity-and-biosafety-with-genome-editors https://www.synbiobeta.com/read/synthego-announces-modified-synthetic-sgrna-for-crispr-genome-editing https://www.synbiobeta.com/read/zio-fungicide-developed-by-agbiome-receives-epa-registration https://www.synbiobeta.com/read/intrexon-ceo-rj-kirk-to-speak-at-sb7-0 https://www.synbiobeta.com/read/editas-medicine-inc-announces-pricing-of-90-million-offering-of-common-stock https://www.synbiobeta.com/read/egenesis-announces-38-million-series-a-financing-led-by-biomatics-capital-and-arch-venture-partners-to-solve-shortage-of-organs-for-donation https://www.synbiobeta.com/read/egenesis-co-founder-luhan-yang-named-young-global-leader-by-world-economic-forum https://www.synbiobeta.com/read/evolva-teams-up-with-fci-to-expand-nootkatone-and-valencene-sales-marketing-in-europe https://www.synbiobeta.com/read/eurofins-genomics-us-announces-commercial-launch-of-next-generation-dna-synthesis-service https://www.synbiobeta.com/read/synpromics-granted-key-patent-in-synthetic-promoter-development https://www.synbiobeta.com/read/thermo-fisher-scientific-announces-first-ever-cloud-based-application-for-connectivity-to-electronic-pipettes https://www.synbiobeta.com/read/biobright-tools-bring-superpowers-to-the-biology-lab https://www.synbiobeta.com/read/lord-david-prior-of-brampton-to-keynote-synbiobeta-london https://www.synbiobeta.com/read/allergan-and-editas-medicine-enter-into-strategic-r-d-alliance-to-discover-and-develop-crispr-genome-editing-medicines-for-eye-diseases https://www.synbiobeta.com/read/crispr-therapeutics-and-casebia-therapeutics-announce-commercial-license-agreement-with-maxcyte https://www.synbiobeta.com/read/the-tools-challenges-and-future-uses-for-renewable-bio-based-materials https://www.synbiobeta.com/read/intrexon-creates-precigen-inc-and-accelerates-strategic-review-of-structural-options-related-to-health-assets https://www.synbiobeta.com/read/annual-synthetic-biology-industry-investment-update-over-1-billion-usd-invested-in-past-12-months https://www.synbiobeta.com/read/horizon-discovery-enters-into-r-d-and-licensing-partnership-with-amplycell-s-a-for-bioproduction-cell-line-optimisation https://www.synbiobeta.com/read/bolt-threads-brings-a-glimpse-of-the-future-of-advanced-materials-to-sxsw https://www.synbiobeta.com/read/drew-endy-to-keynote-synbiobeta-london https://www.synbiobeta.com/read/federal-regulatory-agencies-need-to-prepare-for-greater-quantity-and-range-of-biotechnology-products https://www.synbiobeta.com/read/evolva-achieves-second-milestone-in-fragrance-flavour-alliance-with-takasago https://www.synbiobeta.com/read/molecular-assemblies-appoints-floyd-e-romesberg-from-the-scripps-research-institute-to-scientific-advisory-board https://www.synbiobeta.com/read/researchers-assemble-five-new-synthetic-yeast-chromosomes https://www.synbiobeta.com/read/intellia-therapeutics-demonstrates-pioneering-crispr-cas9-genome-editing-efficiency-data-using-lipid-nanoparticle-delivery-technology https://www.synbiobeta.com/read/kite-pharmas-engineered-t-cell-therapies-for-cancers-delivers-astonishing-results https://www.synbiobeta.com/read/heurisko-is-supporting-the-development-of-the-bioeconomy-through-directed-evolution-in-vivo https://www.synbiobeta.com/read/amyris-kuraray-deliver-superior-performance-in-sumitomos-dunlop-winter-maxx-02-car-tires-driving-accelerated-growth-for-amyris https://www.synbiobeta.com/read/andy-bass-to-lead-biological-popular-culture-intrexons-consumer-sector https://www.synbiobeta.com/read/dnastar-releases-lasergene-14-1-software-with-major-enhancements https://www.synbiobeta.com/read/gevo-ranked-10-in-the-digests-2017-50-hottest-companies-in-the-advanced-bioeconomy https://www.synbiobeta.com/read/renewable-energy-group-announces-several-milestones https://www.synbiobeta.com/read/alexandria-launchlabs-nycs-premier-life-science-startup-platform-selects-its-first-member-companies https://www.synbiobeta.com/read/iogens-ceo-brian-foody-receives-lifetime-achievement-award-at-2017-advanced-bioeconomy-leadership-conference https://www.synbiobeta.com/read/46-organizations-making-biology-easier-to-engineer https://www.synbiobeta.com/read/sofinnova-partners-raises-eu106-million-in-a-first-closing-of-its-industrial-biotech-fund https://www.synbiobeta.com/read/intrexon-environment-sector-head-thomas-p-bostick-to-speak-at-synbiobeta-london https://www.synbiobeta.com/read/muse-bio-secures-23m-series-b-financing-led-by-venrock https://www.synbiobeta.com/read/how-automation-is-accelerating-biology-to-improve-reproducibility-and-standardization https://www.synbiobeta.com/read/how-protocols-io-is-advancing-life-sciences-through-the-sharing-of-protocols https://www.synbiobeta.com/read/clariant-enters-next-phase-with-global-bioenergies-renewable-isobutene-for-high-value-application https://www.synbiobeta.com/read/dna-synthesis-will-eclipse-dna-sequencing-says-hermann-hauser-evonetix-investor https://www.synbiobeta.com/read/extremers-extra-long-oligonucleotides-with-lowest-error-rate-on-eurofinss-new-synthesis-platform https://www.synbiobeta.com/read/inovio-reports-new-positive-clinical-data-on-vaccine-advances-in-the-fight-against-emerging-infectious-diseases https://www.synbiobeta.com/read/lt-gen-ret-thomas-p-bostick-head-of-intrexons-environment-sector-elected-to-national-academy-of-engineering https://www.synbiobeta.com/read/biotech-meets-beauty-as-biossance-tm-announces-a-new-look-and-product-launches https://www.synbiobeta.com/read/survey-over-80-percent-of-new-crispr-users-are-conducting-gene-editing-for-the-first-time https://www.synbiobeta.com/read/isogenica-announces-new-licence-agreement-with-top-25-global-pharmaceutical-company https://www.synbiobeta.com/read/launching-a-moonshot-factory-in-the-rebel-country-corks-synbio-scene https://www.synbiobeta.com/read/3-biotech-trends-in-2017 https://www.synbiobeta.com/read/oxford-genetics-secures-ps1-61m-innovate-uk-grant-to-establish-next-generation-bioproduction-technologies https://www.synbiobeta.com/read/verdezyne-launches-new-corrosion-inhibitor https://www.synbiobeta.com/read/an-interview-with-daniela-quaglia-on-synbio-and-science-communication https://www.synbiobeta.com/read/cell-design-labs-scientific-founder-co-authors-review-article-illustrating-power-and-potential-of-engineered-human-cells-to-treat-cancer https://www.synbiobeta.com/read/genes-in-space-competition-launches https://www.synbiobeta.com/read/idt-sustainability-award-supports-biodiversity-research-for-second-year https://www.synbiobeta.com/read/first-production-in-history-of-fully-renewable-etbe-global-bioenergies https://www.synbiobeta.com/read/integrated-dna-technologies-acquires-oligo-manufacturing-business-of-geneworks-australia https://www.synbiobeta.com/read/evolva-launches-veri-te-tm-the-brand-for-high-purity-sustainably-produced-resveratrol https://www.synbiobeta.com/read/accessible-bio-companies-back-up-the-importance-of-criminal-diy-kits-for-the-future-of-science-education https://www.synbiobeta.com/read/cellana-and-living-ink-enter-into-a-joint-development-and-offtake-agreement-for-sustainable-algae-inks https://www.synbiobeta.com/read/smarter-approaches-to-gm-regulation https://www.synbiobeta.com/read/five-pioneering-female-leaders-in-synthetic-biology https://www.synbiobeta.com/read/global-bioenergies-finalizes-acquisition-of-syngip https://www.synbiobeta.com/read/thermo-fisher-scientific-innovations-designed-to-accelerate-research-productivity-and-discovery-on-display-at-slas-2017 https://www.synbiobeta.com/read/teselagen-receives-500-000-award-for-gene-editing-and-engineering-software https://www.synbiobeta.com/read/isogenica-announces-new-licence-agreement-with-maverick-therapeutics https://www.synbiobeta.com/read/riffyn-and-novozymes-join-forces-to-accelerate-the-digital-future-of-scientific-research https://www.synbiobeta.com/read/idt-first-to-market-with-complete-cpf1-based-crispr-genome-editing-system https://www.synbiobeta.com/read/benchling-announces-first-of-its-kind-molecular-biology-2-0-software-enabling-scientists-to-run-thousands-of-experiments-at-once https://www.synbiobeta.com/read/indiebio-reveals-its-fourth-class-of-synbio-startups-part-2 https://www.synbiobeta.com/read/meet-the-speakers-will-synthetic-biology-be-the-key-to-our-future-health https://www.synbiobeta.com/read/twist-bioscience-issues-official-response-to-lawsuit-from-agilent-technologies https://www.synbiobeta.com/read/exemplar-genetics-awarded-subcontract-to-advance-new-therapeutic-models-for-sickle-cell-disease https://www.synbiobeta.com/read/agbiome-receives-inaugural-2016-innovation-award https://www.synbiobeta.com/read/cyrus-biotechnology-supports-the-boston-area-group-for-informatics-and-modeling https://www.synbiobeta.com/read/bactevo-wins-innovate-award https://www.synbiobeta.com/read/indiebio-sf-reveals-its-fourth-class-of-start-ups https://www.synbiobeta.com/read/intrexon-to-acquire-genvec-to-expand-industry-leading-gene-delivery-platform https://www.synbiobeta.com/read/oxitec-and-gbit-announce-launch-of-friendly-tm-aedes-project-in-india https://www.synbiobeta.com/read/takara-bio-usa-inc-and-teselagen-biotechnology-inc-release-a-powerful-new-primer-tool-for-easy-design-of-in-fusion-cloning-experiments https://www.synbiobeta.com/read/organism-company-ginkgo-bioworks-acquires-synthetic-dna-supplier-gen9 https://www.synbiobeta.com/read/agrimetis-raises-23-5-million-in-series-b-funding https://www.synbiobeta.com/read/ginkgo-bioworks-acquires-leading-synthetic-dna-provider-gen9 https://www.synbiobeta.com/read/aobiome-partners-with-icarbonx-and-secures-30-million-investment-for-drug-development https://www.synbiobeta.com/read/eurofins-genomics-expands-express-oligo-service https://www.synbiobeta.com/read/synthomics-announces-completion-of-seed-financing-and-launch-of-early-access-program-for-next-generation-dna-synthesis-platform https://www.synbiobeta.com/read/demonstration-of-multi-season-efficacy-and-immunogenicity-of-codagenixs-codavax-intranasal-influenza-vaccine https://www.synbiobeta.com/read/roosterbio-inc-unites-with-manufacturing-innovation-institutes-joining-manufacturing-usa-network https://www.synbiobeta.com/read/synthetic-genomics-and-exxonmobil-renew-algae-biofuels-research-agreement https://www.synbiobeta.com/read/confronting-the-problem-of-knowledge-mismanagement-in-life-science-r-d https://www.synbiobeta.com/read/horizon-broadens-industry-leading-gene-editing-capabilities-through-extension-of-key-crispr-license-and-grant-funded-research https://www.synbiobeta.com/read/butagaz-becomes-the-first-gas-distributor-in-france-to-market-butane-and-propane-containing-bio-isobutene-in-an-exclusive-partnership-with-global-bioenergies https://www.synbiobeta.com/read/igem-startup-pvp-biologics-closes-a-35-million-agreement-with-pharmaceutical-company-takeda https://www.synbiobeta.com/read/molecular-assemblies-takes-on-the-next-generation-of-dna-synthesis https://www.synbiobeta.com/read/codexis-to-offer-high-performance-enzymes-for-diagnostics-markets https://www.synbiobeta.com/read/evolva-provides-update-on-stevia-collaboration-and-2016-preliminary-top-line-numbers https://www.synbiobeta.com/read/gevo-provides-luverne-plant-update https://www.synbiobeta.com/read/mount-tam-biotechnologies-inc-and-isomerase-therapeutics-announce-expansion-of-their-collaboration-to-discover-and-develop-novel-rapalogs https://www.synbiobeta.com/read/ziopharm-and-intrexon-announce-cooperative-research-and-development-agreement-with-the-national-cancer-institute-utilizing-sleeping-beauty-system-to-generate-t-cells-targeting-neoantigens https://www.synbiobeta.com/read/monsanto-announces-global-genome-editing-licensing-agreement-with-broad-institute-for-newly-characterized-crispr-system https://www.synbiobeta.com/read/sangamo-biosciences-changes-name-to-sangamo-therapeutics-underscoring-focus-on-clinical-development-of-genomic-therapies https://www.synbiobeta.com/read/twist-bioscience-supplying-3-2kb-genes-to-ginkgo-bioworks https://www.synbiobeta.com/read/metabolix-inc-announces-name-change-to-yield10-bioscience-inc https://www.synbiobeta.com/read/synthetic-genomics-announces-collaboration-with-johnson-johnson-innovation-to-develop-novel-therapeutics-using-synthetic-genomics-replicon-rna-technology https://www.synbiobeta.com/read/not-just-for-cars-anymore-lanzatech-takes-future-of-biofuels-sky-high https://www.synbiobeta.com/read/sosv-the-accelerator-vc-closes-150-million-fund-iii https://www.synbiobeta.com/read/success-and-last-payment-in-the-bioma-project-financed-by-the-french-state https://www.synbiobeta.com/read/synthetic-genomics-sgi-dna-launches-vmax-tm-express-a-next-generation-protein-expression-platform-for-the-biotech-industry https://www.synbiobeta.com/read/prokarium-and-probiomed-in-uk-mexico-collaboration-to-scale-up-manufacture-of-thermostable-vaccines-with-a-focus-on-diarrhoea https://www.synbiobeta.com/read/synpromics-announces-a-research-collaboration-with-ge-healthcare-to-extend-the-toolbox-for-production-of-biologics https://www.synbiobeta.com/read/synthego-raises-41-million-in-series-b-financing-led-by-8vc-to-advance-crispr-genome-engineering https://www.synbiobeta.com/read/global-bioenergies-plans-to-acquire-dutch-start-up-syngip-b-v https://www.synbiobeta.com/read/horizon-discovery-announces-a-progress-update-on-its-cell-line-catalogue-business https://www.synbiobeta.com/read/keeping-biosecurity-in-the-forefront-a-conversation-with-renee-wegrzyn https://www.synbiobeta.com/read/pivotal-evolva-stevia-sweetener-patent-receives-us-notice-of-allowance https://www.synbiobeta.com/read/crispr-therapeutics-intellia-therapeutics-caribou-biosciences-and-ers-genomics-announce-global-agreement-on-the-foundational-intellectual-property-for-crispr-cas9-gene-editing-technology https://www.synbiobeta.com/read/global-bioenergies-continues-to-bring-its-demo-plant-into-operation-successfully-and-lays-out-its-strategy-for-using-renewable-resources https://www.synbiobeta.com/read/chevron-makes-equity-investment-in-novvi-and-its-high-performance-renewable-base-oil-technology https://www.synbiobeta.com/read/intrexon-advances-actobiotics-tm-platform-to-development-phase-for-biological-crop-protection https://www.synbiobeta.com/read/diversity-at-ginkgo-tech-companies-have-issues-with-diversity-we-dont-want-to-be-like-other-tech-companies https://www.synbiobeta.com/read/editas-medicine-extends-crispr-genome-editing-leadership-through-licensing-of-new-crispr-technologies https://www.synbiobeta.com/read/worlds-first-biotech-accelerator-synbioaxlr8r-indiebio-eu-is-now-rebelbio https://www.synbiobeta.com/read/living-ink-technologies-awarded-competitive-grant-from-the-national-science-foundation https://www.synbiobeta.com/read/synbiobeta-ceo-presents-on-synthetic-biology-the-next-industrial-revolution-at-un-biodiversity-conference https://www.synbiobeta.com/read/synthetic-biology-startup-lygos-closes-13-million-venture-financing-to-target-trillion-dollar-oil-based-specialty-chemical-industry https://www.synbiobeta.com/read/transcriptic-introduces-agilent-product-lines-to-their-robotic-cloud-laboratory https://www.synbiobeta.com/read/desktop-genetics-and-lgc-will-pursue-standardized-approach-to-genome-editing-with-support-from-synbicite https://www.synbiobeta.com/read/bio-start-competition-announces-additional-cash-prizes-and-sponsors https://www.synbiobeta.com/read/dna2-0-inc-becomes-atum https://www.synbiobeta.com/read/sgi-dna-launches-custom-cloning-module-for-bioxp-tm-3200-system-to-advance-protein-and-antibody-engineering-capabilities https://www.synbiobeta.com/read/molecular-assemblies-raises-2-3-million-in-seed-round https://www.synbiobeta.com/read/benchling-launches-bioregistration-and-inventory-management-system-to-enable-accelerated-biologics-r-d https://www.synbiobeta.com/read/synpromics-announces-expansion-of-research-collaboration-with-adverum-biotechnologies https://www.synbiobeta.com/read/codexis-to-commercially-supply-proprietary-enzyme-to-tate-lyle https://www.synbiobeta.com/read/lgc-and-desktop-genetics-receive-funding-for-crispr-efficiency-assay https://www.synbiobeta.com/read/amyris-partners-with-queensland-to-create-the-leading-industrial-biotechnology-hub-in-southeast-asia https://www.synbiobeta.com/read/amyris-signs-multi-year-collaboration-extension-with-kuraray https://www.synbiobeta.com/read/inovio-pharmaceuticals-awarded-6-1-million-sub-grant-through-wistar-institute-to-develop-dna-based-monoclonal-antibodies-against-zika-virus https://www.synbiobeta.com/read/synpromics-announces-collaboration-with-sartorius-stedim-cellca-to-develop-improved-biologicals-manufacturing-process-using-synthetic-promoters https://www.synbiobeta.com/read/thermo-fisher-scientific-crispr-cas9-genome-editing-tools-named-top-innovations-of-2016 https://www.synbiobeta.com/read/bayer-crispr-therapeutics-joint-venture-casebia-therapeutics-named-most-valuable-pharma-deal-of-the-year-by-biopharma-dive https://www.synbiobeta.com/read/ibioics-3rd-annual-conference-delivering-impact https://www.synbiobeta.com/read/medimmune-and-abpro-enter-into-a-collaborative-agreement-for-a-novel-bispecific-antibody https://www.synbiobeta.com/read/board-of-florida-keys-mosquito-control-district-approves-investigational-agreement-for-effectiveness-trial-of-oxitecs-friendly-tm-mosquitoes-in-monroe-county-florida https://www.synbiobeta.com/read/edinburgh-genome-foundry-and-molecular-devices-team-up-in-uks-first-fully-automated-synbio-lab https://www.synbiobeta.com/read/synthegos-12-days-of-crispr-educates-scientists-on-crispr-genome-editing-offers-grants-totaling-100-000-of-synthetic-rna https://www.synbiobeta.com/read/transcriptic-raises-13-4-in-series-a-to-fuel-expansion-of-cloud-laboratory-services https://www.synbiobeta.com/read/new-algaprime-tm-dha-an-algae-based-alternative-to-fish-oil-addresses-declining-omega-3-content-in-farmed-salmon https://www.synbiobeta.com/read/ecovative-and-biomason-collaborate-to-advance-biofabricated-furniture-for-the-home-and-office https://www.synbiobeta.com/read/eurofins-genomics-looks-to-disrupt-dna-synthesis-market-with-smaller-scale-high-throughput-service-featuring-rapid-turnaround-and-lower-price https://www.synbiobeta.com/read/opentrons-new-interface-for-automated-pipetting-robot-streamlines-workflow-programming https://www.synbiobeta.com/read/cutting-through-the-controversy-crispr-in-action https://www.synbiobeta.com/read/the-construction-of-global-bioenergies-leuna-demo-plant-is-completed https://www.synbiobeta.com/read/synlogic-secures-patent-on-proprietary-synthetic-probiotic-bacteria-for-the-treatment-of-hyperammonemia https://www.synbiobeta.com/read/deinove-signs-a-partnership-with-processium-to-prepare-for-the-industrialization-of-its-carotenoid-production-process https://www.synbiobeta.com/read/igem-rocks-the-world-once-again https://www.synbiobeta.com/read/ers-genomics-and-knudra-transgenics-sign-license-agreement-on-crispr-cas9-genome-editing-patents-for-model-organisms https://www.synbiobeta.com/read/arzeda-scales-high-throughput-automated-molecule-development-pipeline https://www.synbiobeta.com/read/global-bioenergies-strengthens-its-intellectual-property-position-in-the-field-of-direct-fermentative-production-of-isobutene-and-other-light-olefins https://www.synbiobeta.com/read/worlds-top-life-sciences-institutions-using-synthegos-synthetic-guide-rna-in-crispr-research https://www.synbiobeta.com/read/ers-genomics-will-license-key-crispr-patents-to-evolva https://www.synbiobeta.com/read/gen9-synthesizes-largest-functional-virus-for-oncology-research-joined-by-auburn-university-and-autodesk-to-enable-personalized-cancer-treatment https://www.synbiobeta.com/read/renewable-energy-group-unveils-first-commercial-product-in-transaction-with-aroma-chemical-services https://www.synbiobeta.com/read/amyris-enters-collaboration-with-top-10-pharmaceutical-company-for-biosynthetic-drug-discovery https://www.synbiobeta.com/read/biossance-tm-to-launch-in-sephora-stores https://www.synbiobeta.com/read/ers-genomics-and-evolva-sign-license-agreement-on-crispr-cas9-genome-editing-patents-for-industrial-applications https://www.synbiobeta.com/read/reg-delivers-first-life-sciences-commercial-product https://www.synbiobeta.com/read/the-jackson-laboratory-and-caribou-biosciences-announce-crispr-cas9-license-agreement https://www.synbiobeta.com/read/oxitec-opens-large-scale-mosquito-production-facility-in-brazil https://www.synbiobeta.com/read/crispr-the-future-of-food https://www.synbiobeta.com/read/crispr-therapeutics-announces-pricing-of-initial-public-offering https://www.synbiobeta.com/read/landmark-alliance-launched-to-support-the-growth-of-the-uk-bioeconomy https://www.synbiobeta.com/read/evolva-pre-launches-portal-for-online-product-sales https://www.synbiobeta.com/read/frost-sullivan-applauds-genewizs-commitment-to-providing-cutting-edge-services-in-the-life-science-research-services-market https://www.synbiobeta.com/read/agilent-technologies-launches-sureguide-crispr-libraries-for-functional-genomics https://www.synbiobeta.com/read/amyris-agrees-to-collaboration-terms-with-leading-global-food-ingredients-and-nutraceuticals-partner https://www.synbiobeta.com/read/horizon-discovery-signs-subscription-based-licensing-agreement-for-biomanufacturing-cell-lines https://www.synbiobeta.com/read/ginkgo-bioworks-and-prospect-bio-will-collaborate-to-develop-and-deploy-biosensors https://www.synbiobeta.com/read/doe-awards-microvi-grant-for-innovative-biogas-conversion-technology https://www.synbiobeta.com/read/green-biologics-announces-new-brands-for-high-purity-bio-based-products https://www.synbiobeta.com/read/ibioic-ps3-million-investment-set-to-accelerate-global-healthcare-materials-and-skincare-markets https://www.synbiobeta.com/read/takeaways-from-synbiobeta-sf-2016-for-entrepreneurs-and-investors https://www.synbiobeta.com/read/last-week-in-biotech-10-highlights-from-synbiobeta-sf-2016 https://www.synbiobeta.com/read/recapping-synbiobeta-sf-2016 https://www.synbiobeta.com/read/synbicite-and-imperial-college-london-choose-sas-r-to-spur-synthetic-biology-industry https://www.synbiobeta.com/read/thought-for-food-global-challenge-launches-its-4th-competition-to-compel-student-innovators-to-tackle-food-and-nutrition-security https://www.synbiobeta.com/read/elemental-machines-ships-groundbreaking-sensory-network-tm-for-science-based-industries https://www.synbiobeta.com/read/gevo-produces-first-cellulosic-renewable-jet-fuel-specified-for-use-on-commercial-airline-flights https://www.synbiobeta.com/read/twist-bioscience-and-distributed-bio-partner-to-offer-antibody-design-and-optimization-services https://www.synbiobeta.com/read/verdezyne-signs-distribution-agreement-with-aceto-corporation https://www.synbiobeta.com/read/zymergen-completes-blockbuster-series-b-with-130-million-in-funding https://www.synbiobeta.com/read/bio-start-confirms-sir-richard-sykes-as-chair-of-judging-panel https://www.synbiobeta.com/read/codexis-completes-transfer-of-codeevolver-r-technology-to-merck https://www.synbiobeta.com/read/riffyn-launches-process-design-and-data-analytics-software-at-synbiobeta-sf-2016 https://www.synbiobeta.com/read/sgi-dna-announces-commercial-launch-of-syn2-0-tm-and-syn3-0-tm-minimal-synthetic-cells https://www.synbiobeta.com/read/amyris-and-autodesk-offer-powerful-open-source-tools-for-genetic-design-to-enable-rapid-dna-engineering https://www.synbiobeta.com/read/global-bioenergies-and-clariant-announce-the-first-isobutene-production-from-a-wheat-straw-hydrolysate https://www.synbiobeta.com/read/novamont-opens-worlds-first-commercial-plant-for-bio-based-intermediate-chemical https://www.synbiobeta.com/read/ginkgo-genomatica-alliance-to-accelerate-commercialization-of-high-volume-chemicals https://www.synbiobeta.com/read/first-ever-commercial-harvest-of-okanagan-specialty-fruits-arctic-r-golden-apples-completed https://www.synbiobeta.com/read/kraig-labs-begins-spider-silk-production-with-first-batch-totaling-more-than-40-000-silkworms https://www.synbiobeta.com/read/monsanto-and-dow-agrosciences-announce-global-licensing-agreement-on-exzact-precision-technology-genome-editing-platform https://www.synbiobeta.com/read/metabolix-and-north-carolina-state-university-enter-into-worldwide-exclusive-license-agreement-for-advanced-crop-technologies https://www.synbiobeta.com/read/amyris-expands-in-global-nutraceuticals-market-with-new-collaboration-and-partner-funding-of-30-million https://www.synbiobeta.com/read/how-do-we-build-better-genes-proteins-pathways-to-genomes https://www.synbiobeta.com/read/ecovative-launches-new-line-of-biofabricated-furniture-for-the-home-fully-grown-from-mushroom-r-materials https://www.synbiobeta.com/read/the-bio-report-harnessing-biology-to-transform-the-economy https://www.synbiobeta.com/read/ginkgo-bioworks-unveils-next-generation-organism-foundry-to-bring-biotech-into-new-markets https://www.synbiobeta.com/read/the-synthetic-biology-ecosystem-is-born https://www.synbiobeta.com/read/engineering-the-microbiome-using-synthetic-biology-as-the-interface-between-ourselves-and-our-ecology https://www.synbiobeta.com/read/new-opportunities-and-challenges-in-agriculture https://www.synbiobeta.com/read/the-investor-panel-at-synbiobeta-sf-2016-meet-the-panelists https://www.synbiobeta.com/read/at-synbiobeta-sf-2016-international-panel-will-offer-diverse-perspectives-on-regulatory-systems https://www.synbiobeta.com/read/these-33-synthetic-biology-companies-raised-more-than-900-million-in-2016 https://www.synbiobeta.com/read/gen9-announces-university-of-east-anglia-and-start-up-company-biosyntia-are-winners-of-fourth-annual-g-prize https://www.synbiobeta.com/read/california-life-sciences-association-partners-with-la-biomed-and-lab-launch-to-grow-world-class-life-sciences-innovation-hub-in-los-angeles-opens-los-angeles-office https://www.synbiobeta.com/read/arctic-r-fuji-gains-usda-approval https://www.synbiobeta.com/read/global-bioenergies-joins-preem-sekab-and-sveaskog-in-the-bio-based-gasoline-project-in-sweden https://www.synbiobeta.com/read/calysta-wins-global-award-for-protein-innovation https://www.synbiobeta.com/read/intrexon-to-develop-disease-modifying-therapies-in-new-collaborations-with-harvest-intrexon-enterprise-fund https://www.synbiobeta.com/read/caribou-biosciences-president-and-ceo-rachel-haurwitz-named-to-fortunes-2016-40-under-40-list-of-most-influential-young-people-in-business https://www.synbiobeta.com/read/bio-start-announces-david-lawrence-as-competition-finalist-judge https://www.synbiobeta.com/read/ginkgo-bioworks-to-design-custom-microorganisms-for-adm https://www.synbiobeta.com/read/biodesign-for-the-real-world https://www.synbiobeta.com/read/genscript-launches-new-crispr-synthetic-rna-service https://www.synbiobeta.com/read/ginkgo-bioworks-is-tapped-by-cargill-to-help-enhance-its-bioindustrial-fermentation-processes https://www.synbiobeta.com/read/automating-the-extraction-of-dna-rna-and-proteins https://www.synbiobeta.com/read/calysta-uk-opening-marks-first-step-in-global-scale-up-for-novel-aquaculture-protein https://www.synbiobeta.com/read/dna2-0-leapin-transposons-protected-by-newly-issued-u-s-patent https://www.synbiobeta.com/read/terravias-protein-rich-whole-algae-is-emerging-as-a-top-plant-based-protein-source-across-the-grocery-store https://www.synbiobeta.com/read/synthego-announces-first-of-its-kind-crispr-kit https://www.synbiobeta.com/read/amyris-ginkgo-bioworks-complete-collaboration-agreement-to-accelerate-commercialization-of-bio-based-products https://www.synbiobeta.com/read/white-house-announces-updates-to-modernize-biotech-regulations https://www.synbiobeta.com/read/synbios-pathbreaking-new-tools-accelerating-the-design-build-test-cycle https://www.synbiobeta.com/read/promosome-announces-exploratory-collaborations-in-nucleic-acid-therapeutics https://www.synbiobeta.com/read/the-2nd-annual-engineering-biology-awards-recognize-excellence-in-the-synthetic-biology-industry-at-synbiobeta-sf-2016 https://www.synbiobeta.com/read/twist-bioscience-bolsters-executive-leadership-team https://www.synbiobeta.com/read/bringing-biosecurity-to-the-forefront-of-the-synthetic-biology-community https://www.synbiobeta.com/read/how-agbiome-is-using-the-plant-associated-microbiome-to-create-innovative-products-for-agriculture https://www.synbiobeta.com/read/exit-e-coli-enter-vmax https://www.synbiobeta.com/read/how-engineered-cell-therapies-and-antibodies-are-transforming-personalized-medicine https://www.synbiobeta.com/read/sample6-closes-12-5-million-series-c-to-scale-up-commercialization-of-worlds-fastest-food-pathogen-detection-system-for-food-safety https://www.synbiobeta.com/read/call-for-papers-computational-and-structural-biotechnology-journal https://www.synbiobeta.com/read/reviewing-the-synbio-startup-scene-in-2016 https://www.synbiobeta.com/read/inventor-of-gibson-assembly-will-present-keynote-speech-at-synbiobeta-san-francisco https://www.synbiobeta.com/read/venter-institute-and-synthetic-genomics-inc-combine-crispr-cas9-and-yeast-recombination-machinery-to-engineer-16s-ribosomal-rna https://www.synbiobeta.com/read/synthego-launches-to-bring-precision-and-automation-to-genome-engineering https://www.synbiobeta.com/read/biotech-institute-program-seeking-mentors-for-aspiring-teens https://www.synbiobeta.com/read/synbiobeta-names-kate-wildauer-as-chief-executive-officer https://www.synbiobeta.com/read/these-three-companies-will-be-discussing-the-future-of-food-at-synbiobeta-sf-2016 https://www.synbiobeta.com/read/synthorx-raises-10-million-in-series-b-to-expand-the-genetic-code-innovate-new-products https://www.synbiobeta.com/read/bio-based-commercialization-the-focus-as-global-experts-assemble-for-san-francisco https://www.synbiobeta.com/read/the-worlds-first-synbio-accelerator-presents-their-newest-crop-meet-indiebio-eus-class-of-2016-part-2 https://www.synbiobeta.com/read/synbiobeta-opens-memberships-and-registration-for-san-francisco-2016 https://www.synbiobeta.com/read/the-worlds-first-synbio-accelerator-presents-their-newest-crop-meet-indiebio-eus-class-of-2016-part-1 https://www.synbiobeta.com/read/chai-biotechnologies-brings-real-time-pcr-to-biohackers-with-kickstarter-launch https://www.synbiobeta.com/read/indiebios-third-class-of-fourteen-startups-to-be-unveiled-at-demo-day https://www.synbiobeta.com/read/siemens-investment-accelerates-launch-of-riffyns-ground-breaking-r-d-design-software https://www.synbiobeta.com/read/110-nobel-laureates-take-a-stand-against-greenpeace-and-gmo-opponents https://www.synbiobeta.com/read/five-synthetic-biology-companies-named-among-world-economic-forums-top-30-technology-pioneers https://www.synbiobeta.com/read/ginkgo-bioworks-and-amyris-join-forces-to-facilitate-bioproducts-commercialization https://www.synbiobeta.com/read/acs-synthetic-biology-adopts-sbol-synthetic-biology-standards https://www.synbiobeta.com/read/synthace-awarded-technology-pioneer-by-world-economic-forum https://www.synbiobeta.com/read/enbiotix-and-elanco-enter-partnership-to-develop-antibiotic-alternative-through-engineered-phage-technology https://www.synbiobeta.com/read/a-glimpse-into-how-china-is-utilizing-crispr-for-genome-editing https://www.synbiobeta.com/read/advice-from-a-novelist-how-to-prepare-for-the-biodigital-era https://www.synbiobeta.com/read/ginkgo-bioworks-raises-100m-in-series-c-funding-round-and-places-huge-dna-order https://www.synbiobeta.com/read/ginkgo-bioworks-makes-300-million-base-pair-deal-with-gen9 https://www.synbiobeta.com/read/ginkgo-bioworks-triples-the-size-of-dna-supply-agreement-with-twist-bioscience https://www.synbiobeta.com/read/helping-drive-the-synthetic-biology-industry-in-china-a-look-at-dr-yin-li-of-the-tianjin-institute-of-industrial-biotechnology https://www.synbiobeta.com/read/gen9-and-amyris-strike-synthetic-dna-supply-agreement https://www.synbiobeta.com/read/peer-to-peer-probiotics-engineered-microbes-offer-promise-in-addressing-global-malnutrition https://www.synbiobeta.com/read/twist-bioscience-and-desktop-genetics-to-offer-integrated-design-services-and-dna-synthesis-for-gene-editing-research https://www.synbiobeta.com/read/the-rapid-growth-of-synthetic-biology-in-china https://www.synbiobeta.com/read/the-other-silicon-valley-shenzhen-institutes-of-advanced-technology-chinese-academy-of-sciences https://www.synbiobeta.com/read/the-growing-tide-of-china-biotech-investment https://www.synbiobeta.com/read/bolt-threads-raises-50-million-and-forms-new-partnership-to-advance-textile-manufacturing https://www.synbiobeta.com/read/caribou-biosciences-raises-30-million-in-series-b-funding https://www.synbiobeta.com/read/syngulon-announces-the-issuance-by-the-uspto-of-a-first-patent https://www.synbiobeta.com/read/on-helix-translating-uk-scientific-excellence-into-global-therapeutic-strategies https://www.synbiobeta.com/read/intellia-therapeutics-announces-pricing-of-initial-public-offering https://www.synbiobeta.com/read/protecting-intellectual-property-in-china-a-synbiobeta-panel-set-for-june-in-beijing https://www.synbiobeta.com/read/synbiobeta-activate-china-arrives-in-beijing-shanghai-and-shenzhen-this-june-to-boost-growth-of-synthetic-biology-ecosystem https://www.synbiobeta.com/read/the-first-ever-biohackathon-in-the-uk https://www.synbiobeta.com/read/dna2-0-acquires-migs-to-add-antibody-production-capabilities https://www.synbiobeta.com/read/dupont-pioneer-unveils-its-first-product-developed-through-crispr-cas https://www.synbiobeta.com/read/intrexon-responds-to-short-sellers-report https://www.synbiobeta.com/read/gene-editing-company-intellia-therapeutics-files-for-a-120-million-ipo https://www.synbiobeta.com/read/microsoft-purchases-synthetic-dna-for-encoding-digital-data-from-twist-bioscience https://www.synbiobeta.com/read/gen9-and-arzeda-announce-supply-agreement-for-synthetic-dna https://www.synbiobeta.com/read/synpromics-further-strengthens-board-and-management-team https://www.synbiobeta.com/read/consider-scotland-says-ibioic-offering-ps1-million-for-synbio-projects https://www.synbiobeta.com/read/ginkgo-bioworks-hires-peter-boynton-as-chief-commercialization-officer-to-expand-into-commodity-chemicals https://www.synbiobeta.com/read/hot-synthetic-biology-companies-at-synbiobeta-london-2016 https://www.synbiobeta.com/read/rewriting-dna-big-returns-from-gene-editing https://www.synbiobeta.com/read/dow-agrosciences-and-teselagen-biotechnologies-to-partner-in-developing-biological-design-platform https://www.synbiobeta.com/read/dow-agrosciences-and-teselagen-advance-biodesign-technologies-for-agriculture https://www.synbiobeta.com/read/synbicite-uks-first-commercial-synthetic-biology-foundry-goes-into-production https://www.synbiobeta.com/read/synthace-partners-with-microsoft-to-bring-antha-to-azure https://www.synbiobeta.com/read/money-money-money-synbiobeta-londons-investor-panel https://www.synbiobeta.com/read/twist-bioscience-acquires-genome-compiler-to-add-gene-design-capabilities https://www.synbiobeta.com/read/ethics-and-biotech-innovating-responsibly-panel-at-synbiobeta-london-2016 https://www.synbiobeta.com/read/tools-and-trends-forecasts-in-synbio-from-industry-leaders-a-fireside-chat-at-synbiobeta-london-2016 https://www.synbiobeta.com/read/evolva-wellness-and-nutrition-ingredients-production-company-joins-the-fight-against-zika https://www.synbiobeta.com/read/minimal-synthetic-bacterial-cell-jcvi-syn3-0-engineered-with-just-473-genes https://www.synbiobeta.com/read/the-tech-museum-of-innovation-opens-first-interactive-bioengineering-exhibit https://www.synbiobeta.com/read/uk-synthetic-biology-basic-research-moving-towards-commercialization https://www.synbiobeta.com/read/two-perspectives-on-reimagining-life-a-synbiobeta-london-2016-fireside-chat https://www.synbiobeta.com/read/evolva-expanding-its-nootkatone-research-to-include-mosquitoes-that-transmit-zika-and-other-viruses https://www.synbiobeta.com/read/gen9-announces-next-generation-of-the-biofab-r-dna-synthesis-platform https://www.synbiobeta.com/read/the-fourth-industrial-revolution-biology-technology-by-indiebio https://www.synbiobeta.com/read/arzeda-and-zymergen-collaborate-on-development-of-new-molecules https://www.synbiobeta.com/read/technological-tourism-your-handy-guide-to-the-european-synthetic-biology-startup-scene https://www.synbiobeta.com/read/these-four-companies-are-engineering-the-microbiome-to-do-amazing-things https://www.synbiobeta.com/read/a-reflection-on-the-first-20-years-of-synthetic-biology-and-its-prospects-for-the-next-20 https://www.synbiobeta.com/read/idt-donates-1-million-in-dna-to-2016-igem-teams https://www.synbiobeta.com/read/molecula-maxima-a-high-level-bio-programming-language-for-dna-design https://www.synbiobeta.com/read/synbiobeta-exclusive-interview-president-and-ceo-of-circularis-dr-paul-feldstein https://www.synbiobeta.com/read/for-uks-synthetic-biology-community-a-roadmap-evolves-into-strategic-plan https://www.synbiobeta.com/read/the-whos-who-of-the-genetic-tool-companies-attending-synbiobeta-london-2016-part-1 https://www.synbiobeta.com/read/synbiobeta-announces-its-first-activate-china-event https://www.synbiobeta.com/read/dow-agrosciences-and-radiant-genomics-expand-collaboration-to-accelerate-product-development https://www.synbiobeta.com/read/from-one-stop-lab-platforms-to-bio-based-3d-printers-this-is-what-robotics-and-hardware-can-do-for-synthetic-biology https://www.synbiobeta.com/read/sgi-dna-dna-workstation-now-available-to-qualified-researchers-at-north-san-diego-life-science-incubator-bio-tech-and-beyond https://www.synbiobeta.com/read/editing-out-the-competition-editas-medicine-ipo https://www.synbiobeta.com/read/synlogic-secures-40-million-in-series-b-financing https://www.synbiobeta.com/read/dna-synthesis-war-as-agilent-technologies-sues-twist-bioscience https://www.synbiobeta.com/read/eli-lilly-to-acquire-smart-insulin-company-glycostasis-inc https://www.synbiobeta.com/read/synlogic-announces-first-industry-collaboration-to-develop-a-new-class-of-medicines-designed-to-power-the-microbiome https://www.synbiobeta.com/read/sphere-fluidics-raises-7-million-for-development-of-cyto-mine-single-cell-analysis-system https://www.synbiobeta.com/read/gen9-announces-new-multiplex-synthesis-platform-for-rapid-assembly-of-gene-length-dna https://www.synbiobeta.com/read/2016-cshl-synthetic-biology-course-call-for-applications https://www.synbiobeta.com/read/precision-nanosystems-accelerating-nanomedicine-using-miniature-nanoparticle-factories https://www.synbiobeta.com/read/joining-the-dots-in-uk-synthetic-biology-kick-off-2016-with-a-series-of-community-building-workshops-from-ktn https://www.synbiobeta.com/read/whats-next-for-synthetic-biology-in-biopharmaceuticals https://www.synbiobeta.com/read/neurovive-buys-stake-in-isomerase-therapeutics https://www.synbiobeta.com/read/isomerase-therapeutics-has-entered-into-an-agreement-with-agrimetis https://www.synbiobeta.com/read/the-future-is-now-new-synthetic-biology-technologies-for-industrial-chemicals-and-biofuels https://www.synbiobeta.com/read/genscripts-ipo-raises-67-million https://www.synbiobeta.com/read/twist-bioscience-closes-61m-series-d-bringing-total-raised-to-143m-for-dna-synthesis-platform https://www.synbiobeta.com/read/partnership-between-global-bioenergies-and-lanzatech-makes-biofuels-even-greener https://www.synbiobeta.com/read/harvest-capital-strategies-raises-245m-fund-for-companies-utilizing-tools-of-intrexon https://www.synbiobeta.com/read/synpromics-announces-collaboration-to-apply-synthetic-promoters-in-gene-therapy https://www.synbiobeta.com/read/thinking-outside-the-lunch-box-how-bento-bioworks-is-building-a-better-hardware-for-biology https://www.synbiobeta.com/read/editas-medicine-the-first-crispr-company-to-file-for-an-ipo https://www.synbiobeta.com/read/taking-the-high-road-an-introduction-to-ingenza-of-edinburgh https://www.synbiobeta.com/read/biocatalyst-developer-codexis-and-healthcare-giant-merck-to-strengthen-business-ties https://www.synbiobeta.com/read/oxitec-fighting-disease-at-the-insect-level https://www.synbiobeta.com/read/bayer-and-crispr-therapeutics-to-create-300m-joint-venture-based-in-london https://www.synbiobeta.com/read/the-house-of-lords-report-on-genetically-modified-insects https://www.synbiobeta.com/read/a-day-in-the-life-of-josiah-zayner-the-open-discovery-institutes-iconoclast-ceo https://www.synbiobeta.com/read/google-for-nature-metamixis-accepted-into-third-round-of-illumina-accelerator https://www.synbiobeta.com/read/crispr-cpf1-the-next-crispr-cas9 https://www.synbiobeta.com/read/expanding-potential-fostering-an-inclusive-stem-community https://www.synbiobeta.com/read/synthetic-biologys-hidden-gems https://www.synbiobeta.com/read/going-swimmingly-aquabountys-gm-salmon-approved-for-consumption-after-19-years https://www.synbiobeta.com/read/innovation-to-tackle-climate-change-and-feed-a-growing-population-commercializing-synthetic-biology https://www.synbiobeta.com/read/black-gold-from-green-water-red-rock-biofuels-and-joule-unlimited-to-merge https://www.synbiobeta.com/read/friendly-open-innovative-the-face-of-do-it-yourself-biotechnology-diybio https://www.synbiobeta.com/read/synbiobeta-sf-2015-in-summary-the-race-to-bring-valuable-products-to-market https://www.synbiobeta.com/read/at-synbiobeta-sf-2015-companies-announce-exciting-partnerships-to-accelerate-design-to-creation-pipeline https://www.synbiobeta.com/read/ginkgo-bioworks-and-twist-bioscience-just-made-a-100-million-base-pair-deal https://www.synbiobeta.com/read/multifactorial-collaboration-synthace-merck-team-up-to-develop-bio-manufacturing-platform https://www.synbiobeta.com/read/sigma-aldrich-every-chemical-under-the-sun-and-now-genes-as-well https://www.synbiobeta.com/read/thermo-fisher-scientific-makes-genetic-modification-look-easy https://www.synbiobeta.com/read/crispr-cas-just-got-about-one-hundred-million-dollars-hotter https://www.synbiobeta.com/read/from-biotech-to-biotech-meet-serial-entrepreneur-randal-kirk-ceo-of-intrexon https://www.synbiobeta.com/read/the-recipients-of-the-1st-annual-engineering-biology-awards-are https://www.synbiobeta.com/read/gene-editing-has-exploded-in-the-last-12-months-heres-why-it-matters https://www.synbiobeta.com/read/pathfinders-in-synthetic-biology-jay-keasling-and-kinkead-reiling https://www.synbiobeta.com/read/the-number-of-biology-based-startups-funded-by-y-combinator-has-grown-significantly https://www.synbiobeta.com/read/blue-sky-bio-competition-eight-minutes-to-talk-500k-in-prizes-which-team-has-what-it-takes https://www.synbiobeta.com/read/how-the-ceo-of-ecovative-eben-bayer-is-using-biology-to-create-disruptive-solutions https://www.synbiobeta.com/read/what-can-biotechnology-learn-from-open-source https://www.synbiobeta.com/read/programming-in-four-bits-genome-compiler https://www.synbiobeta.com/read/advances-in-automation-tools-are-allowing-us-to-engineer-biology-more-easily-than-ever-before https://www.synbiobeta.com/read/ecovative-and-the-growing-mushroom-materials-boom https://www.synbiobeta.com/read/ecovative-is-taking-over-the-stage-with-mushrooms-at-synbiobeta https://www.synbiobeta.com/read/big-data-managing-the-flow-of-information-in-synthetic-biology https://www.synbiobeta.com/read/from-chaos-discovery-how-labgenius-is-reinventing-randomness https://www.synbiobeta.com/read/caribou-biosciences-and-dupont-to-collaborate-on-crispr-cas https://www.synbiobeta.com/read/investment-trends-in-synthetic-biology-companies-what-are-the-key-updates https://www.synbiobeta.com/read/which-bio-designers-and-bio-producers-are-reengineering-materials-as-we-know-them-today-learn-at-synbiobeta-sf https://www.synbiobeta.com/read/what-incubators-and-accelerators-are-playing-a-critical-role-in-the-synthetic-biology-ecosystem https://www.synbiobeta.com/read/synthace-and-dow-agrosciences-announce-automated-bio-engineering-collaboration https://www.synbiobeta.com/read/synbio-for-all-things-green-an-overview-of-synbiobeta-sf-sigma-aldrich-green-chemistry-session https://www.synbiobeta.com/read/a-bio-inspired-chemical-that-improves-crop-yield-and-water-efficiency-in-farming-by-asilomar-bio https://www.synbiobeta.com/read/ls9-alumni-found-industrial-microbes-and-win-g-prize-contest https://www.synbiobeta.com/read/these-synthetic-biology-companies-have-raised-half-a-billion-dollars-in-2015 https://www.synbiobeta.com/read/gen9-partners-with-igem-to-offer-high-quality-dna-parts https://www.synbiobeta.com/read/intrexon-stock-offering-generates-230-million https://www.synbiobeta.com/read/intellia-therapeutics-closes-70m-in-series-b-funding-to-develop-crispr-cas9-therapies https://www.synbiobeta.com/read/ginkgo-bioworks-to-develop-designer-microbes-for-ajinomoto https://www.synbiobeta.com/read/prokarium-receives-funding-from-synbicite-to-develop-salmonella-derived-vaccines-for-chlamydia https://www.synbiobeta.com/read/igem-catalyzing-entrepreneurs-and-startups-in-synthetic-biology https://www.synbiobeta.com/read/editas-medicine-receives-the-largest-funding-yet-for-a-crispr-cas9-company-120m https://www.synbiobeta.com/read/oxitec-a-pioneer-of-insect-control-solutions-to-be-acquired-by-intrexon-for-160m https://www.synbiobeta.com/read/crispr-genome-editing-is-here-to-stay-regardless-of-pending-regulations https://www.synbiobeta.com/read/ginkgo-bioworks-closes-45m-series-b https://www.synbiobeta.com/read/eligo-bioscience-raises-eu2m-to-develop-crispr-antimicrobials https://www.synbiobeta.com/read/genome-compiler-platform-integrates-snapfast-tm-dna-cloning-system https://www.synbiobeta.com/read/can-engineering-the-pig-genome-provide-a-safe-new-source-of-transplant-organs https://www.synbiobeta.com/read/synthace-integrates-powerful-automation-equipment-with-its-high-level-language-for-biological-research https://www.synbiobeta.com/read/zymergen-raises-44-million-series-a-to-automate-microbial-engineering https://www.synbiobeta.com/read/synthetic-genomics-and-gen9-team-up-to-advance-dna-synthesis https://www.synbiobeta.com/read/twist-bioscience-closes-37-million-series-c-to-accelerate-commercial-scaling-of-silicon-based-dna-synthesis-platform https://www.synbiobeta.com/read/bolt-threads-raises-32-3m-series-b-to-scale-up-engineered-silk-fabrics https://www.synbiobeta.com/read/the-automation-war-cloud-labs-vs-desktop-robots https://www.synbiobeta.com/read/tim-dafforn-is-appointed-biss-chief-scientific-adviser https://www.synbiobeta.com/read/remembering-austen-heinz-1983-2015 https://www.synbiobeta.com/read/brewing-bad-biosecurity-policy https://www.synbiobeta.com/read/zuvasyntha-recycling-cheap-carbon-and-waste-into-commodity-chemicals https://www.synbiobeta.com/read/biosyntia-raises-1-9m-to-engineer-vitamin-producing-microbes https://www.synbiobeta.com/read/a-refreshed-version-of-the-uk-synthetic-biology-roadmap https://www.synbiobeta.com/read/uk-profile-dr-john-collins-commercial-director-of-synbicite https://www.synbiobeta.com/read/indiebio-ups-the-ante-with-250k-for-each-new-startup https://www.synbiobeta.com/read/gen9-announces-online-ordering-platform-with-benchling https://www.synbiobeta.com/read/taking-experiments-from-lab-to-market-thoughts-from-synbiobeta-london https://www.synbiobeta.com/read/is-glowing-plant-changing-its-name-to-taxa https://www.synbiobeta.com/read/desktop-genetics-launches-new-gene-editing-platform https://www.synbiobeta.com/read/twist-bioscience-launches-alpha-manufacturing-program https://www.synbiobeta.com/read/what-were-the-big-4-announcements-from-synbiobeta-london https://www.synbiobeta.com/read/how-the-uk-brings-university-technologies-to-market-a-review-of-rainbow-seed-fund https://www.synbiobeta.com/read/trending-synthetic-biology-companies-to-watch https://www.synbiobeta.com/read/what-we-talk-about-when-we-talk-about-biodesign https://www.synbiobeta.com/read/these-investors-are-betting-big-on-synbio-top-synthetic-biology-investors https://www.synbiobeta.com/read/as-the-world-turns-the-future-of-synthetic-biology https://www.synbiobeta.com/read/bugs-making-drugs https://www.synbiobeta.com/read/openplant-open-technologies-for-plant-synthetic-biology https://www.synbiobeta.com/read/igem-and-idt-announce-free-dna https://www.synbiobeta.com/read/synpromics-custom-control-of-gene-expression-via-synthetic-promoters https://www.synbiobeta.com/read/how-synbicite-is-bridging-the-gap-between-academia-and-industry https://www.synbiobeta.com/read/these-six-companies-are-making-biology-easier-to-engineer https://www.synbiobeta.com/read/future-foods https://www.synbiobeta.com/read/lean-launchpad-the-scientific-method-for-entrepreneurship https://www.synbiobeta.com/read/synbiobeta-returns-to-london https://www.synbiobeta.com/read/caribou-biosciences-raises-11-million-series-a-from-fidelity-biosciences-5-prime-ventures-mission-bay-capital https://www.synbiobeta.com/read/rapid-prototyping-in-biology-with-synbiota https://www.synbiobeta.com/read/sgi-dna-prints-your-plasmids-at-your-bench https://www.synbiobeta.com/read/uk-algae-mission-the-momentum-keeps-growing https://www.synbiobeta.com/read/eusynbios-closing-the-gap https://www.synbiobeta.com/read/mobilizing-the-planets-genetic-diversity-with-synthetic-biology https://www.synbiobeta.com/read/are-microbes-the-taste-makers-of-the-future https://www.synbiobeta.com/read/touchlight-genetics-the-next-stage-in-dna-production-for-therapeutic-and-industrial-applications https://www.synbiobeta.com/read/assembling-a-genome-piece-by-piece https://www.synbiobeta.com/read/short-and-sweet-why-modern-molecular-biology-needs-oligos https://www.synbiobeta.com/read/plug-and-play-with-dna-constructs https://www.synbiobeta.com/read/cleaner-living-through-smarter-microbiology https://www.synbiobeta.com/read/the-brave-new-world-of-dna-synthesis https://www.synbiobeta.com/read/benchling-and-new-england-biolabs-are-developing-better-tools-for-dna-assembly https://www.synbiobeta.com/read/lygos-demonstrates-biologys-advantage-over-petroleum https://www.synbiobeta.com/read/csh-synthetic-biology-course-offers-immersive-training https://www.synbiobeta.com/read/ginkgo-bioworks-secures-9-million-in-a-series-a-financing https://www.synbiobeta.com/read/transcriptic-building-the-lab-of-the-future https://www.synbiobeta.com/read/efficient-genome-editing-on-your-desktop https://www.synbiobeta.com/read/review-of-revbios-crowd-funding-campaign https://www.synbiobeta.com/read/the-newest-synbio-leap-fellows https://www.synbiobeta.com/read/the-year-2015-in-synthetic-biology https://www.synbiobeta.com/read/a-quick-look-at-the-first-indiebio-batch https://www.synbiobeta.com/read/pembient-bioengineered-wildlife-products https://www.synbiobeta.com/read/the-lean-launchpad-for-seed-stage-synbio-companies https://www.synbiobeta.com/read/designing-life https://www.synbiobeta.com/read/antha-to-code-experiments-in-biology https://www.synbiobeta.com/read/how-sos-ventures-is-enabling-indie-bio https://www.synbiobeta.com/read/synbiobeta-a-year-in-review-2014 https://www.synbiobeta.com/read/3-technologies-screaming-for-biological-disruption https://www.synbiobeta.com/read/ten-biotech-companies-in-y-combinators-winter-batch https://www.synbiobeta.com/read/a-sneak-peek-into-the-synbiobeta-company-database https://www.synbiobeta.com/read/moo-ve-over-factory-farms-muufri-is-taking-dairy-milk-animal-free https://www.synbiobeta.com/read/5-fabulous-reasons-to-visit-counter-culture-labs https://www.synbiobeta.com/read/what-u-k-companies-are-traveling-5-400-miles-to-synbiobeta-sf-2014 https://www.synbiobeta.com/read/can-asia-become-a-force-in-synthetic-biology https://www.synbiobeta.com/read/is-synthetic-biology-creating-lifeforms-or-artforms https://www.synbiobeta.com/read/opentrons-brings-rapid-prototyping-to-biotech-with-kickstarter-launch https://www.synbiobeta.com/read/5-things-you-need-to-know-about-the-organism-industry https://www.synbiobeta.com/read/synthetic-biology-bags-two-more-presidential-green-chemistry-challenge-awards https://www.synbiobeta.com/read/are-you-ready-for-plants-that-change-color https://www.synbiobeta.com/read/can-oxitec-end-mosquito-borne-diseases-with-genetic-tools https://www.synbiobeta.com/read/j-craig-venter-to-keynote-synbiobeta-sf-2014 https://www.synbiobeta.com/read/the-ls9-update-youve-long-been-waiting-for https://www.synbiobeta.com/read/metabolize-this-silicolife-finding-its-niche https://www.synbiobeta.com/read/y-combinator-welcomes-glowing-plant https://www.synbiobeta.com/read/morph-bioinformatics-cloning-on-your-smartphone https://www.synbiobeta.com/read/what-the-f-is-synthetic-biology https://www.synbiobeta.com/read/emerald-cloud-lab-taking-biotech-to-the-cloud https://www.synbiobeta.com/read/will-synthetic-biology-doom-the-worlds-small-farmers https://www.synbiobeta.com/read/will-the-genome-compiler-and-dna2-0-settlement-bring-relief-to-synthetic-biology-industry https://www.synbiobeta.com/read/5-considerations-for-synthetic-biology-investors https://www.synbiobeta.com/read/dont-get-hung-up-on-gene-synthesis https://www.synbiobeta.com/read/the-synthetic-biology-investors-lament https://www.synbiobeta.com/read/can-crowd-funding-build-a-biological-answer-to-nuclear-waste https://www.synbiobeta.com/read/can-video-games-inspire-the-next-generation-of-biohackers https://www.synbiobeta.com/read/invista-eucodis-bioscience-on-enzymes-collaboration https://www.synbiobeta.com/read/the-best-industrial-microorganism-youve-never-heard-of https://www.synbiobeta.com/read/when-it-comes-to-nature-complexity-isnt-perfection https://www.synbiobeta.com/read/synbiobeta-weekly-wrap-may-30-2014 https://www.synbiobeta.com/read/synbiobeta-interviews-twist-bioscience-ceo-emily-leproust https://www.synbiobeta.com/read/what-ben-horowitz-would-say-about-the-solazyme-delays https://www.synbiobeta.com/read/synthetic-genomics-reawakens-with-pig-lungs-and-algae-whats-next https://www.synbiobeta.com/read/using-programmable-inks-to-build-with-biology-mashing-up-3d-printing-and-biotech https://www.synbiobeta.com/read/the-innovation-gene-ie-is-out-of-the-bottle-lets-wish-for-better-genetic-technologies-and-rules https://www.synbiobeta.com/read/verdezyne-reaches-key-production-milestone https://www.synbiobeta.com/read/progress-builds-momentum-for-sample6 https://www.synbiobeta.com/read/isobutanol-producer-gevo-faced-with-cash-concerns https://www.synbiobeta.com/read/industrys-growing-maturity-on-display-at-synbiobeta-london https://www.synbiobeta.com/read/how-autodesks-project-cyborg-will-revolutionize-synthetic-biology https://www.synbiobeta.com/read/time-for-new-dna-synthesis-and-sequencing-cost-curves https://www.synbiobeta.com/read/3-potential-new-molecules-for-amyris-portfolio-in-2014 https://www.synbiobeta.com/read/scotland-launches-industrial-biotech-plans https://www.synbiobeta.com/read/how-did-the-u-s-bioeconomy-perform-in-2012 https://www.synbiobeta.com/read/welcome-to-the-synbiobeta-blog-activity-hub-for-the-synthetic-biology-industry https://www.synbiobeta.com/read/should-you-be-starting-a-startup https://www.synbiobeta.com/read/betting-on-the-impact-of-synthetic-biology-in-healthcare https://www.synbiobeta.com/events/events-detail/digital-summit-2025 https://www.synbiobeta.com/events/events-detail/accelerating-the-bioeconomy-with-protein-design-cell-free-initiatives https://www.synbiobeta.com/events/events-detail/ai-in-action-synthesizing-the-future-of-drug-discovery-with-sean-mcclain https://www.synbiobeta.com/events/events-detail/al-bto-east https://www.synbiobeta.com/events/events-detail/al-bto-west https://www.synbiobeta.com/events/events-detail/chemicals-materials-digital-conference https://www.synbiobeta.com/events/events-detail/generative-ai-for-protein-design-balancing-risks-with-opportunities https://www.synbiobeta.com/events/events-detail/making-data-and-computation-accessible-to-scientists-with-kyle-giffin https://www.synbiobeta.com/events/events-detail/mycelium-magic-crafting-a-greener-future-with-eben-bayer https://www.synbiobeta.com/events/events-detail/synbiobeta-2023 https://www.synbiobeta.com/events/events-detail/synbiobeta-2023-investment-report https://www.synbiobeta.com/events/events-detail/synbiobeta-2024 https://www.synbiobeta.com/events/events-detail/synbiobeta-2025-the-global-synthetic-biology-conference https://www.synbiobeta.com/events/events-detail/synbiobeta-2026-the-global-synthetic-biology-conference https://www.synbiobeta.com/events/events-detail/synbiobeta-2027-the-global-synthetic-biology-conference https://www.synbiobeta.com/events/events-detail/synbiobetas-annual-synthetic-biology-investment-report-insights-into-what-could-be-in-store-for-24 https://www.synbiobeta.com/events/events-detail/synthetic-biology-in-china-a-synbiobeta-town-hall https://www.synbiobeta.com/events/events-detail/the-brothers-wright-flight-of-human-health-where-will-synbio-take-us-next-with-mark-kotter https://www.synbiobeta.com/events/events-detail/the-inside-track-biodesign https://www.synbiobeta.com/events/events-detail/the-inside-track-desci https://www.synbiobeta.com/events/events-detail/venture-visions-investing-in-the-future-of-synthetic-biology-with-ursheet-parikh-the-synbiobeta-podcast